
<html lang="en"     class="pb-page"  data-request-id="d981b22f-80c3-4011-89db-40baf9815eea"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2018.61.issue-21;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.8b00800;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Discovery of a Potent Grp94 Selective Inhibitor with Anti-Inflammatory Efficacy in a Mouse Model of Ulcerative Colitis" /></meta><meta name="dc.Creator" content="Fen  Jiang" /></meta><meta name="dc.Creator" content="An-ping  Guo" /></meta><meta name="dc.Creator" content="Jia-chen  Xu" /></meta><meta name="dc.Creator" content="Qi-Dong  You" /></meta><meta name="dc.Creator" content="Xiao-Li  Xu" /></meta><meta name="dc.Description" content="As the endoplasmic reticulum paralogue of Hsp90, Grp94 chaperones a small set of client proteins associated with some diseases, including cancer, primary open-angle glaucoma, and inflammatory disor..." /></meta><meta name="Description" content="As the endoplasmic reticulum paralogue of Hsp90, Grp94 chaperones a small set of client proteins associated with some diseases, including cancer, primary open-angle glaucoma, and inflammatory disor..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 15, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b00800" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00800" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b00800" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00800" /></link>
        
    
    

<title>Discovery of a Potent Grp94 Selective Inhibitor with Anti-Inflammatory Efficacy in a Mouse Model of Ulcerative Colitis | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b00800" /></meta><meta property="og:title" content="Discovery of a Potent Grp94 Selective Inhibitor with Anti-Inflammatory Efficacy in a Mouse Model of Ulcerative Colitis" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/large/jm-2018-00800y_0016.jpeg" /></meta><meta property="og:description" content="As the endoplasmic reticulum paralogue of Hsp90, Grp94 chaperones a small set of client proteins associated with some diseases, including cancer, primary open-angle glaucoma, and inflammatory disorders. Grp94-selective inhibition has been a potential therapeutic strategy for these diseases. In this study, inspired by the conclusion that ligand-induced “Phe199 shift” effect is the structural basis of Grp94-selective inhibition, a series of novel Grp94 selective inhibitors incorporating “benzamide” moiety were developed, among which compound 54 manifested the most potent Grp94 inhibitory activity with an IC50 value of 2 nM and over 1000-fold selectivity to Grp94 against Hsp90α. In a DSS-induced mouse model of ulcerative colitis (UC), compound 54 exhibited significant anti-inflammatory efficacy. This work provides a potent Grp94 selective inhibitor as probe compound for the biological study of Grp94 and represents the first study that confirms the potential therapeutic efficacy of Grp94-selective inhibitors against UC." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b00800"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b00800">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b00800&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b00800&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b00800&amp;href=/doi/10.1021/acs.jmedchem.8b00800" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 21</span><span class="cit-fg-pageRange">, 9513-9533</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/21" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b00736" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b00855" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of a Potent Grp94 Selective Inhibitor with Anti-Inflammatory Efficacy in a Mouse Model of Ulcerative Colitis</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Fen Jiang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Fen Jiang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural Medicines and Jiang Su Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China</div><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Fen++Jiang">Fen Jiang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">An-ping Guo</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">An-ping Guo</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural Medicines and Jiang Su Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China</div><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=An-ping++Guo">An-ping Guo</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jia-chen Xu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jia-chen Xu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural Medicines and Jiang Su Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China</div><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jia-chen++Xu">Jia-chen Xu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Qi-Dong You</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Qi-Dong You</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural Medicines and Jiang Su Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China</div><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China</div></div><span class="conrtib-corresp"><strong>*</strong>Q.-D.Y.: phone/fax, +86 025 83271351; e-mail, <a href="/cdn-cgi/l/email-protection#e891879d99818c87868fa88f85898184c68b8785"><span class="__cf_email__" data-cfemail="ea93859f9b838e85848daa8d878b8386c4898587">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Qi-Dong++You">Qi-Dong You</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8587-0122" title="Orcid link">http://orcid.org/0000-0002-8587-0122</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Xiao-Li Xu</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xiao-Li Xu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural Medicines and Jiang Su Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China</div><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China</div></div><span class="conrtib-corresp"><strong>*</strong>X.-L.X.: phone/fax, +86 025 83271216; e-mail, <a href="/cdn-cgi/l/email-protection#7a020f02131b152516133a4b484c54191517"><span class="__cf_email__" data-cfemail="b2cac7cadbd3ddeddedbf28380849cd1dddf">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xiao-Li++Xu">Xiao-Li Xu</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00800&amp;href=/doi/10.1021%2Facs.jmedchem.8b00800" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 21</span><span class="cit-pageRange">, 9513–9533</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 15, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>19 May 2018</li><li><span class="item_label"><b>Published</b> online</span>15 October 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 November 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b00800" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00800</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D9513%26pageCount%3D21%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DFen%2BJiang%252C%2BAn-ping%2BGuo%252C%2BJia-chen%2BXu%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D21%26contentID%3Dacs.jmedchem.8b00800%26title%3DDiscovery%2Bof%2Ba%2BPotent%2BGrp94%2BSelective%2BInhibitor%2Bwith%2BAnti-Inflammatory%2BEfficacy%2Bin%2Ba%2BMouse%2BModel%2Bof%2BUlcerative%2BColitis%26numPages%3D21%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D9533%26publicationDate%3DNovember%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b00800"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2356</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">9</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b00800" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of a Potent Grp94 Selective Inhibitor with Anti-Inflammatory Efficacy in a Mouse Model of Ulcerative Colitis&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Fen&quot;,&quot;last_name&quot;:&quot;Jiang&quot;},{&quot;first_name&quot;:&quot;An-ping&quot;,&quot;last_name&quot;:&quot;Guo&quot;},{&quot;first_name&quot;:&quot;Jia-chen&quot;,&quot;last_name&quot;:&quot;Xu&quot;},{&quot;first_name&quot;:&quot;Qi-Dong&quot;,&quot;last_name&quot;:&quot;You&quot;},{&quot;first_name&quot;:&quot;Xiao-Li&quot;,&quot;last_name&quot;:&quot;Xu&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;15&quot;,&quot;issue&quot;:&quot;21&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;9513-9533&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b00800&quot;},&quot;abstract&quot;:&quot;As the endoplasmic reticulum paralogue of Hsp90, Grp94 chaperones a small set of client proteins associated with some diseases, including cancer, primary open-angle glaucoma, and inflammatory disorders. Grp94-selective inhibition has been a potential therapeutic strategy for these diseases. In this study, inspired by the conclusion that ligand-induced “Phe199 shift” effect is the structural basis of Grp94-selective inhibition, a series of novel Grp94 selective inhibitors incorporating “benzamide” moiety were developed, among which compound 54 manifested the most potent Grp94 inhibitory activity with an IC50 value of 2 nM and over 1000-fold selectivity to Grp94 against Hsp90α. In a DSS-induced mouse model of ulcerative colitis (UC), compound 54 exhibited significant anti-inflammatory efficacy. This work provides a potent Grp94 selective inhibitor as probe compound for the biological study of Grp94 and represents the first study that confirms the potential therapeutic efficacy of Grp94-selective inhibitors agai&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00800&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00800" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00800&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00800" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00800&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00800" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00800&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00800&amp;href=/doi/10.1021/acs.jmedchem.8b00800" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b00800" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b00800" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (12 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00800&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b00800%26sid%3Dliteratum%253Aachs%26pmid%3D30351001%26genre%3Darticle%26aulast%3DJiang%26date%3D2018%26atitle%3DDiscovery%2Bof%2Ba%2BPotent%2BGrp94%2BSelective%2BInhibitor%2Bwith%2BAnti-Inflammatory%2BEfficacy%2Bin%2Ba%2BMouse%2BModel%2Bof%2BUlcerative%2BColitis%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D21%26spage%3D9513%26epage%3D9533%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (3)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=290978" title="Luminescence">Luminescence</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/21" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/jmcmar.2018.61.issue-21/20181108/jmcmar.2018.61.issue-21.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/medium/jm-2018-00800y_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/large/jm-2018-00800y_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00800&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">As the endoplasmic reticulum paralogue of Hsp90, Grp94 chaperones a small set of client proteins associated with some diseases, including cancer, primary open-angle glaucoma, and inflammatory disorders. Grp94-selective inhibition has been a potential therapeutic strategy for these diseases. In this study, inspired by the conclusion that ligand-induced “Phe199 shift” effect is the structural basis of Grp94-selective inhibition, a series of novel Grp94 selective inhibitors incorporating “benzamide” moiety were developed, among which compound <b>54</b> manifested the most potent Grp94 inhibitory activity with an IC<sub>50</sub> value of 2 nM and over 1000-fold selectivity to Grp94 against Hsp90α. In a DSS-induced mouse model of ulcerative colitis (UC), compound <b>54</b> exhibited significant anti-inflammatory efficacy. This work provides a potent Grp94 selective inhibitor as probe compound for the biological study of Grp94 and represents the first study that confirms the potential therapeutic efficacy of Grp94-selective inhibitors against UC.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64156" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64156" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">As an important family of molecular chaperones, heat shock proteins 90 (Hsp90s) are crucial for the correct folding, stability, and function of a wide range of client proteins.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> Hsp90s in higher eukaryotes include four isoforms: Hsp90α and Hsp90β in cytoplasm, glucose-regulated protein 94 (Grp94) in endoplasmic reticulum (ER), and tumor necrosis factor receptor-associated protein-1 (Trap1) in mitochondria, which have specific biological functions and chaperone different client proteins.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> More than 500 client proteins of Hsp90s have been discovered, and many of them are involved in the initiation and progression of certain diseases.<a onclick="showRef(event, 'ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5">(3−5)</a> Inhibiting the chaperone function of Hsp90s can induce the degradation of disease-related client proteins and then block disease-dependent signaling pathways.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Thus, Hsp90 has emerged as an attractive target.<a onclick="showRef(event, 'ref7 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9">(7−9)</a> To date, many Hsp90 inhibitors have entered clinical trials for the treatment of cancer.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> However, these inhibitors suffer from prevalent adverse effects (ocular toxicity, gastrointestinal disorders, etc.), which have seriously limited their clinical development.<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11,12)</a> The adverse effects are partially due to the pan-Hsp90 inhibitory activity. The indiscriminate inhibition effects of the four isoforms destabilize a large number of client proteins and may lead to the various clinical adverse effects.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Compared with the pan-Hsp90 inhibitors, isoform-selective inhibitors only affect the isoform-specific clients, endowing them with more favorable safety profiles and more clinical potential.<a onclick="showRef(event, 'ref3 ref13 ref14 ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref3 ref13 ref14 ref15 ref16 ref17">(3,13−17)</a> Recently, the development of Hsp90 isoform-selective inhibitors has attracted more attention.</div><div class="NLM_p">As the ER paralogue of Hsp90, Grp94 chaperones a small set of client proteins, most of which are cell surface or secretory proteins, including integrins, Toll-like receptors (TLRs), insulin-like growth factors (IGFs), Her2, and Wnt coreceptor LRP6.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> The promoting effects of Grp94 and its client proteins on some types of cancer and primary open-angle glaucoma (POAG) have been revealed.<a onclick="showRef(event, 'ref19 ref20 ref21 ref22 ref23 ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref19 ref20 ref21 ref22 ref23 ref24 ref25">(19−25)</a> As potential therapeutic agents for these diseases, Grp94-selective inhibitors have been pursued by medicinal chemists in recent years. Despite the high sequence and structural homology among the four Hsp90 isoforms, the 5-amino acid (QEDGQ) insertion of Grp94 leads to the presence of Grp94-specific hydrophobic pockets site 2 and site 3, which can be utilized in the design of Grp94-selective inhibitors.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a></div><div class="NLM_p">To date, three classes of Grp94-selective inhibitors have been developed (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). The purine (PU)-class compound NECA (<b>1</b>) was the first identified Grp94-selective inhibitor, which bound to Grp94 with a <i>K</i><sub>d</sub> value of 0.2 μM without exhibiting affinity for cytoplasmic Hsp90α/β.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The Grp94 selectivity of compound <b>1</b> could be attributed to the occupation of the Grp94-specific site 3 pocket by the <i>N</i>-ethyl moiety.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Because of the off-target adenosine receptor-activating effect, further study of compound <b>1</b> was limited. Compound library screening by the group of Gabriela Chiosis identified another PU-based compound, PU-H54(<b>2</b>), featuring moderate Grp94-selective inhibitory activity over Hsp90α. Structural analysis revealed that Grp94 could adopt a ligand-induced conformation rearrangement to expose an isoform-unique site 2 hydrophobic pocket. The favored occupation of this newly exposed site 2 pocket resulted in the Grp94 selectivity of compound <b>2</b>.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Further structural modification led to PU-WS13 (<b>3</b>), which exhibited improved Grp94 inhibitory activity (FP IC<sub>50</sub>: 0.22 μM) and selectivity (over 120-fold).<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> The excellent works by Gabriela Chiosis’s group suggest that the ligand-induced site 2 pocket can be utilized in the design of Grp94-selective inhibitors. On the basis of the <i>cis</i>-amide binding pose of radamide (RDA, <b>4</b>), Brian S. J. Blagg’s group developed resorcinol-based Grp94-selective inhibitors. Replacing the amide linkage of compound <b>4</b> with the <i>cis</i>-amide bioisostere imidazole led to BnIm (<b>5</b>) possessing 12-fold selectivity for Grp94 over Hsp90α (FP IC<sub>50</sub>: 1.1 μM vs 13.1 μM).<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30,31)</a> The hydrophobic benzyl moiety of compound <b>5</b> was predicted to be inserted into the same pocket (site 3) occupied by the <i>N</i>-ethyl moiety of compound <b>1</b>. Structural modification focused on the benzyl moiety of compound <b>5</b> resulted in the 2-ethoxy substituted KUNG29 (<b>6</b>), which exhibited significantly improved Grp94 inhibition activity (FP IC<sub>50</sub>: 0.2 μM) and selectivity (41-fold).<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> The structure of <b>6</b> soaked into apo-Grp94 crystal was recently determined and interpreted as placing the 2-ethoxybenzyl moiety into the site 3 pocket.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Modification of the imidazole group into a phenyl ring and further SAR explorations gave compound <b>7</b>, which exhibited 73-fold selectivity for Grp94.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Recently, the work of Daniel T. Gewirth’s group reported the accurate binding data of compound <b>5</b> measured by ITC as shown in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a> (<i>K</i><sub>d</sub>: Grp94 vs Hsp90α, 1.38 μM vs 0.62 μM). Additionally, the solved cocrystal structure of <b>5</b>:Grp94 complex revealed a quite different binding mode from previous interpretations. When <b>5</b> was bound to Grp94, the resorcinol moiety was flipped by 180° and adopted a “chloro-out” conformation. The methyl ester group moved the Phe199 residue away and sat in the mouth of the newly exposed site 2 pocket. This Phe199 shift effect was demonstrated to result in the Grp94-selective inhibitory activity. Replacing the 3-chloro substituent with another methyl ester group afforded the bis-methyl ester-containing compound <b>8</b>, which exhibited excellent Grp94 selectivity with a 4.2 μM Grp94 affinity (ITC <i>K</i><sub>d</sub>) and no detectable Hsp90α binding.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Compound <b>8</b> can serve as a lead compound for further optimization to improve the Grp94 inhibitory activity. KUNG94 (<b>9</b>) is another resorcinol-based Grp94-selective inhibitor. Despite its potent Grp94 inhibition (FP IC<sub>50</sub> = 8 nM), further application of <b>9</b> is limited because of the remaining potent Hsp90α affinity (FP IC<sub>50</sub> = 77 nM).<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> The benzamide-containing Grp94-selective inhibitor ACO1 (<b>10</b>) was developed by Brian S. J. Blagg’s group using structure-based design strategies. The hydroxyl-substituted benzyl moiety was introduced to occupy the Grp94-specific site 2 pocket. Compound <b>10</b> demonstrated an IC<sub>50</sub> of 0.44 μM for Grp94 and greater than 200-fold selectivity over Hsp90α.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> The potential efficacy of these Grp94-selective inhibitors against cancer and POAG has been confirmed.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/medium/jm-2018-00800y_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/large/jm-2018-00800y_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures and selectivity profiles of the reported Grp94-selective inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/large/jm-2018-00800y_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00800&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In addition to cancer and POAG, Grp94 is also extensively involved in intestinal inflammation.<a onclick="showRef(event, 'ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref38 ref39">(38,39)</a> Ulcerative colitis (UC) is a chronic intestinal inflammatory disease that may result from sustained stimulation of the mucosal immune system by endogenous luminal microbes in susceptible hosts.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Grp94 has been reported to play multifaceted roles in the development of UC. Zihai Li’s group revealed that Grp94 was essential for maintaining gut homeostasis through direct regulation of the canonical Wnt signaling pathway. Conditional Grp94 knockout (KO) mice and intestinal tissue-specific Grp94 KO mice suffered from serious intestinal lesions.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Another recent study by the same group demonstrated that Grp94 was essential for CD11c<sup>+</sup> cells to induce regulatory T cells and maintain gut homeostasis. CD11c<sup>+</sup> cell-specific Grp94-deficient mice developed spontaneous colitis and were highly susceptible to dextran sulfate sodium (DSS) induced colitis.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> The above results suggested that Grp94 has beneficial roles in maintaining gut homeostasis. However, in another study, macrophage-specific Grp94 KO mice were more resistant to DSS-induced colitis, indicating that Grp94 has harmful roles in exacerbating intestinal inflammation.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Additionally, as the client proteins of Grp94, pattern recognition receptor TLRs expressed in epithelial cells and immune cells are crucial for the recognition of invading bacteria and activation of intestinal immune responses. Considering that Grp94 and TLRs are upregulated in UC patients, Grp94 may have some promoting effects on the inflammatory conditions of UC.<a onclick="showRef(event, 'ref44 ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref44 ref45 ref46">(44−46)</a> Inhibiting the chaperone function of Grp94 can reduce the TLRs’ expression in the intestinal mucosa, which may block the bacteria-stimulated immune responses and then ameliorate the inflammatory symptoms of UC. In general, the comprehensive biological roles of Grp94 in the pathogenesis of UC are still unclear, and the potential therapeutic efficacy of Grp94 selective inhibitors against UC has not been explored.</div><div class="NLM_p last">The currently developed Grp94-selective inhibitors can serve as useful chemical tools for Grp94 study. However, their activity or selectivity is still not high enough. We believe that more potent and selective inhibitors would be more useful. Here, we report the discovery of a potent and selective Grp94 inhibitor and its anti-inflammatory efficacy in a DSS-induced mouse model of UC.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22450" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22450" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Compounds <b>42</b>–<b>70</b> were synthesized according to <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Briefly, commercial reagent <b>12</b> was coupled with various aryl iodides or aryl bromides in dioxane using Pd(PPh<sub>3</sub>)<sub>4</sub> as the catalyst and Cs<sub>2</sub>CO<sub>3</sub> as the base to generate intermediates <b>13</b>–<b>41</b>. Then, the intermediates were reacted with <i>trans</i>-4-aminocyclohexanol in the presence of DIPEA in DMSO at 120 °C for 24 h. Subsequently, the cyano group was hydrolyzed into a carbamoyl moiety in a mixture of ethanol, 1 M NaOH, and 30% H<sub>2</sub>O<sub>2</sub> to afford the desired compounds.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/medium/jm-2018-00800y_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/large/jm-2018-00800y_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Route for Compounds <b>42</b>–<b>70</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/large/jm-2018-00800y_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00800&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) aryl iodide or aryl bromide, Pd(PPh<sub>3</sub>)<sub>4</sub>, Cs<sub>2</sub>CO<sub>3</sub>, dioxane, 90 °C, overnight; (b) <i>trans</i>-4-aminocyclohexanol, DIPEA, DMSO, 120 °C, 24 h; (c) ethanol, 1 M NaOH, 30% H<sub>2</sub>O<sub>2</sub>, 30 °C, overnight.</p></p></figure><div class="NLM_p">Compounds <b>71</b>–<b>86</b> were synthesized according to <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. Intermediate <b>25</b> was reacted with different amines in the presence of DIPEA in DMSO at 120 °C for 24 h, and then the cyano group hydrolyzed into a carbamoyl moiety to afford compounds <b>71</b>–<b>78</b>. Intermediate <b>25</b> was reacted with 4-amino-1-Boc-piperidine, followed by hydrolysis of the cyano group and removal of the Boc protecting group to give compound <b>79</b>. For compounds <b>80</b>–<b>86</b> featuring amino acid side chains, <b>79</b> was condensed with different Boc-protected amino acids using Bop as a coupling agent, and then the Boc protecting group was removed to yield the desired compounds.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/medium/jm-2018-00800y_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/large/jm-2018-00800y_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Route for Compounds <b>71</b>–<b>86</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/large/jm-2018-00800y_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00800&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) different amines, DIPEA, 120 °C, 24 h; (b) 4-amino-1-Boc-piperidine, DIPEA, 120 °C, 24 h; (c) ethanol, 1 M NaOH, 30% H<sub>2</sub>O<sub>2</sub>, 30 °C, overnight; (d) TFA, DCM, rt, 48 h; (e) different Boc-protected amino acids, BOP, DIPEA, DMF, rt, 5 h; (f) TFA, DCM, rt, 36 h.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63444" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63444" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Structure-Based Design of Lead Compound <b>42</b></h3><div class="NLM_p">To discover novel Grp94-selective inhibitors, we should determine how a compound can discriminate between different Hsp90 isoforms to achieve Grp94-selective inhibition. The research of Gabriela Chiosis’s group provides us some structural insights.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> When bound to Hsp90α (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A, referred to as “binding mode A”, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3O0I">3O0I</a>), compound <b>2</b> adopts a “forward bent” conformation, the 8-aryl group inserts into the site 1 hydrophobic pocket, and the Phe138 residue adopts a “plane” conformation. When bound to Grp94 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B, referred to as “binding mode B”, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3O2F">3O2F</a>), compound <b>2</b> adopts a “backwards bent” conformation, the 8-aryl group inserts into the newly exposed site 2 hydrophobic pocket, and the Phe199 residue (equivalent to Phe138 in Hsp90α) adopts an “oblique” conformation. In contrast, in the Apo-Grp94 ATP-binding pocket (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>C, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1YT2">1YT2</a>), Phe199 adopts the same “plane” conformation as the Phe138 in the <b>2</b>:Hsp90α complex. Superposition of the crystal structures clearly reveals that Phe199 in the <b>2</b>:Grp94 complex shifts to some degree compared with Phe199 in Apo-Grp94 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>D). This ligand-induced “Phe199 shift” effect leads to the conformational change in Grp94 and exposure of the Grp94-specific site 2 hydrophobic pocket. On the basis of these analyses, we conclude that the ligand-induced “Phe199 shift” effect is the structural basis of Grp94-selective inhibition. This conclusion has recently been confirmed by Daniel T. Gewirth’s group via the cocrystallization method.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Compound <b>2</b> and further optimized compound <b>3</b> selectively bind to Grp94 by means of conformational changes in both the compounds and protein. Therefore, the Grp94 selectivity profiles are dependent on the conformation that the compounds prefer to adopt when bind to Grp94. We hypothesize that compounds incorporating rigid moieties to induce the “Phe199 shift” should possess more favorable Grp94 selectivity.</div><figure id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/medium/jm-2018-00800y_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/large/jm-2018-00800y_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structural basis of the Grp94-selective inhibitory activity of PU-class compounds. (A) Compound <b>2</b> adopts “binding mode A” to bind with Hsp90α (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3O0I">3O0I</a>). Phe138 is shown as a pink stick. (B) Compound <b>2</b> adopts “binding mode B” to bind with Grp94 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3O2F">3O2F</a>). Phe199 is shown as a gray stick. (C) ATP binding pocket of Apo-Grp94<sup>N</sup> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1YT2">1YT2</a>). Phe199 is shown in blue stick. (D) Superimposition of the <b>2</b>:Grp94 complex and Apo-Grp94<sup>N</sup>. The “Phe199 shift” effect is indicated by a small magenta arrow, and the conformational change in Grp94 (H5 helix rearrangement) is indicated by a large magenta arrow.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/large/jm-2018-00800y_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00800&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">By comparing the three kinds of fragments that interact with the Asp149 and Thr245 residues in the Grp94 ATP-binding pocket, we find that the benzamide fragment is suitable as the starting point for the design of Grp94-selective inhibitors. The benzene ring provides an appropriate position for the introduction of rigid moieties. SNX0723(<b>11</b>) is a benzamide Hsp90 inhibitor that binds with Grp94 via “binding mode A” (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4NH9">4NH9</a>), in which the Phe199 residue adopts a “plane” conformation (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A). Superposition of the <b>11</b>:Grp94 complex and <b>2</b>:Grp94 complex clearly reveals that the meta position to the carbamoyl group (3-position, numbered according to compound <b>11</b>), which points toward Phe199, is ideal for the introduction of rigid moieties to induce the “Phe199 shift” (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B). Considering the strictly hydrophobic property of the induced site 2 pocket, a rigid and hydrophobic phenyl ring B was introduced. We expected that phenyl ring B could induce the “Phe199 shift” and occupy the newly exposed site 2 hydrophobic pocket. These efforts led to the design of compound <b>42</b>, the Grp94 and Hsp90α inhibitory activity of which was determined. Encouragingly, compound <b>42</b> had moderate Grp94 inhibitory activity with an IC<sub>50</sub> value of 2.77 μM without exhibiting obvious Hsp90α inhibition at 100 μM, indicating a favorable Grp94 selectivity profile.</div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/medium/jm-2018-00800y_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/large/jm-2018-00800y_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Design strategies for Grp94-selective inhibitors. (A) Benzamide Hsp90 inhibitor <b>11</b> adopts “binding mode A” to bind with Grp94 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4NH9">4NH9</a>). Compound <b>11</b> is shown as a pink stick. (B) Superposition of the <b>11</b>:Grp94 complex and <b>2</b>:Grp94 complex. Compound <b>2</b> is shown as a yellow stick, the meta position to the carbamoyl group in <b>11</b> is indicated by a red arrow, and the “Phe199 shift” is indicated by a magenta arrow. (C) Predicted binding mode of compound <b>42</b>. Compound <b>42</b> and the residues in the Grp94 active site are shown as green and gray sticks, respectively. Conserved water molecules are shown as red spheres, and H-bonds are indicated by magenta dashed lines. (D) Superimposition of the <b>42</b>:Grp94 complex and <b>2</b>:Grp94 complex.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/large/jm-2018-00800y_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00800&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Compound <b>42</b> docked well into the Grp94 ATP-binding pocket (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>C). The carbamoyl group formed tight H-bonds with Asp149, Thr245, and two conserved water molecules. These key H-bond interactions anchored <b>42</b> into the ATP-binding pocket. The hydroxyl group on the <i>trans</i>-aminocyclohexanol moiety formed another H-bond with the Lys114 residue. The newly introduced phenyl ring B inserted into the site 2 pocket and formed hydrophobic interactions with the surrounding residues. The superposition of compound <b>42</b> and compound <b>2</b> in the Grp94 ATP-binding pocket showed that phenyl ring B of compound <b>42</b> was well overlapped with the 8-aryl group of compound <b>2</b>.</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Modification of the Phenyl B</h3><div class="NLM_p">Compound <b>42</b> is a promising lead compound for further optimization, as it possesses favorable Grp94-selective inhibitory activity (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) and ligand efficiency (0.33). Docking analysis reveals that phenyl ring B in <b>42</b> does not fully occupy the deep site 2 pocket and that hydrophobic moieties can be introduced to fit the pocket more snugly to improve the Grp94 affinity. In addition, substituents on phenyl ring B may modulate the dihedral angle between the two benzene rings and then generate some influence on the Grp94-selective inhibitory activity. Considering the above two factors, we conducted structure modification of <b>42</b> focused on the phenyl B.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Grp94 Inhibitory Activity of Compounds <b>42</b>–<b>70</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/medium/jm-2018-00800y_0012.gif" alt="" id="GRAPHIC-d7e833-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/medium/jm-2018-00800y_0013.gif" alt="" id="gr12" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Values shown are the mean ± SD (<i>n</i> = 3). All compounds exhibited no Hsp90α inhibition at 100 μM (data not shown). Pan-Hsp90 inhibitors AT13387 and SNX-2112, which were selected as positive controls, have Hsp90 inhibitory activities (IC<sub>50</sub>) of 0.022 μM and 0.034 μM, respectively.</p></div></div><div></div></div><div class="NLM_p">Various single hydrophobic substituents (methyl, chlorine, methoxy, ethyl) were introduced at the 2′-, 3′-, 4′-position of phenyl B, leading to compounds <b>43</b>–<b>53</b>. For the 2′- and 3′-position, the methyl (<b>43</b>, <b>44</b>), chlorine (<b>46</b>, <b>47</b>), and ethyl (<b>52</b>) substituted compounds exhibited retained or moderately improved Grp94 inhibitory activity. In contrast, methoxy-substituted compounds <b>49</b> and <b>50</b> exhibited obviously decreased Grp94 inhibition, possibly due to the presence of the hydrophilic oxygen atoms, which were detrimental to the hydrophobic interactions with the site 2 pocket. Compared with their 2′- or 3′-substituted analogues, the 4′-substituted compounds (<b>45</b>, <b>48</b>, <b>51</b>, <b>53</b>) displayed significantly improved Grp94 inhibitory activity, especially ethyl substituted <b>53</b>, which had an IC<sub>50</sub> value of 7 nM. For a given substituent, the Grp94-selective inhibition displayed a trend of 4′-subtituted > 3′-subtituted > 2′-subtituted. The above results indicated that hydrophobic substituents at the 4′-position were favorable for Grp94 inhibition. This finding was coincident with the docking analysis, which indicated that the 4′-position pointed toward the hydrophobic bottom of the site 2 pocket and that hydrophobic substituents could form additional hydrophobic interactions with the surrounding residues. Inspired by the above SARs, we introduced several other larger hydrophobic substituents (isopropyl, propyl, <i>tert</i>-butyl, ethoxy) to afford compounds <b>54</b>–<b>57</b>. The 4′-isopropyl-substituted compound (<b>54</b>) exhibited further improved Grp94 inhibition compared with ethyl-substituted <b>53</b>, providing an IC<sub>50</sub> value of 2 nM. Compounds incorporating propyl (<b>55</b>), <i>tert</i>-butyl (<b>56</b>), and ethoxy (<b>57</b>) groups, however, were less potent. These results revealed that among the monosubstituted compounds, the 4′-isopropyl group was the most favorable substituent.</div><div class="NLM_p">We next expanded the scope of our investigations to explore the SARs of disubstituted and trisubstituted compounds. The 2′,3′-, 2′,4′-, 2′,6′-, and 3′,4′-dimethyl-substituted compounds (<b>58</b>–<b>61</b>) and 2′,4′,6′-trimethyl-substituted <b>63</b> exhibited 2- to 6-fold improvements in activity compared with lead compound <b>42</b>. Additionally, the 2′,3′-, 2′,6′-, and 3′,4′-dichloro compounds (<b>64</b>–<b>66</b>) displayed better activity than the corresponding dimethyl-substituted compounds (<b>64</b> vs <b>58</b>, <b>65</b> vs <b>60</b>, <b>66</b> vs <b>61</b>), indicating that dichloro substitutions at these positions were more favorable than dimethyl substitutions. However, the 3′,5′-dimethyl (<b>62</b>) and 3′,5′-dichloro (<b>67</b>) compounds exhibited dramatically decreased activity, which was most likely caused by steric interference with the surrounding residues.</div><div class="NLM_p">To further explore the volume and plasticity of the site 2 pocket, phenyl ring B was replaced by larger moieties. The Grp94 inhibitory activity of 1-naphthyl-substituted compound <b>68</b> sharply dropped to zero, while the 2-naphthyl compound <b>69</b> exhibited ∼5-fold decreased activity. Introducing another aryl (pyrrolyl) at the 4′-position led to compound <b>70</b>, which exhibited no Grp94 inhibition. These results revealed that site 2 pocket had limited volume and moiety tolerance.</div><div class="NLM_p last">All the above-mentioned compounds exhibited no Hsp90α inhibitory activity at 100 μM, indicating excellent Grp94 selectivity of the biphenyl structure. In general, through structure modification focused on phenyl ring B, we obtained compound <b>54</b> featuring a 4′-isopropyl group as the most potent Grp94-selective inhibitor. Additionally, the SARs of phenyl ring B matched the hydrophobic property of the site 2 pocket, which confirmed the rationality of our design strategy.</div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Binding Mode Analysis of Compound <b>54</b></h3><div class="NLM_p">The binding mode of compound <b>54</b> was analyzed by molecular docking methods. As shown in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>, compound <b>54</b> fitted well into the Grp94 ATP-binding pocket snugly (the protein structure of Grp94 was extracted from PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3O2F">3O2F</a>). Direct and water-mediated H-bonds were formed between the carbamoyl moiety and Asp149, Thr245. The hydroxyl group on the <i>trans</i>-aminocyclohexanol moiety formed another H-bond with the Lys114 residue. The 4′-isopropyl-substituted phenyl ring B tightly occupied the hydrophobic site 2 pocket. Compared with lead compound <b>42</b>, compound <b>54</b> inserted the newly introduced 4′-isopropyl group into the bottom of site 2 pocket and formed additional hydrophobic interactions with the Leu104, Phe199, Ala202, Phe203, Val209, and Leu249 residues. These additional hydrophobic interactions contributed to the potent Grp94 inhibitory activity of compound <b>54</b>.</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/medium/jm-2018-00800y_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/large/jm-2018-00800y_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Predicted binding mode of compound <b>54</b>. The protein structure of Grp94 was extracted from PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3O2F">3O2F</a>. Active site of Grp94 is surfaced in the hydrophobic state, and compound <b>54</b> and the surrounded residues are shown as green and gray sticks, respectively. Conserved water molecules are shown as red spheres, and H-bonds are indicated by magenta dashed lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/large/jm-2018-00800y_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00800&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> SAR Study of the 4-Position Amino Side Chains (R Position)</h3><div class="NLM_p">We next focused our attention on the 4-position of benzene ring A. Docking analysis (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>) showed that the 4-position directed into a pocket formed by both hydrophobic residues (Ala111, Val152, Met154, Leu191, Phe195) and polar residues (Lys114, Glu158, Asn162), indicating that substituents at this position should have some influence on Grp94 inhibitory activity and selectivity. In the discovery of benzamide Hsp90 inhibitors, amino side chains were demonstrated as favorable substituents for the same position.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> To explore the SARs of the 4-position for Grp94, various amino side chains were introduced to afford compounds <b>71</b>–<b>86</b>.</div><div class="NLM_p">Compound <b>71</b> without a hydroxyl group displayed seriously reduced Grp94 inhibitory activity, suggesting that the H-bond between the hydroxyl group and Lys114 was important (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). The isobutylamine analogue (<b>72</b>) and cyclopentylamine analogue (<b>73</b>) were even less potent than <b>71</b>. Moreover, the cyclohexylmethanamine analogue (<b>74</b>) exhibited no Grp94 inhibition. Compared with the above-mentioned compounds, H-bond acceptor-bearing analogues <b>75</b>–<b>78</b> exhibited improved activity, especially compounds <b>77</b> and <b>78</b>, which featured six-membered ring side chains. The oxygen atom or carbonyl group in the side chains could form H-bonds with the Lys114 or Glu158 residue. Compound <b>79</b> without an acetyl group exhibited reduced activity compared with compound <b>78</b>, confirming the importance of the H-bond acceptor. The above results indicated that H-bond acceptor-bearing six-membered ring side chains were favorable substituents for the 4-position. Various amino acids were then introduced on the piperidine NH of compound <b>79</b> while maintaining the carbonyl group as an H-bond acceptor to afford compounds <b>80</b>–<b>86</b>. Among them, compounds <b>80</b>, <b>82</b>, and <b>86</b> bearing linear amino acids had Grp94 inhibitory activity in the range from 150 nM to 220 nM, while the α-position substituted analogues (<b>81</b>, <b>83</b>–<b>85</b>) were less potent. Compounds <b>71</b>–<b>86</b> also exhibited no Hsp90α inhibitory activity at 100 μM. Taken together, the results of these extensive investigations revealed the SARs of the 4-position and demonstrated the importance of H-bond acceptors on the amino side chains.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Grp94 Inhibitory Activity of Compounds <b>71</b>–<b>86</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/medium/jm-2018-00800y_0014.gif" alt="" id="GRAPHIC-d7e1142-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/medium/jm-2018-00800y_0015.gif" alt="" id="gr13" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Values shown are the mean ± SD (<i>n</i> = 3). All compounds exhibit no Hsp 90α inhibition at 100 μM.</p></div></div><div></div></div><div class="NLM_p">In the above discovery process, compound <b>54</b> was established as the most potent Grp94 inhibitor with an IC<sub>50</sub> value of 2 nM in an FP assay. Additionally, <b>54</b> exhibited no obvious Hsp90α inhibition at 100 μM, indicating significant Grp94 selectivity (the inhibition curves are shown in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A). The remarkable Grp94 affinity and selectivity of compound <b>54</b> was further evaluated by using BLI assay. As shown in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B,C, compound <b>54</b> bound to Grp94 and Hsp90α with <i>K</i><sub>D</sub> values of 19.6 nM and 20.6 μM, respectively. These results confirmed the more than 1000-fold selectivity of <b>54</b> to Grp94 over Hsp90α. Considering that FP assay is a probe competitive binding method and the IC<sub>50</sub> values determined are partially dependent on the intrinsic affinity of the fluorescent probe to the two isoforms, it is reasonable that no Hsp90 inhibition was detected for compound <b>54</b> in the FP assay.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> In general, compound <b>54</b> exhibited excellent Grp94 selectivity in both FP assay and BLI assay, and the selectivity profile is high enough for it as a probe to study the Grp94-specific biological functions. Additionally, in NMR-based Carr–Purcell–Meiboom–Gill (CPMG) experiment, the NMR signals of compound <b>54</b> were dose-dependently attenuated after Grp94<sup>N</sup> protein was added, which indicated the interaction between compound <b>54</b> and Grp94.</div><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/medium/jm-2018-00800y_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/large/jm-2018-00800y_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Selectivity of compound <b>54</b> to Grp94 and Hsp90α. (A) Inhibition curves of compound <b>54</b> to inhibit Grp94 and Hsp90α. The mP values for negative control and blank control in the determination of Hsp90α are 428 and 318, respectively. The results are shown as the mean ± SD, <i>n</i> = 3. (B) BLI dose–response curves reflecting the direct binding of <b>54</b> to Grp94. (C) BLI dose–response curves reflecting the direct binding of <b>54</b> to Hsp90α. (D) NMR-based CPMG determination of direct binding of <b>54</b> to Grp94. NMR spectra of <b>54</b> at different concentrations of Grp94<sup>N</sup> are shown in different colors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/large/jm-2018-00800y_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00800&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Molecular Dynamics (MD) Simulation To Analyze the Structural Basis of Grp94 Selectivity</h3><div class="NLM_p">As mentioned above, Grp94 isoform-selective binding is a dynamic process that involves a “Phe199 shift” and conformational changes in the Grp94 protein. To further understand this dynamic process and confirm the structural basis of the Grp94 isoform selectivity of our compounds, MD simulation was conducted. In ligand-free Apo-Grp94<sup>N</sup> (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A), Phe199 adopts a “plane” conformation, while in compound <b>2</b>-bound Grp94<sup>N</sup> (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>D), Phe199 adopts an “oblique” conformation. After compound <b>2</b> was removed from Grp94<sup>N</sup>, a 20 ns MD simulation was performed (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B,C). The results revealed that the Phe199 returned to the “plane” conformation, similar to the Phe199 in Apo-Grp94<sup>N</sup>, indicating that the “plane” conformation was favored for Phe199 in ligand-free Grp94<sup>N</sup>. Meanwhile, the <b>54</b>:Grp94<sup>N</sup> docking complex was also subjected to a 20 ns MD simulation. In the resultant complex (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>E,F), the Phe199 residue still remained in the “oblique” conformation, which was well overlapped with Phe199 in the <b>2</b>:Grp94<sup>N</sup> complex. In general, these MD simulation results helped us understand that the ligand-induced “Phe199 shift” effect was the structural basis of Grp94-selective inhibition.</div><figure id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/medium/jm-2018-00800y_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/large/jm-2018-00800y_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. MD simulation to analyze the structural basis of Grp94-selective inhibition. (A) ATP binding pocket of Apo-Grp94<sup>N</sup> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1YT2">1YT2</a>), Phe199 is shown in blue stick. (B) MD simulation results (20 ns) of the compound <b>2</b> removed Grp94<sup>N</sup> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3O2F">3O2F</a>). Phe199 is shown in gray stick. (C) Superimposition of (A) and (B). (D) ATP binding pocket of compound <b>2</b> bound Grp94<sup>N</sup> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3O2F">3O2F</a>). Phe199 and compound <b>2</b> are shown in green and yellow sticks, respectively. (E) MD simulation results (20 ns) of the <b>54</b>:Grp94<sup>N</sup> docking complex. Phe199 and compound <b>54</b> are shown in pink and navy blue sticks, respectively. (F) Superimposition of (D) and (E).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/large/jm-2018-00800y_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00800&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Confirming the Grp94-Selective Inhibitory Activity of Compound <b>54</b> in Cells</h3><div class="NLM_p">Grp94-specific clients include a subset of integrin subunits such as integrin α2 and integrin αL. Their maturation and trafficking to the cell surface are dependent on the Grp94 chaperone function but have no association with cytoplasmic Hsp90α. Inhibiting or knocking down Grp94 in cells will decrease cell surface secretion of integrins. Moreover, unlike Hsp90α inhibition, Grp94-selective inhibition does not induce heat shock response and has no influence on the Hsp70 expression level. To characterize the Grp94-selective inhibitory activity of compound <b>54</b> in cells, Western blot analysis was conducted to evaluate the expression levels of the selected biomarkers in <b>54</b>-treated panc-1 cells.</div><div class="NLM_p">As shown in <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>A, treatment with <b>54</b> significantly downregulated the cell surface expression levels of integrin α2 and integrin αL in a dose-dependent manner. Additionally, no modulation of Hsp70 and Akt (Hsp90α specific client) was observed. In contrast, the pan-Hsp90 inhibitor AT13387 obviously induced upregulation of Hsp70 and degradation of Akt. These results confirmed the Grp94-selective inhibitory activity of compound <b>54</b> in cells.</div><figure id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/medium/jm-2018-00800y_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/large/jm-2018-00800y_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Western blot analysis of some biomarkers in <b>54</b> treated panc-1 cells. (A) Integrin α2 and integrin αL levels in cell surface protein extracts after treatment with <b>54</b> at indicated concentrations for 36 h. (B) Hsp70 and Akt levels in total protein extracts after treatment with <b>54</b> at indicated concentrations for 36 h. AT13387 (AT) is used as the reference. β-Actin is used as the control for protein loading.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/large/jm-2018-00800y_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00800&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Anti-Inflammatory Efficacy of Compound <b>54</b> in a DSS-Induced Mouse Model of UC</h3><div class="NLM_p">DSS-induced colitis can simulate the disease characteristics of human UC, including weight loss, diarrhea, rectal bleeding, intestinal mucosal damage, and proinflammatory cytokine elevation in serum and colonic tissues. This model has been widely used to study the pathogenesis of UC and screen potential therapeutic agents. To explore the exact biological roles of Grp94 in UC pathogenesis and the potential anti-inflammatory efficacy of Grp94-selective inhibitors against UC, compound <b>54</b> was applied to the DSS-induced mouse model of UC.</div><div class="NLM_p">In this study, C57BL/6 mice were given 3% DSS drinking water, and then typical symptoms of UC (weight loss, diarrhea, and rectal bleeding) were observed, indicating that the model was successfully established. Mice in the two treatment groups were coadministrated <b>54</b> at 10 mg/kg or 30 mg/kg dosage. As shown in <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>A, compared with those of the “normal control” group mice, the body weights of the “disease control” group mice were seriously decreased from day 3. Clearly, administrationof <b>54</b> slowed down the body weight loss. Disease activity index (DAI), another indicator used to evaluate the disease severity of UC mice, is calculated by scoring changes in weight loss, stool consistency, and stool blood.<a onclick="showRef(event, 'ref48 ref49'); return false;" href="javascript:void(0);" class="ref ref48 ref49">(48,49)</a> As shown in <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>B, DAI scores of the “disease control” group mice were significantly increased from day 3, while for the <b>54</b>-treated mice, DAI scores were significantly increased from day 5. At day 7, DAI scores of the <b>54</b>-treated mice were significantly lower than those of the “disease control” group mice, indicating that <b>54</b> treatment ameliorated the symptoms of the UC mice. Additionally, at day 7, three mice in “disease control” group were dead, one mouse in 10 mg/kg treatment group was dead, and no mice in 30 mg/kg treatment group were dead (data not shown). All the above results confirmed the treatment efficacy of <b>54</b> against the DSS-induced UC in mice.</div><figure id="fig8" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/medium/jm-2018-00800y_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/large/jm-2018-00800y_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Anti-inflammatory efficacy of compound <b>54</b> in DSS-induced UC mice (<i>n</i> = 8). (A) Body weight changes of the mice during treatment. (B) DAI score changes during treatment. (C) Colon length of each group on day 7. (D) Representative H&E images of the colon samples. Scale bar, 200 μm. (E) TNFα and IL-6 levels in the serum and colonic tissues of each group of mice (<i>n</i> = 5, five samples were analyzed): (∗) <i>p</i> < 0.05; (∗∗) <i>p</i> < 0.01; (∗∗∗) <i>p</i> < 0.001, compared with the “disease control” group. (F) Western blot analysis of the biomarkers in colonic tissues. β-Actin is used as the control for protein loading.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/large/jm-2018-00800y_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00800&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Significant colon shortening, which is another obvious symptom, was observed in DSS-induced colitis. However, administration of <b>54</b> did not attenuate the colon shortening (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>C). Additionally, histological observation showed that colonic tissue damage in the treated mice was not obviously reduced (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>D). These results suggested that <b>54</b> could not protect the colonic tissue from the DSS-induced damage. Proinflammatory cytokines such as TNF-α and IL-6 are important factors involved in UC pathogenesis and are often elevated in UC patients. To further confirm the anti-inflammatory efficacy of <b>54</b> against DSS-induced UC, the levels of the cytokine TNF-α and IL-6 were determined. As shown in <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>E, DSS administration led to significant elevation of TNF-α and IL-6 in serum and colonic tissues. As expected, treatment with <b>54</b> significantly reduced the cytokine levels in a dose-dependent manner.</div><div class="NLM_p last">TLRs are typical Grp94-specific clients that play important roles in the pathogenesis of UC. As the best-investigated pattern recognition receptor, TLRs can recognize the pathogen-associated molecular patterns (PAMPs) of pathogenic microorganisms in the intestine. Upon PAMP stimulation, TLRs will trigger the activation of some inflammatory signaling pathways, such as the NF-κB signaling pathway, and then lead to inflammatory responses. In the anti-inflammatory mechanism study, the TLR2 and TLR9 levels in colonic tissues were analyzed by Western blot assay. As shown in <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>F, DSS administration significantly upregulated TLR2 and TLR9 expressions in colonic tissues of the mice. Compared with the “disease control” group mice, the <b>54</b>-treated mice had reduced TLR2 and TLR9 levels in colonic tissues. Moreover, the NF-κB subunit p65 in colonic tissues of the UC mice was also significantly upregulated, indicting the activation of the NF-κB signaling pathway. Interestingly, treatment with <b>54</b> significantly reduced the p65 expression in colonic tissues, especially those in the 30 mg/kg dose group. To further confirm the Grp94 selectivity of <b>54</b> in vivo, the Hsp70 and Hsp90 client protein Akt levels in colonic tissues were evaluated. The Akt expression level in colonic tissues of the DSS-administrated mice was greatly increased, suggesting that Akt-related signaling pathways were also activated in UC mice, as reported in previous studies.<a onclick="showRef(event, 'ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref50 ref51">(50,51)</a> Compared with the “disease control” group, Hsp70 and Akt expression levels in colonic tissues of the <b>54</b>-treated mice were not affected, indicating no Hsp90α inhibition. The above results demonstrated that compound <b>54</b> could inhibit the chaperone function of Grp94 selectively in vivo, then led to the degradation of some TLRs and blockage of the TLR-dependent NF-κB signaling pathway.</div></div><div id="sec3_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Safety Evaluation of Compound <b>54</b> in Healthy Mice</h3><div class="NLM_p">Safety is concerned in the development of therapeutic agents for chronic inflammation. To evaluate the safety of compound <b>54</b>, a subacute toxicity assay was carried out. Healthy C57BL/6 mice were administrated compound <b>54</b> (ip, q.d.) at three different dosages (30 mg/kg, 60 mg/kg, and 90 mg/kg) for 2 weeks. During the treatment, no behavioral abnormalities and obvious body weight loss were observed (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>A). Additionally, hematoxylin–eosin (HE) staining of the harvested organs showed no organ damage in the <b>54</b> treated mice (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>B). These results confirmed the safety of compound <b>54</b> as a potential UC treatment agent.</div><figure id="fig9" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/medium/jm-2018-00800y_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/large/jm-2018-00800y_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Subacute toxicity evaluation of compound <b>54</b> in healthy C57BL/6 mice (<i>n</i> = 8). The mice were treated with vehicle or three different dosages of compound <b>54</b>. (A) Body weight change of each group during the treatment. (B) H&E staining analysis for the different organs of the mice in each group. Scale bar, 50 μm.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/large/jm-2018-00800y_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00800&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56532" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56532" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In this paper, we described the structure-based discovery of a potent Grp94 selective inhibitor. On the basis of the <b>2</b>:Grp94<sup>N</sup> cocrystal structure, we conclude that the ligand-induced “Phe199 shift” effect is the structural basis of Grp94-selective inhibition. Inspired by this conclusion, we selected the “benzamide” moiety as the active fragment and introduced a rigid “phenyl” ring at the meta position to the carbamoyl moiety to shift the Phe199 residue. Encouragingly, these efforts led to the discovery of lead compound <b>42</b>, which exhibited moderate Grp94-selective inhibitory activity with an IC<sub>50</sub> value of 2.77 μM. A systematic SAR study provided compound <b>54</b>, which manifested significantly improved Grp94 inhibitory activity with an IC<sub>50</sub> value of 2 nM without exhibiting obvious Hsp90α inhibition even at 100 μM. BLI assay revealed a 19.6 nM binding affinity of <b>54</b> to Grp94 and over 1000-fold selectivity against Hsp90α. Docking and MD simulation revealed that compound <b>54</b> could induce the “Phe199 shift” and suitably occupied the Grp94-specific site 2 pocket. At cellular level, treatment with compound <b>54</b> downregulated the Grp94-specific client proteins and exhibited no influence on the expression of Hsp70 and Akt (client protein of Hsp90). The discovery of compound <b>54</b> confirmed that the ligand-induced site 2 pocket could be utilized for the design of novel Grp94-selective inhibitors. Then, compound <b>54</b> was used as a tool compound to explore Grp94 inhibitory effects in a DSS-induced mouse model of UC. The results showed that <b>54</b> could ameliorate the inflammatory symptoms of UC mice and reduce the levels of proinflammatory cytokines (TNF-α and IL-6) in serum and colonic tissues. Western blot analysis showed that <b>54</b> treatment downregulated TLR2 and TLR9 in colonic tissues and inhibited TLR-dependent NF-κB pathway activation. Additionally, no modulation on the expression levels of Hsp70 and Akt was observed. These results indicated that the anti-inflammatory efficacy of compound <b>54</b> in UC model resulted from Grp94-selective inhibition. This work represents the first study that confirms the therapeutic efficacy of Grp94-selective inhibitors against UC. As the most potent Grp94 selective inhibitor, compound <b>54</b> can be further used in the exploration of Grp94 biological functions.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31171" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31171" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19">1.  Biology. 1.1. Protein Expression and Purification</h3><div class="NLM_p last">Recombinant canine Grp94<sup>NΔ41</sup> (residues 69–337; residues 286–328 were replaced by four glycine residues) and human Hsp90α<sup>N</sup> (residues 1–236) were expressed as GST- and His-tagged fusions in <i>E. coli</i> BL21star (DE3) as previously reported.<a onclick="showRef(event, 'ref28 ref32 ref35'); return false;" href="javascript:void(0);" class="ref ref28 ref32 ref35">(28,32,35)</a> The GST- and His-tagged proteins were purified using GSTrap HP column (GE Healthcare, Sweden, 17528202) and HisTrap HP column (GE Healthcare, Sweden, 17524802) according to standard protocols, respectively.</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20">1.2.  FP Competition Assay</h3><div class="NLM_p last">FP competition assay was used to evaluate the inhibition activities of the compounds to Grp94<sup>N</sup> and Hsp90α<sup>N</sup>. The compounds (10 mM in DMSO) were prepared in various concentration solutions by serial diluted in assay buffer (20 mM HEPES, 50 mM KCl, 5 mM MgCl<sub>2</sub>, pH 7.4, 0.01% NP40, 2 mM DTT, 0.1 mg/mL BGG). The fluorescent geldanamycin (GM-FITC, no. BML-EI361-0001) and purified Grp94<sup>N</sup> and Hsp90α<sup>N</sup> were diluted into the needed concentrations in assay buffer. The experiments were conducted in 384-well black flat-bottomed polystyrene plates (Corning no. 3575). For each assay, equal volumes of the diluted compounds (20 μL), Grp94<sup>N</sup> or Hsp90α<sup>N</sup> (15 nM final) and GM-FITC solution (6 nM final) were added into the plate wells successively and yielded a final volume of 60 μL. Plates were covered and rocked for 4 h at 4 °C in the dark, and then the FP values were detected using a SpectraMax multimode microplate reader (Molecular Devices) with excitation and emission wavelength at 485 and 535 nm, respectively. For each assay, the FP values of blank controls (GM-FITC only) were recorded as <i>P</i><sub>min</sub>, the FP values of negative controls (GM-FITC and protein) were recorded as <i>P</i><sub>max</sub>, and the FP values of test wells (compounds, GM-FITC, and protein) were recorded as <i>P</i><sub>test</sub>. The inhibition rate of the compounds at each concentration was calculated using the equation as follows: inhibition rate (%) = [1 – (<i>P</i><sub>test</sub> – <i>P</i><sub>min</sub>)/(<i>P</i><sub>max</sub> – <i>P</i><sub>min</sub>)] × 100. IC<sub>50</sub> values were calculated using GraphPad Prim 6.0 software.</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21">1.3.  BLI Assay</h3><div class="NLM_p last">Biolayer interferometry (BLI) assay was performed based on the protocols previously described.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> The interaction between the ligand and protein was measured in 96-well black microplate (no. 655209, Greiner) by biolayer interferometry using an Octet Red 96 instrument (FortéBio, MenloPark, CA, USA). His-tagged Grp94<sup>N</sup> and Hsp90<sup>N</sup> protein were biotinylated in 1× PBS (pH 7.4) with 1 molar ratio using EZ link sulfo-NHS-LC-biotinylation kit (no. 21340, Thermo Pierce) as the manufacturer’s instructions. Excess biotin reagent was removed by overnight dialysis in PBS. Super Streptavidin (SSA) biosensors tips (FortéBio, Inc., Menlo Park, CA) were prewetted with BLI kinetics buffer (PBS, 0.05% BSA, 0.01% Tween-20) for 10 min to establish a baseline before immobilization. Then biotinylated protein was bound by dipping SSA sensors into biotinylated Grp94<sup>N</sup> (a final concentration of 400 nM) or Hsp90<sup>N</sup> (a final concentration of 400 nM). Then four concentrations of compound <b>54</b> prepared in BLI kinetics buffer was immobilized onto SSA sensors. All of the binding data were collected at 30 °C. The experiments comprised five steps: (1) baseline acquisition (60 s), (2) protein loading onto the sensor (1000 s), (3) second baseline acquisition (120 s), (4) association of compound for the measurement of <i>K</i><sub>on</sub> (300 s), and (5) dissociation of compound for the measurement of <i>K</i><sub>off</sub> (300 s). Baseline and dissociation steps were performed in the buffer only. The association and dissociation plot and kinetic constants (<i>K</i><sub>on</sub> and <i>K</i><sub>off</sub>) were step corrected, reference corrected, fit globally to a 1:1 binding model, and automatically obtained with Octet data analysis software (7.1). Equilibrium dissociation constants (<i>K</i><sub>D</sub>) were calculated by the ratio of <i>K</i><sub>off</sub> to <i>K</i><sub>on</sub>.</div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22">1.4.  NMR Based CPMG Assay</h3><div class="NLM_p last">NMR-based CPMG assay was applied to verify the <b>54</b>:Grp94<sup>N</sup> interaction. The assay was conducted at 25 °C on a Bruker Avance III-600 MHz (proton frequency) spectrometer equipped with a cryogenically cooled probe (Bruker BioSpin, Germany). Samples containing 40 μM <b>54</b>, 40 μM <b>54</b> in addition to 0.02 μM, 0.03 μM, or 0.04 μM Grp94<sup>N</sup> in assay buffer (5% DMSO in PBS) were used in NMR data acquisition.</div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23">1.5.  Induction of UC Mice Model and <b>54</b> Treatment</h3><div class="NLM_p last">The studies were conducted according to protocols approved by Institutional Animal Care and Use Committee of China Pharmaceutical University. C57BL/6 mice (male, 20–22 g) were randomly divided into four groups (<i>n</i> = 8). Mice in “normal control” group were supplied with distilled water, and the other three groups were given 3% DSS (36–50 KD) orally in drinking water for 7 days. For the <b>54</b>-treated groups, two dosages of compound <b>54</b> (10 mg/kg, 30 mg/kg) were coadministrated (ip, q.d.) with DSS, while mice in the “normal control” group and “disease control” group were treated with vehicle. The body weight, stool consistency, and rectal bleeding of the mice were recorded every day. Disease activity index (DAI) scores were calculated according to the above three factors to quantify the severity of colitis, and the detailed scoring criteria were illustrated in <a href="/doi/suppl/10.1021/acs.jmedchem.8b00800/suppl_file/jm8b00800_si_001.pdf" class="ext-link">Supporting Information (Table S1)</a>. After the mice were sacrificed at day 7, serum and colons were collected. The serum was used for the determination of cytokines. Section of distal colons were fixed in 4% formaldehyde and embedded in paraffin for sectioning, and the sections were subjected to H&E staining analysis. Other parts of the colons were immediately flash-frozen in liquid nitrogen.</div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24">1.6.  Cytokines Determination</h3><div class="NLM_p last">Cytokine (TNFα and IL-6) expression levels in serum and colonic tissues were determined using ELISA method. For colonic tissues, homogenates were prepared, and the supernatants were used for determination. Mouse TNFα ELISA kit (BOSTER Biological Technology Co. Ltd., China, EK0527) and IL-6 ELISA kit (BOSTER Biological Technology Co. Ltd., China, EK0411) were used following the manufacturer’s instructions.</div></div><div id="sec5_1_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25">1.7.  Western Blot</h3><div class="NLM_p last">Biomarker expression levels were analyzed by Western blot. For the biomarkers in <b>54</b>-treated cells, Panc-1 cells seeded in Petri dishes were treated with <b>54</b> for 36 h at indicated concentrations. Surface protein was extracted using a commercial kit (KeyGEN BioTECH, China, KGBSP002) according to the instructions. In general, the harvested cells were lysed in 1 mL of cold buffer A and centrifuged to remove the supernatant as the cytoplasmic protein. Then 500 μL of cold buffer B was added into the residue, lysed, and centrifuged to remove the supernatant as the nuclear protein. After that, 500 μL of cold buffer C was added to the obtained precipitates, then lysed and centrifuged to obtain the supernatant as the surface protein, which was used for the analysis of integrin α2 and integrin αL located on the cell surface. Total protein was extracted for the analysis of Hsp70 and Akt levels using a commercial kit (KeyGEN BioTECH, China, KGP250). Cells were lysed in the lysis buffer and centrifuged to obtain the supernatant as the total protein. For biomarkers in colonic tissues, the tissues were homogenized and lysed in lysis buffer, and the supernatants were used. Before use, protease and phosphatase inhibitors were added into the above-mentioned buffers. The protein concentrations were determined using BCA kit (Thermo, Waltham, MA). Equal amounts of the protein extracts were separated by SDS–PAGE and then transferred onto PVDF membranes (PerkinElmer, Northwalk, CT, USA). After blocking the nonspecific binding sites with 1% BSA for 1 h, membranes were incubated at 37 °C for 1 h and then at 4 °C overnight with the following primary antibodies: anti-integrin α2 (Santa Cruz Biotechnology, Inc., USA, sc-74466), anti-integrin αL (Santa Cruz Biotechnology, Inc., USA, sc-374172), anti-Hsp70 (Santa Cruz Biotechnology, Inc., USA, sc-24), anti-Akt (Cell Signaling Technology, Inc., USA, no. 2920), anti-TLR2 (Abcam, U.K., ab209217), anti-TLR9 (Santa Cruz Biotechnology, Inc., USA, sc-52966), anti-p65 (Cell Signaling Technology, Inc., USA, no. 8242), and anti-actin (Proteintech Group, Inc., China). Then the membranes were washed and treated with a DyLight 800 labeled secondary antibody at 37 °C for 1 h and scanned using the Odyssey infrared imaging system (LI-COR, Lincoln, NE, USA).</div></div><div id="sec5_1_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26">1.8.  Subacute Toxicity Evaluation</h3><div class="NLM_p last">The studies were conducted according to protocols approved by Institutional Animal Care and Use Committee of China Pharmaceutical University. C57BL/6 mice (male, 20–22 g) were randomly divided into four groups (<i>n</i> = 8). Mice in the three treatment groups were treated (ip, q.d.) with <b>54</b> in different dosages (30 mg/kg, 60 mg/kg, and 90 mg/kg) for 2 weeks. Mice in the control group were treated (ip, q.d.) with vehicle. Body weight was measured every other day. The first day was recorded as day 0. At day 14, the mice were sacrificed and the heart, lung, spleen, liver, and kidney organs were collected. The organs were fixed in 4% formaldehyde and embedded in paraffin for sectioning, and the sections were subjected to H&E staining analysis.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27">2.  Docking</h3><div class="NLM_p last">Molecular docking studies were carried out using Discovery Studio (DS) 4.0 software. The <b>2</b>:Grp94<sup>N</sup> complex (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3O2F">3O2F</a>) downloaded from the Protein Data Bank was chosen for docking studies. The protein was prepared, and the conserved water molecules HOH22, HOH441 were kept for docking. Protein residues around compound <b>2</b> (radius 11.0 Å) that completely covered the ATP binding site were defined as the “SBD_Site_Sphere”. CHARMm force field was applied for the compounds. Then docking studies were conducted using “CDOCKER” module and the docking parameters were used as default. After completion of each docking calculation, the docking poses were analyzed.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28">3.  Molecular Dynamics (MD) Simulation</h3><div class="NLM_p last">Molecular dynamics simulations were carried out for Grp94<sup>N</sup> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3O2F">3O2F</a>, compound <b>2</b> was removed) and <b>54</b>:Grp94<sup>N</sup> docking complex to analyze the structural basis of the Grp94 selectivity. All simulations were performed using Amber14 package, and gaff force field and ff14SB force field were used to generate the topology and coordinate files. The protein was solvated in a rectangular parallelepiped water box filled with TIP3P water molecules with a 11 Å water cap. Sodium ions were added to neutralize the system. Prior to MD simulations, two minimization steps were performed. In the first step, the protein was fixed and the water molecules were solely minimized (5000 cycles, 1500 cycles steepest descent were proceeded first). In the second step, the entire system was minimized (5000 cycles, 2000 cycles steepest descent were proceeded first). The equilibration process including two stages. In the heating stage, the system was annealed from 100 to 300 K over 100 ps at constant volume conditions. In the equilibration stage, the system was equilibrated at constant pressure over 100 ps. Then 20 ns simulations of the systems were performed and atomic coordinates, energies, and temperatures were sampled every 20 ps. The cutoff for the nonbonded interaction was 10 Å, PME method was used to calculate the long-range electrostatics, and SHAKE was employed to keep all bonds involving hydrogen atoms rigid. After completion, the results were analyzed.</div></div><div id="sec5_4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29">4.  Chemistry. General Methods</h3><div class="NLM_p last">All solvents and reagents were obtained commercially. Solvents were dried according to standard procedures, and air and moisture sensitive reactions were performed under nitrogen. Reactions were monitored by thin-layer chromatography (TLC) on 0.25 mm silica gel plates (GF254) and visualized under UV light. Melting points were determined with a Melt-Temp II apparatus. The <sup>1</sup>H NMR and <sup>13</sup>C NMR spectra were measured on a Bruker AV-300 instrument using deuterated solvents with tetramethylsilane (TMS) as internal standard. ESI-mass and high resolution mass spectra (HRMS) were recorded on a Water Q-Tof micro mass spectrometer. The purity (≥95%) of the compounds was verified by the HPLC study performed on Agilent C18 (4.6 mm × 150 mm, 3.5 μm) column using a mixture of solvent methanol/water at a flow rate of 0.5 mL/min and monitoring by UV absorption at 254 nm.</div></div><div id="sec5_4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> General Procedures for the Synthesis of Intermediates <b>13</b>–<b>41</b></h3><div class="NLM_p last">3-Cyano-4-fluorophenylboronic acid pinacol ester (<b>12</b>) and aryl iodide or aryl bromide (1.5 equiv) were dissolved in dioxane, and then Pd(PPh<sub>3</sub>)<sub>4</sub> (0.1 equiv) and Cs<sub>2</sub>CO<sub>3</sub> (2.0 equiv) were added. After reaction at 90 °C overnight under nitrogen atmosphere, the mixture was filtered through Celite and the filtrate was concentrated. The residue was redissolved in 20 mL of EA, then washed with water (20 mL × 2) and brine (20 mL × 2). The EA layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, concentrated, and purified by normal phase column chromatography with petroleum ether to afford intermediates <b>13</b>–<b>41</b>.</div></div><div id="sec5_4_2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 4-Fluoro-[1,1′-biphenyl]-3-carbonitrile (<b>13</b>)</h3><div class="NLM_p last">Intermediate <b>13</b> was prepared from <b>12</b> (247 mg, 1.0 mmol) and iodobenzene (306 mg, 1.5 mmol) according to the general procedures. Colorless oil (168 mg, 85.3%). <sup>1</sup>H NMR (300 MHz, chloroform-<i>d</i>) δ 7.86–7.81 (m, 2H), 7.61–7.46 (m, 5H), 7.32 (m, 1H).</div></div><div id="sec5_4_2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 4-Fluoro-2′-methyl-[1,1′-biphenyl]-3-carbonitrile (<b>14</b>)</h3><div class="NLM_p last">Intermediate <b>14</b> was prepared from <b>12</b> (247 mg, 1.0 mmol) and 1-iodo-2-methylbenzene (327 mg, 1.5 mmol) according to the general procedures. Colorless oil (130 mg, 61.6%). <sup>1</sup>H NMR (300 MHz, chloroform-<i>d</i>) δ 7.63–7.57 (m, 2H), 7.34–7.30 (m, 4H), 7.20 (m, 1H), 2.28 (s, 3H).</div></div><div id="sec5_4_2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 4-Fluoro-3′-methyl-[1,1′-biphenyl]-3-carbonitrile (<b>15</b>)</h3><div class="NLM_p last">Intermediate <b>15</b> was prepared from <b>12</b> (247 mg, 1.0 mmol) and 1-iodo-3-methylbenzene (327 mg, 1.5 mmol) according to the general procedures. Light brown oil (180 mg, 85.2%). <sup>1</sup>H NMR (300 MHz, chloroform-<i>d</i>) δ 7.85–7.80 (m, 2H), 7.43–7.26 (m, 5H), 2.47 (s, 3H).</div></div><div id="sec5_4_2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 4-Fluoro-4′-methyl-[1,1′-biphenyl]-3-carbonitrile (<b>16</b>)</h3><div class="NLM_p last">Intermediate <b>16</b> was prepared from <b>12</b> (247 mg, 1.0 mmol) and 1-iodo-4-methylbenzene (327 mg, 1.5 mmol) according to the general procedures. Colorless oil (140 mg, 66.3%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.22 (dd, <i>J</i> = 6.2, 2.4 Hz, 1H), 8.08–8.03 (m, 1H), 7.63–7.56 (m, 3H), 7.29 (d, <i>J</i> = 8.1 Hz, 2H), 2.34 (s, 3H).</div></div><div id="sec5_4_2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 2′-Chloro-4-fluoro-[1,1′-biphenyl]-3-carbonitrile (<b>17</b>)</h3><div class="NLM_p last">Intermediate <b>17</b> was prepared from <b>12</b> (247 mg, 1.0 mmol) and 1-chloro-2-iodobenzene (358 mg, 1.5 mmol) according to the general procedures. White solid (100 mg, 43.3%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.91 (dd, <i>J</i> = 6.2, 2.4 Hz, 1H), 7.77–7.71 (m, 1H), 7.54–7.46 (m, 2H), 7.35–7.31 (m, 3H).</div></div><div id="sec5_4_2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 3′-Chloro-4-fluoro-[1,1′-biphenyl]-3-carbonitrile (<b>18</b>)</h3><div class="NLM_p last">Intermediate <b>18</b> was prepared from <b>12</b> (247 mg, 1.0 mmol) and 1-chloro-3-iodobenzene (358 mg, 1.5 mmol) according to the general procedures. Colorless oil (160 mg, 69.3%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.33 (dd, <i>J</i> = 6.1, 2.5 Hz, 1H), 8.16–8.11 (m, 1H), 7.85–7.84 (m, 1H), 7.72–7.69 (m, 1H), 7.63 (t, <i>J</i> = 9.1 Hz, 1H), 7.54–7.46 (m, 2H).</div></div><div id="sec5_4_2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 4′-Chloro-4-fluoro-[1,1′-biphenyl]-3-carbonitrile (<b>19</b>)</h3><div class="NLM_p last">Intermediate <b>19</b> was prepared from <b>12</b> (247 mg, 1.0 mmol) and 1-chloro-4-iodobenzene (358 mg, 1.5 mmol) according to the general procedures. Colorless oil (192 mg, 82.9%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.15 (dd, <i>J</i> = 6.2, 2.5 Hz, 1H), 7.99–7.94 (m, 1H), 7.63 (d, <i>J</i> = 8.6 Hz, 2H), 7.49 (t, <i>J</i> = 9.1 Hz, 1H), 7.41 (d, <i>J</i> = 8.6 Hz, 2H).</div></div><div id="sec5_4_2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 4-Fluoro-2′-methoxy-[1,1′-biphenyl]-3-carbonitrile (<b>20</b>)</h3><div class="NLM_p last">Intermediate <b>20</b> was prepared from <b>12</b> (247 mg, 1.0 mmol) and 1-iodo-2-methoxybenzene (351 mg, 1.5 mmol) according to the general procedures. Colorless oil (197 mg, 86.7%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.00 (dd, <i>J</i> = 6.3, 2.3 Hz, 1H), 7.91–7.86 (m, 1H), 7.56 (t, <i>J</i> = 9.1 Hz, 1H), 7.43–7.33 (m, 2H), 7.14 (d, <i>J</i> = 7.8 Hz, 1H), 7.05 (t, <i>J</i> = 7.5 Hz, 1H), 3.78 (s, 3H).</div></div><div id="sec5_4_2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 4-Fluoro-3′-methoxy-[1,1′-biphenyl]-3-carbonitrile (<b>21</b>)</h3><div class="NLM_p last">Intermediate <b>21</b> was prepared from <b>12</b> (247 mg, 1.0 mmol) and 1-iodo-3-methoxybenzene (351 mg, 1.5 mmol) according to the general procedures. Light brown oil (181 mg, 79.7%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.19 (dd, <i>J</i> = 6.2, 2.5 Hz, 1H), 8.04–7.98 (m, 1H), 7.52 (t, <i>J</i> = 9.0 Hz, 1H), 7.31 (t, <i>J</i> = 8.2 Hz, 1H), 7.21–7.18 (m, 2H), 6.91–6.87 (m, 1H), 3.74 (s, 3H).</div></div><div id="sec5_4_2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 4-Fluoro-4′-methoxy-[1,1′-biphenyl]-3-carbonitrile (<b>22</b>)</h3><div class="NLM_p last">Intermediate <b>22</b> was prepared from <b>12</b> (247 mg, 1.0 mmol) and 1-iodo-4-methoxybenzene (351 mg, 1.5 mmol) according to the general procedures. Colorless oil (189 mg, 93.2%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.10 (dd, <i>J</i> = 6.2, 2.5 Hz, 1H), 7.97–7.91 (m, 1H), 7.61–7.56 (m, 2H), 7.48 (t, <i>J</i> = 9.0 Hz, 1H), 6.97–6.92 (m, 2H), 3.71 (s, 3H).</div></div><div id="sec5_4_2_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 2′-Ethyl-4-fluoro-[1,1′-biphenyl]-3-carbonitrile (<b>23</b>)</h3><div class="NLM_p last">Intermediate <b>23</b> was prepared from <b>12</b> (247 mg, 1.0 mmol) and 1-ethyl-2-iodobenzene (348 mg, 1.5 mmol) according to the general procedures. Colorless oil (119 mg, 53.0%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.90 (dd, <i>J</i> = 6.3, 2.3 Hz, 1H), 7.75–7.70 (m, 1H), 7.59 (t, <i>J</i> = 9.0 Hz, 1H), 7.40–7.34 (m, 2H), 7.31–7.23 (m, 1H), 7.19–7.16 (m, 1H), 2.55–2.51 (m, 2H), 1.02 (t, <i>J</i> = 7.5 Hz, 3H).</div></div><div id="sec5_4_2_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 4′-Ethyl-4-fluoro-[1,1′-biphenyl]-3-carbonitrile (<b>24</b>)</h3><div class="NLM_p last">Intermediate <b>24</b> was prepared from <b>12</b> (247 mg, 1.0 mmol) and 1-ethyl-4-iodobenzene (348 mg, 1.5 mmol) according to the general procedures. Colorless oil (192 mg, 85.3%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.20 (dd, <i>J</i> = 6.1, 2.4 Hz, 1H), 8.07–8.02 (m, 1H), 7.65–7.55 (m, 3H), 7.34–7.30 (m, 2H), 2.64 (q, <i>J</i> = 7.6 Hz, 2H), 1.20 (t, <i>J</i> = 7.6 Hz, 3H).</div></div><div id="sec5_4_2_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 4-Fluoro-4′-isopropyl-[1,1′-biphenyl]-3-carbonitrile (<b>25</b>)</h3><div class="NLM_p last">Intermediate <b>25</b> was prepared from <b>12</b> (1.98 g, 8.0 mmol) and 1-bromo-4-isopropylbenzene (2.39 g, 12 mmol) according to the general procedures. Colorless oil (1.35 g, 70.6%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.19 (dd, <i>J</i> = 6.2, 2.5 Hz, 1H), 8.07–8.02 (m, 1H), 7.64–7.55 (m, 3H), 7.34 (d, <i>J</i> = 8.2 Hz, 2H), 2.98–2.86 (m, 1H), 1.23 (d, <i>J</i> = 6.9 Hz, 6H).</div></div><div id="sec5_4_2_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 4-Fluoro-4′-propyl-[1,1′-biphenyl]-3-carbonitrile (<b>26</b>)</h3><div class="NLM_p last">Intermediate <b>26</b> was prepared from <b>12</b> (247 mg, 1.0 mmol) and 1-bromo-4-propylbenzene (299 mg, 1.5 mmol) according to the general procedures. Colorless oil (228 mg, 95.4%). <sup>1</sup>H NMR (300 MHz, chloroform-<i>d</i>) δ 7.82–7.76 (m, 2H), 7.45–7.43 (m, 2H), 7.29 (d, <i>J</i> = 8.6 Hz, 3H), 2.66 (t, <i>J</i> = 7.6 Hz, 2H), 1.76–1.64 (m, 2H), 0.99 (t, <i>J</i> = 7.3 Hz, 3H).</div></div><div id="sec5_4_2_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 4′-(<i>tert</i>-Butyl)-4-fluoro-[1,1′-biphenyl]-3-carbonitrile (<b>27</b>)</h3><div class="NLM_p last">Intermediate <b>27</b> was prepared from <b>12</b> (247 mg, 1.0 mmol) and 1-<i>tert</i>-butyl-4-iodobenzene (390 mg, 1.5 mmol) according to the general procedures. Colorless oil (186 mg, 73.5%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.21 (dd, <i>J</i> = 6.2, 2.4 Hz, 1H), 8.09–8.03 (m, 1H), 7.67–7.57 (m, 3H), 7.52–7.47 (m, 2H), 1.31 (s, 9H).</div></div><div id="sec5_4_2_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 4′-Ethoxy-4-fluoro-[1,1′-biphenyl]-3-carbonitrile (<b>28</b>)</h3><div class="NLM_p last">Intermediate <b>28</b> was prepared from <b>12</b> (247 mg, 1.0 mmol) and 4-iodophenetole (372 mg, 1.5 mmol) according to the general procedures. Colorless oil (100 mg, 41.5%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.18 (dd, <i>J</i> = 6.1, 2.5 Hz, 1H), 8.05–8.00 (m, 1H), 7.66 (d, <i>J</i> = 8.8 Hz, 2H), 7.56 (t, <i>J</i> = 9.1 Hz, 1H), 7.02 ((d, <i>J</i> = 8.8 Hz, 2H), 4.08 (q, <i>J</i> = 7.0 Hz, 2H), 1.34 (t, <i>J</i> = 7.0 Hz, 3H).</div></div><div id="sec5_4_2_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 4-Fluoro-2′,3′-dimethyl-[1,1′-biphenyl]-3-carbonitrile (<b>29</b>)</h3><div class="NLM_p last">Intermediate <b>29</b> was prepared from <b>12</b> (247 mg, 1.0 mmol) and 1-iodo-2,3-dimethylbenzene (348 mg, 1.5 mmol) according to the general procedures. Colorless oil (179 mg, 80.0%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.87 (dd, <i>J</i> = 6.3, 2.3 Hz, 1H), 7.73–7.68 (m, 1H), 7.58 (t, <i>J</i> = 9.0 Hz, 1H), 7.40–7.38 (m, 1H), 7.25–7.13 (m, 2H), 2.29 (s, 3H), 2.08 (s, 3H).</div></div><div id="sec5_4_2_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 4-Fluoro-2′,4′-dimethyl-[1,1′-biphenyl]-3-carbonitrile (<b>30</b>)</h3><div class="NLM_p last">Intermediate <b>30</b> was prepared from <b>12</b> (247 mg, 1.0 mmol) and 4-iodo-<i>m</i>-xylene (348 mg, 1.5 mmol) according to the general procedures. Light yellow oil (200 mg, 88.9%). <sup>1</sup>H NMR (300 MHz, chloroform-<i>d</i>) δ 7.60–7.55 (m, 2H), 7.33–7.24 (m, 1H), 7.20–7.08 (m, 3H), 2.41 (s, 3H), 2.25 (s, 3H).</div></div><div id="sec5_4_2_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 4-Fluoro-2′,6′-dimethyl-[1,1′-biphenyl]-3-carbonitrile (<b>31</b>)</h3><div class="NLM_p last">Intermediate <b>31</b> was prepared from <b>12</b> (247 mg, 1.0 mmol) and 2-iodo-1,3-dimethylbenzene (348 mg, 1.5 mmol) according to the general procedures. Colorless oil (149 mg, 66.1%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.80–7.77 (m, 1H), 7.64–7.57 (m, 2H), 7.23–7.18 (m, 1H), 7.15–7.12 (m, 2H), 1.96 (s, 6H).</div></div><div id="sec5_4_2_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 4-Fluoro-3′,4′-dimethyl-[1,1′-biphenyl]-3-carbonitrile (<b>32</b>)</h3><div class="NLM_p last">Intermediate <b>32</b> was prepared from <b>12</b> (247 mg, 1.0 mmol) and 4-iodo-1,2-dimethylbenzene (348 mg, 1.5 mmol) according to the general procedures. Colorless oil (210 mg, 93.3%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.11 (dd, <i>J</i> = 6.2, 2.5 Hz, 1H), 7.98–7.93 (m, 1H), 7.52–7.43 (m, 2H), 7.37–7.32 (m, 1H), 7.14 (d, <i>J</i> = 7.9 Hz, 1H), 2.19 (s, 3H), 2.16 (s, 3H).</div></div><div id="sec5_4_2_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 4-Fluoro-3′,5′-dimethyl-[1,1′-biphenyl]-3-carbonitrile (<b>33</b>)</h3><div class="NLM_p last">Intermediate <b>33</b> was prepared from <b>12</b> (247 mg, 1.0 mmol) and 1-iodo-3,5-dimethylbenzene (348 mg, 1.5 mmol) according to the general procedures. Colorless oil (170 mg, 75.5%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.21 (dd, <i>J</i> = 6.2, 2.4 Hz, 1H), 8.07–8.02 (m, 1H), 7.58 (t, <i>J</i> = 9.1 Hz, 1H), 7.33 (s, 2H), 7.04 (s, 1H), 2.33 (s, 6H).</div></div><div id="sec5_4_2_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 4-Fluoro-2′,4′,6′-trimethyl-[1,1′-biphenyl]-3-carbonitrile (<b>34</b>)</h3><div class="NLM_p last">Intermediate <b>34</b> was prepared from <b>12</b> (247 mg, 1.0 mmol) and 2,4,6-trimethyliodobenzene (369 mg, 1.5 mmol) according to the general procedures. Colorless oil (196 mg, 82.0%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.74 (dd, <i>J</i> = 6.3, 2.0 Hz, 1H), 7.62–7.52 (m, 2H), 6.95 (s, 2H), 2.26 (s, 3H), 1.92 (s, 6H).</div></div><div id="sec5_4_2_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 2′,3′-Dichloro-4-fluoro-[1,1′-biphenyl]-3-carbonitrile (<b>35</b>)</h3><div class="NLM_p last">Intermediate <b>35</b> was prepared from <b>12</b> (247 mg, 1.0 mmol) and 1,2-dichloro-3-iodobenzene (409 mg, 1.5 mmol) according to the general procedures. Colorless oil (60 mg, 22.6%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.95 (dd, <i>J</i> = 6.2, 2.3 Hz, 1H), 7.78–7.73 (m, 1H), 7.60 (dd, <i>J</i> = 7.5, 2.1 Hz, 1H), 7.52 (t, <i>J</i> = 9.1 Hz, 1H), 7.37–7.29 (m, 2H).</div></div><div id="sec5_4_2_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> 2′,6′-Dichloro-4-fluoro-[1,1′-biphenyl]-3-carbonitrile (<b>36</b>)</h3><div class="NLM_p last">Intermediate <b>36</b> was prepared from <b>12</b> (247 mg, 1.0 mmol) and 1,3-dichloro-2-iodobenzene (409 mg, 1.5 mmol) according to the general procedures. Colorless oil (100 mg, 37.7%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.02 (dd, <i>J</i> = 6.2, 2.3 Hz, 1H), 7.79–7.74 (m, 1H), 7.71–7.62 (m, 3H), 7.52–7.46 (m, 1H).</div></div><div id="sec5_4_2_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> 3′,4′-Dichloro-4-fluoro-[1,1′-biphenyl]-3-carbonitrile (<b>37</b>)</h3><div class="NLM_p last">Intermediate <b>37</b> was prepared from <b>12</b> (247 mg, 1.0 mmol) and 1,2-dichloro-4-iodobenzene (409 mg, 1.5 mmol) according to the general procedures. Colorless oil (113 mg, 42.6%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.38 (dd, <i>J</i> = 6.1, 2.5 Hz, 1H), 8.20–8.15 (m, 1H), 8.08 (t, <i>J</i> = 1.3 Hz, 1H), 7.76 (d, <i>J</i> = 1.3 Hz, 2H), 7.65 (t, <i>J</i> = 9.1 Hz, 1H).</div></div><div id="sec5_4_2_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> 3′,5′-Dichloro-4-fluoro-[1,1′-biphenyl]-3-carbonitrile (<b>38</b>)</h3><div class="NLM_p last">Intermediate <b>38</b> was prepared from <b>12</b> (247 mg, 1.0 mmol) and 1,3-dichloro-5-iodobenzene (409 mg, 1.5 mmol) according to the general procedures. Colorless oil (138 mg, 51.9%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.40 (dd, <i>J</i> = 6.1, 2.5 Hz, 1H), 8.22–8.17 (m, 1H), 7.86 (d, <i>J</i> = 1.9 Hz, 2H), 7.67–7.61 (m, 2H).</div></div><div id="sec5_4_2_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> 2-Fluoro-5-(naphthalen-1-yl)benzonitrile (<b>39</b>)</h3><div class="NLM_p last">Intermediate <b>39</b> was prepared from <b>12</b> (247 mg, 1.0 mmol) and 1-iodonaphthalene (381 mg, 1.5 mmol) according to the general procedures. Colorless oil (215 mg, 87.0%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.42 (dd, <i>J</i> = 6.2, 2.4 Hz, 1H), 8.33 (d, <i>J</i> = 1.9 Hz, 1H), 8.28–8.22 (m, 1H), 8.05–7.95 (m, 3H), 7.92–7.88 (m, 1H), 7.67 (t, <i>J</i> = 9.1 Hz, 1H), 7.61–7.52 (m, 2H).</div></div><div id="sec5_4_2_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> 2-Fluoro-5-(naphthalen-2-yl)benzonitrile (<b>40</b>)</h3><div class="NLM_p last">Intermediate <b>40</b> was prepared from <b>12</b> (247 mg, 1.0 mmol) and 2-iodonaphthalene (381 mg, 1.5 mmol) according to the general procedures. Colorless oil (168 mg, 68.0%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.08–8.00 (m, 3H), 7.91–7.86 (m, 1H), 7.73–7.68 (m, 2H), 7.65–7.52 (m, 3H), 7.50–7.46 (m, 1H).</div></div><div id="sec5_4_2_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> 4-Fluoro-4′-(1<i>H</i>-pyrrol-1-yl)-[1,1′-biphenyl]-3-carbonitrile (<b>41</b>)</h3><div class="NLM_p last">Intermediate <b>41</b> was prepared from <b>12</b> (247 mg, 1.0 mmol) and 1-(4-iodophenyl)pyrrole (404 mg, 1.5 mmol) according to the general procedures. Light yellow oil (173 mg, 66.0%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.30 (dd, <i>J</i> = 6.2, 2.5 Hz, 1H), 8.16–8.10(m, 1H), 7.85–7.81 (m, 2H), 7.73–7.69 (m, 2H), 7.62 (t, <i>J</i> = 9.1 Hz, 1H), 7.46 (t, <i>J</i> = 2.2 Hz, 2H), 6.30 (t, <i>J</i> = 2.2 Hz, 2H).</div></div><div id="sec5_4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> General Procedures for the Synthesis of Compounds <b>42</b>–<b>70</b></h3><div class="NLM_p last">Intermediates <b>13</b>–<b>41</b> were dissolved in 5 mL of DMSO, and <i>trans</i>-4-aminocyclohexanol (4.5 equiv) and DIPEA (9.0 equiv) were added. The mixture was heated at 120 °C for 24 h and then poured into 20 mL of water and extracted with 20 mL of EA two times. The EA layer was combined and dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. After concentration, the residue was dissolved in 20 mL of ethanol, and 2 mL of 1 M NaOH solution and 2 mL 30% H<sub>2</sub>O<sub>2</sub> were added. Then the mixture was stirred at 30 °C overnight. After removing ethanol under reduced pressure, the residue was dissolved in 20 mL of EA and washed with water (20 mL × 2) and brine (20 mL × 1). The EA layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> and then concentrated. The residue was triturated with DCM to afford compounds <b>42</b>–<b>70</b>.</div></div><div id="sec5_4_3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> 4-(((1<i>r</i>,4<i>r</i>)-4-Hydroxycyclohexyl)amino)-[1,1′-biphenyl]-3-carboxamide (<b>42</b>)</h3><div class="NLM_p last">Compound <b>42</b> was prepared from intermediate <b>13</b> (168 mg, 0.85 mmol) according to the general procedures. White solid. 78 mg, yield 29.6%. Mp 189–191 °C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.17 (d, <i>J</i> = 7.7 Hz, 1H), 8.02 (s, 1H), 7.90 (s, 1H), 7.64 (d, <i>J</i> = 7.7 Hz, 2H), 7.58 (d, <i>J</i> = 8.7 Hz, 1H), 7.39 (t, <i>J</i> = 7.6 Hz, 2H), 7.23 (t, <i>J</i> = 7.3 Hz, 1H), 7.17 (s, 1H), 6.79 (d, <i>J</i> = 8.8 Hz, 1H), 4.57 (s, 1H), 3.52–3.43 (m, 1H), 3.39–3.33 (m, 1H), 2.01–1.96 (m, 2H), 1.85–1.81 (m, 2H), 1.38–1.14 (m, 4H). HRMS (ESI): calcd for C<sub>19</sub>H<sub>23</sub>N<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup> 311.1681, found 311.1757. <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 171.65, 148.37, 139.92, 130.61, 128.65, 127.29, 125.91, 125.57, 125.37, 113.93, 112.15, 68.03, 49.43, 33.45, 30.25. Purity: 95.68% by HPLC (MeOH/H<sub>2</sub>O = 90:10).</div></div><div id="sec5_4_3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> 4-(((1<i>r</i>,4<i>r</i>)-4-Hydroxycyclohexyl)amino)-2′-methyl-[1,1′-biphenyl]-3-carboxamide (<b>43</b>)</h3><div class="NLM_p last">Compound <b>43</b> was prepared from intermediate <b>14</b> (130 mg, 0.62 mmol) according to the general procedures. White solid. 85 mg, yield 42.3%. Mp 186–188 °C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.19 (d, <i>J</i> = 7.6 Hz, 1H), 7.86 (s, 1H), 7.58 (s, 1H), 7.26–7.21 (m, 5H), 7.12 (s, 1H), 6.75 (d, <i>J</i> = 8.7 Hz, 1H), 4.60 (s, 1H), 3.52–3.35 (m, 1H), 3.32–3.27 (m, 1H), 2.26 (s, 3H), 2.01–1.98 (m, 2H), 1.85–1.81 (m, 2H), 1.38–1.30 (m, 2H), 1.26–1.15 (m, 2H). HRMS (ESI): calcd for C<sub>20</sub>H<sub>25</sub>N<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup> 325.1838, found 325.1915. Purity: 97.07% by HPLC (MeOH/H<sub>2</sub>O = 90:10).</div></div><div id="sec5_4_3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> 4-(((1<i>r</i>,4<i>r</i>)-4-Hydroxycyclohexyl)amino)-3′-methyl-[1,1′-biphenyl]-3-carboxamide (<b>44</b>)</h3><div class="NLM_p last">Compound <b>44</b> was prepared from intermediate <b>15</b> (180 mg, 0.85 mmol) according to the general procedures. White solid. 52 mg, yield 18.9%. Mp 179–181 °C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.16 (d, <i>J</i> = 7.7 Hz, 1H), 8.02 (s, 1H), 7.87 (d, <i>J</i> = 1.9 Hz, 1H), 7.56 (dd, <i>J</i> = 8.7, 1.7 Hz, 1H), 7.47(s, 1H), 7.42 (d, <i>J</i> = 8.2 Hz, 1H), 7.27 (t, <i>J</i> = 7.5 Hz, 1H), 7.19 (s, 1H), 7.05 (d, <i>J</i> = 7.4 Hz, 1H), 6.78 (d, <i>J</i> = 8.9 Hz, 1H), 4.58 (d, <i>J</i> = 4.1 Hz, 1H), 3.52–3.44 (m, 1H), 3.40–3.34 (m, 1H), 2.35 (s, 3H), 2.00–1.96 (m, 2H), 1.85–1.80 (m, 2H), 1.39–1.29 (m, 2H), 1.27–1.14 (m, 2H). HRMS (ESI): calcd for C<sub>20</sub>H<sub>25</sub>N<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup> 325.1838, found 325.1916. Purity: 97.15% by HPLC (MeOH/H<sub>2</sub>O = 90:10).</div></div><div id="sec5_4_3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> 4-(((1<i>r</i>,4<i>r</i>)-4-Hydroxycyclohexyl)amino)-4′-methyl-[1,1′-biphenyl]-3-carboxamide (<b>45</b>)</h3><div class="NLM_p last">Compound <b>45</b> was prepared from intermediate <b>16</b> (140 mg, 0.66 mmol) according to the general procedures. White solid. 34 mg, yield 15.9%. Mp 219–222 °C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.13 (d, <i>J</i> = 7.7 Hz, 1H), 8.01 (s, 1H), 7.86 (d, <i>J</i> = 2.0 Hz, 1H), 7.54 (d, <i>J</i> = 8.0 Hz, 3H), 7.20 (d, <i>J</i> = 8.0 Hz, 3H), 6.77 (d, <i>J</i> = 8.9 Hz, 1H), 4.58 (d, <i>J</i> = 4.1 Hz, 1H), 3.51–3.42 (m, 1H), 3.34–3.26 (m, 1H), 2.30 (s, 3H), 2.00–1.95 (m, 2H), 1.84–1.81 (m, 2H), 1.38–1.30 (m, 2H), 1.29–1.16 (m, 2H). HRMS (ESI): calcd for C<sub>20</sub>H<sub>25</sub>N<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup> 325.1838, found 325.1913. <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 171.67, 148.15, 137.03, 134.97, 130.38, 129.23, 126.95, 125.39, 125.35, 113.90, 112.12, 68.04, 49.41, 33.46, 30.26, 20.59. Purity: 95.22% by HPLC (MeOH/H<sub>2</sub>O = 90:10).</div></div><div id="sec5_4_3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> 2′-Chloro-4-(((1<i>r</i>,4<i>r</i>)-4-hydroxycyclohexyl)amino)-[1,1′-biphenyl]-3-carboxamide (<b>46</b>)</h3><div class="NLM_p last">Compound <b>46</b> was prepared from intermediate <b>17</b> (100 mg, 0.43 mmol) according to the general procedures. White solid. 33 mg, yield 22.3%. Mp 196–198 °C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.22 (d, <i>J</i> = 7.7 Hz, 1H), 7.87 (s, 1H), 7.66 (d, <i>J</i> = 2.1 Hz, 1H), 7.51 (dd, <i>J</i> = 7.8, 1.2 Hz, 1H), 7.45–7.28 (m, 4H), 7.14 (s, 1H), 6.77 (d, <i>J</i> = 8.9 Hz, 1H), 4.58 (d, <i>J</i> = 4.2 Hz, 1H), 3.51–3.42 (m, 1H), 3.39–3.35 (m, 1H), 2.01–1.96 (m, 2H), 1.85–1.80 (m, 2H), 1.39–1.31 (m, 2H), 1.26–1.14 (m, 2H). HRMS (ESI): calcd for C<sub>19</sub>H<sub>22</sub>ClN<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup> 345.1292, found 345.1367. Purity: 96.52% by HPLC (MeOH/H<sub>2</sub>O = 90:10).</div></div><div id="sec5_4_3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> 3′-Chloro-4-(((1<i>r</i>,4<i>r</i>)-4-hydroxycyclohexyl)amino)-[1,1′-biphenyl]-3-carboxamide (<b>47</b>)</h3><div class="NLM_p last">Compound <b>47</b> was prepared from intermediate <b>18</b> (160 mg, 0.69 mmol) according to the general procedures. White solid. 36 mg, yield 15.2%. Mp 189–191 °C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.29 (d, <i>J</i> = 7.7 Hz, 1H), 8.08 (s, 1H), 7.92 (d, <i>J</i> = 2.3 Hz, 1H), 7.76 (t, <i>J</i> = 1.7 Hz, 1H), 7.61 (dd, <i>J</i> = 8.7, 1.7 Hz, 2H), 7.41 (t, <i>J</i> = 7.9 Hz, 1H), 7.29–7.26 (m, 1H), 7.22 (s, 1H), 6.79 (d, <i>J</i> = 8.9 Hz, 1H), 4.59 (d, <i>J</i> = 4.1 Hz, 1H), 3.52–3.44 (m, 1H), 3.42–3.37 (m, 1H), 2.00–1.95 (m, 2H), 1.85–1.79 (m, 2H), 1.39–1.14 (m, 4H). HRMS (ESI): calcd for C<sub>19</sub>H<sub>22</sub>ClN<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup> 345.1292, found 345.1368. Purity: 95.33% by HPLC (MeOH/H<sub>2</sub>O = 90:10).</div></div><div id="sec5_4_3_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> 4′-Chloro-4-(((1<i>r</i>,4<i>r</i>)-4-hydroxycyclohexyl)amino)-[1,1′-biphenyl]-3-carboxamide (<b>48</b>)</h3><div class="NLM_p last">Compound <b>48</b> was prepared from intermediate <b>19</b> (192 mg, 0.83 mmol) according to the general procedures. White solid. 150 mg, yield 52.5%. Mp >250 °C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.23 (d, <i>J</i> = 7.7 Hz, 1H), 8.04 (s, 1H), 7.90 (d, <i>J</i> = 2.2 Hz, 1H), 7.68 (d, <i>J</i> = 8.6 Hz, 2H), 7.58 (dd, <i>J</i> = 8.8, 2.2 Hz, 1H), 7.44 (d, <i>J</i> = 8.6 Hz, 2H), 7.21 (s, 1H), 6.79 (d, <i>J</i> = 8.9 Hz, 1H), 4.59 (d, <i>J</i> = 4.1 Hz, 1H), 3.51–3.44 (m, 1H), 3.42–3.35 (m, 1H), 2.00–1.96 (m, 2H), 1.85–1.80 (m, 2H), 1.39–1.14 (m, 4H). HRMS (ESI): calcd for C<sub>19</sub>H<sub>22</sub>ClN<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup> 345.1292, found 345.1371. <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 171.55, 148.61, 138.72, 130.53, 128.55, 127.26, 127.16, 123.84, 113.83, 112.19, 68.00, 49.39, 33.42, 30.21. Purity: 97.02% by HPLC (MeOH/H<sub>2</sub>O = 90:10).</div></div><div id="sec5_4_3_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> 4-(((1<i>r</i>,4<i>r</i>)-4-Hydroxycyclohexyl)amino)-2′-methoxy-[1,1′-biphenyl]-3-carboxamide (<b>49</b>)</h3><div class="NLM_p last">Compound <b>49</b> was prepared from intermediate <b>20</b> (197 mg, 0.87 mmol) according to the general procedures. White solid. 97 mg, yield 32.8%. Mp 179–181 °C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.06 (d, <i>J</i> = 7.7 Hz, 1H), 7.83 (s, 1H), 7.66 (d, <i>J</i> = 2.1 Hz, 1H), 7.42 (dd, <i>J</i> = 8.7, 1.7 Hz, 1H), 7.32–7.23 (m, 2H), 7.06 (s, 1H), 7.03–6.95 (m, 2H), 6.72 (d, <i>J</i> = 8.8 Hz, 1H), 4.57 (d, <i>J</i> = 4.1 Hz, 1H), 3.74 (s, 3H), 3.52–3.43 (m, 1H), 3.31–3.26 (m, 1H), 2.01–1.97 (m, 2H), 1.84–1.81 (m, 2H), 1.38–1.27 (m, 2H), 1.24–1.15 (m, 2H). HRMS (ESI): calcd for C<sub>20</sub>H<sub>25</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup> 341.1787, found 341.1865. Purity: 97.90% by HPLC (MeOH/H<sub>2</sub>O = 90:10).</div></div><div id="sec5_4_3_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> 4-(((1<i>r</i>,4<i>r</i>)-4-Hydroxycyclohexyl)amino)-3′-methoxy-[1,1′-biphenyl]-3-carboxamide (<b>50</b>)</h3><div class="NLM_p last">Compound <b>50</b> was prepared from intermediate <b>21</b> (181 mg, 0.80 mmol) according to the general procedures. Light yellow solid. 91 mg, yield 33.5%. Mp 196–198 °C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.10 (d, <i>J</i> = 7.7 Hz, 1H), 7.94 (s, 1H), 7.79 (d, <i>J</i> = 2.3 Hz, 1H), 7.49 (dd, <i>J</i> = 8.8, 2.1 Hz, 1H), 7.21 (t, <i>J</i> = 7.8 Hz, 1H), 7.13–7.10 (m, 3H), 6.74–6.67 (m, 2H), 4.47 (d, <i>J</i> = 4.2 Hz, 1H), 3.72 (s, 3H), 3.43–3.35 (m, 1H), 3.32–3.24 (m, 1H), 1.92–1.88 (m, 2H), 1.75–1.71 (m, 2H), 1.30–1.06 (m, 4H). HRMS (ESI): calcd for C<sub>20</sub>H<sub>25</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup> 341.1787, found 341.1857. Purity: 96.33% by HPLC (MeOH/H<sub>2</sub>O = 90:10).</div></div><div id="sec5_4_3_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> 4-(((1<i>r</i>,4<i>r</i>)-4-Hydroxycyclohexyl)amino)-4′-methoxy-[1,1′-biphenyl]-3-carboxamide (<b>51</b>)</h3><div class="NLM_p last">Compound <b>51</b> was prepared from intermediate <b>22</b> (189 mg, 0.83 mmol) according to the general procedures. Light yellow solid. 60 mg, yield 21.3%. Mp 209–211 °C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.99 (d, <i>J</i> = 7.7 Hz, 1H), 7.90 (s, 1H), 7.73 (d, <i>J</i> = 2.3 Hz, 1H), 7.51–7.45 (d, <i>J</i> = 8.8, 2H), 7.42 (dd, <i>J</i> = 8.7, 2.2 Hz, 1H), 7.05 (s, 1H), 6.87 (d, <i>J</i> = 8.9, 2H), 6.67 (d, <i>J</i> = 8.9 Hz, 1H), 4.47 (d, <i>J</i> = 4.2 Hz, 1H), 3.68 (s, 3H), 3.43–3.37 (m, 1H), 3.30–3.24 (m, 1H), 1.91–1.88 (m, 2H), 1.76–1.71 (m, 2H), 1.30–1.03 (m, 4H). HRMS (ESI): calcd for C<sub>20</sub>H<sub>25</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup> 341.1787, found 341.1855. <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 171.69, 157.82, 147.85, 132.49, 130.24, 126.74, 126.66, 125.32, 114.08, 113.95, 112.15, 68.05, 55.07, 49.43, 33.46, 30.27. Purity: 95.29% by HPLC (MeOH/H<sub>2</sub>O = 90:10).</div></div><div id="sec5_4_3_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> 2′-Ethyl-4-(((1<i>r</i>,4<i>r</i>)-4-Hydroxycyclohexyl)amino)-[1,1′-biphenyl]-3-carboxamide (<b>52</b>)</h3><div class="NLM_p last">Compound <b>52</b> was prepared from intermediate <b>23</b> (119 mg, 0.53 mmol) according to the general procedures. White solid. 125 mg, yield 69.8%. Mp 180–182 °C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.17 (d, <i>J</i> = 7.6 Hz, 1H), 7.83 (s, 1H), 7.55 (d, <i>J</i> = 2.1 Hz, 1H), 7.30–7.14 (m, 5H), 7.08 (s, 1H), 6.75 (d, <i>J</i> = 8.7 Hz, 1H), 4.57 (d, <i>J</i> = 4.2 Hz, 1H), 3.52–3.43 (m, 1H), 3.31–3.23 (m, 1H), 2.58 (q, <i>J</i> = 7.5 Hz, 2H), 2.01–1.97 (m, 2H), 1.85–1.81 (m, 2H), 1.39–1.14 (m, 4H), 1.05 (t, <i>J</i> = 7.5 Hz, 3H). HRMS (ESI): calcd for C<sub>21</sub>H<sub>27</sub>N<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup> 339.1994, found 339.2069. Purity: 97.85% by HPLC (MeOH/H<sub>2</sub>O = 90:10).</div></div><div id="sec5_4_3_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> 4′-Ethyl-4-(((1<i>r</i>,4<i>r</i>)-4-hydroxycyclohexyl)amino)-[1,1′-biphenyl]-3-carboxamide (<b>53</b>)</h3><div class="NLM_p last">Compound <b>53</b> was prepared from intermediate <b>24</b> (192 mg, 0.85 mmol) according to the general procedures. White solid. 55 mg, yield 19.2%. Mp 172–174 °C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.12 (d, <i>J</i> = 7.8 Hz, 1H), 7.98 (s, 1H), 7.86 (d, <i>J</i> = 2.2 Hz, 1H), 7.55 (d, <i>J</i> = 8.2 Hz, 3H), 7.22 (d, <i>J</i> = 7.9 Hz, 2H), 7.12 (s, 1H), 6.77 (d, <i>J</i> = 8.9 Hz, 1H), 4.54 (d, <i>J</i> = 4.2 Hz, 1H), 3.52–3.43 (m, 1H), 3.39–3.30 (m, 1H), 2.61 (q, <i>J</i> = 7.6 Hz, 2H), 2.01–1.96 (m, 2H), 1.85–1.80 (m, 2H), 1.39–1.14 (m, 7H). HRMS (ESI): calcd for C<sub>21</sub>H<sub>27</sub>N<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup> 339.1994, found 339.2063. <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 171.68, 148.16, 141.43, 137.37, 130.45, 128.05, 127.07, 125.53, 125.46, 113.92, 112.12, 68.04, 49.43, 33.46, 30.26, 27.75, 15.74. Purity: 95.59% by HPLC (MeOH/H<sub>2</sub>O = 90:10).</div></div><div id="sec5_4_3_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> 4-(((1<i>r</i>,4<i>r</i>)-4-Hydroxycyclohexyl)amino)-4′-isopropyl-[1,1′-biphenyl]-3-carboxamide (<b>54</b>)</h3><div class="NLM_p last">Compound <b>54</b> was prepared from intermediate <b>25</b> (200 mg, 0.84 mmol) according to the general procedures. White solid. 122 mg, yield 41.3%. Mp 197–199 °C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.14 (d, <i>J</i> = 7.7 Hz, 1H), 8.01 (s, 1H), 7.86 (d, <i>J</i> = 2.3 Hz, 1H), 7.55 (d, <i>J</i> = 8.5 Hz, 3H), 7.26 (d, <i>J</i> = 7.9 Hz, 2H), 7.18 (s, 1H), 6.78 (d, <i>J</i> = 8.8 Hz, 1H), 4.60 (d, <i>J</i> = 4.1 Hz, 1H), 3.52–3.44 (m, 1H), 3.33–3.26 (m, 1H), 2.94–2.85 (m, 1H), 2.00–1.97 (m, 2H), 1.85–1.81 (m, 2H), 1.39–1.28 (m, 2H), 1.22 (d, <i>J</i> = 6.9 Hz, 6H), 1.17–1.14 (m, 2H). HRMS (ESI): calcd for C<sub>22</sub>H<sub>29</sub>N<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup> 353.2151, found 353.2227. <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 171.69, 148.16, 146.06, 137.59, 130.48, 127.16, 126.54, 125.59, 125.55, 113.91, 112.10, 68.04, 49.44, 33.46, 33.01, 30.27, 23.91. Purity: 96.14% by HPLC (MeOH/H<sub>2</sub>O = 90:10).</div></div><div id="sec5_4_3_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> 4-(((1<i>r</i>,4<i>r</i>)-4-Hydroxycyclohexyl)amino)-4′-propyl-[1,1′-biphenyl]-3-carboxamide (<b>55</b>)</h3><div class="NLM_p last">Compound <b>55</b> was prepared from intermediate <b>26</b> (228 mg, 0.95 mmol) according to the general procedures. White solid. 80 mg, yield 23.9%. Mp 196–198 °C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.13 (d, <i>J</i> = 7.7 Hz, 1H), 7.99 (s, 1H), 7.87 (d, <i>J</i> = 2.3 Hz, 1H), 7.56 (d, <i>J</i> = 8.2 Hz, 3H), 7.21 (d, <i>J</i> = 7.9 Hz, 2H), 7.14 (s, 1H), 6.78 (d, <i>J</i> = 8.9 Hz, 1H), 4.55 (d, <i>J</i> = 4.2 Hz, 1H), 3.53–3.43 (m, 1H), 3.39–3.33 (m, 1H), 2.56 (t, <i>J</i> = 7.4 Hz, 2H), 2.00–1.97 (m, 2H), 1.85–1.80 (m, 2H), 1.67–1.54 (m, 2H), 1.31–1.14 (m, 4H), 0.91 (t, <i>J</i> = 7.3 Hz, 3H). HRMS (ESI): calcd for C<sub>22</sub>H<sub>29</sub>N<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup> 353.2151, found 353.2218. Purity: 96.80% by HPLC (MeOH/H<sub>2</sub>O = 90:10).</div></div><div id="sec5_4_3_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> 4′-(<i>tert</i>-Butyl)-4-(((1<i>r</i>,4<i>r</i>)-4-hydroxycyclohexyl)amino)-[1,1′-biphenyl]-3-carboxamide (<b>56</b>)</h3><div class="NLM_p last">Compound <b>56</b> was prepared from intermediate <b>27</b> (186 mg, 0.74 mmol) according to the general procedures. Light yellow solid. 48 mg, yield 17.7%. Mp 199–201 °C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.12 (d, <i>J</i> = 7.7 Hz, 1H), 7.97 (s, 1H), 7.86 (d, <i>J</i> = 2.2 Hz, 1H), 7.55 (d, <i>J</i> = 8.3 Hz, 3H), 7.40 (d, <i>J</i> = 8.4 Hz, 2H), 7.12 (s, 1H), 6.78 (d, <i>J</i> = 8.9 Hz, 1H), 4.54 (d, <i>J</i> = 4.2 Hz, 1H), 3.52–3.43 (m, 1H), 3.39–3.31 (m, 1H), 2.01–1.97 (m, 2H), 1.85–1.81 (m, 2H), 1.38–1.15 (m, 13H). HRMS (ESI): calcd for C<sub>23</sub>H<sub>31</sub>N<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup> 367.2307, found 367.2380. <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 171.67, 148.27, 148.16, 137.17, 130.49, 127.19, 125.46, 125.37, 125.33, 113.92, 112.11, 68.03, 49.43, 34.08, 33.45, 31.13, 30.26. Purity: 95.78% by HPLC (MeOH/H<sub>2</sub>O = 90:10).</div></div><div id="sec5_4_3_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> 4′-Ethoxy-4-(((1<i>r</i>,4<i>r</i>)-4-hydroxycyclohexyl)amino)-[1,1′-biphenyl]-3-carboxamide (<b>57</b>)</h3><div class="NLM_p last">Compound <b>57</b> was prepared from intermediate <b>28</b> (100 mg, 0.41 mmol) according to the general procedures. White solid. 66 mg, yield 45.5%. Mp >250 °C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.08 (d, <i>J</i> = 7.7 Hz, 1H), 7.98 (s, 1H), 7.82 (s, 1H), 7.57–7.50 (m, 3H), 7.12 (s, 1H), 6.94 (d, <i>J</i> = 8.4 Hz, 2H), 6.76 (d, <i>J</i> = 8.8 Hz, 1H), 4.54 (d, <i>J</i> = 4.1 Hz, 1H), 4.04 (q, <i>J</i> = 6.8 Hz, 2H), 3.52–3.44 (m, 1H), 3.40–3.30 (m, 1H), 2.00–1.96 (m, 2H), 1.85–1.80 (m, 2H), 1.33 (t, <i>J</i> = 6.9 Hz, 3H), 1.26–1.13 (m, 4H). HRMS (ESI): calcd for C<sub>21</sub>H<sub>27</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup> 355.1943, found 355.2009. Purity: 99.01% by HPLC (MeOH/H<sub>2</sub>O = 90:10).</div></div><div id="sec5_4_3_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> 4-(((1<i>r</i>,4<i>r</i>)-4-Hydroxycyclohexyl)amino)-2′,3′-dimethyl-[1,1′-biphenyl]-3-carboxamide (<b>58</b>)</h3><div class="NLM_p last">Compound <b>58</b> was prepared from intermediate <b>29</b> (179 mg, 0.80 mmol) according to the general procedures. White solid. 47 mg, yield 17.4%. Mp 222–224 °C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.16 (d, <i>J</i> = 7.6 Hz, 1H), 7.82 (s, 1H), 7.53 (d, <i>J</i> = 2.1 Hz, 1H), 7.18 (dd, <i>J</i> = 8.5, 2.1 Hz, 1H), 7.09 (d, <i>J</i> = 5.1 Hz, 2H), 7.06–7.02 (m, 1H), 6.74 (d, <i>J</i> = 8.7 Hz, 1H), 4.58 (d, <i>J</i> = 4.2 Hz, 1H), 3.52–3.43 (m, 1H), 3.32–3.25 (m, 1H), 2.27 (s, 3H), 2.12 (s, 3H), 2.01–1.97 (m, 2H), 1.85–1.81 (m, 2H), 1.38–1.14 (m, 4H). HRMS (ESI): calcd for C<sub>21</sub>H<sub>27</sub>N<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup> 339.1994, found 339.2069. <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 171.62, 147.79, 141.35, 136.60, 133.49, 133.41, 129.77, 128.01, 127.56, 127.03, 125.14, 113.16, 111.17, 68.07, 49.47, 33.50, 30.33, 20.41, 16.77. Purity: 95.44% by HPLC (MeOH/H<sub>2</sub>O = 90:10).</div></div><div id="sec5_4_3_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> 4-(((1<i>r</i>,4<i>r</i>)-4-Hydroxycyclohexyl)amino)-2′,4′-dimethyl-[1,1′-biphenyl]-3-carboxamide (<b>59</b>)</h3><div class="NLM_p last">Compound <b>59</b> was prepared from intermediate <b>30</b> (200 mg, 0.89 mmol) according to the general procedures. White solid. 67 mg, yield 22.3%. Mp 192–194 °C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.14 (d, <i>J</i> = 7.7 Hz, 1H), 7.83 (s, 1H), 7.54 (d, <i>J</i> = 2.0 Hz, 1H), 7.21 (dd, <i>J</i> = 8.5, 2.1 Hz, 1H), 7.10–7.00 (m, 4H), 6.73 (d, <i>J</i> = 8.8 Hz, 1H), 4.58 (d, <i>J</i> = 4.2 Hz, 1H), 3.53–3.42 (m, 1H), 3.32–3.26 (m, 1H), 2.28 (s, 3H), 2.21 (s, 3H), 2.00–1.97 (m, 2H), 1.85–1.80 (m, 2H), 1.38–1.14 (m, 4H). HRMS (ESI): calcd for C<sub>21</sub>H<sub>27</sub>N<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup> 339.1994, found 339.2070. Purity: 98.99% by HPLC (MeOH/H<sub>2</sub>O = 90:10).</div></div><div id="sec5_4_3_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> 4-(((1<i>r</i>,4<i>r</i>)-4-Hydroxycyclohexyl)amino)-2′,6′-dimethyl-[1,1′-biphenyl]-3-carboxamide (<b>60</b>)</h3><div class="NLM_p last">Compound <b>60</b> was prepared from intermediate <b>31</b> (149 mg, 0.66 mmol) according to the general procedures. Light yellow solid. 86 mg, yield 38.6%. Mp 212–214 °C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.25 (d, <i>J</i> = 7.5 Hz, 1H), 7.77 (s, 1H), 7.39 (d, <i>J</i> = 2.1 Hz, 1H), 7.08 (s, 3H), 7.01 (d, <i>J</i> = 8.4 Hz, 2H), 6.76 (d, <i>J</i> = 8.6 Hz, 1H), 4.57 (d, <i>J</i> = 4.2 Hz, 1H), 3.52–3.44 (m, 1H), 3.31–3.26 (m, 1H), 2.01 (s, 6H), 1.99–1.94 (m, 2H), 1.86–1.82 (m, 2H), 1.39–1.30 (m, 2H), 1.26–1.15 (m, 2H). HRMS (ESI): calcd for C<sub>21</sub>H<sub>27</sub>N<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup> 339.1994, found 339.2068. Purity: 97.78% by HPLC (MeOH/H<sub>2</sub>O = 90:10).</div></div><div id="sec5_4_3_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> 4-(((1<i>r</i>,4<i>r</i>)-4-Hydroxycyclohexyl)amino)-3′,4′-dimethyl-[1,1′-biphenyl]-3-carboxamide (<b>61</b>)</h3><div class="NLM_p last">Compound <b>61</b> was prepared from intermediate <b>32</b> (210 mg, 0.93 mmol) according to the general procedures. White solid. 38 mg, yield 12.1%. Mp 172–174 °C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.03 (d, <i>J</i> = 7.7 Hz, 1H), 7.90 (s, 1H), 7.76 (d, <i>J</i> = 2.2 Hz, 1H), 7.45 (d, <i>J</i> = 8.9 Hz, 1H), 7.35 (s, 1H), 7.26 (d, <i>J</i> = 7.8 Hz, 1H), 7.06–7.03 (m, 2H), 6.67 (d, <i>J</i> = 8.8 Hz, 1H), 4.47 (d, <i>J</i> = 4.1 Hz, 1H), 3.43–3.33 (m, 2H), 2.18 (s, 3H), 2.13 (s, 3H), 1.92–1.88 (m, 2H), 1.76–1.72 (m, 2H), 1.30–1.04 (m, 4H). HRMS (ESI): calcd for C<sub>21</sub>H<sub>27</sub>N<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup>339.1994, found 339.2060. Purity: 96.68% by HPLC (MeOH/H<sub>2</sub>O = 90:10).</div></div><div id="sec5_4_3_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> 4-(((1<i>r</i>,4<i>r</i>)-4-Hydroxycyclohexyl)amino)-3′,5′-dimethyl-[1,1′-biphenyl]-3-carboxamide (<b>62</b>)</h3><div class="NLM_p last">Compound <b>62</b> was prepared from intermediate <b>33</b> (170 mg, 0.76 mmol) according to the general procedures. White solid. 118 mg, yield 45.9%. Mp 209–211 °C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.15 (d, <i>J</i> = 7.7 Hz, 1H), 8.01 (s, 1H), 7.85 (d, <i>J</i> = 2.3 Hz, 1H), 7.54 (d, <i>J</i> = 8.4 Hz, 1H), 7.25 (s, 2H), 7.19 (s, 1H), 6.87 (s, 1H), 6.76 (d, <i>J</i> = 8.7 Hz, 1H), 4.59 (d, <i>J</i> = 4.1 Hz, 1H), 3.53–3.42 (m, 1H), 3.32–3.25 (m, 1H), 2.30 (s, 6H), 2.00–1.96 (m, 2H), 1.85–1.80 (m, 2H), 1.38–1.30 (m, 2H), 1.27–1.13 (m, 2H). HRMS (ESI): calcd for C<sub>21</sub>H<sub>27</sub>N<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup> 339.1994, found 339.2068. Purity: 96.86% by HPLC (MeOH/H<sub>2</sub>O = 90:10).</div></div><div id="sec5_4_3_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> 4-(((1<i>r</i>,4<i>r</i>)-4-Hydroxycyclohexyl)amino)-2′,4′,6′-trimethyl-[1,1′-biphenyl]-3-carboxamide (<b>63</b>)</h3><div class="NLM_p last">Compound <b>63</b> was prepared from intermediate <b>34</b> (196 mg, 0.82 mmol) according to the general procedures. White solid. 126 mg, yield 43.7%. Mp 202–204 °C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.21 (d, <i>J</i> = 7.6 Hz, 1H), 7.73 (s, 1H), 7.36 (d, <i>J</i> = 2.1 Hz, 1H), 6.98 (dd, <i>J</i> = 8.5, 2.0 Hz, 2H), 6.89 (s, 2H), 6.75 (d, <i>J</i> = 8.7 Hz, 1H), 4.54 (d, <i>J</i> = 4.2 Hz, 1H), 3.52–3.43 (m, 1H), 3.36–3.31 (m, 1H), 2.24 (s, 3H), 2.03–1.98 (m, 2H), 1.97 (s, 6H), 1.86–1.82 (m, 2H), 1.39–1.15 (m, 4H). HRMS (ESI): calcd for C<sub>22</sub>H<sub>29</sub>N<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup> 353.2151, found 353.2220. <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 171.61, 147.77, 138.26, 135.85, 135.36, 133.39, 129.51, 127.78, 125.28, 113.08, 111.54, 68.12, 49.53, 33.55, 30.44, 20.68, 20.58. Purity: 98.75% by HPLC (MeOH/H<sub>2</sub>O = 90:10).</div></div><div id="sec5_4_3_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> 2′,3′-Dichloro-4-(((1<i>r</i>,4<i>r</i>)-4-hydroxycyclohexyl)amino)-[1,1′-biphenyl]-3-carboxamide (<b>64</b>)</h3><div class="NLM_p last">Compound <b>64</b> was prepared from intermediate <b>35</b> (60 mg, 0.23 mmol) according to the general procedures. White solid. 31 mg, yield 35.6%. Mp 229–231 °C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.29 (d, <i>J</i> = 7.6 Hz, 1H), 7.86 (s, 1H), 7.67 (d, <i>J</i> = 2.2 Hz, 1H), 7.58 (t, <i>J</i> = 4.8 Hz, 1H), 7.40–7.35 (m, 3H), 7.16 (s, 1H), 6.78 (d, <i>J</i> = 9.0 Hz, 1H), 4.59 (d, <i>J</i> = 4.2 Hz, 1H), 3.52–3.44 (m, 1H), 3.40–3.36 (m, 1H), 2.00–1.97 (m, 2H), 1.85–1.80 (m, 2H), 1.39–1.29 (m, 2H), 1.25–1.14 (m, 2H). HRMS (ESI): calcd for C<sub>19</sub>H<sub>21</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup> 379.0902, found 379.0981. Purity: 95.04% by HPLC (MeOH/H<sub>2</sub>O = 90:10).</div></div><div id="sec5_4_3_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> 2′,6′-Dichloro-4-(((1<i>r</i>,4<i>r</i>)-4-hydroxycyclohexyl)amino)-[1,1′-biphenyl]-3-carboxamide (<b>65</b>)</h3><div class="NLM_p last">Compound <b>65</b> was prepared from intermediate <b>36</b> (100 mg, 0.38 mmol) according to the general procedures. Light yellow solid. 37 mg, yield 25.8%. Mp 189–191 °C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.46 (d, <i>J</i> = 7.5 Hz, 1H), 7.78 (s, 1H), 7.56–7.54 (m, 3H), 7.39–7.34 (m, 1H), 7.18–7.07 (m, 2H), 6.78 (d, <i>J</i> = 8.9 Hz, 1H), 4.58 (d, <i>J</i> = 4.2 Hz, 1H), 3.52–3.45 (m, 1H), 3.32–3.27 (m, 1H), 2.01–1.97 (m, 2H), 1.85–1.82 (m, 2H), 1.38–1.27 (m, 2H), 1.23–1.15 (m, 2H). HRMS (ESI): calcd for C<sub>19</sub>H<sub>21</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup> 379.0902, found 379.0978. <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 171.30, 148.84, 138.62, 134.71, 133.74, 130.40, 129.52, 128.33, 121.21, 112.48, 111.18, 68.02, 49.42, 33.44, 30.29. Purity: 99.51% by HPLC (MeOH/H<sub>2</sub>O = 90:10).</div></div><div id="sec5_4_3_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> 3′,4′-Dichloro-4-(((1<i>r</i>,4<i>r</i>)-4-hydroxycyclohexyl)amino)-[1,1′-biphenyl]-3-carboxamide (<b>66</b>)</h3><div class="NLM_p last">Compound <b>66</b> was prepared from intermediate <b>37</b> (113 mg, 0.42 mmol) according to the general procedures. Light yellow solid. 42 mg, yield 26.4%. Mp 222–224 °C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.34 (d, <i>J</i> = 7.7 Hz, 1H), 8.05 (s, 1H), 7.95 (dd, <i>J</i> = 8.5, 2.1 Hz, 2H), 7.68–7.60 (m, 3H), 7.22 (s, 1H), 6.80 (d, <i>J</i> = 8.9 Hz, 1H), 4.54 (d, <i>J</i> = 4.2 Hz, 1H), 3.52–3.44 (m, 1H), 3.39–3.33 (m, 1H), 2.00–1.96 (m, 2H), 1.85–1.79 (m, 2H), 1.40–1.20 (m, 4H). HRMS (ESI): calcd for C<sub>19</sub>H<sub>21</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup> 379.0902, found 379.0970. Purity: 97.47% by HPLC (MeOH/H<sub>2</sub>O = 90:10).</div></div><div id="sec5_4_3_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> 3′,5′-Dichloro-4-(((1<i>r</i>,4<i>r</i>)-4-hydroxycyclohexyl)amino)-[1,1′-biphenyl]-3-carboxamide (<b>67</b>)</h3><div class="NLM_p last">Compound <b>67</b> was prepared from intermediate <b>38</b> (138 mg, 0.52 mmol) according to the general procedures. White solid. 170 mg, yield 86.5%. Mp 236–238 °C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.41 (d, <i>J</i> = 7.7 Hz, 1H), 8.09 (s, 1H), 7.95 (d, <i>J</i> = 2.3 Hz, 1H), 7.75 (d, <i>J</i> = 1.8 Hz, 2H), 7.67 (dd, <i>J</i> = 8.8, 2.2 Hz, 1H), 7.41 (t, <i>J</i> = 1.9 Hz, 1H), 7.26 (s, 1H), 6.79 (d, <i>J</i> = 8.9 Hz, 1H), 4.58 (d, <i>J</i> = 4.2 Hz, 1H), 3.52–3.38 (m, 2H), 2.00–1.96 (m, 2H), 1.85–1.81 (m, 2H), 1.40–1.15 (m, 4H). HRMS (ESI): calcd for C<sub>19</sub>H<sub>21</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup> 379.0902, found 379.0981. Purity: 99.39% by HPLC (MeOH/H<sub>2</sub>O = 90:10).</div></div><div id="sec5_4_3_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> 2-(((1<i>r</i>,4<i>r</i>)-4-Hydroxycyclohexyl)amino)-5-(naphthalen-1-yl)benzamide (<b>68</b>)</h3><div class="NLM_p last">Compound <b>68</b> was prepared from intermediate <b>39</b> (215 mg, 0.87 mmol) according to the general procedures. White solid. 126 mg, yield 40.3%. Mp >250 °C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.22 (d, <i>J</i> = 7.7 Hz, 1H), 7.98–7.95 (m, 1H), 7.91–7.87 (m, 3H), 7.74 (d, <i>J</i> = 2.1 Hz, 1H), 7.57–7.43 (m, 4H), 7.38 (dd, <i>J</i> = 8.5, 2.1 Hz, 1H), 7.12 (s, 1H), 6.86 (d, <i>J</i> = 8.7 Hz, 1H), 4.59 (d, <i>J</i> = 4.1 Hz, 1H), 3.54–3.47 (m, 1H), 3.42–3.36 (m, 1H), 2.06–2.01 (m, 2H), 1.87–1.83 (m, 2H), 1.40–1.17 (m, 4H). HRMS (ESI): calcd for C<sub>23</sub>H<sub>25</sub>N<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup> 361.1838, found 361.1907. Purity: 96.02% by HPLC (MeOH/H<sub>2</sub>O = 90:10).</div></div><div id="sec5_4_3_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i88" class="anchor-spacer"></div><h3 class="article-section__title" id="_i88"> 2-(((1<i>r</i>,4<i>r</i>)-4-Hydroxycyclohexyl)amino)-5-(naphthalen-2-yl)benzamide (<b>69</b>)</h3><div class="NLM_p last">Compound <b>69</b> was prepared from intermediate <b>40</b> (168 mg, 0.68 mmol) according to the general procedures. Light yellow solid. 48 mg, yield 19.6%. Mp 196–198 °C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.24 (d, <i>J</i> = 7.6 Hz, 1H), 8.16 (s, 1H), 8.10 (s, 1H), 8.06 (d, <i>J</i> = 2.2 Hz, 1H), 7.96–7.87 (m, 4H), 7.75 (dd, <i>J</i> = 8.8, 2.2 Hz, 1H), 7.53–7.42 (m, 2H), 7.24 (s, 1H), 6.84 (d, <i>J</i> = 9.0 Hz, 1H), 4.59 (d, <i>J</i> = 3.8 Hz, 1H), 3.52–3.45 (m, 1H), 3.42–3.37 (m, 1H), 2.02–1.98 (m, 2H), 1.86–1.82 (m, 2H), 1.40–1.15 (m, 4H). HRMS (ESI): calcd for C<sub>23</sub>H<sub>25</sub>N<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup> 361.1838, found 361.1905. Purity: 96.53% by HPLC (MeOH/H<sub>2</sub>O = 90:10).</div></div><div id="sec5_4_3_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i89" class="anchor-spacer"></div><h3 class="article-section__title" id="_i89"> 4-(((1<i>r</i>,4<i>r</i>)-4-Hydroxycyclohexyl)amino)-4′-(1<i>H</i>-pyrrol-1-yl)-[1,1′-biphenyl]-3-carboxamide (<b>70</b>)</h3><div class="NLM_p last">Compound <b>70</b> was prepared from intermediate <b>41</b> (173 mg, 0.66 mmol) according to the general procedures. Light yellow solid. 80 mg, yield 32.3%. Mp >250 °C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.20 (d, <i>J</i> = 7.3 Hz, 1H), 8.03 (s, 1H), 7.94 (s, 1H), 7.76–7.73 (m, 2H), 7.64–7.59 (m, 3H), 7.39 (s, 2H), 7.16 (s, 1H), 6.82 (d, <i>J</i> = 8.7 Hz, 1H), 6.28 (s, 2H), 4.54 (d, <i>J</i> = 3.3 Hz, 1H), 3.55–3.47 (m, 1H), 3.38–3.36 (m, 1H), 2.03–2.00 (m, 2H), 1.87–1.83 (m, 2H), 1.41–1.17 (m, 4H). HRMS (ESI): calcd for C<sub>23</sub>H<sub>26</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup> 376.1947, found 376.2013. Purity: 99.22% by HPLC (MeOH/H<sub>2</sub>O = 90:10).</div></div><div id="sec5_4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i90" class="anchor-spacer"></div><h3 class="article-section__title" id="_i90"> General Procedures for the Synthesis of Compounds <b>71</b>–<b>78</b></h3><div class="NLM_p last">Intermediate <b>25</b> was dissolved in 5 mL of DMSO, and different amines (4.5–10 equiv) and DIPEA (9.0 equiv) were added. The mixture was heated at 120 °C for 24 h and then poured into 20 mL of water and extracted with 20 mL of EA two times. The EA layer was combined and dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. After concentration, the residue was dissolved in 20 mL of ethanol, and 2 mL of 1 M NaOH solution and 2 mL of 30% H<sub>2</sub>O<sub>2</sub> were added. Then the mixture was stirred at 30 °C overnight. After removing ethanol under reduced pressure, the residue was dissolved in 20 mL of EA and washed with water (20 mL × 2) and brine (20 mL × 1). The EA layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> and then concentrated. The residue was triturated with DCM to afford compounds <b>71</b>–<b>78</b>.</div></div><div id="sec5_4_4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i91" class="anchor-spacer"></div><h3 class="article-section__title" id="_i91"> 4-(Cyclohexylamino)-4′-isopropyl-[1,1′-biphenyl]-3-carboxamide (<b>71</b>)</h3><div class="NLM_p last">Compound <b>71</b> was prepared from intermediate <b>25</b> (150 mg, 0.63 mmol) and cyclohexylamine (279 mg, 2.82 mmol) according to the general procedures. Light yellow solid, 75 mg, yield 35.4%. Mp 197–198 °C. <sup>1</sup>H NMR (300 MHz, chloroform-<i>d</i>) δ 7.78 (d, <i>J</i> = 7.6 Hz, 1H), 7.49–7.44 (m, 2H), 7.36 (d, <i>J</i> = 8.2 Hz, 2H), 7.18 (s, 2H), 6.71 (d, <i>J</i> = 8.7 Hz, 1H), 5.58 (s, 2H), 3.38–3.28 (m, 1H), 2.93–2.80 (m, 1H), 1.98–1.94 (m, 2H), 1.74–1.69 (m, 2H), 1.57–1.49 (m, 2H), 1.39–1.26 (m, 4H), 1.21 (d, <i>J</i> = 6.9 Hz, 6H). HRMS (ESI): calcd for C<sub>22</sub>H<sub>29</sub>N<sub>2</sub>O [M + H]<sup>+</sup> 337.2202, found 337.2279. Purity: 97.80% by HPLC (MeOH 100%).</div></div><div id="sec5_4_4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i92" class="anchor-spacer"></div><h3 class="article-section__title" id="_i92"> 4-(Isobutylamino)-4′-isopropyl-[1,1′-biphenyl]-3-carboxamide (<b>72</b>)</h3><div class="NLM_p last">Compound <b>72</b> was prepared from intermediate <b>25</b> (150 mg, 0.63 mmol) and isobutylamine (461 mg, 6.3 mmol) according to the general procedures. Light yellow solid, 107 mg, yield 54.8%. Mp 166–168 °C. <sup>1</sup>H NMR (300 MHz, chloroform-<i>d</i>) δ 8.10 (s, 1H), 7.60–7.56 (m, 2H), 7.46 (d, <i>J</i> = 8.2 Hz, 2H), 7.28 (s, 2H), 6.81 (d, <i>J</i> = 8.6 Hz, 1H), 5.74 (s, 2H), 3.05 (d, <i>J</i> = 6.8 Hz, 2H), 3.01–2.91 (m, 1H), 2.08–1.95 (m, 1H), 1.30 (d, <i>J</i> = 7.0 Hz, 6H), 1.05 (d, <i>J</i> = 6.6 Hz, 6H). HRMS (ESI): calcd for C<sub>20</sub>H<sub>27</sub>N<sub>2</sub>O [M + H]<sup>+</sup> 311.2045, found 311.2116. Purity: 95.00% by HPLC (MeOH/H<sub>2</sub>O = 90:10).</div></div><div id="sec5_4_4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i93" class="anchor-spacer"></div><h3 class="article-section__title" id="_i93"> 4-(Cyclopentylamino)-4′-isopropyl-[1,1′-biphenyl]-3-carboxamide (<b>73</b>)</h3><div class="NLM_p last">Compound <b>73</b> was prepared from intermediate <b>25</b> (150 mg, 0.63 mmol) and cyclopentylamine (240 mg, 2.82 mmol) according to the general procedures. White solid, 108 mg, yield 53.2%. Mp 169–171 °C. <sup>1</sup>H NMR (300 MHz, chloroform-<i>d</i>) δ 7.88 (s, 1H), 7.50–7.47 (m, 2H), 7.36 (d, <i>J</i> = 8.2 Hz, 2H), 7.18 (s, 2H), 6.75 (d, <i>J</i> = 8.6 Hz, 1H), 5.62 (s, 2H), 3.83–3.75 (m, 1H), 2.91–2.82 (m, 1H), 2.02–1.92 (m, 2H), 1.76–1.66 (m, 2H), 1.60–1.48 (m, 4H), 1.21 (d, <i>J</i> = 6.9 Hz, 6H). HRMS (ESI): calcd for C<sub>21</sub>H<sub>27</sub>N<sub>2</sub>O [M + H]<sup>+</sup> 323.2045, found 323.2122. Purity: 98.55% by HPLC (MeOH/H<sub>2</sub>O = 90:10).</div></div><div id="sec5_4_4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i94" class="anchor-spacer"></div><h3 class="article-section__title" id="_i94"> 4-((Cyclohexylmethyl)amino)-4′-isopropyl-[1,1′-biphenyl]-3-carboxamide (<b>74</b>)</h3><div class="NLM_p last">Compound <b>74</b> was prepared from intermediate <b>25</b> (150 mg, 0.63 mmol) and cyclohexylmethanamine (319 mg, 2.82 mmol) according to the general procedures. Light yellow solid, 80 mg, yield 36.3%. Mp 248–249 °C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.27 (t, <i>J</i> = 5.5 Hz, 1H), 8.00 (s, 1H), 7.87 (d, <i>J</i> = 2.3 Hz, 1H), 7.56 (d, <i>J</i> = 8.3 Hz, 3H), 7.26 (d, <i>J</i> = 8.2 Hz, 2H), 7.15 (s, 1H), 6.73 (d, <i>J</i> = 8.7 Hz, 1H), 3.00 (t, <i>J</i> = 6.1 Hz, 2H), 2.94–2.85 (m, 1H), 1.79–1.50 (m, 7H), 1.25–1.18 (m, 8H), 1.04–0.96 (m, 2H). HRMS (ESI): calcd for C<sub>23</sub>H<sub>31</sub>N<sub>2</sub>O [M + H]<sup>+</sup> 351.2358, found 351.2436. Purity: 98.19% by HPLC (MeOH 100%).</div></div><div id="sec5_4_4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i95" class="anchor-spacer"></div><h3 class="article-section__title" id="_i95"> 4′-Isopropyl-4-((2-methoxyethyl)amino)-[1,1′-biphenyl]-3-carboxamide (<b>75</b>)</h3><div class="NLM_p last">Compound <b>75</b> was prepared from intermediate <b>25</b> (150 mg, 0.63 mmol) and 2-methoxyethylamine (212 mg, 2.82 mmol) according to the general procedures. Light yellow solid, 118 mg, yield 60.0%. Mp 169–170 °C. <sup>1</sup>H NMR (300 MHz, chloroform-<i>d</i>) δ 7.62–7.58 (m, 2H), 7.47 (d, <i>J</i> = 8.9 Hz, 2H), 7.28 (s, 2H), 6.88 (d, <i>J</i> = 8.6 Hz, 1H), 5.80 (s, 2H), 3.68 (t, <i>J</i> = 5.6 Hz, 2H), 3.46–3.42 (m, 5H), 3.00–2.91 (m, 1H), 1.30 (d, <i>J</i> = 6.9 Hz, 6H). HRMS (ESI): calcd for C<sub>19</sub>H<sub>25</sub>N<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup> 313.1838, found 313.1913. <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 171.98, 149.28, 146.63, 138.03, 130.93, 127.50, 127.06, 126.48, 126.12, 114.94, 112.06, 70.99, 58.54, 42.42, 33.51, 24.40. Purity: 96.31% by HPLC (MeOH/H<sub>2</sub>O = 90:10).</div></div><div id="sec5_4_4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i96" class="anchor-spacer"></div><h3 class="article-section__title" id="_i96"> (<i>S</i>)-4′-Isopropyl-4-((tetrahydrofuran-3-yl)amino)-[1,1′-biphenyl]-3-carboxamide (<b>76</b>)</h3><div class="NLM_p last">Compound <b>76</b> was prepared from intermediate <b>25</b> (150 mg, 0.63 mmol) and (<i>S</i>)-3-aminotetrahydrofuran hydrochloride (348 mg, 2.82 mmol) according to the general procedures. White solid, 10 mg, yield 4.9%. Mp 224–226 °C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.23 (d, <i>J</i> = 6.6 Hz, 1H), 7.96 (s, 1H), 7.80 (d, <i>J</i> = 2.2 Hz, 1H), 7.50–7.47 (m, 3H), 7.19–7.14 (m, 3H), 6.68 (d, <i>J</i> = 8.7 Hz, 1H), 4.08–4.00 (m, 1H), 3.85–3.80 (m, 1H), 3.77–3.62 (m, 2H), 3.43 (dd, <i>J</i> = 8.8, 3.2 Hz, 1H), 2.85–2.76 (m, 1H), 2.23–2.11 (m, 1H), 1.69–1.59 (m, 1H), 1.13 (d, <i>J</i> = 6.9 Hz, 6H). HRMS (ESI): calcd for C<sub>20</sub>H<sub>25</sub>N<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup> 325.1838, found 325.1915. Purity: 96.57% by HPLC (MeOH/H<sub>2</sub>O = 90:10).</div></div><div id="sec5_4_4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i97" class="anchor-spacer"></div><h3 class="article-section__title" id="_i97"> 4′-Isopropyl-4-((tetrahydro-2<i>H</i>-pyran-4-yl)amino)-[1,1′-biphenyl]-3-carboxamide (<b>77</b>)</h3><div class="NLM_p last">Compound <b>77</b> was prepared from intermediate <b>25</b> (150 mg, 0.63 mmol) and 4-aminotetrahydropyran (285 mg, 2.82 mmol) according to the general procedures. White solid, 83 mg, yield 40.0%. Mp 198–199 °C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.16 (d, <i>J</i> = 7.6 Hz, 1H), 7.94 (s, 1H), 7.79 (d, <i>J</i> = 2.2 Hz, 1H), 7.47 (d, <i>J</i> = 7.8 Hz, 3H), 7.17 (d, <i>J</i> = 8.3 Hz, 2H), 7.11 (s, 1H), 6.75 (d, <i>J</i> = 8.8 Hz, 1H), 3.77–3.73 (m, 2H), 3.58–3.49 (m, 1H), 3.38 (t, <i>J</i> = 10.3 Hz, 2H), 2.85–2.76 (m, 1H), 1.87–1.83 (m, 2H), 1.35–1.22 (m, 2H), 1.13 (d, <i>J</i> = 6.9 Hz, 6H). HRMS (ESI): calcd for C<sub>21</sub>H<sub>27</sub>N<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup> 339.1994, found 339.2073. <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 171.66, 147.73, 146.15, 137.52, 130.47, 127.21, 126.55, 125.95, 125.64, 114.18, 112.21, 65.57, 47.04, 33.02, 32.82, 23.90. Purity: 97.83% by HPLC (MeOH 100%).</div></div><div id="sec5_4_4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i98" class="anchor-spacer"></div><h3 class="article-section__title" id="_i98"> 4-((1-Acetylpiperidin-4-yl)amino)-4′-isopropyl-[1,1′-biphenyl]-3-carboxamide (<b>78</b>)</h3><div class="NLM_p last">Compound <b>78</b> was prepared from intermediate <b>25</b> (150 mg, 0.63 mmol) and 1-acetyl-4-aminopiperidine (401 mg, 2.82 mmol) according to the general procedures. Light yellow solid, 50 mg, yield 20.9%. Mp 203–204 °C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.18 (d, <i>J</i> = 7.9 Hz, 1H), 7.96 (s, 1H), 7.80 (d, <i>J</i> = 2.3 Hz, 1H), 7.47 (d, <i>J</i> = 8.2 Hz, 3H), 7.17 (d, <i>J</i> = 8.0 Hz, 2H), 7.12 (s, 1H), 6.77 (d, <i>J</i> = 8.9 Hz, 1H), 4.04–3.99 (m, 1H), 3.66–3.56 (m, 2H), 3.16 (t, <i>J</i> = 11.1 Hz, 1H), 2.89–2.76 (m, 2H), 1.92 (s, 3H), 1.90–1.82 (m, 2H), 1.33–1.20 (m, 2H), 1.13 (d, <i>J</i> = 6.8 Hz, 6H). HRMS (ESI): calcd for C<sub>23</sub>H<sub>30</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup> 380.226, found 380.2335. <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 171.65, 168.01, 147.79, 146.17, 137.51, 130.50, 127.21, 126.56, 126.03, 125.66, 114.22, 112.27, 47.78, 44.21, 33.01, 32.11, 31.45, 23.90, 21.28. Purity: 96.16% by HPLC (MeOH/H<sub>2</sub>O = 90:10)</div></div><div id="sec5_4_4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i99" class="anchor-spacer"></div><h3 class="article-section__title" id="_i99"> 4′-Isopropyl-4-(piperidin-4-ylamino)-[1,1′-biphenyl]-3-carboxamide (<b>79</b>)</h3><div class="NLM_p last">Intermediate <b>25</b> (1.67 g, 7.0 mmol) was dissolved in 5 mL of DMSO, and 4-amino-1-Boc-piperidine (6.3 g, 31.5 mmol) and DIPEA (11 mL, 63 mmol) were added. The mixture was heated at 120 °C for 24 h and then poured into 60 mL of water and extracted with 60 mL of EA two times. The EA layer was combined and dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. After concentration, the residue was dissolved in 60 mL of ethanol, and 6 mL of 1 M NaOH solution and 6 mL of 30% H<sub>2</sub>O<sub>2</sub> were added. Then the mixture was stirred at 30 °C overnight. After removal of ethanol under reduced pressure, the residue was dissolved in 60 mL of EA and washed with water (60 mL × 2) and brine (60 mL × 1). After concentration, the residue was dissolved in 120 mL of DCM, and TFA (3.9 mL, 52.6 mmol) was added. The mixture was stirred at room temperature for 48 h. After complete reaction, the mixture was concentrated and the residue was dispersed into 50 mL of water. Then the pH was adjusted to 9–10 and light yellow solid precipitated and filtered to afford compound <b>79</b>. Light yellow solid, 1.3 g, yield 55.1%. Mp 216–218 °C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.13 (d, <i>J</i> = 7.9 Hz, 1H), 7.93 (s, 1H), 7.78 (d, <i>J</i> = 2.2 Hz, 1H), 7.48–7.45 (m, 3H), 7.17 (d, <i>J</i> = 8.0 Hz, 2H), 7.09 (s, 1H), 6.70 (d, <i>J</i> = 8.8 Hz, 1H), 3.44–3.37 (m, 2H), 2.88–2.75 (m, 3H), 2.57–2.50 (t, <i>J</i> = 11.2 Hz, 2H), 1.85–1.81 (m, 2H), 1.24–1.17 (m, 2H), 1.13 (d, <i>J</i> = 6.9 Hz, 6H). HRMS (ESI): calcd for C<sub>21</sub>H<sub>28</sub>N<sub>3</sub>O [M + H]<sup>+</sup> 338.2154, found 338.2232. Purity: 96.43% by HPLC (MeOH 100%).</div></div><div id="sec5_4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i100" class="anchor-spacer"></div><h3 class="article-section__title" id="_i100"> General Procedures for the Synthesis of Compounds <b>80</b>–<b>86</b></h3><div class="NLM_p last">Compound <b>79</b> was dissolved in 5 mL of DMF, and various Boc-protected amino acids (1.5 equiv), BOP (1.5 equiv), DIPEA (3 equiv) were added. The mixture was stirred at room temperature for 5 h. Then the mixture was concentrated and redissolved in 20 mL of DCM, washed with water (20 mL × 2) and brine (20 mL × 1). The DCM layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and then purified by silica gel chromatography (PE/EA, 5:1 to 2:1) to afford a white solid. The white product was dissolved in 20 mL of DCM, TFA was added, and the mixture was stirred at room temperature for 36 h. The mixture was dispersed into 20 mL of saturated Na<sub>2</sub>CO<sub>3</sub> solution and 20 mL of EA. After stirring for a while, the EA layer was separated and washed with water (20 mL × 3) and brine (20 mL × 1). The EA layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> and then purified by silica gel chromatography (DCM/MeOH, 50:1 to 30:1) to afford compounds <b>80</b>–<b>86</b>.</div></div><div id="sec5_4_5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i101" class="anchor-spacer"></div><h3 class="article-section__title" id="_i101"> 4-((1-(2-Aminoacetyl)piperidin-4-yl)amino)-4′-isopropyl-[1,1′-biphenyl]-3-carboxamide (<b>80</b>)</h3><div class="NLM_p last">Compound <b>80</b> was prepared from compound <b>79</b> (120 mg, 0.36 mmol) and Boc-glycine (95 mg, 0.54 mmol) according to the general procedures. White solid, 50 mg, yield 35.2%. Mp 110–112 °C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.28 (d, <i>J</i> = 7.2 Hz, 1H), 8.05 (s, 1H), 7.89 (s, 1H), 7.57 (d, <i>J</i> = 8.0 Hz, 3H), 7.27 (d, <i>J</i> = 8.2 Hz, 3H), 6.87 (d, <i>J</i> = 8.8 Hz, 1H), 4.17–4.12 (m, 1H), 3.69–3.64 (m, 2H), 3.50–3.44 (m, 2H), 3.23–3.15 (m, 1H), 3.03–2.96 (m, 1H), 2.94–2.85 (m, 1H), 1.99–1.96 (m, 2H), 1.41–1.31 (m, 2H), 1.22 (d, <i>J</i> = 6.7 Hz, 6H). HRMS (ESI): calcd for C<sub>23</sub>H<sub>31</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup> 395.2369, found 395.2446. Purity: 97.83% by HPLC (MeOH/H<sub>2</sub>O = 90:10, 1‰ Et<sub>3</sub>N).</div></div><div id="sec5_4_5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i102" class="anchor-spacer"></div><h3 class="article-section__title" id="_i102"> 4-((1-(2-Aminopropanoyl)piperidin-4-yl)amino)-4′-isopropyl-[1,1′-biphenyl]-3-carboxamide (<b>81</b>)</h3><div class="NLM_p last">Compound <b>81</b> was prepared from compound <b>79</b> (120 mg, 0.36 mmol) and <i>N</i>-Boc-<span class="smallcaps smallerCapital">dl</span>-alanine (102 mg, 0.54 mmol) according to the general procedures. Light yellow solid, 63 mg, yield 42.9%. Mp 106–108 °C. <sup>1</sup>H NMR (300 MHz, chloroform-<i>d</i>) δ 7.94 (s, 1H), 7.53 (s, 1H), 7.47 (d, <i>J</i> = 8.8 Hz, 1H), 7.36 (d, <i>J</i> = 7.9 Hz, 2H), 7.18 (s, 2H), 6.70 (d, <i>J</i> = 8.8 Hz, 1H), 5.81 (brs, 2H), 4.17 (brs, 1H), 3.81–3.60 (m, 3H), 3.22–3.07 (m, 2H), 2.90–2.81 (m, 1H), 2.19 (brs, 2H), 2.00–1.97 (m, 2H), 1.50 (brs, 2H), 1.21–1.19 (m, 9H). HRMS (ESI): calcd for C<sub>24</sub>H<sub>33</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup> 409.2525, found 409.2603. Purity: 96.34% by HPLC (MeOH/H<sub>2</sub>O = 90:10, 1‰ Et<sub>3</sub>N).</div></div><div id="sec5_4_5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i103" class="anchor-spacer"></div><h3 class="article-section__title" id="_i103"> 4-((1-(3-Aminopropanoyl)piperidin-4-yl)amino)-4′-isopropyl-[1,1′-biphenyl]-3-carboxamide (<b>82</b>)</h3><div class="NLM_p last">Compound <b>82</b> was prepared from compound <b>79</b> (120 mg, 0.36 mmol) and Boc-β-alanine (102 mg, 0.54 mmol) according to the general procedures. Light yellow solid, 30 mg, yield 20.4%. Mp 84–86 °C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.28 (d, <i>J</i> = 8.1 Hz, 1H), 8.07 (s, 1H), 7.89 (s, 1H), 7.57 (d, <i>J</i> = 7.7 Hz, 3H), 7.27 (d, <i>J</i> = 8.0 Hz, 3H), 6.87 (d, <i>J</i> = 8.8 Hz, 1H), 4.18–4.13 (m, 1H), 3.78–3.68 (m, 2H), 3.28–3.21 (m, 2H), 3.01–2.92 (m, 1H), 2.87 (t, <i>J</i> = 6.4 Hz, 2H), 2.59–2.55 (m, 2H), 1.97 (brs, 2H), 1.44–1.25 (m, 2H), 1.22 (d, <i>J</i> = 6.7 Hz, 6H). HRMS (ESI): calcd for C<sub>24</sub>H<sub>33</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup> 409.2525, found 409.2600. Purity: 96.70% by HPLC (MeOH/H<sub>2</sub>O = 90:10, 1‰ Et<sub>3</sub>N).</div></div><div id="sec5_4_5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i104" class="anchor-spacer"></div><h3 class="article-section__title" id="_i104"> 4-((1-(2-Amino-3-methylbutanoyl)piperidin-4-yl)amino)-4′-isopropyl-[1,1′-biphenyl]-3-carboxamide (<b>83</b>)</h3><div class="NLM_p last">Compound <b>83</b> was prepared from compound <b>79</b> (120 mg, 0.36 mmol) and <i>N</i>-Boc-<span class="smallcaps smallerCapital">dl</span>-valine (117 mg, 0.54 mmol) according to the general procedures. White solid, 58 mg, yield 36.9%. Mp 94–96 °C. <sup>1</sup>H NMR (300 MHz, chloroform-<i>d</i>) δ 8.07–8.00 (m, 1H), 7.62 (s, 1H), 7.57 (d, <i>J</i> = 8.1 Hz, 1H), 7.46 (d, <i>J</i> = 8.0 Hz, 2H), 7.28 (s, 2H), 6.81 (d, <i>J</i> = 8.7 Hz, 1H), 5.99 (brs, 2H), 4.32–4.27 (m, 1H), 3.86–3.82 (m, 1H), 3.71–3.66 (m, 2H), 3.38–3.13 (m, 2H), 3.01–2.91 (m, 1H), 2.42 (brs, 2H), 2.09 (brs, 2H), 1.97–1.88 (m, 1H), 1.68–1.50 (m, 2H), 1.31–1.27 (m, 6H), 1.04–0.90 (m, 6H). HRMS (ESI): calcd for C<sub>26</sub>H<sub>37</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup> 437.2838, found 437.2917. Purity: 97.88% by HPLC (MeOH/H<sub>2</sub>O = 90:10, 1‰ Et<sub>3</sub>N).</div></div><div id="sec5_4_5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i105" class="anchor-spacer"></div><h3 class="article-section__title" id="_i105"> (<i>S</i>)-4-((1-(2-Amino-4-methylpentanoyl)piperidin-4-yl)amino)-4′-isopropyl-[1,1′-biphenyl]-3-carboxamide (<b>84</b>)</h3><div class="NLM_p last">Compound <b>84</b> was prepared from compound <b>79</b> (120 mg, 0.36 mmol) and Boc-<span class="smallcaps smallerCapital">l</span>-leucine (125 mg, 0.54 mmol) according to the general procedures. White solid, 48 mg, yield 29.6%. Mp 95–97 °C. <sup>1</sup>H NMR (300 MHz, chloroform-<i>d</i>) δ 8.07–8.02 (m, 1H), 7.61 (s, 1H), 7.57 (d, <i>J</i> = 8.5 Hz, 1H), 7.46 (d, <i>J</i> = 7.9 Hz, 2H), 7.28 (s, 2H), 6.81 (d, <i>J</i> = 8.7 Hz, 1H), 5.94 (brs, 2H), 4.28–4.24 (m, 1H), 3.90–3.83 (m, 1H), 3.70 (brs, 1H), 3.36–3.13 (m, 2H), 3.00–2.91 (m, 1H), 2.32 (brs, 2H), 2.16–2.07 (m, 2H), 1.90 (brs, 1H), 1.68–1.53 (m, 2H), 1.48–1.35 (m, 2H), 1.31–1.27 (m, 6H), 0.98–0.85 (m, 6H). HRMS (ESI): calcd for C<sub>27</sub>H<sub>39</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup> 451.3002, found 451.3074. Purity: 97.67% by HPLC (MeOH/H<sub>2</sub>O = 90:10, 1‰ Et<sub>3</sub>N).</div></div><div id="sec5_4_5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i106" class="anchor-spacer"></div><h3 class="article-section__title" id="_i106"> 4-((1-((2<i>S</i>,3<i>S</i>)-2-Amino-3-methylpentanoyl)piperidin-4-yl)amino)-4′-isopropyl-[1,1′-biphenyl]-3-carboxamide (<b>85</b>)</h3><div class="NLM_p last">Compound <b>85</b> was prepared from compound <b>79</b> (120 mg, 0.36 mmol) and Boc-<span class="smallcaps smallerCapital">l</span>-isoleucine (125 mg, 0.54 mmol) according to the general procedures. White solid, 40 mg, yield 24.7%. Mp 102–104 °C. <sup>1</sup>H NMR (300 MHz, chloroform-<i>d</i>) δ 8.07–8.00 (m, 1H), 7.61–7.56 (m, 2H), 7.45 (d, <i>J</i> = 8.1 Hz, 2H), 7.28 (s, 2H), 6.80 (d, <i>J</i> = 8.7 Hz, 1H), 5.95 (brs, 2H), 4.28 (brs, 1H), 3.87–3.84 (m, 1H), 3.72–3.68 (m, 2H), 3.38–3.14 (m, 2H), 3.00–2.91 (m, 1H), 2.29 (brs, 2H), 2.09 (brs, 2H), 1.65–1.55 (m, 3H), 1.29 (d, <i>J</i> = 6.9 Hz, 6H), 1.19–1.11 (m, 2H), 1.00–0.85 (m, 6H). HRMS (ESI): calcd for C<sub>27</sub>H<sub>39</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup> 451.3000, found 451.3071. Purity: 97.03% by HPLC (MeOH/H<sub>2</sub>O = 90:10, 1‰ Et<sub>3</sub>N).</div></div><div id="sec5_4_5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i107" class="anchor-spacer"></div><h3 class="article-section__title" id="_i107"> 4-((1-(6-Aminohexanoyl)piperidin-4-yl)amino)-4′-isopropyl-[1,1′-biphenyl]-3-carboxamide (<b>86</b>)</h3><div class="NLM_p last">Compound <b>86</b> was prepared from compound <b>79</b> (665 mg, 1.97 mmol) and Boc-6-aminohexanoic acid (683 mg, 2.96 mmol) according to the general procedures. Light yellow solid, 631 mg, yield 71.1%. Mp >250 °C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.27 (d, <i>J</i> = 7.7 Hz, 1H), 8.08 (s, 1H), 7.91 (s, 1H), 7.58 (d, <i>J</i> = 8.0 Hz, 2H), 7.27 (d, <i>J</i> = 8.0 Hz, 2H), 7.20 (brs, 1H), 6.87 (d, <i>J</i> = 8.9 Hz, 1H), 6.30 (brs, 2H), 4.15–4.12 (m, 1H), 3.80–3.67 (m, 2H), 3.27–3.19 (m, 2H), 2.96–2.91 (m, 2H), 2.65 (t, <i>J</i> = 7.4 Hz, 2H), 2.33 (s, 2H), 1.97 (brs, 2H), 1.50–1.48 (m, 3H), 1.32 (s, 3H), 1.23 (d, <i>J</i> = 7.0 Hz, 6H). HRMS (ESI): calcd for C<sub>27</sub>H<sub>39</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup> 451.2995, found 451.3067. Purity: 95.78% by HPLC (MeOH/H<sub>2</sub>O = 90:10, 1‰ Et<sub>3</sub>N).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i108"><a href="/doi/suppl/10.1021/acs.jmedchem.8b00800" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63512" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63512" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b00800" class="ext-link">10.1021/acs.jmedchem.8b00800</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Detailed scoring criteria for DAI (Table S1); representative images to show the general status of the UC mice at day 7 (Figure S1); <sup>1</sup>H, <sup>13</sup>C NMR, and HRMS (ESI) spectra of compounds <b>42</b>–<b>86</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00800/suppl_file/jm8b00800_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Coordinates information for structure representation (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00800/suppl_file/jm8b00800_si_002.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00800/suppl_file/jm8b00800_si_003.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00800/suppl_file/jm8b00800_si_001.pdf">jm8b00800_si_001.pdf (6.65 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00800/suppl_file/jm8b00800_si_002.pdb">jm8b00800_si_002.pdb (142.88 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00800/suppl_file/jm8b00800_si_003.csv">jm8b00800_si_003.csv (3.27 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.8b00800" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23025" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23025" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qi-Dong You</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Natural Medicines and Jiang Su Key Laboratory of
Drug Design and Optimization, China Pharmaceutical
University, Nanjing 210009, China</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8587-0122" title="Orcid link">http://orcid.org/0000-0002-8587-0122</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#81f8eef4f0e8e5eeefe6c1e6ece0e8edafe2eeec"><span class="__cf_email__" data-cfemail="40392f353129242f2e2700272d21292c6e232f2d">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiao-Li Xu</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Natural Medicines and Jiang Su Key Laboratory of
Drug Design and Optimization, China Pharmaceutical
University, Nanjing 210009, China</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#6f171a17060e003003062f5e5d59410c0002"><span class="__cf_email__" data-cfemail="d9a1aca1b0b8b686b5b099e8ebeff7bab6b4">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fen Jiang</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Natural Medicines and Jiang Su Key Laboratory of
Drug Design and Optimization, China Pharmaceutical
University, Nanjing 210009, China</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">An-ping Guo</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Natural Medicines and Jiang Su Key Laboratory of
Drug Design and Optimization, China Pharmaceutical
University, Nanjing 210009, China</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jia-chen Xu</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Natural Medicines and Jiang Su Key Laboratory of
Drug Design and Optimization, China Pharmaceutical
University, Nanjing 210009, China</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i109">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82416" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82416" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by Grants 81573346, 81502990, 81773639, and 81872737 of National Natural Science Foundation of China; Grants 2015ZX09101032, 2017ZX09302003, and 2018ZX09711002-003-006 of the National Major Science and Technology Project of China (Innovation and Development of New Drugs); Grant BK 20150691 of the Natural Science Foundation of Jiangsu Province of China; a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions; Grant CX16B-004HH cofunded by China Pharmaceutical University and Huahai Pharmaceutical Co., Ltd.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">Hsp90</td><td class="NLM_def"><p class="first last">heat-shock protein 90</p></td></tr><tr><td class="NLM_term">Grp94</td><td class="NLM_def"><p class="first last">glucose regulated protein 94</p></td></tr><tr><td class="NLM_term">Trap1</td><td class="NLM_def"><p class="first last">tumor necrosis factor receptor-associated protein-1</p></td></tr><tr><td class="NLM_term">ER</td><td class="NLM_def"><p class="first last">endoplasmic reticulum</p></td></tr><tr><td class="NLM_term">POAG</td><td class="NLM_def"><p class="first last">primary open-angle glaucoma</p></td></tr><tr><td class="NLM_term">UC</td><td class="NLM_def"><p class="first last">ulcerative colitis</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">TLR</td><td class="NLM_def"><p class="first last">Toll-like receptor</p></td></tr><tr><td class="NLM_term">IGF</td><td class="NLM_def"><p class="first last">insulin-like growth factor</p></td></tr><tr><td class="NLM_term">FP</td><td class="NLM_def"><p class="first last">fluorescence polarization</p></td></tr><tr><td class="NLM_term">CPMG</td><td class="NLM_def"><p class="first last">Carr–Purcell–Meiboom–Gill</p></td></tr><tr><td class="NLM_term">MD</td><td class="NLM_def"><p class="first last">molecular dynamics</p></td></tr><tr><td class="NLM_term">Hsp70</td><td class="NLM_def"><p class="first last">heat-shock protein 70</p></td></tr><tr><td class="NLM_term">DAI</td><td class="NLM_def"><p class="first last">disease activity index</p></td></tr><tr><td class="NLM_term">PAMP</td><td class="NLM_def"><p class="first last">pathogen-associated molecular pattern</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term">BGG</td><td class="NLM_def"><p class="first last">bovine γ-globulin</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i111">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42475" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42475" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 52 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chiosis, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vilenchik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solit, D.</span></span> <span> </span><span class="NLM_article-title">Hsp90: the vulnerable chaperone</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">881</span>– <span class="NLM_lpage">888</span>, <span class="refDoi"> DOI: 10.1016/S1359-6446(04)03245-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.1016%2FS1359-6446%2804%2903245-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=15475321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BD2cXotlSku78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=881-888&author=G.+Chiosisauthor=M.+Vilenchikauthor=J.+Kimauthor=D.+Solit&title=Hsp90%3A+the+vulnerable+chaperone&doi=10.1016%2FS1359-6446%2804%2903245-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Hsp90: the vulnerable chaperone</span></div><div class="casAuthors">Chiosis, Gabriela; Vilenchik, Maria; Kim, Joungnam; Solit, David</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">881-888</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Hsp90 inhibitors promise the targeting of wide-range transformation by inhibiting one protein.  Here we present updates on the emerging classes of Hsp90 chaperone inhibitors and their anti-tumor activities.  The mol. chaperone Hsp90 has emerged as an important target in cancer treatment because of its roles in maintaining transformation and regulating the function of proteins involved in apoptotic, survival and growth pathways.  Many Hsp90 inhibitors function by binding to the N-terminal ATP pocket, but the chaperone has many other vulnerable points.  Agents that interact with its C-terminus or modify its post-translational status represent addnl. ways of interfering with chaperone activity.  This review will discuss several emerging classes of Hsp90 inhibitors and their modes of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqP8lFe8f0eeLVg90H21EOLACvtfcHk0lhAtnEEcbhCJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXotlSku78%253D&md5=eb5fcfa150f16d40d0eac02d8fd0e5ce</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903245-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903245-3%26sid%3Dliteratum%253Aachs%26aulast%3DChiosis%26aufirst%3DG.%26aulast%3DVilenchik%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DSolit%26aufirst%3DD.%26atitle%3DHsp90%253A%2520the%2520vulnerable%2520chaperone%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D881%26epage%3D888%26doi%3D10.1016%2FS1359-6446%2804%2903245-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neckers, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Workman, P.</span></span> <span> </span><span class="NLM_article-title">Hsp90 molecular chaperone inhibitors: are we there yet?</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">64</span>– <span class="NLM_lpage">76</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-11-1000</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.1158%2F1078-0432.CCR-11-1000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=22215907" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvFWmsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=64-76&author=L.+Neckersauthor=P.+Workman&title=Hsp90+molecular+chaperone+inhibitors%3A+are+we+there+yet%3F&doi=10.1158%2F1078-0432.CCR-11-1000"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Hsp90 Molecular Chaperone Inhibitors: Are We There Yet?</span></div><div class="casAuthors">Neckers, Len; Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">64-76</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Heat shock protein (Hsp) 90 is an ATP-dependent mol. chaperone that is exploited by malignant cells to support activated oncoproteins, including many cancer-assocd. kinases and transcription factors, and it is essential for oncogenic transformation.  Originally viewed with skepticism, Hsp90 inhibitors are now being actively pursued by the pharmaceutical industry, with 17 agents having entered clin. trials.  Investigators established Hsp90's druggability using the natural products geldanamycin and radicicol, which mimic the unusual ATP structure adopted in the chaperone's N-terminal nucleotide-binding pocket and cause potent and selective blockade of ATP binding/hydrolysis, inhibit chaperone function, deplete oncogenic clients, and show antitumor activity.  Preclin. data obtained with these natural products have heightened interest in Hsp90 as a drug target, and 17-allylamino-17-demethoxygeldanamycin (17-AAG, tanespimycin) has shown clin. activity (as defined by Response Evaluation Criteria in Solid Tumors) in HER2+ breast cancer.  Many optimized synthetic, small-mol. Hsp90 inhibitors from diverse chemotypes are now in clin. trials.  Here, we review the discovery and development of Hsp90 inhibitors and assess their potential.  There has been significant learning from studies of the basic biol. of Hsp90, as well as translational drug development involving this chaperone, enhanced by the use of Hsp90 inhibitors as chem. probes.  Success will likely lie in treating cancers that are addicted to particular driver oncogene products (e.g., HER2, ALK, EGFR, and BRAF) that are sensitive Hsp90 clients, as well as malignancies (esp. multiple myeloma) in which buffering of proteotoxic stress is crit. for survival.  We discuss approaches for enhancing the effectiveness of Hsp90 inhibitors and highlight new chaperone and stress-response pathway targets, including HSF1 and Hsp70.  Clin Cancer Res; 18(1); 64-76.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfICmNu1IWFbVg90H21EOLACvtfcHk0lgEEuRRlQ8GbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvFWmsw%253D%253D&md5=f67c3c11b5847e3866c91af2a16a63b8</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-11-1000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-11-1000%26sid%3Dliteratum%253Aachs%26aulast%3DNeckers%26aufirst%3DL.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DHsp90%2520molecular%2520chaperone%2520inhibitors%253A%2520are%2520we%2520there%2520yet%253F%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2012%26volume%3D18%26spage%3D64%26epage%3D76%26doi%3D10.1158%2F1078-0432.CCR-11-1000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gewirth, D. T.</span></span> <span> </span><span class="NLM_article-title">Paralog specific Hsp90 inhibitors - a brief history and a bright future</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">2779</span>– <span class="NLM_lpage">2791</span>, <span class="refDoi"> DOI: 10.2174/1568026616666160413141154</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.2174%2F1568026616666160413141154" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=27072700" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVOhsrzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=2779-2791&author=D.+T.+Gewirth&title=Paralog+specific+Hsp90+inhibitors+-+a+brief+history+and+a+bright+future&doi=10.2174%2F1568026616666160413141154"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Paralog Specific Hsp90 Inhibitors - A Brief History and a Bright Future</span></div><div class="casAuthors">Gewirth, Daniel T.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">2779-2791</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Background. The high sequence and structural homol. among the hsp90 paralogs - Hsp90α, Hsp90β, Grp94, and Trap-1 - has made the development of paralog-specific inhibitors a challenging proposition.  Objective. This review surveys the state of developments in structural anal., compd. screening, and structure-based design that have been brought to bear on this problem.  Results. First generation compds. that selectively bind to Hsp90, Grp94, or Trap-1 have been identified.  Conclusion. With the proof of principle firmly established, the prospects for further progress are bright.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdyZyrXOyou7Vg90H21EOLACvtfcHk0lgEEuRRlQ8GbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVOhsrzN&md5=208025ff36aa6e2d92d3ee107b20ab5f</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.2174%2F1568026616666160413141154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026616666160413141154%26sid%3Dliteratum%253Aachs%26aulast%3DGewirth%26aufirst%3DD.%2BT.%26atitle%3DParalog%2520specific%2520Hsp90%2520inhibitors%2520-%2520a%2520brief%2520history%2520and%2520a%2520bright%2520future%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2016%26volume%3D16%26spage%3D2779%26epage%3D2791%26doi%3D10.2174%2F1568026616666160413141154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><a href="https://www.picard.ch/downloads/Hsp90interactors.pdf" class="extLink">https://www.picard.ch/downloads/Hsp90interactors.pdf</a> (accessed Mar 25, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=https%3A%2F%2Fwww.picard.ch%2Fdownloads%2FHsp90interactors.pdf+%28accessed+Mar+25%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Solit, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiosis, G.</span></span> <span> </span><span class="NLM_article-title">Development and application of Hsp90 inhibitors</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">38</span>– <span class="NLM_lpage">43</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2007.10.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.1016%2Fj.drudis.2007.10.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=18190862" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlsVWhug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=38-43&author=D.+B.+Solitauthor=G.+Chiosis&title=Development+and+application+of+Hsp90+inhibitors&doi=10.1016%2Fj.drudis.2007.10.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Development and application of Hsp90 inhibitors</span></div><div class="casAuthors">Solit, David B.; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1/2</span>),
    <span class="NLM_cas:pages">38-43</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Heat shock protein 90 has emerged as an important target in several diseases.  The present review will discuss our understanding of the role played by Hsp90 in regulating and maintaining the transformed phenotype in cancers and neurodegenerative diseases, as well as recent findings on its roles in fungal and viral infections.  It will also update the reader on the preclin. development and clin. translation of Hsp90 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobKuG3vjpdrLVg90H21EOLACvtfcHk0lgEEuRRlQ8GbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlsVWhug%253D%253D&md5=a4fa749f37fe96d9f323d437e9afded6</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2007.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2007.10.007%26sid%3Dliteratum%253Aachs%26aulast%3DSolit%26aufirst%3DD.%2BB.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DDevelopment%2520and%2520application%2520of%2520Hsp90%2520inhibitors%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2008%26volume%3D13%26spage%3D38%26epage%3D43%26doi%3D10.1016%2Fj.drudis.2007.10.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Powers, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Workman, P.</span></span> <span> </span><span class="NLM_article-title">Targeting of multiple signalling pathways by heat shock protein 90 molecular chaperone inhibitors</span>. <i>Endocr.-Relat. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">S125</span>– <span class="NLM_lpage">S135</span>, <span class="refDoi"> DOI: 10.1677/erc.1.01324</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.1677%2Ferc.1.01324" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=S125-S135&author=M.+V.+Powersauthor=P.+Workman&title=Targeting+of+multiple+signalling+pathways+by+heat+shock+protein+90+molecular+chaperone+inhibitors&doi=10.1677%2Ferc.1.01324"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1677%2Ferc.1.01324&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1677%252Ferc.1.01324%26sid%3Dliteratum%253Aachs%26aulast%3DPowers%26aufirst%3DM.%2BV.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DTargeting%2520of%2520multiple%2520signalling%2520pathways%2520by%2520heat%2520shock%2520protein%252090%2520molecular%2520chaperone%2520inhibitors%26jtitle%3DEndocr.-Relat.%2520Cancer%26date%3D2006%26volume%3D13%26spage%3DS125%26epage%3DS135%26doi%3D10.1677%2Ferc.1.01324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trepel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mollapour, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giaccone, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neckers, L.</span></span> <span> </span><span class="NLM_article-title">Targeting the dynamic HSP90 complex in cancer</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">537</span>– <span class="NLM_lpage">549</span>, <span class="refDoi"> DOI: 10.1038/nrc2887</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.1038%2Fnrc2887" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=20651736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpt1GjtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=537-549&author=J.+Trepelauthor=M.+Mollapourauthor=G.+Giacconeauthor=L.+Neckers&title=Targeting+the+dynamic+HSP90+complex+in+cancer&doi=10.1038%2Fnrc2887"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the dynamic HSP90 complex in cancer</span></div><div class="casAuthors">Trepel, Jane; Mollapour, Mehdi; Giaccone, Giuseppe; Neckers, Len</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">537-549</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The mol. chaperone, heat-shock protein 90 (HSP90), has been used by cancer cells to facilitate the function of numerous oncoproteins, and it can be argued that cancer cells are 'addicted' to HSP90.  However, although recent reports of the early clin. efficacy of HSP90 inhibitors are encouraging, the optimal use of HSP90-targeted therapeutics will depend on understanding the complexity of HSP90 regulation and the degree to which HSP90 participates in both neoplastic and normal cellular physiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprGEqkx6m7p7Vg90H21EOLACvtfcHk0lgD4xVbQhvv6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpt1GjtLs%253D&md5=8acba020073ebb93cf1dee577420dc32</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnrc2887&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2887%26sid%3Dliteratum%253Aachs%26aulast%3DTrepel%26aufirst%3DJ.%26aulast%3DMollapour%26aufirst%3DM.%26aulast%3DGiaccone%26aufirst%3DG.%26aulast%3DNeckers%26aufirst%3DL.%26atitle%3DTargeting%2520the%2520dynamic%2520HSP90%2520complex%2520in%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2010%26volume%3D10%26spage%3D537%26epage%3D549%26doi%3D10.1038%2Fnrc2887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tukaj, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wegrzyn, G.</span></span> <span> </span><span class="NLM_article-title">Anti-Hsp90 therapy in autoimmune and inflammatory diseases: a review of preclinical studies</span>. <i>Cell Stress Chaperones</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">213</span>– <span class="NLM_lpage">218</span>, <span class="refDoi"> DOI: 10.1007/s12192-016-0670-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.1007%2Fs12192-016-0670-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=26786410" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFOqsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=213-218&author=S.+Tukajauthor=G.+Wegrzyn&title=Anti-Hsp90+therapy+in+autoimmune+and+inflammatory+diseases%3A+a+review+of+preclinical+studies&doi=10.1007%2Fs12192-016-0670-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-Hsp90 therapy in autoimmune and inflammatory diseases: a review of preclinical studies</span></div><div class="casAuthors">Tukaj, Stefan; Wegrzyn, Grzegorz</div><div class="citationInfo"><span class="NLM_cas:title">Cell Stress & Chaperones</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">213-218</span>CODEN:
                <span class="NLM_cas:coden">CSCHFG</span>;
        ISSN:<span class="NLM_cas:issn">1355-8145</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90), a 90-kDa mol. chaperone, is responsible for biol. activities of key signaling mols. (clients) such as protein kinases, ubiquitin ligases, steroid receptors, cell cycle regulators, and transcription factors regulating various cellular processes, including growth, survival, differentiation, and apoptosis.  Because Hsp90 is also involved in stabilization of oncogenic 'client' proteins, its specific chaperone activity blockers are currently being tested as anticancer agents in advanced clin. trials.  Recent in vitro and in vivo studies have shown that Hsp90 is also involved in activation of innate and adaptive cells of the immune system.  For these reasons, pharmacol. inhibition of Hsp90 has been evaluated in murine models of autoimmune and inflammatory diseases.  This mini-review summarizes current knowledge of the effects of Hsp90 inhibitors on autoimmune and inflammatory diseases' features and is based solely on preclin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_LDdiZ_wJSrVg90H21EOLACvtfcHk0lgD4xVbQhvv6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFOqsb0%253D&md5=e0b1d3ea522de06d60ab530e20b2b4d0</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1007%2Fs12192-016-0670-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12192-016-0670-z%26sid%3Dliteratum%253Aachs%26aulast%3DTukaj%26aufirst%3DS.%26aulast%3DWegrzyn%26aufirst%3DG.%26atitle%3DAnti-Hsp90%2520therapy%2520in%2520autoimmune%2520and%2520inflammatory%2520diseases%253A%2520a%2520review%2520of%2520preclinical%2520studies%26jtitle%3DCell%2520Stress%2520Chaperones%26date%3D2016%26volume%3D21%26spage%3D213%26epage%3D218%26doi%3D10.1007%2Fs12192-016-0670-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blair, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabbagh, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickey, C. A.</span></span> <span> </span><span class="NLM_article-title">Targeting Hsp90 and its co-chaperones to treat Alzheimer’s disease</span>. <i>Expert Opin. Ther. Targets</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1219</span>– <span class="NLM_lpage">1232</span>, <span class="refDoi"> DOI: 10.1517/14728222.2014.943185</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.1517%2F14728222.2014.943185" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=25069659" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFOrsb3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2014&pages=1219-1232&author=L.+J.+Blairauthor=J.+J.+Sabbaghauthor=C.+A.+Dickey&title=Targeting+Hsp90+and+its+co-chaperones+to+treat+Alzheimer%E2%80%99s+disease&doi=10.1517%2F14728222.2014.943185"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Hsp90 and its co-chaperones to treat Alzheimer's disease</span></div><div class="casAuthors">Blair, Laura J.; Sabbagh, Jonathan J.; Dickey, Chad A.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1219-1232</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Alzheimer's disease, characterized by the accumulation of hyperphosphorylated tau and β amyloid (Aβ), currently lacks effective treatment.  Chaperone proteins, such as the heat shock protein (Hsp) 90, form macromol. complexes with co-chaperones, which can regulate tau metab. and Aβ processing.  Although small mol. inhibitors of Hsp90 have been successful at ameliorating tau and Aβ burden, their development into drugs to treat disease has been slow due to the off- and on-target effects of this approach as well as challenges with the pharmacol. of current scaffolds.  Thus, other approaches are being developed to improve these compds. and to target co-chaperones of Hsp90 in an effort to limit these liabilities.  This article discusses the most current developments in Hsp90 inhibitors including advances in blood-brain barrier permeability, decreased toxicity and homolog-specific small-mol. inhibitors.  In addn., we discuss current strategies targeting Hsp90 co-chaperones rather than Hsp90 itself to reduce off-target effects.  Although Hsp90 inhibitors have proven their efficacy at reducing tau pathol., they have yet to meet with success in the clinic.  The development of Hsp90/tau complex-specific inhibitors and further development of Hsp90 co-chaperone-specific drugs should yield more potent, less toxic therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwfgbwFb4NDrVg90H21EOLACvtfcHk0lgD4xVbQhvv6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFOrsb3N&md5=e45b44478254d5872c355fec4e32c9d4</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1517%2F14728222.2014.943185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.2014.943185%26sid%3Dliteratum%253Aachs%26aulast%3DBlair%26aufirst%3DL.%2BJ.%26aulast%3DSabbagh%26aufirst%3DJ.%2BJ.%26aulast%3DDickey%26aufirst%3DC.%2BA.%26atitle%3DTargeting%2520Hsp90%2520and%2520its%2520co-chaperones%2520to%2520treat%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2014%26volume%3D18%26spage%3D1219%26epage%3D1232%26doi%3D10.1517%2F14728222.2014.943185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, A.</span></span> <span> </span><span class="NLM_article-title">Development of heat shock protein (Hsp90) inhibitors to combat resistance to tyrosine kinase inhibitors through Hsp90-kinase interactions</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">5563</span>– <span class="NLM_lpage">5586</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01106</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01106" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFOls7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=5563-5586&author=M.+Wangauthor=A.+Shenauthor=C.+Zhangauthor=Z.+Songauthor=J.+Aiauthor=H.+Liuauthor=L.+Sunauthor=J.+Dingauthor=M.+Gengauthor=A.+Zhang&title=Development+of+heat+shock+protein+%28Hsp90%29+inhibitors+to+combat+resistance+to+tyrosine+kinase+inhibitors+through+Hsp90-kinase+interactions&doi=10.1021%2Facs.jmedchem.5b01106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Heat Shock Protein (Hsp90) Inhibitors To Combat Resistance to Tyrosine Kinase Inhibitors through Hsp90-Kinase Interactions</span></div><div class="casAuthors">Wang, Meining; Shen, Aijun; Zhang, Chi; Song, Zilan; Ai, Jing; Liu, Hongchun; Sun, Liping; Ding, Jian; Geng, Meiyu; Zhang, Ao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5563-5586</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) is a ubiquitous chaperone of all of the oncogenic tyrosine kinases.  Many Hsp90 inhibitors, alone or in combination, have shown significant antitumor efficacy against the kinase-pos. na.ovrddot.ive and mutant models.  However, clin. trials of these inhibitors are unsuccessful due to insufficient clin. benefits and nonoptimal safety profiles.  Recently, much progress has been reported on the Hsp90-cochaperone-client complex, which will undoubtedly assist in the understanding of the interactions between Hsp90 and its clients.  Meanwhile, Hsp90 inhibitors have shown promise against patients' resistance caused by early generation tyrosine kinase inhibitors (TKIs), and at least 13 Hsp90 inhibitors are being reevaluated in the clinic.  In this regard, the objectives of the current perspective are to summarize the structure and function of the Hsp90-cochaperone-client complex, to analyze the structural and functional insights into the Hsp90-client interactions to address several existing unresolved problems with Hsp90 inhibitors, and to highlight the preclin. and clin. studies of Hsp90 inhibitors as an effective treatment against resistance to tyrosine kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogrgsVY9MSMrVg90H21EOLACvtfcHk0ljH_ZvDYGoGxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFOls7s%253D&md5=2408b273b2a00136223ff21709c7ae2d</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01106%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DM.%26aulast%3DShen%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DSong%26aufirst%3DZ.%26aulast%3DAi%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DGeng%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DA.%26atitle%3DDevelopment%2520of%2520heat%2520shock%2520protein%2520%2528Hsp90%2529%2520inhibitors%2520to%2520combat%2520resistance%2520to%2520tyrosine%2520kinase%2520inhibitors%2520through%2520Hsp90-kinase%2520interactions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D5563%26epage%3D5586%26doi%3D10.1021%2Facs.jmedchem.5b01106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Carbonero, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carnero, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paz-Ares, L.</span></span> <span> </span><span class="NLM_article-title">Inhibition of HSP90 molecular chaperones: moving into the clinic</span>. <i>Lancet Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">E358</span>– <span class="NLM_lpage">E369</span>, <span class="refDoi"> DOI: 10.1016/S1470-2045(13)70169-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.1016%2FS1470-2045%2813%2970169-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=23896275" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtF2iu7jI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=E358-E369&author=R.+Garcia-Carboneroauthor=A.+Carneroauthor=L.+Paz-Ares&title=Inhibition+of+HSP90+molecular+chaperones%3A+moving+into+the+clinic&doi=10.1016%2FS1470-2045%2813%2970169-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of HSP90 molecular chaperones: moving into the clinic</span></div><div class="casAuthors">Garcia-Carbonero, Rocio; Carnero, Amancio; Paz-Ares, Luis</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Oncology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e358-e369</span>CODEN:
                <span class="NLM_cas:coden">LOANBN</span>;
        ISSN:<span class="NLM_cas:issn">1470-2045</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Heat shock protein 90 (HSP90) is a mol. chaperone that is crucial for the stability and function of many proteins essential for cell survival.  Many oncogenes, including tyrosine kinases, transcription factors, and cell-cycle regulatory proteins, are client proteins of HSP90.  Inhibition of HSP90 causes client protein degrdn. via the ubiquitin-proteasome pathway, and is a mechanism that might simultaneously downregulate several redundant pathways crucial for cell viability and tumor development.  HSP90 inhibitors are currently being developed as anticancer agents, and have shown early promising results in molecularly defined subgroups of solid tumors (eg, ALK-rearranged non-small-cell lung cancer and HER2-amplified breast cancer) and some haematol. malignancies (eg, multiple myeloma).  Here, we review the current status of HSP90 inhibitors in clin. development, including geldanamycin derivs., resorcinol derivs., purine analogs, and other synthetic inhibitors.  We also discuss novel strategies and future perspectives on how to optimize the therapeutic potential of this exciting new class of drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpulM7j4PFcx7Vg90H21EOLACvtfcHk0ljH_ZvDYGoGxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtF2iu7jI&md5=4821e86073624fb17d7343105d6e82cd</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2FS1470-2045%2813%2970169-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1470-2045%252813%252970169-4%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia-Carbonero%26aufirst%3DR.%26aulast%3DCarnero%26aufirst%3DA.%26aulast%3DPaz-Ares%26aufirst%3DL.%26atitle%3DInhibition%2520of%2520HSP90%2520molecular%2520chaperones%253A%2520moving%2520into%2520the%2520clinic%26jtitle%3DLancet%2520Oncol.%26date%3D2013%26volume%3D14%26spage%3DE358%26epage%3DE369%26doi%3D10.1016%2FS1470-2045%2813%2970169-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ying, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tatsuta, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wada, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koya, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bates, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonderfan, A. J.</span></span> <span> </span><span class="NLM_article-title">A rat retinal damage model predicts for potential clinical visual disturbances induced by Hsp90 inhibitors</span>. <i>Toxicol. Appl. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>273</i></span>,  <span class="NLM_fpage">401</span>– <span class="NLM_lpage">409</span>, <span class="refDoi"> DOI: 10.1016/j.taap.2013.09.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.1016%2Fj.taap.2013.09.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=24090817" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslOlsbrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=2013&pages=401-409&author=D.+Zhouauthor=Y.+Liuauthor=J.+Yeauthor=W.+Yingauthor=L.+S.+Ogawaauthor=T.+Inoueauthor=N.+Tatsutaauthor=Y.+Wadaauthor=K.+Koyaauthor=Q.+Huangauthor=R.+C.+Batesauthor=A.+J.+Sonderfan&title=A+rat+retinal+damage+model+predicts+for+potential+clinical+visual+disturbances+induced+by+Hsp90+inhibitors&doi=10.1016%2Fj.taap.2013.09.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">A rat retinal damage model predicts for potential clinical visual disturbances induced by Hsp90 inhibitors</span></div><div class="casAuthors">Zhou, Dan; Liu, Yuan; Ye, Josephine; Ying, Weiwen; Ogawa, Luisa Shin; Inoue, Takayo; Tatsuta, Noriaki; Wada, Yumiko; Koya, Keizo; Huang, Qin; Bates, Richard C.; Sonderfan, Andrew J.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology and Applied Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">273</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">401-409</span>CODEN:
                <span class="NLM_cas:coden">TXAPA9</span>;
        ISSN:<span class="NLM_cas:issn">0041-008X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">In human trials certain heat shock protein 90 (Hsp90) inhibitors, including 17-DMAG and NVP-AUY922, have caused visual disorders indicative of retinal dysfunction; others such as 17-AAG and ganetespib have not.  To understand these safety profile differences we evaluated histopathol. changes and exposure profiles of four Hsp90 inhibitors, with or without clin. reports of adverse ocular effects, using a rat retinal model.  Retinal morphol., Hsp70 expression (a surrogate marker of Hsp90 inhibition), apoptotic induction and pharmacokinetic drug exposure anal. were examd. in rats treated with the ansamycins 17-DMAG and 17-AAG, or with the second-generation compds. NVP-AUY922 and ganetespib.  Both 17-DMAG and NVP-AUY922 induced strong yet restricted retinal Hsp70 up-regulation and promoted marked photoreceptor cell death 24 h after the final dose.  In contrast, neither 17-AAG nor ganetespib elicited photoreceptor injury.  When the relationship between drug distribution and photoreceptor degeneration was examd., 17-DMAG and NVP-AUY922 showed substantial retinal accumulation, with high retina/plasma (R/P) ratios and slow elimination rates, such that 51% of 17-DMAG and 65% of NVP-AUY922 present at 30 min post-injection were retained in the retina 6 h post-dose.  For 17-AAG and ganetespib, retinal elimination was rapid (90% and 70% of drugs eliminated from the retina at 6 h, resp.) which correlated with lower R/P ratios.  These findings indicate that prolonged inhibition of Hsp90 activity in the eye results in photoreceptor cell death.  Moreover, the results suggest that the retina/plasma exposure ratio and retinal elimination rate profiles of Hsp90 inhibitors, irresp. of their chem. class, may predict for ocular toxicity potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8Aq4KcKIoPrVg90H21EOLACvtfcHk0lhnByYbkAxCCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslOlsbrP&md5=39b797991e66b4561c82b991cc0132a6</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.taap.2013.09.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.taap.2013.09.018%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DYe%26aufirst%3DJ.%26aulast%3DYing%26aufirst%3DW.%26aulast%3DOgawa%26aufirst%3DL.%2BS.%26aulast%3DInoue%26aufirst%3DT.%26aulast%3DTatsuta%26aufirst%3DN.%26aulast%3DWada%26aufirst%3DY.%26aulast%3DKoya%26aufirst%3DK.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DBates%26aufirst%3DR.%2BC.%26aulast%3DSonderfan%26aufirst%3DA.%2BJ.%26atitle%3DA%2520rat%2520retinal%2520damage%2520model%2520predicts%2520for%2520potential%2520clinical%2520visual%2520disturbances%2520induced%2520by%2520Hsp90%2520inhibitors%26jtitle%3DToxicol.%2520Appl.%2520Pharmacol.%26date%3D2013%26volume%3D273%26spage%3D401%26epage%3D409%26doi%3D10.1016%2Fj.taap.2013.09.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ernst, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neubert, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sperry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuccola, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turnbull, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleck, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kargo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woody, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alcacio, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nezami, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goulet, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamos, D.</span></span> <span> </span><span class="NLM_article-title">Identification of novel HSP90alpha/beta isoform selective inhibitors using structure-based drug design. Demonstration of potential utility in treating CNS disorders such as Huntington’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">3382</span>– <span class="NLM_lpage">3400</span>, <span class="refDoi"> DOI: 10.1021/jm500042s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500042s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BC2cXltFGlsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=3382-3400&author=J.+T.+Ernstauthor=T.+Neubertauthor=M.+Liuauthor=S.+Sperryauthor=H.+Zuccolaauthor=A.+Turnbullauthor=B.+Fleckauthor=W.+Kargoauthor=L.+Woodyauthor=P.+Chiangauthor=D.+Tranauthor=W.+Chenauthor=P.+Snyderauthor=T.+Alcacioauthor=A.+Nezamiauthor=J.+Reynoldsauthor=K.+Alviauthor=L.+Gouletauthor=D.+Stamos&title=Identification+of+novel+HSP90alpha%2Fbeta+isoform+selective+inhibitors+using+structure-based+drug+design.+Demonstration+of+potential+utility+in+treating+CNS+disorders+such+as+Huntington%E2%80%99s+disease&doi=10.1021%2Fjm500042s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of novel HSP90α/β isoform selective inhibitors using structure-based drug design. Demonstration of potential utility in treating CNS disorders such as Huntington's disease</span></div><div class="casAuthors">Ernst, Justin T.; Neubert, Timothy; Liu, Michael; Sperry, Samuel; Zuccola, Harmon; Turnbull, Amy; Fleck, Beth; Kargo, William; Woody, Lisa; Chiang, Peggy; Tran, Dao; Chen, Weichao; Snyder, Phillip; Alcacio, Timothy; Nezami, Azin; Reynolds, James; Alvi, Khisal; Goulet, Lance; Stamos, Dean</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3382-3400</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A structure-based drug design strategy was used to optimize a novel benzolactam series of HSP90α/β inhibitors to achieve >1000-fold selectivity vs. the HSP90 endoplasmic reticulum and mitochondrial isoforms (GRP94 and TRAP1, resp.).  Selective HSP90α/β inhibitors were found to be equipotent to pan-HSP90 inhibitors in promoting the clearance of mutant huntington protein (mHtt) in vitro, however with less cellular toxicity.  Improved tolerability profiles may enable the use of HSP90α/β selective inhibitors in treating chronic neurodegenerative indications such as Huntington's disease (HD).  A potent, selective, orally available HSP90α/β inhibitor, 8-Cyclopentyl-6-(3,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1H-indol-1-yl)-3,4-dihydroisoquinolin-1(2H)-one, was identified that crosses the blood-brain barrier and demonstrated proof of concept by successfully reducing brain Htt levels following oral dosing in rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKpHcuphxPXbVg90H21EOLACvtfcHk0lhnByYbkAxCCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltFGlsLY%253D&md5=0d55fb738fc0f0615b5336b8dc17056a</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm500042s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500042s%26sid%3Dliteratum%253Aachs%26aulast%3DErnst%26aufirst%3DJ.%2BT.%26aulast%3DNeubert%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DSperry%26aufirst%3DS.%26aulast%3DZuccola%26aufirst%3DH.%26aulast%3DTurnbull%26aufirst%3DA.%26aulast%3DFleck%26aufirst%3DB.%26aulast%3DKargo%26aufirst%3DW.%26aulast%3DWoody%26aufirst%3DL.%26aulast%3DChiang%26aufirst%3DP.%26aulast%3DTran%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DSnyder%26aufirst%3DP.%26aulast%3DAlcacio%26aufirst%3DT.%26aulast%3DNezami%26aufirst%3DA.%26aulast%3DReynolds%26aufirst%3DJ.%26aulast%3DAlvi%26aufirst%3DK.%26aulast%3DGoulet%26aufirst%3DL.%26aulast%3DStamos%26aufirst%3DD.%26atitle%3DIdentification%2520of%2520novel%2520HSP90alpha%252Fbeta%2520isoform%2520selective%2520inhibitors%2520using%2520structure-based%2520drug%2520design.%2520Demonstration%2520of%2520potential%2520utility%2520in%2520treating%2520CNS%2520disorders%2520such%2520as%2520Huntington%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D3382%26epage%3D3400%26doi%3D10.1021%2Fjm500042s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ohkubo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kodama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muraoka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hitotsumachi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshimura, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitade, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomori, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanoh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yonekura, K.</span></span> <span> </span><span class="NLM_article-title">TAS-116, a highly selective inhibitor of heat shock protein 90alpha and beta, demonstrates potent antitumor activity and minimal ocular toxicity in preclinical models</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">14</span>– <span class="NLM_lpage">22</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-14-0219</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.1158%2F1535-7163.MCT-14-0219" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=25416789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnslWgug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=14-22&author=S.+Ohkuboauthor=Y.+Kodamaauthor=H.+Muraokaauthor=H.+Hitotsumachiauthor=C.+Yoshimuraauthor=M.+Kitadeauthor=A.+Hashimotoauthor=K.+Itoauthor=A.+Gomoriauthor=K.+Takahashiauthor=Y.+Shibataauthor=A.+Kanohauthor=K.+Yonekura&title=TAS-116%2C+a+highly+selective+inhibitor+of+heat+shock+protein+90alpha+and+beta%2C+demonstrates+potent+antitumor+activity+and+minimal+ocular+toxicity+in+preclinical+models&doi=10.1158%2F1535-7163.MCT-14-0219"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">TAS-116, a Highly Selective Inhibitor of Heat Shock Protein 90α and β, Demonstrates Potent Antitumor Activity and Minimal Ocular Toxicity in Preclinical Models</span></div><div class="casAuthors">Ohkubo, Shuichi; Kodama, Yasuo; Muraoka, Hiromi; Hitotsumachi, Hiroko; Yoshimura, Chihoko; Kitade, Makoto; Hashimoto, Akihiro; Ito, Kenjiro; Gomori, Akira; Takahashi, Koichi; Shibata, Yoshihiro; Kanoh, Akira; Yonekura, Kazuhiko</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">14-22</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The mol. chaperone HSP90 plays a crucial role in cancer cell growth and survival by stabilizing cancer-related proteins.  A no. of HSP90 inhibitors have been developed clin. for cancer therapy; however, potential off-target and/or HSP90-related toxicities have proved problematic.  The 4-(1H-pyrazolo[3,4-b]pyridine-1-yl)benzamide TAS-116 is a selective inhibitor of cytosolic HSP90α and β that does not inhibit HSP90 paralogs such as endoplasmic reticulum GRP94 or mitochondrial TRAP1.  Oral administration of TAS-116 led to tumor shrinkage in human tumor xenograft mouse models accompanied by depletion of multiple HSP90 clients, demonstrating that the inhibition of HSP90α and β alone was sufficient to exert antitumor activity in certain tumor models.  One of the most notable HSP90-related adverse events universally obsd. to differing degrees in the clin. setting is visual disturbance.  A two-week administration of the isoxazole resorcinol NVP-AUY922, an HSP90 inhibitor, caused marked degeneration and disarrangement of the outer nuclear layer of the retina and induced photoreceptor cell death in rats.  In contrast, TAS-116 did not produce detectable photoreceptor injury in rats, probably due to its lower distribution in retinal tissue.  Importantly, in a rat model, the antitumor activity of TAS-116 was accompanied by a higher distribution of the compd. in s.c. xenografted NCI-H1975 non-small cell lung carcinoma tumors than in retina.  Moreover, TAS-116 showed activity against orthotopically transplanted NCI-H1975 lung tumors.  Together, these data suggest that TAS-116 has a potential to maximize antitumor activity while minimizing adverse effects such as visual disturbances that are obsd. with other compds. of this class.  Mol Cancer Ther; 14(1); 14-22. ©2014 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB25Txc_IcKbVg90H21EOLACvtfcHk0lhnByYbkAxCCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnslWgug%253D%253D&md5=3ffdc26a7f0178d4e44413e22c003f77</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-14-0219&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-14-0219%26sid%3Dliteratum%253Aachs%26aulast%3DOhkubo%26aufirst%3DS.%26aulast%3DKodama%26aufirst%3DY.%26aulast%3DMuraoka%26aufirst%3DH.%26aulast%3DHitotsumachi%26aufirst%3DH.%26aulast%3DYoshimura%26aufirst%3DC.%26aulast%3DKitade%26aufirst%3DM.%26aulast%3DHashimoto%26aufirst%3DA.%26aulast%3DIto%26aufirst%3DK.%26aulast%3DGomori%26aufirst%3DA.%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DShibata%26aufirst%3DY.%26aulast%3DKanoh%26aufirst%3DA.%26aulast%3DYonekura%26aufirst%3DK.%26atitle%3DTAS-116%252C%2520a%2520highly%2520selective%2520inhibitor%2520of%2520heat%2520shock%2520protein%252090alpha%2520and%2520beta%252C%2520demonstrates%2520potent%2520antitumor%2520activity%2520and%2520minimal%2520ocular%2520toxicity%2520in%2520preclinical%2520models%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2015%26volume%3D14%26spage%3D14%26epage%3D22%26doi%3D10.1158%2F1535-7163.MCT-14-0219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ansa-Addo, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thaxton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, B. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fugle, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metelli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riesenberg, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gewirth, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiosis, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span> <span> </span><span class="NLM_article-title">Clients and oncogenic roles of molecular chaperone gp96/grp94</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">2765</span>– <span class="NLM_lpage">2778</span>, <span class="refDoi"> DOI: 10.2174/1568026616666160413141613</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.2174%2F1568026616666160413141613" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=27072698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVOhsrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=2765-2778&author=E.+A.+Ansa-Addoauthor=J.+Thaxtonauthor=F.+Hongauthor=B.+X.+Wuauthor=Y.+Zhangauthor=C.+W.+Fugleauthor=A.+Metelliauthor=B.+Riesenbergauthor=K.+Williamsauthor=D.+T.+Gewirthauthor=G.+Chiosisauthor=B.+Liuauthor=Z.+Li&title=Clients+and+oncogenic+roles+of+molecular+chaperone+gp96%2Fgrp94&doi=10.2174%2F1568026616666160413141613"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Clients and Oncogenic Roles of Molecular Chaperone gp96/grp94</span></div><div class="casAuthors">Ansa-Addo, Ephraim A.; Thaxton, Jessica; Hong, Feng; Wu, Bill X.; Zhang, Yongliang; Fugle, Caroline W.; Metelli, Alessandra; Riesenberg, Brian; Williams, Katelyn; Gewirth, Daniel T.; Chiosis, Gabriela; Liu, Bei; Li, Zihai</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">2765-2778</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">As an endoplasmic reticulum heat shock protein (HSP) 90 paralogue, glycoprotein (gp) 96 possesses immunol. properties by chaperoning antigenic peptides for activation of T cells.  Genetic studies in the last decade have unveiled that gp96 is also an essential master chaperone for multiple receptors and secreting proteins including Toll-like receptors (TLRs), integrins, the Wnt coreceptor, Low D. Lipoprotein Receptor-Related Protein 6 (LRP6), the latent TGF docking receptor, Glycoprotein A Repetitions Predominant (GARP), Glycoprotein (GP) Ib and insulin-like growth factors (IGF).  Clin., elevated expression of gp96 in a variety of cancers correlates with the advanced stage and poor survival of cancer patients.  Recent preclin. studies have also uncovered that gp96 expression is closely linked to cancer progression in multiple myeloma, hepatocellular carcinoma, breast cancer and inflammation-assocd. colon cancer.  Thus, gp96 is an attractive therapeutic target for cancer treatment.  The chaperone function of gp96 depends on its ATPase domain, which is structurally distinct from other HSP90 members, and thus favors the design of highly selective gp96-targeted inhibitors against cancer.  We herein discuss the strategically important oncogenic clients of gp96 and their underlying biol.  The roles of cell-intrinsic gp96 in T cell biol. are also discussed, in part because it offers another opportunity of cancer therapy by manipulating levels of gp96 in T cells to enhance host immune defense.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTKDihIb-tPrVg90H21EOLACvtfcHk0liuXvqYsrrtLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVOhsrnK&md5=52930fd6506186a93a1a8decad51388c</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.2174%2F1568026616666160413141613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026616666160413141613%26sid%3Dliteratum%253Aachs%26aulast%3DAnsa-Addo%26aufirst%3DE.%2BA.%26aulast%3DThaxton%26aufirst%3DJ.%26aulast%3DHong%26aufirst%3DF.%26aulast%3DWu%26aufirst%3DB.%2BX.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DFugle%26aufirst%3DC.%2BW.%26aulast%3DMetelli%26aufirst%3DA.%26aulast%3DRiesenberg%26aufirst%3DB.%26aulast%3DWilliams%26aufirst%3DK.%26aulast%3DGewirth%26aufirst%3DD.%2BT.%26aulast%3DChiosis%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DZ.%26atitle%3DClients%2520and%2520oncogenic%2520roles%2520of%2520molecular%2520chaperone%2520gp96%252Fgrp94%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2016%26volume%3D16%26spage%3D2765%26epage%3D2778%26doi%3D10.2174%2F1568026616666160413141613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Im, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, B. H.</span></span> <span> </span><span class="NLM_article-title">Paralog specificity determines subcellular distribution, action mechanism, and anticancer activity of TRAP1 inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">7569</span>– <span class="NLM_lpage">7578</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00978</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00978" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlCnsrjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=7569-7578&author=H.+K.+Parkauthor=H.+Jeongauthor=E.+Koauthor=G.+Leeauthor=J.+E.+Leeauthor=S.+K.+Leeauthor=A.+J.+Leeauthor=J.+Y.+Imauthor=S.+Huauthor=S.+H.+Kimauthor=J.+H.+Leeauthor=C.+Leeauthor=S.+Kangauthor=B.+H.+Kang&title=Paralog+specificity+determines+subcellular+distribution%2C+action+mechanism%2C+and+anticancer+activity+of+TRAP1+inhibitors&doi=10.1021%2Facs.jmedchem.7b00978"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Paralog Specificity Determines Subcellular Distribution, Action Mechanism, and Anticancer Activity of TRAP1 Inhibitors</span></div><div class="casAuthors">Park, Hye-Kyung; Jeong, Hanbin; Ko, Eunhwa; Lee, Geumwoo; Lee, Ji-Eun; Lee, Sang Kwang; Lee, An-Jung; Im, Jin Young; Hu, Sung; Kim, Seong Heon; Lee, Ji Hoon; Lee, Changwook; Kang, Soosung; Kang, Byoung Heon</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7569-7578</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Although Hsp90 inhibitors can inhibit multiple tumorigenic pathways in cancer cells, their anticancer activity has been disappointingly modest.  However, by forcing Hsp90 inhibitors into the mitochondria with mitochondrial delivery vehicles, they were converted into potent drugs targeting the mitochondrial Hsp90 paralog TRAP1.  Here, to improve mitochondrial drug accumulation without using the mitochondrial delivery vehicle, we increased freely available drug concns. in the cytoplasm by reducing the binding of the drugs to the abundant cytoplasmic Hsp90.  After analyzing X-ray cocrystal structures, the purine ring of the Hsp90 inhibitor 2 (BIIB021) was modified to pyrazolopyrimidine scaffolds.  One pyrazolopyrimidine, 12b (DN401), bound better to TRAP1 than to Hsp90, inactivated the mitochondrial TRAP1 in vivo, and it exhibited potent anticancer activity.  Therefore, the rationale and feasible guidelines for developing 12b can potentially be exploited to design a potent TRAP1 inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUfck9jHWGc7Vg90H21EOLACvtfcHk0liuXvqYsrrtLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlCnsrjM&md5=7cfcb60a5a2691eb7be6950ef7ede0ed</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00978&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00978%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DH.%2BK.%26aulast%3DJeong%26aufirst%3DH.%26aulast%3DKo%26aufirst%3DE.%26aulast%3DLee%26aufirst%3DG.%26aulast%3DLee%26aufirst%3DJ.%2BE.%26aulast%3DLee%26aufirst%3DS.%2BK.%26aulast%3DLee%26aufirst%3DA.%2BJ.%26aulast%3DIm%26aufirst%3DJ.%2BY.%26aulast%3DHu%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DKang%26aufirst%3DS.%26aulast%3DKang%26aufirst%3DB.%2BH.%26atitle%3DParalog%2520specificity%2520determines%2520subcellular%2520distribution%252C%2520action%2520mechanism%252C%2520and%2520anticancer%2520activity%2520of%2520TRAP1%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D7569%26epage%3D7578%26doi%3D10.1021%2Facs.jmedchem.7b00978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khandelwal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kent, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, V. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanian, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holzbeierlein, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matts, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, B. S. J.</span></span> <span> </span><span class="NLM_article-title">Structure-guided design of an Hsp90beta N-terminal isoform-selective inhibitor</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">425</span>, <span class="refDoi"> DOI: 10.1038/s41467-017-02013-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.1038%2Fs41467-017-02013-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=29382832" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A280%3ADC%252BC1MvlsFyksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=425&author=A.+Khandelwalauthor=C.+N.+Kentauthor=M.+Balchauthor=S.+Pengauthor=S.+J.+Mishraauthor=J.+Dengauthor=V.+W.+Dayauthor=W.+Liuauthor=C.+Subramanianauthor=M.+Cohenauthor=J.+M.+Holzbeierleinauthor=R.+Mattsauthor=B.+S.+J.+Blagg&title=Structure-guided+design+of+an+Hsp90beta+N-terminal+isoform-selective+inhibitor&doi=10.1038%2Fs41467-017-02013-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-guided design of an Hsp90β N-terminal isoform-selective inhibitor</span></div><div class="casAuthors">Khandelwal Anuj; Mishra Sanket J; Kent Caitlin N; Blagg Brian S J; Balch Maurie; Peng Shuxia; Deng Junpeng; Matts Robert; Day Victor W; Liu Weiya; Holzbeierlein Jeffery M; Subramanian Chitra; Cohen Mark</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">425</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The 90 kDa heat shock protein (Hsp90) is a molecular chaperone responsible for folding proteins that are directly associated with cancer progression.  Consequently, inhibition of the Hsp90 protein folding machinery results in a combinatorial attack on numerous oncogenic pathways.  Seventeen small-molecule inhibitors of Hsp90 have entered clinical trials, all of which bind the Hsp90 N-terminus and exhibit pan-inhibitory activity against all four Hsp90 isoforms. pan-Inhibition of Hsp90 appears to be detrimental as toxicities have been reported alongside induction of the pro-survival heat shock response.  The development of Hsp90 isoform-selective inhibitors represents an alternative approach towards the treatment of cancer that may limit some of the detriments.  Described herein is a structure-based approach to design isoform-selective inhibitors of Hsp90β, which induces the degradation of select Hsp90 clients without concomitant induction of Hsp90 levels.  Together, these initial studies support the development of Hsp90β-selective inhibitors as a method to overcome the detriments associated with pan-inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTmyRre9-yoQBpyrDyM_m9cfW6udTcc2eZeEnpJ6nIdOLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MvlsFyksA%253D%253D&md5=cfa47e314c9bdbc1c38802108330cba7</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fs41467-017-02013-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-017-02013-1%26sid%3Dliteratum%253Aachs%26aulast%3DKhandelwal%26aufirst%3DA.%26aulast%3DKent%26aufirst%3DC.%2BN.%26aulast%3DBalch%26aufirst%3DM.%26aulast%3DPeng%26aufirst%3DS.%26aulast%3DMishra%26aufirst%3DS.%2BJ.%26aulast%3DDeng%26aufirst%3DJ.%26aulast%3DDay%26aufirst%3DV.%2BW.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DSubramanian%26aufirst%3DC.%26aulast%3DCohen%26aufirst%3DM.%26aulast%3DHolzbeierlein%26aufirst%3DJ.%2BM.%26aulast%3DMatts%26aufirst%3DR.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%2BJ.%26atitle%3DStructure-guided%2520design%2520of%2520an%2520Hsp90beta%2520N-terminal%2520isoform-selective%2520inhibitor%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26spage%3D425%26doi%3D10.1038%2Fs41467-017-02013-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, B. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ansa-Addo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span> <span> </span><span class="NLM_article-title">GRP94/gp96 in cancer: biology, structure, immunology, and drug development</span>. <i>Adv. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">165</span>– <span class="NLM_lpage">190</span>, <span class="refDoi"> DOI: 10.1016/bs.acr.2015.09.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.1016%2Fbs.acr.2015.09.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=26916005" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BC1MXptlWqsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2016&pages=165-190&author=B.+X.+Wuauthor=F.+Hongauthor=Y.+Zhangauthor=E.+Ansa-Addoauthor=Z.+Li&title=GRP94%2Fgp96+in+cancer%3A+biology%2C+structure%2C+immunology%2C+and+drug+development&doi=10.1016%2Fbs.acr.2015.09.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">GRP94/gp96 in cancer: biology, structure, immunology, and drug development</span></div><div class="casAuthors">Wu, Bill X.; Hong, Feng; Zhang, Yongliang; Ansa-Addo, Ephraim; Li, Zihai</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Cancer Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">Hsp90 in Cancer: Beyond the Usual Suspects</span>),
    <span class="NLM_cas:pages">165-190</span>CODEN:
                <span class="NLM_cas:coden">ACRSAJ</span>;
        ISSN:<span class="NLM_cas:issn">0065-230X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">As an endoplasmic reticulum heat-shock protein 90 (HSP90) paralog, GRP94 (glucose-regulated protein 94)/gp96 (hereafter referred to as GRP94) has been shown to be an essential master chaperone for multiple receptors including Toll-like receptors, Wnt coreceptors, and integrins.  Clin., expression of GRP94 correlates with advanced stage and poor survival in a variety of cancers.  Recent preclin. studies have also revealed that GRP94 expression is closely linked to cancer growth and metastasis in melanoma, ovarian cancer, multiple myeloma, lung cancer, and inflammation-assocd. colon cancer.  Thus, GRP94 is an attractive therapeutic target in a no. of malignancies.  The chaperone function of GRP94 depends on its ATPase domain, which is structurally distinct from HSP90, allowing design of highly selective GRP94-targeted inhibitors.  In this chapter, we discuss the biol. and structure-function relationship of GRP94.  We also summarize the immunol. roles of GRP94 based on the studies documented over the last two decades, as these pertain to tumorigenesis and cancer progression.  Finally, the structure-based rationale for the design of selective small-mol. inhibitors of GRP94 and their potential application in the treatment of cancer are highlighted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiOidSXL_76bVg90H21EOLACvtfcHk0li9wWk_pta_LA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXptlWqsrw%253D&md5=aa5f0de87db03540b0902ae305e658fc</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fbs.acr.2015.09.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fbs.acr.2015.09.001%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DB.%2BX.%26aulast%3DHong%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DAnsa-Addo%26aufirst%3DE.%26aulast%3DLi%26aufirst%3DZ.%26atitle%3DGRP94%252Fgp96%2520in%2520cancer%253A%2520biology%252C%2520structure%252C%2520immunology%252C%2520and%2520drug%2520development%26jtitle%3DAdv.%2520Cancer%2520Res.%26date%3D2016%26volume%3D129%26spage%3D165%26epage%3D190%26doi%3D10.1016%2Fbs.acr.2015.09.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Y. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeMayo, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lydon, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubeau, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, A. S.</span></span> <span> </span><span class="NLM_article-title">Glucose-regulated protein 94 deficiency induces squamous cell metaplasia and suppresses PTEN-null driven endometrial epithelial tumor development</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">14885</span>– <span class="NLM_lpage">14897</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.7450</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.18632%2Foncotarget.7450" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=14885-14897&author=J.+Shenauthor=L.+Yaoauthor=Y.+G.+Linauthor=F.+J.+DeMayoauthor=J.+P.+Lydonauthor=L.+Dubeauauthor=A.+S.+Lee&title=Glucose-regulated+protein+94+deficiency+induces+squamous+cell+metaplasia+and+suppresses+PTEN-null+driven+endometrial+epithelial+tumor+development&doi=10.18632%2Foncotarget.7450"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.7450&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.7450%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DJ.%26aulast%3DYao%26aufirst%3DL.%26aulast%3DLin%26aufirst%3DY.%2BG.%26aulast%3DDeMayo%26aufirst%3DF.%2BJ.%26aulast%3DLydon%26aufirst%3DJ.%2BP.%26aulast%3DDubeau%26aufirst%3DL.%26aulast%3DLee%26aufirst%3DA.%2BS.%26atitle%3DGlucose-regulated%2520protein%252094%2520deficiency%2520induces%2520squamous%2520cell%2520metaplasia%2520and%2520suppresses%2520PTEN-null%2520driven%2520endometrial%2520epithelial%2520tumor%2520development%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26spage%3D14885%26epage%3D14897%26doi%3D10.18632%2Foncotarget.7450" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rachidi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, B. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drake, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogretmen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowart, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannun, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiosis, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span> <span> </span><span class="NLM_article-title">Endoplasmic reticulum heat shock protein gp96 maintains liver homeostasis and promotes hepatocellular carcinogenesis</span>. <i>J. Hepatol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">879</span>– <span class="NLM_lpage">888</span>, <span class="refDoi"> DOI: 10.1016/j.jhep.2014.11.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.1016%2Fj.jhep.2014.11.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=25463537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitFCru7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2015&pages=879-888&author=S.+Rachidiauthor=S.+Sunauthor=B.+X.+Wuauthor=E.+Jonesauthor=R.+R.+Drakeauthor=B.+Ogretmenauthor=L.+A.+Cowartauthor=C.+J.+Clarkeauthor=Y.+A.+Hannunauthor=G.+Chiosisauthor=B.+Liuauthor=Z.+Li&title=Endoplasmic+reticulum+heat+shock+protein+gp96+maintains+liver+homeostasis+and+promotes+hepatocellular+carcinogenesis&doi=10.1016%2Fj.jhep.2014.11.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Endoplasmic reticulum heat shock protein gp96 maintains liver homeostasis and promotes hepatocellular carcinogenesis</span></div><div class="casAuthors">Rachidi, Saleh; Sun, Shaoli; Wu, Bill X.; Jones, Elizabeth; Drake, Richard R.; Ogretmen, Besim; Cowart, L. Ashley; Clarke, Christopher J.; Hannun, Yusuf A.; Chiosis, Gabriela; Liu, Bei; Li, Zihai</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hepatology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">879-888</span>CODEN:
                <span class="NLM_cas:coden">JOHEEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-8278</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Background & Aims: gp96, or grp94, is an endoplasmic reticulum (ER)-localized heat shock protein 90 paralog that acts as a protein chaperone and plays an important role for example in ER homeostasis, ER stress, Wnt and integrin signaling, and calcium homeostasis, which are vital processes in oncogenesis.  However, the cancer-intrinsic function of gp96 remains controversial.  Methods: We studied the roles of gp96 in liver biol. in mice via an Albumin promoter-driven Cre recombinase-mediated disruption of gp96 gene, hsp90b1.  The impact of gp96 status on hepatic carcinogenesis in response to diethyl-nitrosoamine (DENA) was probed.  The roles of gp96 on human hepatocellular carcinoma cells (HCC) were also examd. pharmacol. with a targeted gp96 inhibitor.  Results: We demonstrated that gp96 maintains liver development and hepatocyte function in vivo, and its loss genetically promotes adaptive accumulation of long chain ceramides, accompanied by steatotic regeneration of residual gp96+ hepatocytes.  The need for compensatory expansion of gp96+ cells in the gp96- background predisposes mice to develop carcinogen-induced hepatic hyperplasia and cancer from gp96+ but not gp96- hepatocytes.  We also found that genetic and pharmacol. inhibition of gp96 in human HCCs perturbed multiple growth signals, and attenuated proliferation and expansion.  Conclusions: gp96 is a pro-oncogenic chaperone and an attractive therapeutic target for HCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrexEwdBOAeDrVg90H21EOLACvtfcHk0liSQycAzwZD8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitFCru7w%253D&md5=33319c103ee2f44e92089321851ab22d</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.jhep.2014.11.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jhep.2014.11.010%26sid%3Dliteratum%253Aachs%26aulast%3DRachidi%26aufirst%3DS.%26aulast%3DSun%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DB.%2BX.%26aulast%3DJones%26aufirst%3DE.%26aulast%3DDrake%26aufirst%3DR.%2BR.%26aulast%3DOgretmen%26aufirst%3DB.%26aulast%3DCowart%26aufirst%3DL.%2BA.%26aulast%3DClarke%26aufirst%3DC.%2BJ.%26aulast%3DHannun%26aufirst%3DY.%2BA.%26aulast%3DChiosis%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DZ.%26atitle%3DEndoplasmic%2520reticulum%2520heat%2520shock%2520protein%2520gp96%2520maintains%2520liver%2520homeostasis%2520and%2520promotes%2520hepatocellular%2520carcinogenesis%26jtitle%3DJ.%2520Hepatol.%26date%3D2015%26volume%3D62%26spage%3D879%26epage%3D888%26doi%3D10.1016%2Fj.jhep.2014.11.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hua, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White-Gilbertson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kellner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rachidi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Usmani, S. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiosis, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Depinho, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span> <span> </span><span class="NLM_article-title">Molecular chaperone gp96 is a novel therapeutic target of multiple myeloma</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">6242</span>– <span class="NLM_lpage">6251</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-13-2083</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.1158%2F1078-0432.CCR-13-2083" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=24077352" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslyku7jP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=6242-6251&author=Y.+Huaauthor=S.+White-Gilbertsonauthor=J.+Kellnerauthor=S.+Rachidiauthor=S.+Z.+Usmaniauthor=G.+Chiosisauthor=R.+Depinhoauthor=Z.+Liauthor=B.+Liu&title=Molecular+chaperone+gp96+is+a+novel+therapeutic+target+of+multiple+myeloma&doi=10.1158%2F1078-0432.CCR-13-2083"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Chaperone gp96 Is a Novel Therapeutic Target of Multiple Myeloma</span></div><div class="casAuthors">Hua, Yunpeng; White-Gilbertson, Shai; Kellner, Joshua; Rachidi, Saleh; Usmani, Saad Z.; Chiosis, Gabriela; DePinho, Ronald; Li, Zihai; Liu, Bei</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6242-6251</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: gp96 (grp94) is a key downstream chaperone in the endoplasmic reticulum (ER) to mediate unfolded protein response (UPR) and the pathogenesis of multiple myeloma is closely linked to dysregulated UPR.  In this study, we aimed to det. the roles of gp96 in the initiation and progression of multiple myeloma in vivo and in vitro.  Exptl. Design: We generated a mouse model with overexpression of XBP1s and conditional deletion of gp96 in B-cell compartment simultaneously to identify the roles of gp96 in the development of multiple myeloma in vivo.  Using a short hairpin RNA (shRNA) system, we silenced gp96 in multiple human multiple myeloma cells and examd. the effect of gp96 knockdown on multiple myeloma cells by cell proliferation, cell-cycle anal., apoptosis assay, immunohistochem., and human myeloma xenograft model.  The anticancer activity of gp96 selective inhibitor, WS13, was evaluated by apoptosis assay and MTT assay.  Results: Genetic deletion of gp96 in XBP1s-Tg mice attenuates multiple myeloma.  Silencing of gp96 causes severe compromise in human multiple myeloma cell growth through inhibiting Wnt-LRP-survivin pathway.  We also confirmed that knockdown of gp96 decreased human multiple myeloma growth in a murine xenograft model.  The targeted gp96 inhibitor induced apoptosis and blocked multiple myeloma cell growth, but did not induce apoptosis in pre-B leukemic cells.  We have demonstrated that myeloma growth is dependent on gp96 both genetically and pharmacol.  Conclusions: gp96 is essential for multiple myeloma cell proliferation and survival, suggesting that gp96 is a novel therapeutic target for multiple myeloma.  Clin Cancer Res; 19(22); 6242-51. ©2013 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqd-ajwmlaUPrVg90H21EOLACvtfcHk0liSQycAzwZD8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslyku7jP&md5=adb618074ee3e9d6ee4795b95c1d906c</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-13-2083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-13-2083%26sid%3Dliteratum%253Aachs%26aulast%3DHua%26aufirst%3DY.%26aulast%3DWhite-Gilbertson%26aufirst%3DS.%26aulast%3DKellner%26aufirst%3DJ.%26aulast%3DRachidi%26aufirst%3DS.%26aulast%3DUsmani%26aufirst%3DS.%2BZ.%26aulast%3DChiosis%26aufirst%3DG.%26aulast%3DDepinho%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DB.%26atitle%3DMolecular%2520chaperone%2520gp96%2520is%2520a%2520novel%2520therapeutic%2520target%2520of%2520multiple%2520myeloma%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2013%26volume%3D19%26spage%3D6242%26epage%3D6251%26doi%3D10.1158%2F1078-0432.CCR-13-2083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dejeans, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glorieux, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guenin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sid, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rousseau, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bisig, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delvenne, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buc Calderon, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verrax, J.</span></span> <span> </span><span class="NLM_article-title">Overexpression of GRP94 in breast cancer cells resistant to oxidative stress promotes high levels of cancer cell proliferation and migration: Implications for tumor recurrence</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">993</span>– <span class="NLM_lpage">1002</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2011.12.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.1016%2Fj.freeradbiomed.2011.12.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=22245095" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtFSitbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=993-1002&author=N.+Dejeansauthor=C.+Glorieuxauthor=S.+Gueninauthor=R.+Beckauthor=B.+Sidauthor=R.+Rousseauauthor=B.+Bisigauthor=P.+Delvenneauthor=P.+Buc+Calderonauthor=J.+Verrax&title=Overexpression+of+GRP94+in+breast+cancer+cells+resistant+to+oxidative+stress+promotes+high+levels+of+cancer+cell+proliferation+and+migration%3A+Implications+for+tumor+recurrence&doi=10.1016%2Fj.freeradbiomed.2011.12.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of GRP94 in breast cancer cells resistant to oxidative stress promotes high levels of cancer cell proliferation and migration: Implications for tumor recurrence</span></div><div class="casAuthors">Dejeans, Nicolas; Glorieux, Christophe; Guenin, Samuel; Beck, Raphael; Sid, Brice; Rousseau, Rejane; Bisig, Bettina; Delvenne, Philippe; Buc Calderon, Pedro; Verrax, Julien</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">993-1002</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Targeting the altered redox status of cancer cells is emerging as an interesting approach to potentiate chemotherapy.  However, to maximize the effectiveness of this strategy and define the correct chemotherapeutic assocns., it is important to understand the biol. consequences of chronically exposing cancer cells to reactive oxygen species (ROS).  Using an H2O2-generating system, we selected a ROS-resistant MCF-7 breast cancer cell line, namely Resox cells.  By exploring different survival pathways that are usually induced during oxidative stress, we identified a constitutive overexpression of the endoplasmic reticulum chaperone, GRP94, in these cells, whereas levels of its cytoplasmic homolog HSP90, or GRP78, were not modified.  This overexpression was not mediated by constitutive unfolded protein response (UPR) activation.  The increase in GRP94 is tightly linked to an increase in cell proliferation and migration capacities, as shown by GRP94-silencing expts.  Interestingly, we also obsd. that GRP94 silencing inhibits migration and proliferation of the highly aggressive MDA-MB-231 cells.  By immunohistochem., we showed that GRP94 expression was higher in recurrent human breast cancers than in their paired primary neoplasias.  Similar to the situation in the Resox cells, this increase was not assocd. with an increase in UPR activation in recurrent tumors.  In conclusion, this study suggests that GRP94 overexpression may be a hallmark of aggressiveness and recurrence in breast cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvjqFOXM39gbVg90H21EOLACvtfcHk0li9vFUVrn0vmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtFSitbs%253D&md5=7125eef26433c15ec7b357151ecc5d20</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2011.12.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2011.12.019%26sid%3Dliteratum%253Aachs%26aulast%3DDejeans%26aufirst%3DN.%26aulast%3DGlorieux%26aufirst%3DC.%26aulast%3DGuenin%26aufirst%3DS.%26aulast%3DBeck%26aufirst%3DR.%26aulast%3DSid%26aufirst%3DB.%26aulast%3DRousseau%26aufirst%3DR.%26aulast%3DBisig%26aufirst%3DB.%26aulast%3DDelvenne%26aufirst%3DP.%26aulast%3DBuc%2BCalderon%26aufirst%3DP.%26aulast%3DVerrax%26aufirst%3DJ.%26atitle%3DOverexpression%2520of%2520GRP94%2520in%2520breast%2520cancer%2520cells%2520resistant%2520to%2520oxidative%2520stress%2520promotes%2520high%2520levels%2520of%2520cancer%2520cell%2520proliferation%2520and%2520migration%253A%2520Implications%2520for%2520tumor%2520recurrence%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2012%26volume%3D52%26spage%3D993%26epage%3D1002%26doi%3D10.1016%2Fj.freeradbiomed.2011.12.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chiu, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, L. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, A. J.</span></span> <span> </span><span class="NLM_article-title">Molecular chaperones as a common set of proteins that regulate the invasion phenotype of head and neck cancer</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">4629</span>– <span class="NLM_lpage">4641</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-10-2107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.1158%2F1078-0432.CCR-10-2107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=21642380" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovFehtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=4629-4641&author=C.+C.+Chiuauthor=C.+Y.+Linauthor=L.+Y.+Leeauthor=Y.+J.+Chenauthor=Y.+C.+Luauthor=H.+M.+Wangauthor=C.+T.+Liaoauthor=J.+T.+Changauthor=A.+J.+Cheng&title=Molecular+chaperones+as+a+common+set+of+proteins+that+regulate+the+invasion+phenotype+of+head+and+neck+cancer&doi=10.1158%2F1078-0432.CCR-10-2107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Chaperones as a Common Set of Proteins That Regulate the Invasion Phenotype of Head and Neck Cancer</span></div><div class="casAuthors">Chiu, Ching-Chi; Lin, Chien-Yu; Lee, Li-Yu; Chen, Yin-Ju; Lu, Ya-Ching; Wang, Hung-Ming; Liao, Chun-Ta; Chang, Joseph Tung-Chieh; Cheng, Ann-Joy</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4629-4641</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: The goal of this study was to establish a common set of mols. that regulate cell invasion in head and neck cancer (HNC).  Exptl. Design: Five invasive sublines derived from HNC cell lines were established using the Matrigel selection method.  Proteomic technol., MetaCore algorithm, and reverse transcriptase-PCR methods were used to search for mols. that contribute to the invasion phenotype.  Cellular functional analyses and clin. assocn. studies were applied to examine the significance of the mols.  RESULTS: Fifty-two proteins were identified in more than two of the four independent proteomic expts., including 10 (19%) mol. chaperones.  Seven chaperones were confirmed to be differentially expressed in five sublines, Hsp90α, Hsp90β, Hsp90-B1/Gp96, Hsp70-A5/Grp78, and HYOU1, that upregulate, whereas Hsp60 and glucosidase-α neutral AB (GANAB) downregulate.  Four mols. were further investigated.  In all cell lines, knockdown of Hsp60 or GANAB and silencing of Gp96 or Grp78 considerably enhanced or reduced cell migration and invasion, resp.  Clin. assocn. studies consistently revealed that low levels of Hsp60 or GANAB and high levels of Gp96 or Grp78 are significantly assocd. with advanced cancer (P < 0.001 to P = 0.047, resp., for the four mols.) and poor survival (P < 0.001 to P = 0.025, resp., for the four mols.).  CONCLUSION: Our study defined mol. chaperones as a common set of proteins that regulate the invasion phenotype of HNC.  Loss of the tumor suppression function of Hsp60 or GANAB and acquisition of the oncogenic function of Gp96 or Grp78 contribute to aggressive cancers.  These mols. may serve as prognostic markers and targets for cancer drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKUAtEObTjBbVg90H21EOLACvtfcHk0li9vFUVrn0vmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovFehtrg%253D&md5=399536844963a661fedfd375164da245</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-10-2107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-10-2107%26sid%3Dliteratum%253Aachs%26aulast%3DChiu%26aufirst%3DC.%2BC.%26aulast%3DLin%26aufirst%3DC.%2BY.%26aulast%3DLee%26aufirst%3DL.%2BY.%26aulast%3DChen%26aufirst%3DY.%2BJ.%26aulast%3DLu%26aufirst%3DY.%2BC.%26aulast%3DWang%26aufirst%3DH.%2BM.%26aulast%3DLiao%26aufirst%3DC.%2BT.%26aulast%3DChang%26aufirst%3DJ.%2BT.%26aulast%3DCheng%26aufirst%3DA.%2BJ.%26atitle%3DMolecular%2520chaperones%2520as%2520a%2520common%2520set%2520of%2520proteins%2520that%2520regulate%2520the%2520invasion%2520phenotype%2520of%2520head%2520and%2520neck%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2011%26volume%3D17%26spage%3D4629%26epage%3D4641%26doi%3D10.1158%2F1078-0432.CCR-10-2107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masuda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, Y. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takano, Y.</span></span> <span> </span><span class="NLM_article-title">Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas</span>. <i>Hum. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">1042</span>– <span class="NLM_lpage">1049</span>, <span class="refDoi"> DOI: 10.1016/j.humpath.2007.11.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.1016%2Fj.humpath.2007.11.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=18482745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnsF2qu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2008&pages=1042-1049&author=H.+C.+Zhengauthor=H.+Takahashiauthor=X.+H.+Liauthor=T.+Haraauthor=S.+Masudaauthor=Y.+F.+Guanauthor=Y.+Takano&title=Overexpression+of+GRP78+and+GRP94+are+markers+for+aggressive+behavior+and+poor+prognosis+in+gastric+carcinomas&doi=10.1016%2Fj.humpath.2007.11.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas</span></div><div class="casAuthors">Zheng, Hua-chuan; Takahashi, Hiroyuki; Li, Xiao-han; Hara, Takuo; Masuda, Shinji; Guan, Yi-fu; Takano, Yasuo</div><div class="citationInfo"><span class="NLM_cas:title">Human Pathology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1042-1049</span>CODEN:
                <span class="NLM_cas:coden">HPCQA4</span>;
        ISSN:<span class="NLM_cas:issn">0046-8177</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Summary: Glucose-related proteins (GRPs) are ubiquitously expressed in endoplasmic reticulum and able to assist in protein folding and assembly; consequently, they are considered as mol. chaperones.  GRP78 and GRP94 expression was induced by glucose starvation and up-regulated in the malignancies.  To clarify the roles of both mols. in tumorigenesis and progression of gastric carcinomas, immunohistochem. was used on tissue microarray contg. gastric carcinomas, adenomas, and nonneoplastic mucosa using the antibodies against GRP78 and GRP94, with a comparison of their expression with clinicopathol. parameters of carcinomas.  Gastric carcinoma cell lines (MKN28, AGS, MKN45, KATO-III, and HGC-27) were studied for both proteins by immunohistochem. and Western blot.  There was more expression of both proteins in gastric carcinoma and adenoma than in nonneoplastic mucosas (P < .05).  All gastric carcinoma cell lines showed their expression at different levels.  They were pos. correlated with tumor size, depth of invasion, lymphatic and venous invasion, lymph node metastasis, and Union Internationale Contre le Cancer staging (P < .05), with pos. relationship between both proteins (P < .05).  Univariate anal. indicated the postsurgical cumulative survival rate of patients with pos. GRP78 or GRP94 expression to be lower than that in those without GRP78 or GRP94 expression (P < .05), but the close link disappeared if stratified according to depth of invasion (P > .05).  Multivariate anal. showed that age, depth of invasion, lymphatic invasion, lymph node metastasis, Union Internationale Contre le Cancer staging, and Lauren classification (P < .05), but not GRP78 and GRP94 expression, were independent prognostic factors for carcinomas (P > .05).  Up-regulated expression of GRP78 and GRP94 was possibly involved in pathogenesis, growth, invasion, and metastasis of gastric carcinomas.  They were considered objective and effective markers for the aggressive behavior and poor prognosis in gastric carcinomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokt8ggPAG35rVg90H21EOLACvtfcHk0li5apVS2P21Hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnsF2qu74%253D&md5=7b96bfff001cb6c04ade258a1f7c64a3</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.humpath.2007.11.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.humpath.2007.11.009%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DH.%2BC.%26aulast%3DTakahashi%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DX.%2BH.%26aulast%3DHara%26aufirst%3DT.%26aulast%3DMasuda%26aufirst%3DS.%26aulast%3DGuan%26aufirst%3DY.%2BF.%26aulast%3DTakano%26aufirst%3DY.%26atitle%3DOverexpression%2520of%2520GRP78%2520and%2520GRP94%2520are%2520markers%2520for%2520aggressive%2520behavior%2520and%2520poor%2520prognosis%2520in%2520gastric%2520carcinomas%26jtitle%3DHum.%2520Pathol.%26date%3D2008%26volume%3D39%26spage%3D1042%26epage%3D1049%26doi%3D10.1016%2Fj.humpath.2007.11.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stothert, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suntharalingam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huard, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fontaine, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crowley, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lieberman, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickey, C. A.</span></span> <span> </span><span class="NLM_article-title">Exploiting the interaction between Grp94 and aggregated myocilin to treat glaucoma</span>. <i>Hum. Mol. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">6470</span>– <span class="NLM_lpage">6480</span>, <span class="refDoi"> DOI: 10.1093/hmg/ddu367</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.1093%2Fhmg%2Fddu367" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=25027323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitl2ntb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2014&pages=6470-6480&author=A.+R.+Stothertauthor=A.+Suntharalingamauthor=D.+J.+Huardauthor=S.+N.+Fontaineauthor=V.+M.+Crowleyauthor=S.+Mishraauthor=B.+S.+Blaggauthor=R.+L.+Liebermanauthor=C.+A.+Dickey&title=Exploiting+the+interaction+between+Grp94+and+aggregated+myocilin+to+treat+glaucoma&doi=10.1093%2Fhmg%2Fddu367"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Exploiting the interaction between Grp94 and aggregated myocilin to treat glaucoma</span></div><div class="casAuthors">Stothert, Andrew R.; Suntharalingam, Amirthaa; Huard, Dustin J. E.; Fontaine, Sarah N.; Crowley, Vincent M.; Mishra, Sanket; Blagg, Brian S. J.; Lieberman, Raquel L.; Dickey, Chad A.</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6470-6480</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Gain-of-function mutations in the olfactomedin domain of the MYOC gene facilitate the toxic accumulation of amyloid-contg. myocilin aggregates, hastening the onset of the prevalent ocular disorder primary open-angle glaucoma.  Aggregation of wild-type myocilin has been reported in other glaucoma subtypes, suggesting broader relevance of misfolded myocilin across the disease spectrum, but the absence of myocilin does not cause disease.  Thus, strategies aimed at eliminating myocilin could be therapeutically relevant for glaucoma.  Here, a novel and selective Grp94 inhibitor reduced the levels of several mutant myocilin proteins as well as wild-type myocilin when forced to misfold in cells.  This inhibitor rescued mutant myocilin toxicity in primary human trabecular meshwork cells.  Mechanistically, in vitro kinetics studies demonstrate that Grp94 recognizes on-pathway aggregates of the myocilin olfactomedin domain (myoc-OLF), accelerates rates of aggregation and co-ppts. with myoc-OLF.  These results indicate that aberrant myocilin quaternary structure drives Grp94 recognition, rather than peptide motifs exposed by unfolded protein.  Inhibition of Grp94 ameliorates the effects of Grp94-accelerated myoc-OLF aggregation, and Grp94 remains in soln.  In cells, when wild-type myocilin is driven to misfold and aggregate, it becomes a client of Grp94 and sensitive to Grp94 inhibition.  Taken together, the interaction of Grp94 with myocilin aggregates can be manipulated by cellular environment and genetics; this process can be exploited with Grp94 inhibitors to promote the clearance of toxic forms of myocilin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeQYeK777kKLVg90H21EOLACvtfcHk0li5apVS2P21Hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitl2ntb8%253D&md5=cbabbce383403838a4cbc3ffe24bdce8</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddu367&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddu367%26sid%3Dliteratum%253Aachs%26aulast%3DStothert%26aufirst%3DA.%2BR.%26aulast%3DSuntharalingam%26aufirst%3DA.%26aulast%3DHuard%26aufirst%3DD.%2BJ.%26aulast%3DFontaine%26aufirst%3DS.%2BN.%26aulast%3DCrowley%26aufirst%3DV.%2BM.%26aulast%3DMishra%26aufirst%3DS.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%26aulast%3DLieberman%26aufirst%3DR.%2BL.%26aulast%3DDickey%26aufirst%3DC.%2BA.%26atitle%3DExploiting%2520the%2520interaction%2520between%2520Grp94%2520and%2520aggregated%2520myocilin%2520to%2520treat%2520glaucoma%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2014%26volume%3D23%26spage%3D6470%26epage%3D6480%26doi%3D10.1093%2Fhmg%2Fddu367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rosser, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicchitta, C. V.</span></span> <span> </span><span class="NLM_article-title">Ligand interactions in the adenosine nucleotide-binding domain of the Hsp90 chaperone, GRP94. I. Evidence for allosteric regulation of ligand binding</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>275</i></span>,  <span class="NLM_fpage">22798</span>– <span class="NLM_lpage">22805</span>, <span class="refDoi"> DOI: 10.1074/jbc.M001477200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.1074%2Fjbc.M001477200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=22798-22805&author=M.+F.+Rosserauthor=C.+V.+Nicchitta&title=Ligand+interactions+in+the+adenosine+nucleotide-binding+domain+of+the+Hsp90+chaperone%2C+GRP94.+I.+Evidence+for+allosteric+regulation+of+ligand+binding&doi=10.1074%2Fjbc.M001477200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M001477200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M001477200%26sid%3Dliteratum%253Aachs%26aulast%3DRosser%26aufirst%3DM.%2BF.%26aulast%3DNicchitta%26aufirst%3DC.%2BV.%26atitle%3DLigand%2520interactions%2520in%2520the%2520adenosine%2520nucleotide-binding%2520domain%2520of%2520the%2520Hsp90%2520chaperone%252C%2520GRP94.%2520I.%2520Evidence%2520for%2520allosteric%2520regulation%2520of%2520ligand%2520binding%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D22798%26epage%3D22805%26doi%3D10.1074%2Fjbc.M001477200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Soldano, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jivan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicchitta, C. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gewirth, D. T.</span></span> <span> </span><span class="NLM_article-title">Structure of the N-terminal domain of GRP94. Basis for ligand specificity and regulation</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>278</i></span>,  <span class="NLM_fpage">48330</span>– <span class="NLM_lpage">48338</span>, <span class="refDoi"> DOI: 10.1074/jbc.M308661200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.1074%2Fjbc.M308661200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=12970348" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpt1Gjt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=48330-48338&author=K.+L.+Soldanoauthor=A.+Jivanauthor=C.+V.+Nicchittaauthor=D.+T.+Gewirth&title=Structure+of+the+N-terminal+domain+of+GRP94.+Basis+for+ligand+specificity+and+regulation&doi=10.1074%2Fjbc.M308661200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the N-terminal Domain of GRP94: Basis for Ligand Specificity and Regulation</span></div><div class="casAuthors">Soldano, Karen L.; Jivan, Arif; Nicchitta, Christopher V.; Gewirth, Daniel T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">48330-48338</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">GRP94, the endoplasmic reticulum (ER) paralog of the chaperone Hsp90, plays an essential role in the structural maturation or secretion of a subset of proteins destined for transport to the cell surface, such as the Toll-like receptors 2 and 4, and IgG, resp.  GRP94 differs from cytoplasmic Hsp90 by exhibiting very weak ATP binding and hydrolysis activity.  GRP94 also binds selectively to a series of substituted adenosine analogs.  The high resoln. crystal structures at 1.75-2.1 Å of the N-terminal and adjacent charged domains of GRP94 in complex with N-ethylcarboxamidoadenosine (NECA), radicicol, and 2-chlorodideoxyadenosine reveals a structural mechanism for ligand discrimination among hsp90 family members.  The structures also identify a putative subdomain that may act as a ligand-responsive switch.  The residues of the charged region fold into a disordered loop whose termini are ordered and continue the twisted beta sheet that forms the structural core of the N-domain.  This continuation of the beta sheet past the charged domain suggests a structural basis for the assocn. of the N-terminal and middle domains of the full-length chaperone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1SkIPU21-TLVg90H21EOLACvtfcHk0li5apVS2P21Hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpt1Gjt78%253D&md5=0d83c7ac820dbdab6faf940dd1052ad0</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M308661200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M308661200%26sid%3Dliteratum%253Aachs%26aulast%3DSoldano%26aufirst%3DK.%2BL.%26aulast%3DJivan%26aufirst%3DA.%26aulast%3DNicchitta%26aufirst%3DC.%2BV.%26aulast%3DGewirth%26aufirst%3DD.%2BT.%26atitle%3DStructure%2520of%2520the%2520N-terminal%2520domain%2520of%2520GRP94.%2520Basis%2520for%2520ligand%2520specificity%2520and%2520regulation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D48330%26epage%3D48338%26doi%3D10.1074%2Fjbc.M308661200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patel, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seidler, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Que, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taldone, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finotti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephani, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gewirth, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiosis, G.</span></span> <span> </span><span class="NLM_article-title">Paralog-selective Hsp90 inhibitors define tumor-specific regulation of HER2</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">677</span>– <span class="NLM_lpage">684</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1335</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.1038%2Fnchembio.1335" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=23995768" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlGltb7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=677-684&author=P.+D.+Patelauthor=P.+Yanauthor=P.+M.+Seidlerauthor=H.+J.+Patelauthor=W.+Sunauthor=C.+Yangauthor=N.+S.+Queauthor=T.+Taldoneauthor=P.+Finottiauthor=R.+A.+Stephaniauthor=D.+T.+Gewirthauthor=G.+Chiosis&title=Paralog-selective+Hsp90+inhibitors+define+tumor-specific+regulation+of+HER2&doi=10.1038%2Fnchembio.1335"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Paralog-selective Hsp90 inhibitors define tumor-specific regulation of HER2</span></div><div class="casAuthors">Patel, Pallav D.; Yan, Pengrong; Seidler, Paul M.; Patel, Hardik J.; Sun, Weilin; Yang, Chenghua; Que, Nanette S.; Taldone, Tony; Finotti, Paola; Stephani, Ralph A.; Gewirth, Daniel T.; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">677-684</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Although the Hsp90 chaperone family, comprised in humans of four paralogs, Hsp90α, Hsp90β, Grp94 and Trap-1, has important roles in malignancy, the contribution of each paralog to the cancer phenotype is poorly understood.  This is in large part because reagents to study paralog-specific functions in cancer cells have been unavailable.  Here the authors combine compd. library screening with structural and computational analyses to identify purine-based chem. tools that are specific for Hsp90 paralogs.  The authors show that Grp94 selectivity is due to the insertion of these compds. into a new allosteric pocket.  The authors use these tools to demonstrate that cancer cells use individual Hsp90 paralogs to regulate a client protein in a tumor-specific manner and in response to proteome alterations.  Finally, the authors provide new mechanistic evidence explaining why selective Grp94 inhibition is particularly efficacious in certain breast cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAIwIoA9btZLVg90H21EOLACvtfcHk0lgP0TEvUIckkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlGltb7J&md5=8bdfb2c60b4171bbdd6046e455e413bb</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1335&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1335%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DP.%2BD.%26aulast%3DYan%26aufirst%3DP.%26aulast%3DSeidler%26aufirst%3DP.%2BM.%26aulast%3DPatel%26aufirst%3DH.%2BJ.%26aulast%3DSun%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DQue%26aufirst%3DN.%2BS.%26aulast%3DTaldone%26aufirst%3DT.%26aulast%3DFinotti%26aufirst%3DP.%26aulast%3DStephani%26aufirst%3DR.%2BA.%26aulast%3DGewirth%26aufirst%3DD.%2BT.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DParalog-selective%2520Hsp90%2520inhibitors%2520define%2520tumor-specific%2520regulation%2520of%2520HER2%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2013%26volume%3D9%26spage%3D677%26epage%3D684%26doi%3D10.1038%2Fnchembio.1335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patel, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ochiana, S. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tramentozzi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brooks, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolaender, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shrestha, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finotti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leifer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gewirth, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taldone, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiosis, G.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship in a purine-scaffold compound series with selectivity for the endoplasmic reticulum Hsp90 paralog Grp94</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">3922</span>– <span class="NLM_lpage">3943</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00197</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00197" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BC2MXntVWnsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3922-3943&author=H.+J.+Patelauthor=P.+D.+Patelauthor=S.+O.+Ochianaauthor=P.+Yanauthor=W.+Sunauthor=M.+R.+Patelauthor=S.+K.+Shahauthor=E.+Tramentozziauthor=J.+Brooksauthor=A.+Bolaenderauthor=L.+Shresthaauthor=R.+Stephaniauthor=P.+Finottiauthor=C.+Leiferauthor=Z.+Liauthor=D.+T.+Gewirthauthor=T.+Taldoneauthor=G.+Chiosis&title=Structure-activity+relationship+in+a+purine-scaffold+compound+series+with+selectivity+for+the+endoplasmic+reticulum+Hsp90+paralog+Grp94&doi=10.1021%2Facs.jmedchem.5b00197"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationship in a Purine-Scaffold Compound Series with Selectivity for the Endoplasmic Reticulum Hsp90 Paralog Grp94</span></div><div class="casAuthors">Patel, Hardik J.; Patel, Pallav D.; Ochiana, Stefan O.; Yan, Pengrong; Sun, Weilin; Patel, Maulik R.; Shah, Smit K.; Tramentozzi, Elisa; Brooks, James; Bolaender, Alexander; Shrestha, Liza; Stephani, Ralph; Finotti, Paola; Leifer, Cynthia; Li, Zihai; Gewirth, Daniel T.; Taldone, Tony; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3922-3943</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Grp94 is involved in the regulation of a restricted no. of proteins and represents a potential target in a host of diseases, including cancer, septic shock, autoimmune diseases, chronic inflammatory conditions, diabetes, coronary thrombosis, and stroke.  The authors have recently identified a novel allosteric pocket located in the Grp94 N-terminal binding site that can be used to design ligands with a 2-log selectivity over the other Hsp90 paralogs.  Here the authors perform extensive SAR investigations in this ligand series and rationalize the affinity and paralog selectivity of choice derivs. by mol. modeling.  The authors then use this to design I, a deriv. with good potency for Grp94 (IC50 = 0.22 μM) and selectivity over other paralogs (>100- and 33-fold for Hsp90α/β and Trap-1, resp.).  The paralog selectivity and target-mediated activity of I was confirmed in cells through several functional readouts.  Compd. I was also inert when tested against a large panel of kinases.  The authors show that I has biol. activity in several cellular models of inflammation and cancer and also present here for the first time the in vivo profile of a Grp94 inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-3SSMDJ2Ti7Vg90H21EOLACvtfcHk0lgP0TEvUIckkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXntVWnsbg%253D&md5=4c341cedaf3aa4d08afa43cbca301717</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00197%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DH.%2BJ.%26aulast%3DPatel%26aufirst%3DP.%2BD.%26aulast%3DOchiana%26aufirst%3DS.%2BO.%26aulast%3DYan%26aufirst%3DP.%26aulast%3DSun%26aufirst%3DW.%26aulast%3DPatel%26aufirst%3DM.%2BR.%26aulast%3DShah%26aufirst%3DS.%2BK.%26aulast%3DTramentozzi%26aufirst%3DE.%26aulast%3DBrooks%26aufirst%3DJ.%26aulast%3DBolaender%26aufirst%3DA.%26aulast%3DShrestha%26aufirst%3DL.%26aulast%3DStephani%26aufirst%3DR.%26aulast%3DFinotti%26aufirst%3DP.%26aulast%3DLeifer%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DGewirth%26aufirst%3DD.%2BT.%26aulast%3DTaldone%26aufirst%3DT.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DStructure-activity%2520relationship%2520in%2520a%2520purine-scaffold%2520compound%2520series%2520with%2520selectivity%2520for%2520the%2520endoplasmic%2520reticulum%2520Hsp90%2520paralog%2520Grp94%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D3922%26epage%3D3943%26doi%3D10.1021%2Facs.jmedchem.5b00197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Immormino, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metzger, L. E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reardon, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dollins, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gewirth, D. T.</span></span> <span> </span><span class="NLM_article-title">Different poses for ligand and chaperone in inhibitor-bound Hsp90 and GRP94: Implications for paralog-specific drug design</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>388</i></span>,  <span class="NLM_fpage">1033</span>– <span class="NLM_lpage">1042</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2009.03.071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.1016%2Fj.jmb.2009.03.071" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=388&publication_year=2009&pages=1033-1042&author=R.+M.+Immorminoauthor=L.+E.+T.+Metzgerauthor=P.+N.+Reardonauthor=D.+E.+Dollinsauthor=B.+S.+Blaggauthor=D.+T.+Gewirth&title=Different+poses+for+ligand+and+chaperone+in+inhibitor-bound+Hsp90+and+GRP94%3A+Implications+for+paralog-specific+drug+design&doi=10.1016%2Fj.jmb.2009.03.071"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2009.03.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2009.03.071%26sid%3Dliteratum%253Aachs%26aulast%3DImmormino%26aufirst%3DR.%2BM.%26aulast%3DMetzger%26aufirst%3DL.%2BE.%2BT.%26aulast%3DReardon%26aufirst%3DP.%2BN.%26aulast%3DDollins%26aufirst%3DD.%2BE.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%26aulast%3DGewirth%26aufirst%3DD.%2BT.%26atitle%3DDifferent%2520poses%2520for%2520ligand%2520and%2520chaperone%2520in%2520inhibitor-bound%2520Hsp90%2520and%2520GRP94%253A%2520Implications%2520for%2520paralog-specific%2520drug%2520design%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2009%26volume%3D388%26spage%3D1033%26epage%3D1042%26doi%3D10.1016%2Fj.jmb.2009.03.071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duerfeldt, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maynard, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eletto, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostrovsky, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shinogle, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argon, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicchitta, C. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, B. S.</span></span> <span> </span><span class="NLM_article-title">Development of a Grp94 inhibitor</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">9796</span>– <span class="NLM_lpage">9804</span>, <span class="refDoi"> DOI: 10.1021/ja303477g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja303477g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BC38XnslGqsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2012&pages=9796-9804&author=A.+S.+Duerfeldtauthor=L.+B.+Petersonauthor=J.+C.+Maynardauthor=C.+L.+Ngauthor=D.+Elettoauthor=O.+Ostrovskyauthor=H.+E.+Shinogleauthor=D.+S.+Mooreauthor=Y.+Argonauthor=C.+V.+Nicchittaauthor=B.+S.+Blagg&title=Development+of+a+Grp94+inhibitor&doi=10.1021%2Fja303477g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a Grp94 inhibitor</span></div><div class="casAuthors">Duerfeldt, Adam S.; Peterson, Laura B.; Maynard, Jason C.; Ng, Chun Leung; Eletto, Davide; Ostrovsky, Olga; Shinogle, Heather E.; Moore, David S.; Argon, Yair; Nicchitta, Christopher V.; Blagg, Brian S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9796-9804</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) represents a promising therapeutic target for the treatment of cancer and other diseases.  Unfortunately, results from clin. trials have been disappointing as off-target effects and toxicities have been obsd.  These detriments may be a consequence of pan-Hsp90 inhibition, as all clin. evaluated Hsp90 inhibitors simultaneously disrupt all four human Hsp90 isoforms.  Using a structure-based approach, we designed an inhibitor of Grp94, the ER-resident Hsp90.  The effect manifested by compd. (I) on several Grp94 and Hsp90α/β (cytosolic isoforms) clients were investigated.  Compd. I prevented intracellular trafficking of the Toll receptor, inhibited the secretion of IGF-II, affected the conformation of Grp94, and suppressed Drosophila larval growth, all Grp94-dependent processes.  In contrast, compd. I had no effect on cell viability or cytosolic Hsp90α/β client proteins at similar concns.  The design, synthesis, and evaluation of I are described herein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoayCAvZU_mzrVg90H21EOLACvtfcHk0lgWKnn0ac3e6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnslGqsLw%253D&md5=00c0b3f15f2cfd04658225c8a6fb708d</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fja303477g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja303477g%26sid%3Dliteratum%253Aachs%26aulast%3DDuerfeldt%26aufirst%3DA.%2BS.%26aulast%3DPeterson%26aufirst%3DL.%2BB.%26aulast%3DMaynard%26aufirst%3DJ.%2BC.%26aulast%3DNg%26aufirst%3DC.%2BL.%26aulast%3DEletto%26aufirst%3DD.%26aulast%3DOstrovsky%26aufirst%3DO.%26aulast%3DShinogle%26aufirst%3DH.%2BE.%26aulast%3DMoore%26aufirst%3DD.%2BS.%26aulast%3DArgon%26aufirst%3DY.%26aulast%3DNicchitta%26aufirst%3DC.%2BV.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%26atitle%3DDevelopment%2520of%2520a%2520Grp94%2520inhibitor%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2012%26volume%3D134%26spage%3D9796%26epage%3D9804%26doi%3D10.1021%2Fja303477g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crowley, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khandelwal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stothert, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huard, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muth, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duerfeldt, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kizziah, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lieberman, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickey, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, B. S.</span></span> <span> </span><span class="NLM_article-title">Development of glucose regulated protein 94-selective inhibitors based on the BnIm and Radamide scaffold</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">3471</span>– <span class="NLM_lpage">3488</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00085</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00085" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BC28XksFGrs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=3471-3488&author=V.+M.+Crowleyauthor=A.+Khandelwalauthor=S.+Mishraauthor=A.+R.+Stothertauthor=D.+J.+Huardauthor=J.+Zhaoauthor=A.+Muthauthor=A.+S.+Duerfeldtauthor=J.+L.+Kizziahauthor=R.+L.+Liebermanauthor=C.+A.+Dickeyauthor=B.+S.+Blagg&title=Development+of+glucose+regulated+protein+94-selective+inhibitors+based+on+the+BnIm+and+Radamide+scaffold&doi=10.1021%2Facs.jmedchem.6b00085"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Glucose Regulated Protein 94-Selective Inhibitors Based on the BnIm and Radamide Scaffold</span></div><div class="casAuthors">Crowley, Vincent M.; Khandelwal, Anuj; Mishra, Sanket; Stothert, Andrew R.; Huard, Dustin J. E.; Zhao, Jinbo; Muth, Aaron; Duerfeldt, Adam S.; Kizziah, James L.; Lieberman, Raquel L.; Dickey, Chad A.; Blagg, Brian S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3471-3488</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">(Arylmethyl)imidazolylethyl chlorodihydroxybenzoates I (R = Ph, 4-FC6H4, 4-ClC6H4, 4-BrC6H4, 4-IC6H4, 4-MeC6H4, 4-EtC6H4, 4-i-PrC6H4, 4-NCC6H4, 4-HC≡CC6H4, 4-F3CC6H4, 4-PhC6H4, 4-MeOC6H4, 3,4-Cl2C6H3, 1-naphthyl, 2-naphthyl, 5-quinolinyl, 3-FC6H4, 3-ClC6H4, 3-BrC6H4, 3-IC6H4, 3-MeOC6H4, 3-MeC6H4, 3-PhC6H4, 2-FC6H4, 2-ClC6H4, 2-BrC6H4, 2-MeC6H4, 2-H2NC6H4, 2-MeOC6H4, 2-EtC6H4, 2-EtOC6H4, 2-i-PrOC6H4, 2-n-PrOC6H4, 2-F3CC6H4, 2-MeO-4-MeC6H3, 3-furanyl, 2-furanyl, 5-Me-2-furanyl, 5-Cl-2-furanyl, 3,5-dimethyl-2-furanyl, 2-thienyl, 3-thienyl, 5-Me-2-thienyl, 5-Cl-2-thienyl, 4-Cl-2-thienyl, 3-Cl-2-thienyl, 5-isoxazolyl, 2-thiazolyl, 3-vinyl-2-thienyl, 3-vinyl-2-furanyl, 3-Et-2-thienyl, 2-pyridinyl, 3-pyridinyl, 4-pyridinyl, 5-pyrimidinyl) were prepd. as selective inhibitors of glucose regulated protein 94 (Grp94), the endoplasmic reticulum-resident isoform of the heat shock protein 90 (Hsp90), for potential use in the treatment of glaucoma and cancer; the effect of the aryl substituents on Grp94 binding and selectivity was detd.  I were prepd. by the cyclocondensation of a bissilylated chloro(oxopropyl)dihydroxybenzoate with glyoxal and arylmethylamines RCH2NH2 (R = Ph, 4-FC6H4, 4-ClC6H4, 4-BrC6H4, 4-IC6H4, 4-MeC6H4, 4-EtC6H4, 4-i-PrC6H4, 4-NCC6H4, 4-HC≡CC6H4, 4-F3CC6H4, 4-PhC6H4, 4-MeOC6H4, 3,4-Cl2C6H3, 1-naphthyl, 2-naphthyl, 5-quinolinyl, 3-FC6H4, 3-ClC6H4, 3-BrC6H4, 3-IC6H4, 3-MeOC6H4, 3-MeC6H4, 3-PhC6H4, 2-FC6H4, 2-ClC6H4, 2-BrC6H4, 2-MeC6H4, 2-H2NC6H4, 2-MeOC6H4, 2-EtC6H4, 2-EtOC6H4, 2-i-PrOC6H4, 2-n-PrOC6H4, 2-F3CC6H4, 2-MeO-4-MeC6H3, 3-furanyl, 2-furanyl, 5-Me-2-furanyl, 5-Cl-2-furanyl, 3,5-dimethyl-2-furanyl, 2-thienyl, 3-thienyl, 5-Me-2-thienyl, 5-Cl-2-thienyl, 4-Cl-2-thienyl, 3-Cl-2-thienyl, 5-isoxazolyl, 2-thiazolyl, 3-vinyl-2-thienyl, 3-vinyl-2-furanyl, 3-Et-2-thienyl, 2-pyridinyl, 3-pyridinyl, 4-pyridinyl, 5-pyrimidinyl) followed by desilylation.  I (R = 2-MeO-4-MeC6H3CH2, 5-chloro-2-furanylmethyl) were tested as inhibitors of cell migration in a cancer metastasis model and for their enhancement of the degrdn. of mutants of the protein myocilin in a glaucoma model.  The structures of the lead compd. radamide bound to Hsp82 and Grp94 and of I (R = 5-chloro-2-furanyl) bound to the N-terminal domain of Hsp94 lacking its acidic linker were detd. by X-ray crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3v_0NEYj1Z7Vg90H21EOLACvtfcHk0lhMxrXkgfDlmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XksFGrs7k%253D&md5=c73bbf30c243e281aae197689162c9e1</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00085%26sid%3Dliteratum%253Aachs%26aulast%3DCrowley%26aufirst%3DV.%2BM.%26aulast%3DKhandelwal%26aufirst%3DA.%26aulast%3DMishra%26aufirst%3DS.%26aulast%3DStothert%26aufirst%3DA.%2BR.%26aulast%3DHuard%26aufirst%3DD.%2BJ.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DMuth%26aufirst%3DA.%26aulast%3DDuerfeldt%26aufirst%3DA.%2BS.%26aulast%3DKizziah%26aufirst%3DJ.%2BL.%26aulast%3DLieberman%26aufirst%3DR.%2BL.%26aulast%3DDickey%26aufirst%3DC.%2BA.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%26atitle%3DDevelopment%2520of%2520glucose%2520regulated%2520protein%252094-selective%2520inhibitors%2520based%2520on%2520the%2520BnIm%2520and%2520Radamide%2520scaffold%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D3471%26epage%3D3488%26doi%3D10.1021%2Facs.jmedchem.6b00085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huard, D. J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crowley, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cordova, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomlin, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickey, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koren, J.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blair, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, B. S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lieberman, R. L.</span></span> <span> </span><span class="NLM_article-title">Trifunctional high-throughput screen identifies promising scaffold to inhibit Grp94 and treat myocilin-associated glaucoma</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">933</span>– <span class="NLM_lpage">941</span>, <span class="refDoi"> DOI: 10.1021/acschembio.7b01083</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.7b01083" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFOnurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&pages=933-941&author=D.+J.+E.+Huardauthor=V.+M.+Crowleyauthor=Y.+Duauthor=R.+A.+Cordovaauthor=Z.+Sunauthor=M.+O.+Tomlinauthor=C.+A.+Dickeyauthor=J.+Korenauthor=L.+Blairauthor=H.+Fuauthor=B.+S.+J.+Blaggauthor=R.+L.+Lieberman&title=Trifunctional+high-throughput+screen+identifies+promising+scaffold+to+inhibit+Grp94+and+treat+myocilin-associated+glaucoma&doi=10.1021%2Facschembio.7b01083"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Trifunctional High-Throughput Screen Identifies Promising Scaffold To Inhibit Grp94 and Treat Myocilin-Associated Glaucoma</span></div><div class="casAuthors">Huard, Dustin J. E.; Crowley, Vincent M.; Du, Yuhong; Cordova, Ricardo A.; Sun, Zheying; Tomlin, Moya O.; Dickey, Chad A.; Koren, John; Blair, Laura; Fu, Haian; Blagg, Brian S. J.; Lieberman, Raquel L.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">933-941</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Gain-of-function mutations within the olfactomedin (OLF) domain of myocilin result in its toxic intracellular accumulation and hasten the onset of open-angle glaucoma.  The absence of myocilin does not cause disease; therefore, strategies aimed at eliminating myocilin could lead to a successful glaucoma treatment.  The endoplasmic reticulum Hsp90 paralog Grp94 accelerates OLF aggregation.  Knockdown or pharmacol. inhibition of Grp94 in cells facilitates clearance of mutant myocilin via a non-proteasomal pathway.  Here, the authors expanded the support for targeting Grp94 over cytosolic paralogs Hsp90α and Hsp90β.  The authors then developed a high-throughput screening assay to identify new chem. matter capable of disrupting the Grp94/OLF interaction.  When applied to a blind, focused library of 17 Hsp90 inhibitors, the authors' miniaturized single-read in vitro thioflavin T -based kinetics aggregation assay exclusively identified compds. that target the chaperone N-terminal nucleotide binding site.  In follow up studies, one compd. decreased the extent of co-aggregation of Grp94 with OLF in a dose-dependent manner in vitro, and enabled clearance of the aggregation-prone full-length myocilin variant I477N in cells without inducing the heat shock response or causing cytotoxicity.  Comparison of the co-crystal structure of compd. 2 (I) and another non-selective hit in complex with the N-terminal domain of Grp94 reveals a docking mode tailored to Grp94 and explains its selectivity.  A new lead compd. has been identified, supporting a targeted chem. biol. assay approach to develop a protein degrdn.-based therapy for myocilin-assocd. glaucoma by selectively inhibiting Grp94.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrxuX4fPaDAbVg90H21EOLACvtfcHk0lhMxrXkgfDlmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFOnurk%253D&md5=166a3573601578f4662206eeee3cca85</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Facschembio.7b01083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.7b01083%26sid%3Dliteratum%253Aachs%26aulast%3DHuard%26aufirst%3DD.%2BJ.%2BE.%26aulast%3DCrowley%26aufirst%3DV.%2BM.%26aulast%3DDu%26aufirst%3DY.%26aulast%3DCordova%26aufirst%3DR.%2BA.%26aulast%3DSun%26aufirst%3DZ.%26aulast%3DTomlin%26aufirst%3DM.%2BO.%26aulast%3DDickey%26aufirst%3DC.%2BA.%26aulast%3DKoren%26aufirst%3DJ.%26aulast%3DBlair%26aufirst%3DL.%26aulast%3DFu%26aufirst%3DH.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%2BJ.%26aulast%3DLieberman%26aufirst%3DR.%2BL.%26atitle%3DTrifunctional%2520high-throughput%2520screen%2520identifies%2520promising%2520scaffold%2520to%2520inhibit%2520Grp94%2520and%2520treat%2520myocilin-associated%2520glaucoma%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2018%26volume%3D13%26spage%3D933%26epage%3D941%26doi%3D10.1021%2Facschembio.7b01083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crowley, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huard, D. J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lieberman, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, B. S. J.</span></span> <span> </span><span class="NLM_article-title">Second generation Grp94-selective inhibitors provide opportunities for the inhibition of metastatic cancer</span>. <i>Chem. - Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">15775</span>– <span class="NLM_lpage">15782</span>, <span class="refDoi"> DOI: 10.1002/chem.201703398</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.1002%2Fchem.201703398" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=28857290" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFOltrjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=15775-15782&author=V.+M.+Crowleyauthor=D.+J.+E.+Huardauthor=R.+L.+Liebermanauthor=B.+S.+J.+Blagg&title=Second+generation+Grp94-selective+inhibitors+provide+opportunities+for+the+inhibition+of+metastatic+cancer&doi=10.1002%2Fchem.201703398"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Second Generation Grp94-Selective Inhibitors Provide Opportunities for the Inhibition of Metastatic Cancer</span></div><div class="casAuthors">Crowley, Vincent M.; Huard, Dustin J. E.; Lieberman, Raquel L.; Blagg, Brian S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">62</span>),
    <span class="NLM_cas:pages">15775-15782</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Glucose regulated protein 94 (Grp94) is the endoplasmic reticulum (ER) resident isoform of the 90-kDa heat shock protein (Hsp90) family and its inhibition represents a promising therapeutic target for the treatment of many diseases.  Modification of the first generation cis-amide bioisostere imidazole to alter the angle between the resorcinol ring and the benzyl side chain via cis-amide replacements produced compds. with improved Grp94 affinity and selectivity.  Structure-activity relationship studies led to the discovery of compd. 30 (Me 3-chloro-2-(2-(4-fluorobenzyl)phenethyl)-4,6-dihydroxybenzoate), which exhibits 540 nM affinity and 73-fold selectivity towards Grp94.  Grp94 is responsible for the maturation and trafficking of proteins assocd. with cell signaling and motility, including select integrins.  The Grp94-selective inhibitor 30 was shown to exhibit potent anti-migratory effects against multiple aggressive and metastatic cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQGZJljYE02LVg90H21EOLACvtfcHk0ljuuAxd8RmnDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFOltrjN&md5=784809d71abe5da007438172fbdb7f0d</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1002%2Fchem.201703398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201703398%26sid%3Dliteratum%253Aachs%26aulast%3DCrowley%26aufirst%3DV.%2BM.%26aulast%3DHuard%26aufirst%3DD.%2BJ.%2BE.%26aulast%3DLieberman%26aufirst%3DR.%2BL.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%2BJ.%26atitle%3DSecond%2520generation%2520Grp94-selective%2520inhibitors%2520provide%2520opportunities%2520for%2520the%2520inhibition%2520of%2520metastatic%2520cancer%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2017%26volume%3D23%26spage%3D15775%26epage%3D15782%26doi%3D10.1002%2Fchem.201703398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Que, N. L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crowley, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duerfeldt, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kent, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, B. S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gewirth, D. T.</span></span> <span> </span><span class="NLM_article-title">Structure based design of a Grp94-selective inhibitor: Exploiting a key residue in Grp94 to optimize paralog-selective binding</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">2793</span>– <span class="NLM_lpage">2805</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01608</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01608" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BC1cXktlGhsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=2793-2805&author=N.+L.+S.+Queauthor=V.+M.+Crowleyauthor=A.+S.+Duerfeldtauthor=J.+Zhaoauthor=C.+N.+Kentauthor=B.+S.+J.+Blaggauthor=D.+T.+Gewirth&title=Structure+based+design+of+a+Grp94-selective+inhibitor%3A+Exploiting+a+key+residue+in+Grp94+to+optimize+paralog-selective+binding&doi=10.1021%2Facs.jmedchem.7b01608"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Structure Based Design of a Grp94-Selective Inhibitor: Exploiting a Key Residue in Grp94 To Optimize Paralog-Selective Binding</span></div><div class="casAuthors">Que, Nanette L. S.; Crowley, Vincent M.; Duerfeldt, Adam S.; Zhao, Jinbo; Kent, Caitlin N.; Blagg, Brian S. J.; Gewirth, Daniel T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2793-2805</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Grp94 and Hsp90, the ER and cytoplasmic hsp90 paralogs, share a conserved ATP-binding pocket that has been targeted for therapeutics.  Paralog-selective inhibitors may lead to drugs with fewer side effects.  Here, the authors analyzed 1 (BnIm), a benzyl imidazole resorcinylic inhibitor, for its mode of binding.  The structures of 1 bound to Hsp90 and Grp94 reveal large conformational changes in Grp94 but not Hsp90 that expose site 2, a binding pocket adjacent to the central ATP cavity that is ordinarily blocked.  The Grp94:1 structure reveals a flipped pose of the resorcinylic scaffold that inserts into the exposed site 2.  The authors exploited this flipped binding pose to develop a Grp94-selective deriv. of 1.  The authors' structural anal. shows that the ability of the ligand to insert its benzyl imidazole substituent into site 1, a different side pocket off the ATP binding cavity, is the key to exposing site 2 in Grp94.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhACqcGHClIrVg90H21EOLACvtfcHk0ljuuAxd8RmnDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXktlGhsLw%253D&md5=a44f6bf0bd3df65cf20ca570a1ef37b8</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01608&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01608%26sid%3Dliteratum%253Aachs%26aulast%3DQue%26aufirst%3DN.%2BL.%2BS.%26aulast%3DCrowley%26aufirst%3DV.%2BM.%26aulast%3DDuerfeldt%26aufirst%3DA.%2BS.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DKent%26aufirst%3DC.%2BN.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%2BJ.%26aulast%3DGewirth%26aufirst%3DD.%2BT.%26atitle%3DStructure%2520based%2520design%2520of%2520a%2520Grp94-selective%2520inhibitor%253A%2520Exploiting%2520a%2520key%2520residue%2520in%2520Grp94%2520to%2520optimize%2520paralog-selective%2520binding%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D2793%26epage%3D2805%26doi%3D10.1021%2Facs.jmedchem.7b01608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khandelwal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crowley, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, B. S. J.</span></span> <span> </span><span class="NLM_article-title">Resorcinol-based Grp94-selective inhibitors</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1013</span>– <span class="NLM_lpage">1018</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.7b00193</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.7b00193" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVejs73K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=1013-1018&author=A.+Khandelwalauthor=V.+M.+Crowleyauthor=B.+S.+J.+Blagg&title=Resorcinol-based+Grp94-selective+inhibitors&doi=10.1021%2Facsmedchemlett.7b00193"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Resorcinol-Based Grp94-Selective Inhibitors</span></div><div class="casAuthors">Khandelwal, Anuj; Crowley, Vincent M.; Blagg, Brian S. J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1013-1018</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Glucose regulated protein 94 (Grp94) is the endoplasmic reticulum resident of the 90 kDa heat shock protein (Hsp90) family and represents a promising therapeutic target for the treatment of several diseases.  Grp94 is the most unique member of the 90 kDa heat shock protein family due to a five amino acid insertion into its primary sequence, which creates hydrophobic subpockets exclusive to Grp94 that can be utilized for selective inhibition.  The first resorcinol-based Grp94-selective inhibitor I to take advantage of the hydrophobic S2 subpocket has been developed and shown to manifest low nanomolar affinity and ∼10-fold selectivity for Grp94.  Furthermore, these Grp94-selective inhibitors manifest low micromolar GI50 values against multiple myeloma cells, supporting Grp94 as an emerging target for the treatment of this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGok_wSMzlEsHLVg90H21EOLACvtfcHk0lj7c0XV9sUlJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVejs73K&md5=a398cf6e5adaacc4892aed8b2340b901</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.7b00193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.7b00193%26sid%3Dliteratum%253Aachs%26aulast%3DKhandelwal%26aufirst%3DA.%26aulast%3DCrowley%26aufirst%3DV.%2BM.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%2BJ.%26atitle%3DResorcinol-based%2520Grp94-selective%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D8%26spage%3D1013%26epage%3D1018%26doi%3D10.1021%2Facsmedchemlett.7b00193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stothert, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickey, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, B. S.</span></span> <span> </span><span class="NLM_article-title">Transformation of the non-selective aminocyclohexanol-based Hsp90 inhibitor into a Grp94-seletive scaffold</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">244</span>– <span class="NLM_lpage">253</span>, <span class="refDoi"> DOI: 10.1021/acschembio.6b00747</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.6b00747" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVGqurjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=244-253&author=S.+J.+Mishraauthor=S.+Ghoshauthor=A.+R.+Stothertauthor=C.+A.+Dickeyauthor=B.+S.+Blagg&title=Transformation+of+the+non-selective+aminocyclohexanol-based+Hsp90+inhibitor+into+a+Grp94-seletive+scaffold&doi=10.1021%2Facschembio.6b00747"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Transformation of the Non-Selective Aminocyclohexanol-Based Hsp90 Inhibitor into a Grp94-Seletive Scaffold</span></div><div class="casAuthors">Mishra, Sanket J.; Ghosh, Suman; Stothert, Andrew R.; Dickey, Chad A.; Blagg, Brian S. J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">244-253</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Glucose regulated protein 94 kDa, Grp94, is the endoplasmic reticulum (ER) localized isoform of heat shock protein 90 (Hsp90) that is responsible for the trafficking and maturation of toll-like receptors, Igs, and integrins.  As a result, Grp94 has emerged as a therapeutic target to disrupt cellular communication, adhesion, and tumor proliferation, potentially with fewer side effects compared to pan-inhibitors of all Hsp90 isoforms.  Although, the N-terminal ATP binding site is highly conserved among all four Hsp90 isoforms, recent cocrystal structures of Grp94 have revealed subtle differences between Grp94 and other Hsp90 isoforms that has been exploited for the development of Grp94-selective inhibitors.  In the current study, a structure-based approach has been applied to a Grp94 nonselective compd., SNX 2112, which led to the development of 8j (ACO1), a Grp94-selective inhibitor that manifests ∼440 nM affinity and >200-fold selectivity against cytosolic Hsp90 isoforms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEVr4w6ywqwLVg90H21EOLACvtfcHk0lj7c0XV9sUlJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVGqurjF&md5=5e9924483ab0c13f9a819a2d4bda55ee</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Facschembio.6b00747&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.6b00747%26sid%3Dliteratum%253Aachs%26aulast%3DMishra%26aufirst%3DS.%2BJ.%26aulast%3DGhosh%26aufirst%3DS.%26aulast%3DStothert%26aufirst%3DA.%2BR.%26aulast%3DDickey%26aufirst%3DC.%2BA.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%26atitle%3DTransformation%2520of%2520the%2520non-selective%2520aminocyclohexanol-based%2520Hsp90%2520inhibitor%2520into%2520a%2520Grp94-seletive%2520scaffold%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2017%26volume%3D12%26spage%3D244%26epage%3D253%26doi%3D10.1021%2Facschembio.6b00747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cosinroger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hausmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogler, G.</span></span> <span> </span><span class="NLM_article-title">The role of the chaperone Grp94/Gp96 in the intestinal barrier and innate immune functions</span>. <i>Curr. Immunol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">64</span>– <span class="NLM_lpage">70</span>, <span class="refDoi"> DOI: 10.2174/1573395513666170316105529</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.2174%2F1573395513666170316105529" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2017&pages=64-70&author=J.+Cosinrogerauthor=M.+Hausmannauthor=G.+Rogler&title=The+role+of+the+chaperone+Grp94%2FGp96+in+the+intestinal+barrier+and+innate+immune+functions&doi=10.2174%2F1573395513666170316105529"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.2174%2F1573395513666170316105529&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1573395513666170316105529%26sid%3Dliteratum%253Aachs%26aulast%3DCosinroger%26aufirst%3DJ.%26aulast%3DHausmann%26aufirst%3DM.%26aulast%3DRogler%26aufirst%3DG.%26atitle%3DThe%2520role%2520of%2520the%2520chaperone%2520Grp94%252FGp96%2520in%2520the%2520intestinal%2520barrier%2520and%2520innate%2520immune%2520functions%26jtitle%3DCurr.%2520Immunol.%2520Rev.%26date%3D2017%26volume%3D13%26spage%3D64%26epage%3D70%26doi%3D10.2174%2F1573395513666170316105529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span> <span> </span><span class="NLM_article-title">Endoplasmic reticulum stress in hepatic steatosis and inflammatory bowel diseases</span>. <i>Front. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">242</span>, <span class="refDoi"> DOI: 10.3389/fgene.2014.00242</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.3389%2Ffgene.2014.00242" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=25120559" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A280%3ADC%252BC2M%252Fhs1agug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=242&author=B.+Guoauthor=Z.+Li&title=Endoplasmic+reticulum+stress+in+hepatic+steatosis+and+inflammatory+bowel+diseases&doi=10.3389%2Ffgene.2014.00242"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Endoplasmic reticulum stress in hepatic steatosis and inflammatory bowel diseases</span></div><div class="casAuthors">Guo Beichu; Li Zihai</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in genetics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">242</span>
        ISSN:<span class="NLM_cas:issn">1664-8021</span>.
    </div><div class="casAbstract">As an adaptive response to the overloading with misfolded proteins in the endoplasmic reticulum (ER), ER stress plays critical roles in maintaining protein homeostasis in the secretory pathway to avoid damage to the host.  Such a conserved mechanism is accomplished through three well-orchestrated pathways known collectively as unfolded protein response (UPR).  Persistent and pathological ER stress has been implicated in a variety of diseases in metabolic, inflammatory, and malignant conditions.  Furthermore, ER stress is directly linked with inflammation through UPR pathways, which modulate transcriptional programs to induce the expression of inflammatory genes.  Importantly, the inflammation induced by ER stress is directly responsible for the pathogenesis of metabolic and inflammatory diseases.  In this review, we will discuss the potential signaling pathways connecting ER stress with inflammation.  We will also depict the interplay between ER stress and inflammation in the pathogenesis of hepatic steatosis, inflammatory bowel diseases and colitis-associated colon cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSmNUMurqDlwe_Q9URG6Dx8fW6udTcc2eYagARIjbPYaLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M%252Fhs1agug%253D%253D&md5=1c05f05871761f9fd931b24efa4953a9</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.3389%2Ffgene.2014.00242&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffgene.2014.00242%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DZ.%26atitle%3DEndoplasmic%2520reticulum%2520stress%2520in%2520hepatic%2520steatosis%2520and%2520inflammatory%2520bowel%2520diseases%26jtitle%3DFront.%2520Genet.%26date%3D2014%26volume%3D5%26spage%3D242%26doi%3D10.3389%2Ffgene.2014.00242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xavier, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Podolsky, D. K.</span></span> <span> </span><span class="NLM_article-title">Unravelling the pathogenesis of inflammatory bowel disease</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>448</i></span>,  <span class="NLM_fpage">427</span>– <span class="NLM_lpage">434</span>, <span class="refDoi"> DOI: 10.1038/nature06005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.1038%2Fnature06005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=17653185" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotFajurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=448&publication_year=2007&pages=427-434&author=R.+J.+Xavierauthor=D.+K.+Podolsky&title=Unravelling+the+pathogenesis+of+inflammatory+bowel+disease&doi=10.1038%2Fnature06005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Unraveling the pathogenesis of inflammatory bowel disease</span></div><div class="casAuthors">Xavier, R. J.; Podolsky, D. K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">448</span>
        (<span class="NLM_cas:issue">7152</span>),
    <span class="NLM_cas:pages">427-434</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Recently, substantial advances in the understanding of the mol. pathogenesis of inflammatory bowel disease (IBD) have been made owing to three related lines of investigation.  First, IBD has been found to be the most tractable of complex disorders for discovering susceptibility genes, and these have shown the importance of epithelial barrier function, and innate and adaptive immunity in disease pathogenesis.  Second, efforts directed towards the identification of environmental factors implicate commensal bacteria (or their products), rather than conventional pathogens, as drivers of dysregulated immunity and IBD.  Third, murine models, which exhibit many of the features of ulcerative colitis and seem to be bacteria-driven, have helped unravel the pathogenesis/mucosal immunopathol. of IBD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-TNsEuEfK-rVg90H21EOLACvtfcHk0li7DA-O-_KH1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotFajurs%253D&md5=36ac0f7c55f5cef41249390397ec9562</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1038%2Fnature06005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature06005%26sid%3Dliteratum%253Aachs%26aulast%3DXavier%26aufirst%3DR.%2BJ.%26aulast%3DPodolsky%26aufirst%3DD.%2BK.%26atitle%3DUnravelling%2520the%2520pathogenesis%2520of%2520inflammatory%2520bowel%2520disease%26jtitle%3DNature%26date%3D2007%26volume%3D448%26spage%3D427%26epage%3D434%26doi%3D10.1038%2Fnature06005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staron, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, B. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morales, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crosson, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomlinson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span> <span> </span><span class="NLM_article-title">Essential roles of grp94 in gut homeostasis via chaperoning canonical Wnt pathway</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">6877</span>– <span class="NLM_lpage">6882</span>, <span class="refDoi"> DOI: 10.1073/pnas.1302933110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.1073%2Fpnas.1302933110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=23572575" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BC3sXot1Ghtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=6877-6882&author=B.+Liuauthor=M.+Staronauthor=F.+Hongauthor=B.+X.+Wuauthor=S.+Sunauthor=C.+Moralesauthor=C.+E.+Crossonauthor=S.+Tomlinsonauthor=I.+Kimauthor=D.+Wuauthor=Z.+Li&title=Essential+roles+of+grp94+in+gut+homeostasis+via+chaperoning+canonical+Wnt+pathway&doi=10.1073%2Fpnas.1302933110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Essential roles of grp94 in gut homeostasis via chaperoning canonical Wnt pathway</span></div><div class="casAuthors">Liu, Bei; Staron, Matthew; Hong, Feng; Wu, Bill X.; Sun, Shaoli; Morales, Crystal; Crosson, Craig E.; Tomlinson, Stephen; Kim, Ingyu; Wu, Dianqing; Li, Zihai</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6877-6882</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Increasing evidence points to a role for the protein quality control in the endoplasmic reticulum (ER) in maintaining intestinal homeostasis.  However, the specific role for general ER chaperones in this process remains unknown.  Herein, we report that a major ER heat shock protein grp94 interacts with MesD, a crit. chaperone for the Wnt coreceptor low-d. lipoprotein receptor-related protein 6 (LRP6).  Without grp94, LRP6 fails to export from the ER to the cell surface, resulting in a profound loss of canonical Wnt signaling.  The significance of this finding is demonstrated in vivo in that grp94 loss causes a rapid and profound compromise in intestinal homeostasis with gut-intrinsic defect in the proliferation of intestinal crypts, compromise of nuclear β-catenin translocation, loss of crypt-villus structure, and impaired barrier function.  Taken together, our work has uncovered the role of grp94 in chaperoning LRP6-MesD in coordinating intestinal homeostasis, placing canonical Wnt-signaling pathway under the direct regulation of the general protein quality control machinery in the ER.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7emg80iB5gLVg90H21EOLACvtfcHk0lho7OOgzlHa9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXot1Ghtrs%253D&md5=221593fe9162fee07b700367633663e1</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1302933110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1302933110%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DStaron%26aufirst%3DM.%26aulast%3DHong%26aufirst%3DF.%26aulast%3DWu%26aufirst%3DB.%2BX.%26aulast%3DSun%26aufirst%3DS.%26aulast%3DMorales%26aufirst%3DC.%26aulast%3DCrosson%26aufirst%3DC.%2BE.%26aulast%3DTomlinson%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DI.%26aulast%3DWu%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DZ.%26atitle%3DEssential%2520roles%2520of%2520grp94%2520in%2520gut%2520homeostasis%2520via%2520chaperoning%2520canonical%2520Wnt%2520pathway%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D6877%26epage%3D6882%26doi%3D10.1073%2Fpnas.1302933110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hua, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwanowycz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westwater, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reizis, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span> <span> </span><span class="NLM_article-title">Gut homeostasis and regulatory T cell induction depend on molecular chaperone gp96 in CD11c+ cells</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">2171</span>, <span class="refDoi"> DOI: 10.1038/s41598-017-02415-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.1038%2Fs41598-017-02415-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=28526855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A280%3ADC%252BC1crpsFehtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=2171&author=Y.+Huaauthor=Y.+Yangauthor=S.+Sunauthor=S.+Iwanowyczauthor=C.+Westwaterauthor=B.+Reizisauthor=Z.+Liauthor=B.+Liu&title=Gut+homeostasis+and+regulatory+T+cell+induction+depend+on+molecular+chaperone+gp96+in+CD11c%2B+cells&doi=10.1038%2Fs41598-017-02415-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Gut homeostasis and regulatory T cell induction depend on molecular chaperone gp96 in CD11c(+) cells</span></div><div class="casAuthors">Hua Yunpeng; Yang Yi; Iwanowycz Stephen; Li Zihai; Liu Bei; Hua Yunpeng; Sun Shaoli; Westwater Caroline; Reizis Boris</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2171</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The intestinal immunity and tolerance are orchestrated by both the innate and the adaptive immune system.  Intestinal professional antigen presenting cells (pAPCs) recognize and respond to the gut microbiota through multiple pattern-recognition receptors, including TLRs and NLRs.  How gut pAPCs maintain mucosal homeostasis remains incompletely understood.  Heat shock protein gp96, also known as grp94, is an essential immune chaperone for TLRs.  However, the role of gp96 in regulating CD11c(+) APCs in the gut immunity and tolerance is unknown.  By a genetic strategy, we report here that selective deletion of gp96 from CD11c(+) cells in mice results in alteration of dendritic cell and T cell subsets in the gut as well as loss of antigen-specific regulatory T cell induction in the mesenteric lymph nodes.  Strikingly, these conditional gp96-null mice developed spontaneous colitis, had increased levels of systemic and fecal IgA, and were highly susceptible to chemical-induced colitis.  Our findings for the first time demonstrate that gp96 is essential for CD11c(+) cells to induce regulatory T cells and maintain gut homeostasis, illustrating the importance of protein immune chaperone in safeguarding against immune pathology.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT6YKB3A0KYQdbHMBt0mMIXfW6udTcc2eZa-fY-eYibCLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1crpsFehtQ%253D%253D&md5=5af60a8e5e10da36da1c0fcbfcdd02ff</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1038%2Fs41598-017-02415-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-017-02415-7%26sid%3Dliteratum%253Aachs%26aulast%3DHua%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DS.%26aulast%3DIwanowycz%26aufirst%3DS.%26aulast%3DWestwater%26aufirst%3DC.%26aulast%3DReizis%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DB.%26atitle%3DGut%2520homeostasis%2520and%2520regulatory%2520T%2520cell%2520induction%2520depend%2520on%2520molecular%2520chaperone%2520gp96%2520in%2520CD11c%252B%2520cells%26jtitle%3DSci.%2520Rep.%26date%3D2017%26volume%3D7%26spage%3D2171%26doi%3D10.1038%2Fs41598-017-02415-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morales, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rachidi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouyang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallace, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garret-Mayer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span> <span> </span><span class="NLM_article-title">Immune chaperone gp96 drives the contributions of macrophages to inflammatory colon tumorigenesis</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">446</span>– <span class="NLM_lpage">459</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-13-1677</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.1158%2F0008-5472.CAN-13-1677" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2014&pages=446-459&author=C.+Moralesauthor=S.+Rachidiauthor=F.+Hongauthor=S.+Sunauthor=X.+Ouyangauthor=C.+Wallaceauthor=Y.+Zhangauthor=E.+Garret-Mayerauthor=J.+Wuauthor=B.+Liuauthor=Z.+Li&title=Immune+chaperone+gp96+drives+the+contributions+of+macrophages+to+inflammatory+colon+tumorigenesis&doi=10.1158%2F0008-5472.CAN-13-1677"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-13-1677&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-13-1677%26sid%3Dliteratum%253Aachs%26aulast%3DMorales%26aufirst%3DC.%26aulast%3DRachidi%26aufirst%3DS.%26aulast%3DHong%26aufirst%3DF.%26aulast%3DSun%26aufirst%3DS.%26aulast%3DOuyang%26aufirst%3DX.%26aulast%3DWallace%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DGarret-Mayer%26aufirst%3DE.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DZ.%26atitle%3DImmune%2520chaperone%2520gp96%2520drives%2520the%2520contributions%2520of%2520macrophages%2520to%2520inflammatory%2520colon%2520tumorigenesis%26jtitle%3DCancer%2520Res.%26date%3D2014%26volume%3D74%26spage%3D446%26epage%3D459%26doi%3D10.1158%2F0008-5472.CAN-13-1677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schreiter, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hausmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spoettl, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strauch, U. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bataille, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoelmerich, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herfarth, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falk, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogler, G.</span></span> <span> </span><span class="NLM_article-title">Glycoprotein (gp) 96 expression: induced during differentiation of intestinal macrophages but impaired in Crohn’s disease</span>. <i>Gut</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">935</span>– <span class="NLM_lpage">943</span>, <span class="refDoi"> DOI: 10.1136/gut.2004.053116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.1136%2Fgut.2004.053116" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2005&pages=935-943&author=K.+Schreiterauthor=M.+Hausmannauthor=T.+Spoettlauthor=U.+G.+Strauchauthor=F.+Batailleauthor=J.+Schoelmerichauthor=H.+Herfarthauthor=W.+Falkauthor=G.+Rogler&title=Glycoprotein+%28gp%29+96+expression%3A+induced+during+differentiation+of+intestinal+macrophages+but+impaired+in+Crohn%E2%80%99s+disease&doi=10.1136%2Fgut.2004.053116"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1136%2Fgut.2004.053116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fgut.2004.053116%26sid%3Dliteratum%253Aachs%26aulast%3DSchreiter%26aufirst%3DK.%26aulast%3DHausmann%26aufirst%3DM.%26aulast%3DSpoettl%26aufirst%3DT.%26aulast%3DStrauch%26aufirst%3DU.%2BG.%26aulast%3DBataille%26aufirst%3DF.%26aulast%3DSchoelmerich%26aufirst%3DJ.%26aulast%3DHerfarth%26aufirst%3DH.%26aulast%3DFalk%26aufirst%3DW.%26aulast%3DRogler%26aufirst%3DG.%26atitle%3DGlycoprotein%2520%2528gp%2529%252096%2520expression%253A%2520induced%2520during%2520differentiation%2520of%2520intestinal%2520macrophages%2520but%2520impaired%2520in%2520Crohn%25E2%2580%2599s%2520disease%26jtitle%3DGut%26date%3D2005%26volume%3D54%26spage%3D935%26epage%3D943%26doi%3D10.1136%2Fgut.2004.053116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hausmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiessling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mestermann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webb, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spottl, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andus, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scholmerich, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herfarth, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falk, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogler, G.</span></span> <span> </span><span class="NLM_article-title">Toll-like receptors 2 and 4 are up-regulated during intestinal inflammation</span>. <i>Gastroenterology</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>122</i></span>,  <span class="NLM_fpage">1987</span>– <span class="NLM_lpage">2000</span>, <span class="refDoi"> DOI: 10.1053/gast.2002.33662</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.1053%2Fgast.2002.33662" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2002&pages=1987-2000&author=M.+Hausmannauthor=S.+Kiesslingauthor=S.+Mestermannauthor=G.+Webbauthor=T.+Spottlauthor=T.+Andusauthor=J.+Scholmerichauthor=H.+Herfarthauthor=K.+Rayauthor=W.+Falkauthor=G.+Rogler&title=Toll-like+receptors+2+and+4+are+up-regulated+during+intestinal+inflammation&doi=10.1053%2Fgast.2002.33662"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1053%2Fgast.2002.33662&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fgast.2002.33662%26sid%3Dliteratum%253Aachs%26aulast%3DHausmann%26aufirst%3DM.%26aulast%3DKiessling%26aufirst%3DS.%26aulast%3DMestermann%26aufirst%3DS.%26aulast%3DWebb%26aufirst%3DG.%26aulast%3DSpottl%26aufirst%3DT.%26aulast%3DAndus%26aufirst%3DT.%26aulast%3DScholmerich%26aufirst%3DJ.%26aulast%3DHerfarth%26aufirst%3DH.%26aulast%3DRay%26aufirst%3DK.%26aulast%3DFalk%26aufirst%3DW.%26aulast%3DRogler%26aufirst%3DG.%26atitle%3DToll-like%2520receptors%25202%2520and%25204%2520are%2520up-regulated%2520during%2520intestinal%2520inflammation%26jtitle%3DGastroenterology%26date%3D2002%26volume%3D122%26spage%3D1987%26epage%3D2000%26doi%3D10.1053%2Fgast.2002.33662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span> <span> </span><span class="NLM_article-title">Expression of Toll-like receptors in the mucosa of patients with ulcerative colitis</span>. <i>Exp. Ther. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1455</span>– <span class="NLM_lpage">1459</span>, <span class="refDoi"> DOI: 10.3892/etm.2015.2258</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.3892%2Fetm.2015.2258" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=25780451" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnvValsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2015&pages=1455-1459&author=Y.+Fanauthor=B.+Liu&title=Expression+of+Toll-like+receptors+in+the+mucosa+of+patients+with+ulcerative+colitis&doi=10.3892%2Fetm.2015.2258"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of Toll-like receptors in the mucosa of patients with ulcerative colitis</span></div><div class="casAuthors">Fan, Yujing; Liu, Bingrong</div><div class="citationInfo"><span class="NLM_cas:title">Experimental and Therapeutic Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1455-1459</span>CODEN:
                <span class="NLM_cas:coden">ETMXA2</span>;
        ISSN:<span class="NLM_cas:issn">1792-0981</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">Patients with ulcerative colitis (UC) have a high risk of developing colorectal cancer.  The aim of the present study was to evaluate the expression pattern of Toll-like receptors (TLRs) in the colonic mucosa of patients with UC.  Colonic mucosal biopsy specimens were collected during colonoscopy from 30 patients with UC and 30 patients with normal findings as controls.  The protein and mRNA expression levels of TLRs 1-4 and TLR9 were measured by immunohistochem. and reverse transcription-quant. polymerase chain reaction anal., resp.  The results showed that the mRNA and protein expression of TLR2, TLR4 and TLR9, but not TLR1 and TLR3, was significantly increased in the colonic mucosa of patients with UC compared with that in the normal controls.  TLR (TLR2, TLR4 and TLR9) immunoreactivity was found in the cytoplasm of epithelial cells in the mucosa, and occasionally in the endothelium of small vessels of the stromal tissues.  In conclusion, TLR2, TLR4 and TLR9 expression may be important in the biol. pathogenesis of UC.  TLR alterations in the innate response system may contribute to the pathogenesis of UC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFQxXqpNl3bbVg90H21EOLACvtfcHk0lg_E3Ronk8zvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnvValsL8%253D&md5=df8e09126d636769f10f1f7ea6f7c4f0</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.3892%2Fetm.2015.2258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fetm.2015.2258%26sid%3Dliteratum%253Aachs%26aulast%3DFan%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DB.%26atitle%3DExpression%2520of%2520Toll-like%2520receptors%2520in%2520the%2520mucosa%2520of%2520patients%2520with%2520ulcerative%2520colitis%26jtitle%3DExp.%2520Ther.%2520Med.%26date%3D2015%26volume%3D9%26spage%3D1455%26epage%3D1459%26doi%3D10.3892%2Fetm.2015.2258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veal, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fadden, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rice, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eaves, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strachan, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barabasz, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foley, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barta, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silinski, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Partridge, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DuBois, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freed, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steed, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ommen, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodward, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCall, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markworth, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinkley, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenks, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otto, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pronk, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verleysen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, S. E.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel 2-aminobenzamide inhibitors of heat shock protein 90 as potent, selective and orally active antitumor agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">4288</span>– <span class="NLM_lpage">4305</span>, <span class="refDoi"> DOI: 10.1021/jm900230j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900230j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BD1MXns1Onsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4288-4305&author=K.+H.+Huangauthor=J.+M.+Vealauthor=R.+P.+Faddenauthor=J.+W.+Riceauthor=J.+Eavesauthor=J.+P.+Strachanauthor=A.+F.+Barabaszauthor=B.+E.+Foleyauthor=T.+E.+Bartaauthor=W.+Maauthor=M.+A.+Silinskiauthor=M.+Huauthor=J.+M.+Partridgeauthor=A.+Scottauthor=L.+G.+DuBoisauthor=T.+Freedauthor=P.+M.+Steedauthor=A.+J.+Ommenauthor=E.+D.+Smithauthor=P.+F.+Hughesauthor=A.+R.+Woodwardauthor=G.+J.+Hansonauthor=W.+S.+McCallauthor=C.+J.+Markworthauthor=L.+Hinkleyauthor=M.+Jenksauthor=L.+Gengauthor=M.+Lewisauthor=J.+Ottoauthor=B.+Pronkauthor=K.+Verleysenauthor=S.+E.+Hall&title=Discovery+of+novel+2-aminobenzamide+inhibitors+of+heat+shock+protein+90+as+potent%2C+selective+and+orally+active+antitumor+agents&doi=10.1021%2Fjm900230j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Novel 2-Aminobenzamide Inhibitors of Heat Shock Protein 90 as Potent, Selective and Orally Active Antitumor Agents</span></div><div class="casAuthors">Huang, Kenneth H.; Veal, James M.; Fadden, R. Patrick; Rice, John W.; Eaves, Jeron; Strachan, Jon-Paul; Barabasz, Amy F.; Foley, Briana E.; Barta, Thomas E.; Ma, Wei; Silinski, Melanie A.; Hu, Mei; Partridge, Jeffrey M.; Scott, Anisa; DuBois, Laura G.; Freed, Tiffany; Steed, Paul M.; Ommen, Andy J.; Smith, Emilie D.; Hughes, Philip F.; Woodward, Angela R.; Hanson, Gunnar J.; McCall, W. Stephen; Markworth, Christopher J.; Hinkley, Lindsay; Jenks, Matthew; Geng, Lifeng; Lewis, Meredith; Otto, James; Pronk, Bert; Verleysen, Katleen; Hall, Steven E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4288-4305</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel class of heat shock protein 90 (Hsp90) inhibitors was developed from an unbiased screen to identify protein targets for a diverse compd. library.  These indol-4-one and indazol-4-one derived 2-aminobenzamides showed strong binding affinity to Hsp90, and optimized analogs exhibited nanomolar antiproliferative activity across multiple cancer cell lines.  Heat shock protein 70 (Hsp70) induction and specific client protein degrdn. in cells on treatment with the inhibitors supported Hsp90 inhibition as the mechanism of action.  Computational chem. and X-ray crystallog. anal. of selected member compds. clearly defined the protein-inhibitor interaction and assisted the design of analogs. 4-[6,6-Dimethyl-4-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl]-2-[(trans-4-hydroxycyclohexyl)amino]benzamide (SNX-2112) (I) was identified as highly selective and potent (IC50 Her2 = 11 nM, HT-29 = 3 nM); its prodrug amino-acetic acid 4-[2-carbamoyl-5-(6,6-dimethyl-4-oxo-3-trifluoromethyl-4,5,6,7-tetrahydro-indazol-1-yl)-phenylamino]-cyclohexyl ester methanesulfonate (SNX-5422) (II)was orally bioavailable and efficacious in a broad range of xenograft tumor models (e.g. 67% growth delay in a HT-29 model) and is now in multiple phase I clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFjrhELWrFkbVg90H21EOLACvtfcHk0liJUr0tTa19NA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXns1Onsrk%253D&md5=99e5039e1761e9099d634acd79a15a6a</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm900230j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900230j%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DK.%2BH.%26aulast%3DVeal%26aufirst%3DJ.%2BM.%26aulast%3DFadden%26aufirst%3DR.%2BP.%26aulast%3DRice%26aufirst%3DJ.%2BW.%26aulast%3DEaves%26aufirst%3DJ.%26aulast%3DStrachan%26aufirst%3DJ.%2BP.%26aulast%3DBarabasz%26aufirst%3DA.%2BF.%26aulast%3DFoley%26aufirst%3DB.%2BE.%26aulast%3DBarta%26aufirst%3DT.%2BE.%26aulast%3DMa%26aufirst%3DW.%26aulast%3DSilinski%26aufirst%3DM.%2BA.%26aulast%3DHu%26aufirst%3DM.%26aulast%3DPartridge%26aufirst%3DJ.%2BM.%26aulast%3DScott%26aufirst%3DA.%26aulast%3DDuBois%26aufirst%3DL.%2BG.%26aulast%3DFreed%26aufirst%3DT.%26aulast%3DSteed%26aufirst%3DP.%2BM.%26aulast%3DOmmen%26aufirst%3DA.%2BJ.%26aulast%3DSmith%26aufirst%3DE.%2BD.%26aulast%3DHughes%26aufirst%3DP.%2BF.%26aulast%3DWoodward%26aufirst%3DA.%2BR.%26aulast%3DHanson%26aufirst%3DG.%2BJ.%26aulast%3DMcCall%26aufirst%3DW.%2BS.%26aulast%3DMarkworth%26aufirst%3DC.%2BJ.%26aulast%3DHinkley%26aufirst%3DL.%26aulast%3DJenks%26aufirst%3DM.%26aulast%3DGeng%26aufirst%3DL.%26aulast%3DLewis%26aufirst%3DM.%26aulast%3DOtto%26aufirst%3DJ.%26aulast%3DPronk%26aufirst%3DB.%26aulast%3DVerleysen%26aufirst%3DK.%26aulast%3DHall%26aufirst%3DS.%2BE.%26atitle%3DDiscovery%2520of%2520novel%25202-aminobenzamide%2520inhibitors%2520of%2520heat%2520shock%2520protein%252090%2520as%2520potent%252C%2520selective%2520and%2520orally%2520active%2520antitumor%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4288%26epage%3D4305%26doi%3D10.1021%2Fjm900230j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Larrosa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tome-Carneiro, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yanez-Gascon, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alcantara, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selma, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beltran, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Conesa, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urban, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucas, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomas-Barberan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morales, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espin, J. C.</span></span> <span> </span><span class="NLM_article-title">Preventive oral treatment with resveratrol pro-prodrugs drastically reduce colon inflammation in rodents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">7365</span>– <span class="NLM_lpage">7376</span>, <span class="refDoi"> DOI: 10.1021/jm1007006</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1007006" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=7365-7376&author=M.+Larrosaauthor=J.+Tome-Carneiroauthor=M.+J.+Yanez-Gasconauthor=D.+Alcantaraauthor=M.+V.+Selmaauthor=D.+Beltranauthor=M.+T.+Garcia-Conesaauthor=C.+Urbanauthor=R.+Lucasauthor=F.+Tomas-Barberanauthor=J.+C.+Moralesauthor=J.+C.+Espin&title=Preventive+oral+treatment+with+resveratrol+pro-prodrugs+drastically+reduce+colon+inflammation+in+rodents&doi=10.1021%2Fjm1007006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjm1007006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1007006%26sid%3Dliteratum%253Aachs%26aulast%3DLarrosa%26aufirst%3DM.%26aulast%3DTome-Carneiro%26aufirst%3DJ.%26aulast%3DYanez-Gascon%26aufirst%3DM.%2BJ.%26aulast%3DAlcantara%26aufirst%3DD.%26aulast%3DSelma%26aufirst%3DM.%2BV.%26aulast%3DBeltran%26aufirst%3DD.%26aulast%3DGarcia-Conesa%26aufirst%3DM.%2BT.%26aulast%3DUrban%26aufirst%3DC.%26aulast%3DLucas%26aufirst%3DR.%26aulast%3DTomas-Barberan%26aufirst%3DF.%26aulast%3DMorales%26aufirst%3DJ.%2BC.%26aulast%3DEspin%26aufirst%3DJ.%2BC.%26atitle%3DPreventive%2520oral%2520treatment%2520with%2520resveratrol%2520pro-prodrugs%2520drastically%2520reduce%2520colon%2520inflammation%2520in%2520rodents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D7365%26epage%3D7376%26doi%3D10.1021%2Fjm1007006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span> <span> </span><span class="NLM_article-title">Cathelicidin-BF, a novel antimicrobial peptide from bungarus fasciatus, attenuates disease in a dextran sulfate sodium model of colitis</span>. <i>Mol. Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1648</span>– <span class="NLM_lpage">1661</span>, <span class="refDoi"> DOI: 10.1021/acs.molpharmaceut.5b00069</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.molpharmaceut.5b00069" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BC2MXltFSms74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=1648-1661&author=H.+Zhangauthor=X.+Xiaauthor=F.+Hanauthor=Q.+Jiangauthor=Y.+Rongauthor=D.+Songauthor=Y.+Wang&title=Cathelicidin-BF%2C+a+novel+antimicrobial+peptide+from+bungarus+fasciatus%2C+attenuates+disease+in+a+dextran+sulfate+sodium+model+of+colitis&doi=10.1021%2Facs.molpharmaceut.5b00069"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Cathelicidin-BF, a novel antimicrobial peptide from Bungarus fasciatus, attenuates disease in a dextran sulfate sodium model of colitis</span></div><div class="casAuthors">Zhang, Haiwen; Xia, Xi; Han, Feifei; Jiang, Qin; Rong, Yili; Song, Deguang; Wang, Yizhen</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1648-1661</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Antimicrobial peptides are mols. of innate immunity.  Cathelicidin-BF is the first cathelicidin peptide found in reptiles.  However, the immunoregulatory and epithelial barrier protective properties of C-BF have not been reported.  Inflammatory bowel diseases, including ulcerative colitis and Crohn's disease, can lead to colon cancer, the third most common malignant tumor.  The objective is to develop the new found cathelicidin-BF as a therapeutic to patients of ulcerative colitis.  The morphol. of the colon epithelium was obsd. by H&E staining; apoptosis index and infiltration of inflammatory cells in colonic epithelium were measured by TUNEL and immunohistochem.; the expression level of endogenous mCRAMP was analyzed by immunofluorescence; and phosphorylation of the transcription factors c-jun and NF-κB in colon were analyzed by Western blot.  Our results showed that the morphol. of the colon epithelium in the C-BF+DSS group was improved compared with the DSS group.  Apoptosis and infiltration of inflammatory cells in colonic epithelium were also significantly attenuated in the C-BF+DSS group compared with the DSS group, and the expression level of endogenous mCRAMP in the DSS group was significantly higher than other groups.  DSS-induced phosphorylation level of c-jun and NF-κB while C-BF effectively inhibited phosphorylation of NF-κB (p65).  The barrier protective effect of C-BF was still excellent.  In conclusion, C-BF effectively attenuated inflammation and improved disrupted barrier function.  Notably, this is the first report to demonstrate that C-BF attenuates DSS-induced UC both through the regulation of intestinal immune and retention of barrier function, and the exact pathway was through NF-κB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruWkK6y3u4sbVg90H21EOLACvtfcHk0ljFd0axzlopIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXltFSms74%253D&md5=2a6bf9718f3072d3b629287027634844</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Facs.molpharmaceut.5b00069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.molpharmaceut.5b00069%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DXia%26aufirst%3DX.%26aulast%3DHan%26aufirst%3DF.%26aulast%3DJiang%26aufirst%3DQ.%26aulast%3DRong%26aufirst%3DY.%26aulast%3DSong%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DY.%26atitle%3DCathelicidin-BF%252C%2520a%2520novel%2520antimicrobial%2520peptide%2520from%2520bungarus%2520fasciatus%252C%2520attenuates%2520disease%2520in%2520a%2520dextran%2520sulfate%2520sodium%2520model%2520of%2520colitis%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2015%26volume%3D12%26spage%3D1648%26epage%3D1661%26doi%3D10.1021%2Facs.molpharmaceut.5b00069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, B. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gan, H. T.</span></span> <span> </span><span class="NLM_article-title">PI3K/Akt signaling pathway is involved in the pathogenesis of ulcerative colitis</span>. <i>Inflammation Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">727</span>– <span class="NLM_lpage">734</span>, <span class="refDoi"> DOI: 10.1007/s00011-011-0325-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.1007%2Fs00011-011-0325-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=21442372" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotFClsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2011&pages=727-734&author=X.+L.+Huangauthor=J.+Xuauthor=X.+H.+Zhangauthor=B.+Y.+Qiuauthor=L.+Pengauthor=M.+Zhangauthor=H.+T.+Gan&title=PI3K%2FAkt+signaling+pathway+is+involved+in+the+pathogenesis+of+ulcerative+colitis&doi=10.1007%2Fs00011-011-0325-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">PI3K/Akt signaling pathway is involved in the pathogenesis of ulcerative colitis</span></div><div class="casAuthors">Huang, Xiao Li; Xu, Jin; Zhang, Xiao Hui; Qiu, Bo Yun; Peng, Lan; Zhang, Meng; Gan, Hua Tian</div><div class="citationInfo"><span class="NLM_cas:title">Inflammation Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">727-734</span>CODEN:
                <span class="NLM_cas:coden">INREFB</span>;
        ISSN:<span class="NLM_cas:issn">1023-3830</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Basel</span>)
        </div><div class="casAbstract">The purpose of this study was to investigate the role of the PI3K/Akt signaling pathway in the pathogenesis of ulcerative colitis (UC).  Mucosal biopsy specimens from 54 active UC cases and adjacent normal tissues from 18 colon cancer cases were investigated.  Twenty-eight Balb/c mice were randomly divided into 4 groups.  Dextran sulfate sodium (DSS) soln. (5%) was used to develop the mouse colitis model.  After treatment with wortmannin (a PI3K inhibitor), disease activity index (DAI) and histol. score was detd. for each group of mice.  Expression of phosphorylated Akt (p-Akt) in UC patients and mouse intestinal mucosa was detd. by immunohistochem. staining.  The authors also detd. the effect of wortmannin on tumor necrosis factor-α (TNF-α) expression in intestinal biopsy tissues of UC patients and mice with DSS-induced colitis.  Wortmannin significantly reduced the level of p-Akt and TNF-α in the colitis tissues of UC patients and DSS-treated mice.  Wortmannin significantly alleviated the inflammation of colitis as assessed by DAI and histol. score in DSS-treated mice.  The PI3K/Akt signal transduction pathway is involved in the regulation and release of pro-inflammatory cytokines such as TNF-α and plays an important role in the development and progression of UC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6MaR3fUqW_bVg90H21EOLACvtfcHk0lgHklTL3enE-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotFClsLs%253D&md5=82007486848ee52dd95b9f076852a74c</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1007%2Fs00011-011-0325-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00011-011-0325-6%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DX.%2BL.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DX.%2BH.%26aulast%3DQiu%26aufirst%3DB.%2BY.%26aulast%3DPeng%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DGan%26aufirst%3DH.%2BT.%26atitle%3DPI3K%252FAkt%2520signaling%2520pathway%2520is%2520involved%2520in%2520the%2520pathogenesis%2520of%2520ulcerative%2520colitis%26jtitle%3DInflammation%2520Res.%26date%3D2011%26volume%3D60%26spage%3D727%26epage%3D734%26doi%3D10.1007%2Fs00011-011-0325-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Setia, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nehru, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanyal, S. N.</span></span> <span> </span><span class="NLM_article-title">Upregulation of MAPK/Erk and PI3K/Akt pathways in ulcerative colitis-associated colon cancer</span>. <i>Biomed. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">1023</span>– <span class="NLM_lpage">1029</span>, <span class="refDoi"> DOI: 10.1016/j.biopha.2014.09.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.1016%2Fj.biopha.2014.09.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=25443414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1WitbjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2014&pages=1023-1029&author=S.+Setiaauthor=B.+Nehruauthor=S.+N.+Sanyal&title=Upregulation+of+MAPK%2FErk+and+PI3K%2FAkt+pathways+in+ulcerative+colitis-associated+colon+cancer&doi=10.1016%2Fj.biopha.2014.09.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Upregulation of MAPK/Erk and PI3K/Akt pathways in ulcerative colitis-associated colon cancer</span></div><div class="casAuthors">Setia, Shruti; Nehru, Bimla; Sanyal, Sankar Nath</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine & Pharmacotherapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1023-1029</span>CODEN:
                <span class="NLM_cas:coden">BIPHEX</span>;
        ISSN:<span class="NLM_cas:issn">0753-3322</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">An extracellular signal like a cytokine or chemokine, secreted in the inflammatory microenvironment can activate the mitogen activated protein kinase (MAPK) pathway by binding to a cytokine receptor tyrosine kinase, which further activates tyrosine kinases such as Janus Kinase-3 (Jak-3).  This signal is transferred from Jak-3 to the DNA in the nucleus of the cell by a chain of kinases, ultimately activating extracellular receptor kinase (Erk/MAPK).  The latter phosphorylates c-myc, an oncogene, which alters the levels and activities of many transcription factors leading to cell survival, proliferation and invasion.  The oncogenic PI3K pathway plays a similar role by activating c-myc, leading to cell survival and proliferation.  The present study explores the role of ulcerative colitis in colon cancer by investigating the activities of tyrosine kinase activated MAPK pathway and various components of the PI3K pathway including PI3K, PTEN, PDK1, GSK3β, Akt, mTOR, Wnt and β-catenin.  This was done by western blot and fluorescent immunohistochem. anal. of the above-mentioned proteins.  Also, the morphol. and histol. investigation of the colonic samples from various animal groups revealed significant alterations as compared to the control in both inflammatory as well as carcinogenic conditions.  These effects were reduced to a large extent by the co-administration of celecoxib, a second-generation non-steroidal anti-inflammatory drug (NSAID).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoULXkCB2i94rVg90H21EOLACvtfcHk0lgHklTL3enE-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1WitbjO&md5=04b413fe62457c940100c2ddcc7504ab</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.biopha.2014.09.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopha.2014.09.006%26sid%3Dliteratum%253Aachs%26aulast%3DSetia%26aufirst%3DS.%26aulast%3DNehru%26aufirst%3DB.%26aulast%3DSanyal%26aufirst%3DS.%2BN.%26atitle%3DUpregulation%2520of%2520MAPK%252FErk%2520and%2520PI3K%252FAkt%2520pathways%2520in%2520ulcerative%2520colitis-associated%2520colon%2520cancer%26jtitle%3DBiomed.%2520Pharmacother.%26date%3D2014%26volume%3D68%26spage%3D1023%26epage%3D1029%26doi%3D10.1016%2Fj.biopha.2014.09.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z. Y.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and initial evaluation of affinity-based small-molecule probes for fluorescent visualization and specific detection of keap1</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">7305</span>– <span class="NLM_lpage">7310</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00775</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00775" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=7305-7310&author=M.+C.+Luauthor=H.+S.+Zhouauthor=Q.+D.+Youauthor=Z.+Y.+Jiang&title=Design%2C+synthesis%2C+and+initial+evaluation+of+affinity-based+small-molecule+probes+for+fluorescent+visualization+and+specific+detection+of+keap1&doi=10.1021%2Facs.jmedchem.6b00775"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00775&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00775%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DM.%2BC.%26aulast%3DZhou%26aufirst%3DH.%2BS.%26aulast%3DYou%26aufirst%3DQ.%2BD.%26aulast%3DJiang%26aufirst%3DZ.%2BY.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520initial%2520evaluation%2520of%2520affinity-based%2520small-molecule%2520probes%2520for%2520fluorescent%2520visualization%2520and%2520specific%2520detection%2520of%2520keap1%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D7305%26epage%3D7310%26doi%3D10.1021%2Facs.jmedchem.6b00775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 9 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Li Li, Lei Wang, Qi-Dong You, <span class="NLM_string-name hlFld-ContribAuthor">Xiao-Li Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Heat Shock Protein 90 Inhibitors: An Update on Achievements, Challenges, and Future Directions. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (5)
                                     , 1798-1822. <a href="https://doi.org/10.1021/acs.jmedchem.9b00940" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00940</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00940&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00940%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHeat%252BShock%252BProtein%252B90%252BInhibitors%25253A%252BAn%252BUpdate%252Bon%252BAchievements%25252C%252BChallenges%25252C%252Band%252BFuture%252BDirections%26aulast%3DLi%26aufirst%3DLi%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D13062019%26date%3D12112019%26date%3D30102019%26volume%3D63%26issue%3D5%26spage%3D1798%26epage%3D1822" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shicheng  Xu</span>, <span class="hlFld-ContribAuthor ">Anping  Guo</span>, <span class="hlFld-ContribAuthor ">Nan-nan  Chen</span>, <span class="hlFld-ContribAuthor ">Wei  Dai</span>, <span class="hlFld-ContribAuthor ">Huan-aoyu  Yang</span>, <span class="hlFld-ContribAuthor ">Wenqin  Xie</span>, <span class="hlFld-ContribAuthor ">Mengjie  Wang</span>, <span class="hlFld-ContribAuthor ">Qi-Dong  You</span>, <span class="hlFld-ContribAuthor ">Xiao-Li  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of Grp94 selective inhibitors based on Phe199 induced fit mechanism and their anti-inflammatory effects. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>223 </em>, 113604. <a href="https://doi.org/10.1016/j.ejmech.2021.113604" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113604</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113604&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113604%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252BGrp94%252Bselective%252Binhibitors%252Bbased%252Bon%252BPhe199%252Binduced%252Bfit%252Bmechanism%252Band%252Btheir%252Banti-inflammatory%252Beffects%26aulast%3DXu%26aufirst%3DShicheng%26date%3D2021%26volume%3D223%26spage%3D113604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaofeng  Duan</span>, <span class="hlFld-ContribAuthor ">Stephen  Iwanowycz</span>, <span class="hlFld-ContribAuthor ">Soo  Ngoi</span>, <span class="hlFld-ContribAuthor ">Megan  Hill</span>, <span class="hlFld-ContribAuthor ">Qiang  Zhao</span>, <span class="hlFld-ContribAuthor ">Bei  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Chaperone GRP94/GP96 in Cancers: Oncogenesis and Therapeutic Target. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Oncology</span><span> <strong>2021,</strong> <em>11 </em><a href="https://doi.org/10.3389/fonc.2021.629846" title="DOI URL">https://doi.org/10.3389/fonc.2021.629846</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fonc.2021.629846&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffonc.2021.629846%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Oncology%26atitle%3DMolecular%252BChaperone%252BGRP94%25252FGP96%252Bin%252BCancers%25253A%252BOncogenesis%252Band%252BTherapeutic%252BTarget%26aulast%3DDuan%26aufirst%3DXiaofeng%26date%3D2021%26date%3D2021%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lei  Wang</span>, <span class="hlFld-ContribAuthor ">Xiaoli  Xu</span>, <span class="hlFld-ContribAuthor ">Zhengyu  Jiang</span>, <span class="hlFld-ContribAuthor ">Qidong  You</span>. </span><span class="cited-content_cbyCitation_article-title">Modulation of protein fate decision by small molecules: targeting molecular chaperone machinery. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2020,</strong> <em>10 </em>
                                    (10)
                                     , 1904-1925. <a href="https://doi.org/10.1016/j.apsb.2020.01.018" title="DOI URL">https://doi.org/10.1016/j.apsb.2020.01.018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2020.01.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2020.01.018%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DModulation%252Bof%252Bprotein%252Bfate%252Bdecision%252Bby%252Bsmall%252Bmolecules%25253A%252Btargeting%252Bmolecular%252Bchaperone%252Bmachinery%26aulast%3DWang%26aufirst%3DLei%26date%3D2020%26volume%3D10%26issue%3D10%26spage%3D1904%26epage%3D1925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jackee  Sanchez</span>, <span class="hlFld-ContribAuthor ">Trever R.  Carter</span>, <span class="hlFld-ContribAuthor ">Mark S.  Cohen</span>, <span class="hlFld-ContribAuthor ">Brian S.J.  Blagg</span>. </span><span class="cited-content_cbyCitation_article-title">Old and New Approaches to Target the Hsp90 Chaperone. </span><span class="cited-content_cbyCitation_journal-name">Current Cancer Drug Targets</span><span> <strong>2020,</strong> <em>20 </em>
                                    (4)
                                     , 253-270. <a href="https://doi.org/10.2174/1568009619666191202101330" title="DOI URL">https://doi.org/10.2174/1568009619666191202101330</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1568009619666191202101330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1568009619666191202101330%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Cancer%2520Drug%2520Targets%26atitle%3DOld%252Band%252BNew%252BApproaches%252Bto%252BTarget%252Bthe%252BHsp90%252BChaperone%26aulast%3DSanchez%26aufirst%3DJackee%26date%3D2020%26volume%3D20%26issue%3D4%26spage%3D253%26epage%3D270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sejin  Jung</span>, <span class="hlFld-ContribAuthor ">Nam Gu  Yoon</span>, <span class="hlFld-ContribAuthor ">Sujae  Yang</span>, <span class="hlFld-ContribAuthor ">Darong  Kim</span>, <span class="hlFld-ContribAuthor ">Won Seok  Lee</span>, <span class="hlFld-ContribAuthor ">Ki Bum  Hong</span>, <span class="hlFld-ContribAuthor ">Changwook  Lee</span>, <span class="hlFld-ContribAuthor ">Byoung Heon  Kang</span>, <span class="hlFld-ContribAuthor ">Ji Hoon  Lee</span>, <span class="hlFld-ContribAuthor ">Soosung  Kang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 2-((4-resorcinolyl)-5-aryl-1,2,3-triazol-1-yl)acetates as potent Hsp90 inhibitors with selectivity over TRAP1. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (2)
                                     , 126809. <a href="https://doi.org/10.1016/j.bmcl.2019.126809" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.126809</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.126809&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.126809%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252B2-%252528%2525284-resorcinolyl%252529-5-aryl-1%25252C2%25252C3-triazol-1-yl%252529acetates%252Bas%252Bpotent%252BHsp90%252Binhibitors%252Bwith%252Bselectivity%252Bover%252BTRAP1%26aulast%3DJung%26aufirst%3DSejin%26date%3D2020%26volume%3D30%26issue%3D2%26spage%3D126809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhiyan  Li</span>, <span class="hlFld-ContribAuthor ">Zhenguo  Zhang</span>, <span class="hlFld-ContribAuthor ">Huiyong  Sun</span>, <span class="hlFld-ContribAuthor ">Lili  Xu</span>, <span class="hlFld-ContribAuthor ">Cheng  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of novel peptidomimetics targeting the polo-box domain of polo-like kinase 1. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>91 </em>, 103148. <a href="https://doi.org/10.1016/j.bioorg.2019.103148" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.103148</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.103148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.103148%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DIdentification%252Bof%252Bnovel%252Bpeptidomimetics%252Btargeting%252Bthe%252Bpolo-box%252Bdomain%252Bof%252Bpolo-like%252Bkinase%252B1%26aulast%3DLi%26aufirst%3DZhiyan%26date%3D2019%26volume%3D91%26spage%3D103148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hoter</span>, <span class="hlFld-ContribAuthor ">Rizk</span>, <span class="hlFld-ContribAuthor ">Naim</span>. </span><span class="cited-content_cbyCitation_article-title">The Multiple Roles and Therapeutic Potential of Molecular Chaperones in Prostate Cancer. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2019,</strong> <em>11 </em>
                                    (8)
                                     , 1194. <a href="https://doi.org/10.3390/cancers11081194" title="DOI URL">https://doi.org/10.3390/cancers11081194</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers11081194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers11081194%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DThe%252BMultiple%252BRoles%252Band%252BTherapeutic%252BPotential%252Bof%252BMolecular%252BChaperones%252Bin%252BProstate%252BCancer%26aulast%3DHoter%26date%3D2019%26date%3D2019%26volume%3D11%26issue%3D8%26spage%3D1194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michele  Montaruli</span>, <span class="hlFld-ContribAuthor ">Domenico  Alberga</span>, <span class="hlFld-ContribAuthor ">Fulvio  Ciriaco</span>, <span class="hlFld-ContribAuthor ">Daniela  Trisciuzzi</span>, <span class="hlFld-ContribAuthor ">Anna Rita  Tondo</span>, <span class="hlFld-ContribAuthor ">Giuseppe Felice  Mangiatordi</span>, <span class="hlFld-ContribAuthor ">Orazio  Nicolotti</span>. </span><span class="cited-content_cbyCitation_article-title">Accelerating Drug Discovery by Early Protein Drug Target Prediction Based on a Multi-Fingerprint Similarity Search †. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (12)
                                     , 2233. <a href="https://doi.org/10.3390/molecules24122233" title="DOI URL">https://doi.org/10.3390/molecules24122233</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24122233&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24122233%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DAccelerating%252BDrug%252BDiscovery%252Bby%252BEarly%252BProtein%252BDrug%252BTarget%252BPrediction%252BBased%252Bon%252Ba%252BMulti-Fingerprint%252BSimilarity%252BSearch%252B%2525E2%252580%2525A0%26aulast%3DMontaruli%26aufirst%3DMichele%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D12%26spage%3D2233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/medium/jm-2018-00800y_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/large/jm-2018-00800y_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00800&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/medium/jm-2018-00800y_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/large/jm-2018-00800y_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures and selectivity profiles of the reported Grp94-selective inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/large/jm-2018-00800y_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00800&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/medium/jm-2018-00800y_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/large/jm-2018-00800y_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Route for Compounds <b>42</b>–<b>70</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/large/jm-2018-00800y_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00800&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) aryl iodide or aryl bromide, Pd(PPh<sub>3</sub>)<sub>4</sub>, Cs<sub>2</sub>CO<sub>3</sub>, dioxane, 90 °C, overnight; (b) <i>trans</i>-4-aminocyclohexanol, DIPEA, DMSO, 120 °C, 24 h; (c) ethanol, 1 M NaOH, 30% H<sub>2</sub>O<sub>2</sub>, 30 °C, overnight.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/medium/jm-2018-00800y_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/large/jm-2018-00800y_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Route for Compounds <b>71</b>–<b>86</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/large/jm-2018-00800y_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00800&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) different amines, DIPEA, 120 °C, 24 h; (b) 4-amino-1-Boc-piperidine, DIPEA, 120 °C, 24 h; (c) ethanol, 1 M NaOH, 30% H<sub>2</sub>O<sub>2</sub>, 30 °C, overnight; (d) TFA, DCM, rt, 48 h; (e) different Boc-protected amino acids, BOP, DIPEA, DMF, rt, 5 h; (f) TFA, DCM, rt, 36 h.</p></p></figure><figure data-id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/medium/jm-2018-00800y_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/large/jm-2018-00800y_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structural basis of the Grp94-selective inhibitory activity of PU-class compounds. (A) Compound <b>2</b> adopts “binding mode A” to bind with Hsp90α (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3O0I">3O0I</a>). Phe138 is shown as a pink stick. (B) Compound <b>2</b> adopts “binding mode B” to bind with Grp94 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3O2F">3O2F</a>). Phe199 is shown as a gray stick. (C) ATP binding pocket of Apo-Grp94<sup>N</sup> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1YT2">1YT2</a>). Phe199 is shown in blue stick. (D) Superimposition of the <b>2</b>:Grp94 complex and Apo-Grp94<sup>N</sup>. The “Phe199 shift” effect is indicated by a small magenta arrow, and the conformational change in Grp94 (H5 helix rearrangement) is indicated by a large magenta arrow.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/large/jm-2018-00800y_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00800&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/medium/jm-2018-00800y_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/large/jm-2018-00800y_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Design strategies for Grp94-selective inhibitors. (A) Benzamide Hsp90 inhibitor <b>11</b> adopts “binding mode A” to bind with Grp94 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4NH9">4NH9</a>). Compound <b>11</b> is shown as a pink stick. (B) Superposition of the <b>11</b>:Grp94 complex and <b>2</b>:Grp94 complex. Compound <b>2</b> is shown as a yellow stick, the meta position to the carbamoyl group in <b>11</b> is indicated by a red arrow, and the “Phe199 shift” is indicated by a magenta arrow. (C) Predicted binding mode of compound <b>42</b>. Compound <b>42</b> and the residues in the Grp94 active site are shown as green and gray sticks, respectively. Conserved water molecules are shown as red spheres, and H-bonds are indicated by magenta dashed lines. (D) Superimposition of the <b>42</b>:Grp94 complex and <b>2</b>:Grp94 complex.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/large/jm-2018-00800y_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00800&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/medium/jm-2018-00800y_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/large/jm-2018-00800y_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Predicted binding mode of compound <b>54</b>. The protein structure of Grp94 was extracted from PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3O2F">3O2F</a>. Active site of Grp94 is surfaced in the hydrophobic state, and compound <b>54</b> and the surrounded residues are shown as green and gray sticks, respectively. Conserved water molecules are shown as red spheres, and H-bonds are indicated by magenta dashed lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/large/jm-2018-00800y_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00800&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/medium/jm-2018-00800y_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/large/jm-2018-00800y_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Selectivity of compound <b>54</b> to Grp94 and Hsp90α. (A) Inhibition curves of compound <b>54</b> to inhibit Grp94 and Hsp90α. The mP values for negative control and blank control in the determination of Hsp90α are 428 and 318, respectively. The results are shown as the mean ± SD, <i>n</i> = 3. (B) BLI dose–response curves reflecting the direct binding of <b>54</b> to Grp94. (C) BLI dose–response curves reflecting the direct binding of <b>54</b> to Hsp90α. (D) NMR-based CPMG determination of direct binding of <b>54</b> to Grp94. NMR spectra of <b>54</b> at different concentrations of Grp94<sup>N</sup> are shown in different colors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/large/jm-2018-00800y_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00800&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/medium/jm-2018-00800y_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/large/jm-2018-00800y_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. MD simulation to analyze the structural basis of Grp94-selective inhibition. (A) ATP binding pocket of Apo-Grp94<sup>N</sup> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1YT2">1YT2</a>), Phe199 is shown in blue stick. (B) MD simulation results (20 ns) of the compound <b>2</b> removed Grp94<sup>N</sup> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3O2F">3O2F</a>). Phe199 is shown in gray stick. (C) Superimposition of (A) and (B). (D) ATP binding pocket of compound <b>2</b> bound Grp94<sup>N</sup> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3O2F">3O2F</a>). Phe199 and compound <b>2</b> are shown in green and yellow sticks, respectively. (E) MD simulation results (20 ns) of the <b>54</b>:Grp94<sup>N</sup> docking complex. Phe199 and compound <b>54</b> are shown in pink and navy blue sticks, respectively. (F) Superimposition of (D) and (E).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/large/jm-2018-00800y_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00800&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/medium/jm-2018-00800y_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/large/jm-2018-00800y_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Western blot analysis of some biomarkers in <b>54</b> treated panc-1 cells. (A) Integrin α2 and integrin αL levels in cell surface protein extracts after treatment with <b>54</b> at indicated concentrations for 36 h. (B) Hsp70 and Akt levels in total protein extracts after treatment with <b>54</b> at indicated concentrations for 36 h. AT13387 (AT) is used as the reference. β-Actin is used as the control for protein loading.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/large/jm-2018-00800y_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00800&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/medium/jm-2018-00800y_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/large/jm-2018-00800y_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Anti-inflammatory efficacy of compound <b>54</b> in DSS-induced UC mice (<i>n</i> = 8). (A) Body weight changes of the mice during treatment. (B) DAI score changes during treatment. (C) Colon length of each group on day 7. (D) Representative H&E images of the colon samples. Scale bar, 200 μm. (E) TNFα and IL-6 levels in the serum and colonic tissues of each group of mice (<i>n</i> = 5, five samples were analyzed): (∗) <i>p</i> < 0.05; (∗∗) <i>p</i> < 0.01; (∗∗∗) <i>p</i> < 0.001, compared with the “disease control” group. (F) Western blot analysis of the biomarkers in colonic tissues. β-Actin is used as the control for protein loading.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/large/jm-2018-00800y_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00800&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/medium/jm-2018-00800y_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/large/jm-2018-00800y_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Subacute toxicity evaluation of compound <b>54</b> in healthy C57BL/6 mice (<i>n</i> = 8). The mice were treated with vehicle or three different dosages of compound <b>54</b>. (A) Body weight change of each group during the treatment. (B) H&E staining analysis for the different organs of the mice in each group. Scale bar, 50 μm.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00800/20181101/images/large/jm-2018-00800y_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00800&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i111">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34434" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34434" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 52 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chiosis, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vilenchik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solit, D.</span></span> <span> </span><span class="NLM_article-title">Hsp90: the vulnerable chaperone</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">881</span>– <span class="NLM_lpage">888</span>, <span class="refDoi"> DOI: 10.1016/S1359-6446(04)03245-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.1016%2FS1359-6446%2804%2903245-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=15475321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BD2cXotlSku78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=881-888&author=G.+Chiosisauthor=M.+Vilenchikauthor=J.+Kimauthor=D.+Solit&title=Hsp90%3A+the+vulnerable+chaperone&doi=10.1016%2FS1359-6446%2804%2903245-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Hsp90: the vulnerable chaperone</span></div><div class="casAuthors">Chiosis, Gabriela; Vilenchik, Maria; Kim, Joungnam; Solit, David</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">881-888</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Hsp90 inhibitors promise the targeting of wide-range transformation by inhibiting one protein.  Here we present updates on the emerging classes of Hsp90 chaperone inhibitors and their anti-tumor activities.  The mol. chaperone Hsp90 has emerged as an important target in cancer treatment because of its roles in maintaining transformation and regulating the function of proteins involved in apoptotic, survival and growth pathways.  Many Hsp90 inhibitors function by binding to the N-terminal ATP pocket, but the chaperone has many other vulnerable points.  Agents that interact with its C-terminus or modify its post-translational status represent addnl. ways of interfering with chaperone activity.  This review will discuss several emerging classes of Hsp90 inhibitors and their modes of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqP8lFe8f0eeLVg90H21EOLACvtfcHk0liDNHmJ_zUBqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXotlSku78%253D&md5=eb5fcfa150f16d40d0eac02d8fd0e5ce</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903245-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903245-3%26sid%3Dliteratum%253Aachs%26aulast%3DChiosis%26aufirst%3DG.%26aulast%3DVilenchik%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DSolit%26aufirst%3DD.%26atitle%3DHsp90%253A%2520the%2520vulnerable%2520chaperone%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D881%26epage%3D888%26doi%3D10.1016%2FS1359-6446%2804%2903245-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neckers, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Workman, P.</span></span> <span> </span><span class="NLM_article-title">Hsp90 molecular chaperone inhibitors: are we there yet?</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">64</span>– <span class="NLM_lpage">76</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-11-1000</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.1158%2F1078-0432.CCR-11-1000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=22215907" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvFWmsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=64-76&author=L.+Neckersauthor=P.+Workman&title=Hsp90+molecular+chaperone+inhibitors%3A+are+we+there+yet%3F&doi=10.1158%2F1078-0432.CCR-11-1000"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Hsp90 Molecular Chaperone Inhibitors: Are We There Yet?</span></div><div class="casAuthors">Neckers, Len; Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">64-76</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Heat shock protein (Hsp) 90 is an ATP-dependent mol. chaperone that is exploited by malignant cells to support activated oncoproteins, including many cancer-assocd. kinases and transcription factors, and it is essential for oncogenic transformation.  Originally viewed with skepticism, Hsp90 inhibitors are now being actively pursued by the pharmaceutical industry, with 17 agents having entered clin. trials.  Investigators established Hsp90's druggability using the natural products geldanamycin and radicicol, which mimic the unusual ATP structure adopted in the chaperone's N-terminal nucleotide-binding pocket and cause potent and selective blockade of ATP binding/hydrolysis, inhibit chaperone function, deplete oncogenic clients, and show antitumor activity.  Preclin. data obtained with these natural products have heightened interest in Hsp90 as a drug target, and 17-allylamino-17-demethoxygeldanamycin (17-AAG, tanespimycin) has shown clin. activity (as defined by Response Evaluation Criteria in Solid Tumors) in HER2+ breast cancer.  Many optimized synthetic, small-mol. Hsp90 inhibitors from diverse chemotypes are now in clin. trials.  Here, we review the discovery and development of Hsp90 inhibitors and assess their potential.  There has been significant learning from studies of the basic biol. of Hsp90, as well as translational drug development involving this chaperone, enhanced by the use of Hsp90 inhibitors as chem. probes.  Success will likely lie in treating cancers that are addicted to particular driver oncogene products (e.g., HER2, ALK, EGFR, and BRAF) that are sensitive Hsp90 clients, as well as malignancies (esp. multiple myeloma) in which buffering of proteotoxic stress is crit. for survival.  We discuss approaches for enhancing the effectiveness of Hsp90 inhibitors and highlight new chaperone and stress-response pathway targets, including HSF1 and Hsp70.  Clin Cancer Res; 18(1); 64-76.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfICmNu1IWFbVg90H21EOLACvtfcHk0liDNHmJ_zUBqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvFWmsw%253D%253D&md5=f67c3c11b5847e3866c91af2a16a63b8</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-11-1000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-11-1000%26sid%3Dliteratum%253Aachs%26aulast%3DNeckers%26aufirst%3DL.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DHsp90%2520molecular%2520chaperone%2520inhibitors%253A%2520are%2520we%2520there%2520yet%253F%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2012%26volume%3D18%26spage%3D64%26epage%3D76%26doi%3D10.1158%2F1078-0432.CCR-11-1000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gewirth, D. T.</span></span> <span> </span><span class="NLM_article-title">Paralog specific Hsp90 inhibitors - a brief history and a bright future</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">2779</span>– <span class="NLM_lpage">2791</span>, <span class="refDoi"> DOI: 10.2174/1568026616666160413141154</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.2174%2F1568026616666160413141154" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=27072700" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVOhsrzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=2779-2791&author=D.+T.+Gewirth&title=Paralog+specific+Hsp90+inhibitors+-+a+brief+history+and+a+bright+future&doi=10.2174%2F1568026616666160413141154"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Paralog Specific Hsp90 Inhibitors - A Brief History and a Bright Future</span></div><div class="casAuthors">Gewirth, Daniel T.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">2779-2791</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Background. The high sequence and structural homol. among the hsp90 paralogs - Hsp90α, Hsp90β, Grp94, and Trap-1 - has made the development of paralog-specific inhibitors a challenging proposition.  Objective. This review surveys the state of developments in structural anal., compd. screening, and structure-based design that have been brought to bear on this problem.  Results. First generation compds. that selectively bind to Hsp90, Grp94, or Trap-1 have been identified.  Conclusion. With the proof of principle firmly established, the prospects for further progress are bright.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdyZyrXOyou7Vg90H21EOLACvtfcHk0lih2MLC5vGr2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVOhsrzN&md5=208025ff36aa6e2d92d3ee107b20ab5f</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.2174%2F1568026616666160413141154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026616666160413141154%26sid%3Dliteratum%253Aachs%26aulast%3DGewirth%26aufirst%3DD.%2BT.%26atitle%3DParalog%2520specific%2520Hsp90%2520inhibitors%2520-%2520a%2520brief%2520history%2520and%2520a%2520bright%2520future%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2016%26volume%3D16%26spage%3D2779%26epage%3D2791%26doi%3D10.2174%2F1568026616666160413141154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><a href="https://www.picard.ch/downloads/Hsp90interactors.pdf" class="extLink">https://www.picard.ch/downloads/Hsp90interactors.pdf</a> (accessed Mar 25, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=https%3A%2F%2Fwww.picard.ch%2Fdownloads%2FHsp90interactors.pdf+%28accessed+Mar+25%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Solit, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiosis, G.</span></span> <span> </span><span class="NLM_article-title">Development and application of Hsp90 inhibitors</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">38</span>– <span class="NLM_lpage">43</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2007.10.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.1016%2Fj.drudis.2007.10.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=18190862" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlsVWhug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=38-43&author=D.+B.+Solitauthor=G.+Chiosis&title=Development+and+application+of+Hsp90+inhibitors&doi=10.1016%2Fj.drudis.2007.10.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Development and application of Hsp90 inhibitors</span></div><div class="casAuthors">Solit, David B.; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1/2</span>),
    <span class="NLM_cas:pages">38-43</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Heat shock protein 90 has emerged as an important target in several diseases.  The present review will discuss our understanding of the role played by Hsp90 in regulating and maintaining the transformed phenotype in cancers and neurodegenerative diseases, as well as recent findings on its roles in fungal and viral infections.  It will also update the reader on the preclin. development and clin. translation of Hsp90 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobKuG3vjpdrLVg90H21EOLACvtfcHk0lih2MLC5vGr2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlsVWhug%253D%253D&md5=a4fa749f37fe96d9f323d437e9afded6</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2007.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2007.10.007%26sid%3Dliteratum%253Aachs%26aulast%3DSolit%26aufirst%3DD.%2BB.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DDevelopment%2520and%2520application%2520of%2520Hsp90%2520inhibitors%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2008%26volume%3D13%26spage%3D38%26epage%3D43%26doi%3D10.1016%2Fj.drudis.2007.10.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Powers, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Workman, P.</span></span> <span> </span><span class="NLM_article-title">Targeting of multiple signalling pathways by heat shock protein 90 molecular chaperone inhibitors</span>. <i>Endocr.-Relat. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">S125</span>– <span class="NLM_lpage">S135</span>, <span class="refDoi"> DOI: 10.1677/erc.1.01324</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.1677%2Ferc.1.01324" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=S125-S135&author=M.+V.+Powersauthor=P.+Workman&title=Targeting+of+multiple+signalling+pathways+by+heat+shock+protein+90+molecular+chaperone+inhibitors&doi=10.1677%2Ferc.1.01324"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1677%2Ferc.1.01324&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1677%252Ferc.1.01324%26sid%3Dliteratum%253Aachs%26aulast%3DPowers%26aufirst%3DM.%2BV.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DTargeting%2520of%2520multiple%2520signalling%2520pathways%2520by%2520heat%2520shock%2520protein%252090%2520molecular%2520chaperone%2520inhibitors%26jtitle%3DEndocr.-Relat.%2520Cancer%26date%3D2006%26volume%3D13%26spage%3DS125%26epage%3DS135%26doi%3D10.1677%2Ferc.1.01324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trepel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mollapour, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giaccone, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neckers, L.</span></span> <span> </span><span class="NLM_article-title">Targeting the dynamic HSP90 complex in cancer</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">537</span>– <span class="NLM_lpage">549</span>, <span class="refDoi"> DOI: 10.1038/nrc2887</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.1038%2Fnrc2887" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=20651736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpt1GjtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=537-549&author=J.+Trepelauthor=M.+Mollapourauthor=G.+Giacconeauthor=L.+Neckers&title=Targeting+the+dynamic+HSP90+complex+in+cancer&doi=10.1038%2Fnrc2887"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the dynamic HSP90 complex in cancer</span></div><div class="casAuthors">Trepel, Jane; Mollapour, Mehdi; Giaccone, Giuseppe; Neckers, Len</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">537-549</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The mol. chaperone, heat-shock protein 90 (HSP90), has been used by cancer cells to facilitate the function of numerous oncoproteins, and it can be argued that cancer cells are 'addicted' to HSP90.  However, although recent reports of the early clin. efficacy of HSP90 inhibitors are encouraging, the optimal use of HSP90-targeted therapeutics will depend on understanding the complexity of HSP90 regulation and the degree to which HSP90 participates in both neoplastic and normal cellular physiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprGEqkx6m7p7Vg90H21EOLACvtfcHk0lih2MLC5vGr2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpt1GjtLs%253D&md5=8acba020073ebb93cf1dee577420dc32</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnrc2887&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2887%26sid%3Dliteratum%253Aachs%26aulast%3DTrepel%26aufirst%3DJ.%26aulast%3DMollapour%26aufirst%3DM.%26aulast%3DGiaccone%26aufirst%3DG.%26aulast%3DNeckers%26aufirst%3DL.%26atitle%3DTargeting%2520the%2520dynamic%2520HSP90%2520complex%2520in%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2010%26volume%3D10%26spage%3D537%26epage%3D549%26doi%3D10.1038%2Fnrc2887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tukaj, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wegrzyn, G.</span></span> <span> </span><span class="NLM_article-title">Anti-Hsp90 therapy in autoimmune and inflammatory diseases: a review of preclinical studies</span>. <i>Cell Stress Chaperones</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">213</span>– <span class="NLM_lpage">218</span>, <span class="refDoi"> DOI: 10.1007/s12192-016-0670-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.1007%2Fs12192-016-0670-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=26786410" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFOqsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=213-218&author=S.+Tukajauthor=G.+Wegrzyn&title=Anti-Hsp90+therapy+in+autoimmune+and+inflammatory+diseases%3A+a+review+of+preclinical+studies&doi=10.1007%2Fs12192-016-0670-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-Hsp90 therapy in autoimmune and inflammatory diseases: a review of preclinical studies</span></div><div class="casAuthors">Tukaj, Stefan; Wegrzyn, Grzegorz</div><div class="citationInfo"><span class="NLM_cas:title">Cell Stress & Chaperones</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">213-218</span>CODEN:
                <span class="NLM_cas:coden">CSCHFG</span>;
        ISSN:<span class="NLM_cas:issn">1355-8145</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90), a 90-kDa mol. chaperone, is responsible for biol. activities of key signaling mols. (clients) such as protein kinases, ubiquitin ligases, steroid receptors, cell cycle regulators, and transcription factors regulating various cellular processes, including growth, survival, differentiation, and apoptosis.  Because Hsp90 is also involved in stabilization of oncogenic 'client' proteins, its specific chaperone activity blockers are currently being tested as anticancer agents in advanced clin. trials.  Recent in vitro and in vivo studies have shown that Hsp90 is also involved in activation of innate and adaptive cells of the immune system.  For these reasons, pharmacol. inhibition of Hsp90 has been evaluated in murine models of autoimmune and inflammatory diseases.  This mini-review summarizes current knowledge of the effects of Hsp90 inhibitors on autoimmune and inflammatory diseases' features and is based solely on preclin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_LDdiZ_wJSrVg90H21EOLACvtfcHk0ljuicrU3rlq3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFOqsb0%253D&md5=e0b1d3ea522de06d60ab530e20b2b4d0</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1007%2Fs12192-016-0670-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12192-016-0670-z%26sid%3Dliteratum%253Aachs%26aulast%3DTukaj%26aufirst%3DS.%26aulast%3DWegrzyn%26aufirst%3DG.%26atitle%3DAnti-Hsp90%2520therapy%2520in%2520autoimmune%2520and%2520inflammatory%2520diseases%253A%2520a%2520review%2520of%2520preclinical%2520studies%26jtitle%3DCell%2520Stress%2520Chaperones%26date%3D2016%26volume%3D21%26spage%3D213%26epage%3D218%26doi%3D10.1007%2Fs12192-016-0670-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blair, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabbagh, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickey, C. A.</span></span> <span> </span><span class="NLM_article-title">Targeting Hsp90 and its co-chaperones to treat Alzheimer’s disease</span>. <i>Expert Opin. Ther. Targets</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1219</span>– <span class="NLM_lpage">1232</span>, <span class="refDoi"> DOI: 10.1517/14728222.2014.943185</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.1517%2F14728222.2014.943185" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=25069659" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFOrsb3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2014&pages=1219-1232&author=L.+J.+Blairauthor=J.+J.+Sabbaghauthor=C.+A.+Dickey&title=Targeting+Hsp90+and+its+co-chaperones+to+treat+Alzheimer%E2%80%99s+disease&doi=10.1517%2F14728222.2014.943185"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Hsp90 and its co-chaperones to treat Alzheimer's disease</span></div><div class="casAuthors">Blair, Laura J.; Sabbagh, Jonathan J.; Dickey, Chad A.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1219-1232</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Alzheimer's disease, characterized by the accumulation of hyperphosphorylated tau and β amyloid (Aβ), currently lacks effective treatment.  Chaperone proteins, such as the heat shock protein (Hsp) 90, form macromol. complexes with co-chaperones, which can regulate tau metab. and Aβ processing.  Although small mol. inhibitors of Hsp90 have been successful at ameliorating tau and Aβ burden, their development into drugs to treat disease has been slow due to the off- and on-target effects of this approach as well as challenges with the pharmacol. of current scaffolds.  Thus, other approaches are being developed to improve these compds. and to target co-chaperones of Hsp90 in an effort to limit these liabilities.  This article discusses the most current developments in Hsp90 inhibitors including advances in blood-brain barrier permeability, decreased toxicity and homolog-specific small-mol. inhibitors.  In addn., we discuss current strategies targeting Hsp90 co-chaperones rather than Hsp90 itself to reduce off-target effects.  Although Hsp90 inhibitors have proven their efficacy at reducing tau pathol., they have yet to meet with success in the clinic.  The development of Hsp90/tau complex-specific inhibitors and further development of Hsp90 co-chaperone-specific drugs should yield more potent, less toxic therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwfgbwFb4NDrVg90H21EOLACvtfcHk0ljuicrU3rlq3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFOrsb3N&md5=e45b44478254d5872c355fec4e32c9d4</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1517%2F14728222.2014.943185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.2014.943185%26sid%3Dliteratum%253Aachs%26aulast%3DBlair%26aufirst%3DL.%2BJ.%26aulast%3DSabbagh%26aufirst%3DJ.%2BJ.%26aulast%3DDickey%26aufirst%3DC.%2BA.%26atitle%3DTargeting%2520Hsp90%2520and%2520its%2520co-chaperones%2520to%2520treat%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2014%26volume%3D18%26spage%3D1219%26epage%3D1232%26doi%3D10.1517%2F14728222.2014.943185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, A.</span></span> <span> </span><span class="NLM_article-title">Development of heat shock protein (Hsp90) inhibitors to combat resistance to tyrosine kinase inhibitors through Hsp90-kinase interactions</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">5563</span>– <span class="NLM_lpage">5586</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01106</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01106" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFOls7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=5563-5586&author=M.+Wangauthor=A.+Shenauthor=C.+Zhangauthor=Z.+Songauthor=J.+Aiauthor=H.+Liuauthor=L.+Sunauthor=J.+Dingauthor=M.+Gengauthor=A.+Zhang&title=Development+of+heat+shock+protein+%28Hsp90%29+inhibitors+to+combat+resistance+to+tyrosine+kinase+inhibitors+through+Hsp90-kinase+interactions&doi=10.1021%2Facs.jmedchem.5b01106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Heat Shock Protein (Hsp90) Inhibitors To Combat Resistance to Tyrosine Kinase Inhibitors through Hsp90-Kinase Interactions</span></div><div class="casAuthors">Wang, Meining; Shen, Aijun; Zhang, Chi; Song, Zilan; Ai, Jing; Liu, Hongchun; Sun, Liping; Ding, Jian; Geng, Meiyu; Zhang, Ao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5563-5586</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) is a ubiquitous chaperone of all of the oncogenic tyrosine kinases.  Many Hsp90 inhibitors, alone or in combination, have shown significant antitumor efficacy against the kinase-pos. na.ovrddot.ive and mutant models.  However, clin. trials of these inhibitors are unsuccessful due to insufficient clin. benefits and nonoptimal safety profiles.  Recently, much progress has been reported on the Hsp90-cochaperone-client complex, which will undoubtedly assist in the understanding of the interactions between Hsp90 and its clients.  Meanwhile, Hsp90 inhibitors have shown promise against patients' resistance caused by early generation tyrosine kinase inhibitors (TKIs), and at least 13 Hsp90 inhibitors are being reevaluated in the clinic.  In this regard, the objectives of the current perspective are to summarize the structure and function of the Hsp90-cochaperone-client complex, to analyze the structural and functional insights into the Hsp90-client interactions to address several existing unresolved problems with Hsp90 inhibitors, and to highlight the preclin. and clin. studies of Hsp90 inhibitors as an effective treatment against resistance to tyrosine kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogrgsVY9MSMrVg90H21EOLACvtfcHk0ljuicrU3rlq3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFOls7s%253D&md5=2408b273b2a00136223ff21709c7ae2d</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01106%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DM.%26aulast%3DShen%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DSong%26aufirst%3DZ.%26aulast%3DAi%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DGeng%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DA.%26atitle%3DDevelopment%2520of%2520heat%2520shock%2520protein%2520%2528Hsp90%2529%2520inhibitors%2520to%2520combat%2520resistance%2520to%2520tyrosine%2520kinase%2520inhibitors%2520through%2520Hsp90-kinase%2520interactions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D5563%26epage%3D5586%26doi%3D10.1021%2Facs.jmedchem.5b01106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Carbonero, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carnero, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paz-Ares, L.</span></span> <span> </span><span class="NLM_article-title">Inhibition of HSP90 molecular chaperones: moving into the clinic</span>. <i>Lancet Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">E358</span>– <span class="NLM_lpage">E369</span>, <span class="refDoi"> DOI: 10.1016/S1470-2045(13)70169-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.1016%2FS1470-2045%2813%2970169-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=23896275" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtF2iu7jI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=E358-E369&author=R.+Garcia-Carboneroauthor=A.+Carneroauthor=L.+Paz-Ares&title=Inhibition+of+HSP90+molecular+chaperones%3A+moving+into+the+clinic&doi=10.1016%2FS1470-2045%2813%2970169-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of HSP90 molecular chaperones: moving into the clinic</span></div><div class="casAuthors">Garcia-Carbonero, Rocio; Carnero, Amancio; Paz-Ares, Luis</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Oncology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e358-e369</span>CODEN:
                <span class="NLM_cas:coden">LOANBN</span>;
        ISSN:<span class="NLM_cas:issn">1470-2045</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Heat shock protein 90 (HSP90) is a mol. chaperone that is crucial for the stability and function of many proteins essential for cell survival.  Many oncogenes, including tyrosine kinases, transcription factors, and cell-cycle regulatory proteins, are client proteins of HSP90.  Inhibition of HSP90 causes client protein degrdn. via the ubiquitin-proteasome pathway, and is a mechanism that might simultaneously downregulate several redundant pathways crucial for cell viability and tumor development.  HSP90 inhibitors are currently being developed as anticancer agents, and have shown early promising results in molecularly defined subgroups of solid tumors (eg, ALK-rearranged non-small-cell lung cancer and HER2-amplified breast cancer) and some haematol. malignancies (eg, multiple myeloma).  Here, we review the current status of HSP90 inhibitors in clin. development, including geldanamycin derivs., resorcinol derivs., purine analogs, and other synthetic inhibitors.  We also discuss novel strategies and future perspectives on how to optimize the therapeutic potential of this exciting new class of drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpulM7j4PFcx7Vg90H21EOLACvtfcHk0lhkorb4DqRDtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtF2iu7jI&md5=4821e86073624fb17d7343105d6e82cd</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2FS1470-2045%2813%2970169-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1470-2045%252813%252970169-4%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia-Carbonero%26aufirst%3DR.%26aulast%3DCarnero%26aufirst%3DA.%26aulast%3DPaz-Ares%26aufirst%3DL.%26atitle%3DInhibition%2520of%2520HSP90%2520molecular%2520chaperones%253A%2520moving%2520into%2520the%2520clinic%26jtitle%3DLancet%2520Oncol.%26date%3D2013%26volume%3D14%26spage%3DE358%26epage%3DE369%26doi%3D10.1016%2FS1470-2045%2813%2970169-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ying, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tatsuta, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wada, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koya, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bates, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonderfan, A. J.</span></span> <span> </span><span class="NLM_article-title">A rat retinal damage model predicts for potential clinical visual disturbances induced by Hsp90 inhibitors</span>. <i>Toxicol. Appl. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>273</i></span>,  <span class="NLM_fpage">401</span>– <span class="NLM_lpage">409</span>, <span class="refDoi"> DOI: 10.1016/j.taap.2013.09.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.1016%2Fj.taap.2013.09.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=24090817" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslOlsbrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=2013&pages=401-409&author=D.+Zhouauthor=Y.+Liuauthor=J.+Yeauthor=W.+Yingauthor=L.+S.+Ogawaauthor=T.+Inoueauthor=N.+Tatsutaauthor=Y.+Wadaauthor=K.+Koyaauthor=Q.+Huangauthor=R.+C.+Batesauthor=A.+J.+Sonderfan&title=A+rat+retinal+damage+model+predicts+for+potential+clinical+visual+disturbances+induced+by+Hsp90+inhibitors&doi=10.1016%2Fj.taap.2013.09.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">A rat retinal damage model predicts for potential clinical visual disturbances induced by Hsp90 inhibitors</span></div><div class="casAuthors">Zhou, Dan; Liu, Yuan; Ye, Josephine; Ying, Weiwen; Ogawa, Luisa Shin; Inoue, Takayo; Tatsuta, Noriaki; Wada, Yumiko; Koya, Keizo; Huang, Qin; Bates, Richard C.; Sonderfan, Andrew J.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology and Applied Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">273</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">401-409</span>CODEN:
                <span class="NLM_cas:coden">TXAPA9</span>;
        ISSN:<span class="NLM_cas:issn">0041-008X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">In human trials certain heat shock protein 90 (Hsp90) inhibitors, including 17-DMAG and NVP-AUY922, have caused visual disorders indicative of retinal dysfunction; others such as 17-AAG and ganetespib have not.  To understand these safety profile differences we evaluated histopathol. changes and exposure profiles of four Hsp90 inhibitors, with or without clin. reports of adverse ocular effects, using a rat retinal model.  Retinal morphol., Hsp70 expression (a surrogate marker of Hsp90 inhibition), apoptotic induction and pharmacokinetic drug exposure anal. were examd. in rats treated with the ansamycins 17-DMAG and 17-AAG, or with the second-generation compds. NVP-AUY922 and ganetespib.  Both 17-DMAG and NVP-AUY922 induced strong yet restricted retinal Hsp70 up-regulation and promoted marked photoreceptor cell death 24 h after the final dose.  In contrast, neither 17-AAG nor ganetespib elicited photoreceptor injury.  When the relationship between drug distribution and photoreceptor degeneration was examd., 17-DMAG and NVP-AUY922 showed substantial retinal accumulation, with high retina/plasma (R/P) ratios and slow elimination rates, such that 51% of 17-DMAG and 65% of NVP-AUY922 present at 30 min post-injection were retained in the retina 6 h post-dose.  For 17-AAG and ganetespib, retinal elimination was rapid (90% and 70% of drugs eliminated from the retina at 6 h, resp.) which correlated with lower R/P ratios.  These findings indicate that prolonged inhibition of Hsp90 activity in the eye results in photoreceptor cell death.  Moreover, the results suggest that the retina/plasma exposure ratio and retinal elimination rate profiles of Hsp90 inhibitors, irresp. of their chem. class, may predict for ocular toxicity potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8Aq4KcKIoPrVg90H21EOLACvtfcHk0lhkorb4DqRDtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslOlsbrP&md5=39b797991e66b4561c82b991cc0132a6</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.taap.2013.09.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.taap.2013.09.018%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DYe%26aufirst%3DJ.%26aulast%3DYing%26aufirst%3DW.%26aulast%3DOgawa%26aufirst%3DL.%2BS.%26aulast%3DInoue%26aufirst%3DT.%26aulast%3DTatsuta%26aufirst%3DN.%26aulast%3DWada%26aufirst%3DY.%26aulast%3DKoya%26aufirst%3DK.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DBates%26aufirst%3DR.%2BC.%26aulast%3DSonderfan%26aufirst%3DA.%2BJ.%26atitle%3DA%2520rat%2520retinal%2520damage%2520model%2520predicts%2520for%2520potential%2520clinical%2520visual%2520disturbances%2520induced%2520by%2520Hsp90%2520inhibitors%26jtitle%3DToxicol.%2520Appl.%2520Pharmacol.%26date%3D2013%26volume%3D273%26spage%3D401%26epage%3D409%26doi%3D10.1016%2Fj.taap.2013.09.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ernst, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neubert, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sperry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuccola, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turnbull, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleck, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kargo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woody, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alcacio, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nezami, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goulet, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamos, D.</span></span> <span> </span><span class="NLM_article-title">Identification of novel HSP90alpha/beta isoform selective inhibitors using structure-based drug design. Demonstration of potential utility in treating CNS disorders such as Huntington’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">3382</span>– <span class="NLM_lpage">3400</span>, <span class="refDoi"> DOI: 10.1021/jm500042s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500042s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BC2cXltFGlsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=3382-3400&author=J.+T.+Ernstauthor=T.+Neubertauthor=M.+Liuauthor=S.+Sperryauthor=H.+Zuccolaauthor=A.+Turnbullauthor=B.+Fleckauthor=W.+Kargoauthor=L.+Woodyauthor=P.+Chiangauthor=D.+Tranauthor=W.+Chenauthor=P.+Snyderauthor=T.+Alcacioauthor=A.+Nezamiauthor=J.+Reynoldsauthor=K.+Alviauthor=L.+Gouletauthor=D.+Stamos&title=Identification+of+novel+HSP90alpha%2Fbeta+isoform+selective+inhibitors+using+structure-based+drug+design.+Demonstration+of+potential+utility+in+treating+CNS+disorders+such+as+Huntington%E2%80%99s+disease&doi=10.1021%2Fjm500042s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of novel HSP90α/β isoform selective inhibitors using structure-based drug design. Demonstration of potential utility in treating CNS disorders such as Huntington's disease</span></div><div class="casAuthors">Ernst, Justin T.; Neubert, Timothy; Liu, Michael; Sperry, Samuel; Zuccola, Harmon; Turnbull, Amy; Fleck, Beth; Kargo, William; Woody, Lisa; Chiang, Peggy; Tran, Dao; Chen, Weichao; Snyder, Phillip; Alcacio, Timothy; Nezami, Azin; Reynolds, James; Alvi, Khisal; Goulet, Lance; Stamos, Dean</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3382-3400</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A structure-based drug design strategy was used to optimize a novel benzolactam series of HSP90α/β inhibitors to achieve >1000-fold selectivity vs. the HSP90 endoplasmic reticulum and mitochondrial isoforms (GRP94 and TRAP1, resp.).  Selective HSP90α/β inhibitors were found to be equipotent to pan-HSP90 inhibitors in promoting the clearance of mutant huntington protein (mHtt) in vitro, however with less cellular toxicity.  Improved tolerability profiles may enable the use of HSP90α/β selective inhibitors in treating chronic neurodegenerative indications such as Huntington's disease (HD).  A potent, selective, orally available HSP90α/β inhibitor, 8-Cyclopentyl-6-(3,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1H-indol-1-yl)-3,4-dihydroisoquinolin-1(2H)-one, was identified that crosses the blood-brain barrier and demonstrated proof of concept by successfully reducing brain Htt levels following oral dosing in rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKpHcuphxPXbVg90H21EOLACvtfcHk0li2ZGZvz_-N0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltFGlsLY%253D&md5=0d55fb738fc0f0615b5336b8dc17056a</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm500042s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500042s%26sid%3Dliteratum%253Aachs%26aulast%3DErnst%26aufirst%3DJ.%2BT.%26aulast%3DNeubert%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DSperry%26aufirst%3DS.%26aulast%3DZuccola%26aufirst%3DH.%26aulast%3DTurnbull%26aufirst%3DA.%26aulast%3DFleck%26aufirst%3DB.%26aulast%3DKargo%26aufirst%3DW.%26aulast%3DWoody%26aufirst%3DL.%26aulast%3DChiang%26aufirst%3DP.%26aulast%3DTran%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DSnyder%26aufirst%3DP.%26aulast%3DAlcacio%26aufirst%3DT.%26aulast%3DNezami%26aufirst%3DA.%26aulast%3DReynolds%26aufirst%3DJ.%26aulast%3DAlvi%26aufirst%3DK.%26aulast%3DGoulet%26aufirst%3DL.%26aulast%3DStamos%26aufirst%3DD.%26atitle%3DIdentification%2520of%2520novel%2520HSP90alpha%252Fbeta%2520isoform%2520selective%2520inhibitors%2520using%2520structure-based%2520drug%2520design.%2520Demonstration%2520of%2520potential%2520utility%2520in%2520treating%2520CNS%2520disorders%2520such%2520as%2520Huntington%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D3382%26epage%3D3400%26doi%3D10.1021%2Fjm500042s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ohkubo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kodama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muraoka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hitotsumachi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshimura, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitade, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomori, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanoh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yonekura, K.</span></span> <span> </span><span class="NLM_article-title">TAS-116, a highly selective inhibitor of heat shock protein 90alpha and beta, demonstrates potent antitumor activity and minimal ocular toxicity in preclinical models</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">14</span>– <span class="NLM_lpage">22</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-14-0219</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.1158%2F1535-7163.MCT-14-0219" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=25416789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnslWgug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=14-22&author=S.+Ohkuboauthor=Y.+Kodamaauthor=H.+Muraokaauthor=H.+Hitotsumachiauthor=C.+Yoshimuraauthor=M.+Kitadeauthor=A.+Hashimotoauthor=K.+Itoauthor=A.+Gomoriauthor=K.+Takahashiauthor=Y.+Shibataauthor=A.+Kanohauthor=K.+Yonekura&title=TAS-116%2C+a+highly+selective+inhibitor+of+heat+shock+protein+90alpha+and+beta%2C+demonstrates+potent+antitumor+activity+and+minimal+ocular+toxicity+in+preclinical+models&doi=10.1158%2F1535-7163.MCT-14-0219"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">TAS-116, a Highly Selective Inhibitor of Heat Shock Protein 90α and β, Demonstrates Potent Antitumor Activity and Minimal Ocular Toxicity in Preclinical Models</span></div><div class="casAuthors">Ohkubo, Shuichi; Kodama, Yasuo; Muraoka, Hiromi; Hitotsumachi, Hiroko; Yoshimura, Chihoko; Kitade, Makoto; Hashimoto, Akihiro; Ito, Kenjiro; Gomori, Akira; Takahashi, Koichi; Shibata, Yoshihiro; Kanoh, Akira; Yonekura, Kazuhiko</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">14-22</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The mol. chaperone HSP90 plays a crucial role in cancer cell growth and survival by stabilizing cancer-related proteins.  A no. of HSP90 inhibitors have been developed clin. for cancer therapy; however, potential off-target and/or HSP90-related toxicities have proved problematic.  The 4-(1H-pyrazolo[3,4-b]pyridine-1-yl)benzamide TAS-116 is a selective inhibitor of cytosolic HSP90α and β that does not inhibit HSP90 paralogs such as endoplasmic reticulum GRP94 or mitochondrial TRAP1.  Oral administration of TAS-116 led to tumor shrinkage in human tumor xenograft mouse models accompanied by depletion of multiple HSP90 clients, demonstrating that the inhibition of HSP90α and β alone was sufficient to exert antitumor activity in certain tumor models.  One of the most notable HSP90-related adverse events universally obsd. to differing degrees in the clin. setting is visual disturbance.  A two-week administration of the isoxazole resorcinol NVP-AUY922, an HSP90 inhibitor, caused marked degeneration and disarrangement of the outer nuclear layer of the retina and induced photoreceptor cell death in rats.  In contrast, TAS-116 did not produce detectable photoreceptor injury in rats, probably due to its lower distribution in retinal tissue.  Importantly, in a rat model, the antitumor activity of TAS-116 was accompanied by a higher distribution of the compd. in s.c. xenografted NCI-H1975 non-small cell lung carcinoma tumors than in retina.  Moreover, TAS-116 showed activity against orthotopically transplanted NCI-H1975 lung tumors.  Together, these data suggest that TAS-116 has a potential to maximize antitumor activity while minimizing adverse effects such as visual disturbances that are obsd. with other compds. of this class.  Mol Cancer Ther; 14(1); 14-22. ©2014 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB25Txc_IcKbVg90H21EOLACvtfcHk0li2ZGZvz_-N0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnslWgug%253D%253D&md5=3ffdc26a7f0178d4e44413e22c003f77</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-14-0219&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-14-0219%26sid%3Dliteratum%253Aachs%26aulast%3DOhkubo%26aufirst%3DS.%26aulast%3DKodama%26aufirst%3DY.%26aulast%3DMuraoka%26aufirst%3DH.%26aulast%3DHitotsumachi%26aufirst%3DH.%26aulast%3DYoshimura%26aufirst%3DC.%26aulast%3DKitade%26aufirst%3DM.%26aulast%3DHashimoto%26aufirst%3DA.%26aulast%3DIto%26aufirst%3DK.%26aulast%3DGomori%26aufirst%3DA.%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DShibata%26aufirst%3DY.%26aulast%3DKanoh%26aufirst%3DA.%26aulast%3DYonekura%26aufirst%3DK.%26atitle%3DTAS-116%252C%2520a%2520highly%2520selective%2520inhibitor%2520of%2520heat%2520shock%2520protein%252090alpha%2520and%2520beta%252C%2520demonstrates%2520potent%2520antitumor%2520activity%2520and%2520minimal%2520ocular%2520toxicity%2520in%2520preclinical%2520models%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2015%26volume%3D14%26spage%3D14%26epage%3D22%26doi%3D10.1158%2F1535-7163.MCT-14-0219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ansa-Addo, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thaxton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, B. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fugle, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metelli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riesenberg, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gewirth, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiosis, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span> <span> </span><span class="NLM_article-title">Clients and oncogenic roles of molecular chaperone gp96/grp94</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">2765</span>– <span class="NLM_lpage">2778</span>, <span class="refDoi"> DOI: 10.2174/1568026616666160413141613</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.2174%2F1568026616666160413141613" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=27072698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVOhsrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=2765-2778&author=E.+A.+Ansa-Addoauthor=J.+Thaxtonauthor=F.+Hongauthor=B.+X.+Wuauthor=Y.+Zhangauthor=C.+W.+Fugleauthor=A.+Metelliauthor=B.+Riesenbergauthor=K.+Williamsauthor=D.+T.+Gewirthauthor=G.+Chiosisauthor=B.+Liuauthor=Z.+Li&title=Clients+and+oncogenic+roles+of+molecular+chaperone+gp96%2Fgrp94&doi=10.2174%2F1568026616666160413141613"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Clients and Oncogenic Roles of Molecular Chaperone gp96/grp94</span></div><div class="casAuthors">Ansa-Addo, Ephraim A.; Thaxton, Jessica; Hong, Feng; Wu, Bill X.; Zhang, Yongliang; Fugle, Caroline W.; Metelli, Alessandra; Riesenberg, Brian; Williams, Katelyn; Gewirth, Daniel T.; Chiosis, Gabriela; Liu, Bei; Li, Zihai</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">2765-2778</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">As an endoplasmic reticulum heat shock protein (HSP) 90 paralogue, glycoprotein (gp) 96 possesses immunol. properties by chaperoning antigenic peptides for activation of T cells.  Genetic studies in the last decade have unveiled that gp96 is also an essential master chaperone for multiple receptors and secreting proteins including Toll-like receptors (TLRs), integrins, the Wnt coreceptor, Low D. Lipoprotein Receptor-Related Protein 6 (LRP6), the latent TGF docking receptor, Glycoprotein A Repetitions Predominant (GARP), Glycoprotein (GP) Ib and insulin-like growth factors (IGF).  Clin., elevated expression of gp96 in a variety of cancers correlates with the advanced stage and poor survival of cancer patients.  Recent preclin. studies have also uncovered that gp96 expression is closely linked to cancer progression in multiple myeloma, hepatocellular carcinoma, breast cancer and inflammation-assocd. colon cancer.  Thus, gp96 is an attractive therapeutic target for cancer treatment.  The chaperone function of gp96 depends on its ATPase domain, which is structurally distinct from other HSP90 members, and thus favors the design of highly selective gp96-targeted inhibitors against cancer.  We herein discuss the strategically important oncogenic clients of gp96 and their underlying biol.  The roles of cell-intrinsic gp96 in T cell biol. are also discussed, in part because it offers another opportunity of cancer therapy by manipulating levels of gp96 in T cells to enhance host immune defense.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTKDihIb-tPrVg90H21EOLACvtfcHk0lik9lnL-ygTrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVOhsrnK&md5=52930fd6506186a93a1a8decad51388c</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.2174%2F1568026616666160413141613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026616666160413141613%26sid%3Dliteratum%253Aachs%26aulast%3DAnsa-Addo%26aufirst%3DE.%2BA.%26aulast%3DThaxton%26aufirst%3DJ.%26aulast%3DHong%26aufirst%3DF.%26aulast%3DWu%26aufirst%3DB.%2BX.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DFugle%26aufirst%3DC.%2BW.%26aulast%3DMetelli%26aufirst%3DA.%26aulast%3DRiesenberg%26aufirst%3DB.%26aulast%3DWilliams%26aufirst%3DK.%26aulast%3DGewirth%26aufirst%3DD.%2BT.%26aulast%3DChiosis%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DZ.%26atitle%3DClients%2520and%2520oncogenic%2520roles%2520of%2520molecular%2520chaperone%2520gp96%252Fgrp94%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2016%26volume%3D16%26spage%3D2765%26epage%3D2778%26doi%3D10.2174%2F1568026616666160413141613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Im, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, B. H.</span></span> <span> </span><span class="NLM_article-title">Paralog specificity determines subcellular distribution, action mechanism, and anticancer activity of TRAP1 inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">7569</span>– <span class="NLM_lpage">7578</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00978</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00978" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlCnsrjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=7569-7578&author=H.+K.+Parkauthor=H.+Jeongauthor=E.+Koauthor=G.+Leeauthor=J.+E.+Leeauthor=S.+K.+Leeauthor=A.+J.+Leeauthor=J.+Y.+Imauthor=S.+Huauthor=S.+H.+Kimauthor=J.+H.+Leeauthor=C.+Leeauthor=S.+Kangauthor=B.+H.+Kang&title=Paralog+specificity+determines+subcellular+distribution%2C+action+mechanism%2C+and+anticancer+activity+of+TRAP1+inhibitors&doi=10.1021%2Facs.jmedchem.7b00978"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Paralog Specificity Determines Subcellular Distribution, Action Mechanism, and Anticancer Activity of TRAP1 Inhibitors</span></div><div class="casAuthors">Park, Hye-Kyung; Jeong, Hanbin; Ko, Eunhwa; Lee, Geumwoo; Lee, Ji-Eun; Lee, Sang Kwang; Lee, An-Jung; Im, Jin Young; Hu, Sung; Kim, Seong Heon; Lee, Ji Hoon; Lee, Changwook; Kang, Soosung; Kang, Byoung Heon</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7569-7578</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Although Hsp90 inhibitors can inhibit multiple tumorigenic pathways in cancer cells, their anticancer activity has been disappointingly modest.  However, by forcing Hsp90 inhibitors into the mitochondria with mitochondrial delivery vehicles, they were converted into potent drugs targeting the mitochondrial Hsp90 paralog TRAP1.  Here, to improve mitochondrial drug accumulation without using the mitochondrial delivery vehicle, we increased freely available drug concns. in the cytoplasm by reducing the binding of the drugs to the abundant cytoplasmic Hsp90.  After analyzing X-ray cocrystal structures, the purine ring of the Hsp90 inhibitor 2 (BIIB021) was modified to pyrazolopyrimidine scaffolds.  One pyrazolopyrimidine, 12b (DN401), bound better to TRAP1 than to Hsp90, inactivated the mitochondrial TRAP1 in vivo, and it exhibited potent anticancer activity.  Therefore, the rationale and feasible guidelines for developing 12b can potentially be exploited to design a potent TRAP1 inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUfck9jHWGc7Vg90H21EOLACvtfcHk0lik9lnL-ygTrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlCnsrjM&md5=7cfcb60a5a2691eb7be6950ef7ede0ed</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00978&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00978%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DH.%2BK.%26aulast%3DJeong%26aufirst%3DH.%26aulast%3DKo%26aufirst%3DE.%26aulast%3DLee%26aufirst%3DG.%26aulast%3DLee%26aufirst%3DJ.%2BE.%26aulast%3DLee%26aufirst%3DS.%2BK.%26aulast%3DLee%26aufirst%3DA.%2BJ.%26aulast%3DIm%26aufirst%3DJ.%2BY.%26aulast%3DHu%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DKang%26aufirst%3DS.%26aulast%3DKang%26aufirst%3DB.%2BH.%26atitle%3DParalog%2520specificity%2520determines%2520subcellular%2520distribution%252C%2520action%2520mechanism%252C%2520and%2520anticancer%2520activity%2520of%2520TRAP1%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D7569%26epage%3D7578%26doi%3D10.1021%2Facs.jmedchem.7b00978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khandelwal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kent, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, V. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanian, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holzbeierlein, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matts, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, B. S. J.</span></span> <span> </span><span class="NLM_article-title">Structure-guided design of an Hsp90beta N-terminal isoform-selective inhibitor</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">425</span>, <span class="refDoi"> DOI: 10.1038/s41467-017-02013-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.1038%2Fs41467-017-02013-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=29382832" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A280%3ADC%252BC1MvlsFyksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=425&author=A.+Khandelwalauthor=C.+N.+Kentauthor=M.+Balchauthor=S.+Pengauthor=S.+J.+Mishraauthor=J.+Dengauthor=V.+W.+Dayauthor=W.+Liuauthor=C.+Subramanianauthor=M.+Cohenauthor=J.+M.+Holzbeierleinauthor=R.+Mattsauthor=B.+S.+J.+Blagg&title=Structure-guided+design+of+an+Hsp90beta+N-terminal+isoform-selective+inhibitor&doi=10.1038%2Fs41467-017-02013-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-guided design of an Hsp90β N-terminal isoform-selective inhibitor</span></div><div class="casAuthors">Khandelwal Anuj; Mishra Sanket J; Kent Caitlin N; Blagg Brian S J; Balch Maurie; Peng Shuxia; Deng Junpeng; Matts Robert; Day Victor W; Liu Weiya; Holzbeierlein Jeffery M; Subramanian Chitra; Cohen Mark</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">425</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The 90 kDa heat shock protein (Hsp90) is a molecular chaperone responsible for folding proteins that are directly associated with cancer progression.  Consequently, inhibition of the Hsp90 protein folding machinery results in a combinatorial attack on numerous oncogenic pathways.  Seventeen small-molecule inhibitors of Hsp90 have entered clinical trials, all of which bind the Hsp90 N-terminus and exhibit pan-inhibitory activity against all four Hsp90 isoforms. pan-Inhibition of Hsp90 appears to be detrimental as toxicities have been reported alongside induction of the pro-survival heat shock response.  The development of Hsp90 isoform-selective inhibitors represents an alternative approach towards the treatment of cancer that may limit some of the detriments.  Described herein is a structure-based approach to design isoform-selective inhibitors of Hsp90β, which induces the degradation of select Hsp90 clients without concomitant induction of Hsp90 levels.  Together, these initial studies support the development of Hsp90β-selective inhibitors as a method to overcome the detriments associated with pan-inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTmyRre9-yoQBpyrDyM_m9cfW6udTcc2eY7duc7kLNOorntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MvlsFyksA%253D%253D&md5=cfa47e314c9bdbc1c38802108330cba7</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fs41467-017-02013-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-017-02013-1%26sid%3Dliteratum%253Aachs%26aulast%3DKhandelwal%26aufirst%3DA.%26aulast%3DKent%26aufirst%3DC.%2BN.%26aulast%3DBalch%26aufirst%3DM.%26aulast%3DPeng%26aufirst%3DS.%26aulast%3DMishra%26aufirst%3DS.%2BJ.%26aulast%3DDeng%26aufirst%3DJ.%26aulast%3DDay%26aufirst%3DV.%2BW.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DSubramanian%26aufirst%3DC.%26aulast%3DCohen%26aufirst%3DM.%26aulast%3DHolzbeierlein%26aufirst%3DJ.%2BM.%26aulast%3DMatts%26aufirst%3DR.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%2BJ.%26atitle%3DStructure-guided%2520design%2520of%2520an%2520Hsp90beta%2520N-terminal%2520isoform-selective%2520inhibitor%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26spage%3D425%26doi%3D10.1038%2Fs41467-017-02013-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, B. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ansa-Addo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span> <span> </span><span class="NLM_article-title">GRP94/gp96 in cancer: biology, structure, immunology, and drug development</span>. <i>Adv. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">165</span>– <span class="NLM_lpage">190</span>, <span class="refDoi"> DOI: 10.1016/bs.acr.2015.09.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.1016%2Fbs.acr.2015.09.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=26916005" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BC1MXptlWqsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2016&pages=165-190&author=B.+X.+Wuauthor=F.+Hongauthor=Y.+Zhangauthor=E.+Ansa-Addoauthor=Z.+Li&title=GRP94%2Fgp96+in+cancer%3A+biology%2C+structure%2C+immunology%2C+and+drug+development&doi=10.1016%2Fbs.acr.2015.09.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">GRP94/gp96 in cancer: biology, structure, immunology, and drug development</span></div><div class="casAuthors">Wu, Bill X.; Hong, Feng; Zhang, Yongliang; Ansa-Addo, Ephraim; Li, Zihai</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Cancer Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">Hsp90 in Cancer: Beyond the Usual Suspects</span>),
    <span class="NLM_cas:pages">165-190</span>CODEN:
                <span class="NLM_cas:coden">ACRSAJ</span>;
        ISSN:<span class="NLM_cas:issn">0065-230X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">As an endoplasmic reticulum heat-shock protein 90 (HSP90) paralog, GRP94 (glucose-regulated protein 94)/gp96 (hereafter referred to as GRP94) has been shown to be an essential master chaperone for multiple receptors including Toll-like receptors, Wnt coreceptors, and integrins.  Clin., expression of GRP94 correlates with advanced stage and poor survival in a variety of cancers.  Recent preclin. studies have also revealed that GRP94 expression is closely linked to cancer growth and metastasis in melanoma, ovarian cancer, multiple myeloma, lung cancer, and inflammation-assocd. colon cancer.  Thus, GRP94 is an attractive therapeutic target in a no. of malignancies.  The chaperone function of GRP94 depends on its ATPase domain, which is structurally distinct from HSP90, allowing design of highly selective GRP94-targeted inhibitors.  In this chapter, we discuss the biol. and structure-function relationship of GRP94.  We also summarize the immunol. roles of GRP94 based on the studies documented over the last two decades, as these pertain to tumorigenesis and cancer progression.  Finally, the structure-based rationale for the design of selective small-mol. inhibitors of GRP94 and their potential application in the treatment of cancer are highlighted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiOidSXL_76bVg90H21EOLACvtfcHk0liD79eQNBeyuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXptlWqsrw%253D&md5=aa5f0de87db03540b0902ae305e658fc</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fbs.acr.2015.09.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fbs.acr.2015.09.001%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DB.%2BX.%26aulast%3DHong%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DAnsa-Addo%26aufirst%3DE.%26aulast%3DLi%26aufirst%3DZ.%26atitle%3DGRP94%252Fgp96%2520in%2520cancer%253A%2520biology%252C%2520structure%252C%2520immunology%252C%2520and%2520drug%2520development%26jtitle%3DAdv.%2520Cancer%2520Res.%26date%3D2016%26volume%3D129%26spage%3D165%26epage%3D190%26doi%3D10.1016%2Fbs.acr.2015.09.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Y. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeMayo, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lydon, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubeau, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, A. S.</span></span> <span> </span><span class="NLM_article-title">Glucose-regulated protein 94 deficiency induces squamous cell metaplasia and suppresses PTEN-null driven endometrial epithelial tumor development</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">14885</span>– <span class="NLM_lpage">14897</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.7450</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.18632%2Foncotarget.7450" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=14885-14897&author=J.+Shenauthor=L.+Yaoauthor=Y.+G.+Linauthor=F.+J.+DeMayoauthor=J.+P.+Lydonauthor=L.+Dubeauauthor=A.+S.+Lee&title=Glucose-regulated+protein+94+deficiency+induces+squamous+cell+metaplasia+and+suppresses+PTEN-null+driven+endometrial+epithelial+tumor+development&doi=10.18632%2Foncotarget.7450"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.7450&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.7450%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DJ.%26aulast%3DYao%26aufirst%3DL.%26aulast%3DLin%26aufirst%3DY.%2BG.%26aulast%3DDeMayo%26aufirst%3DF.%2BJ.%26aulast%3DLydon%26aufirst%3DJ.%2BP.%26aulast%3DDubeau%26aufirst%3DL.%26aulast%3DLee%26aufirst%3DA.%2BS.%26atitle%3DGlucose-regulated%2520protein%252094%2520deficiency%2520induces%2520squamous%2520cell%2520metaplasia%2520and%2520suppresses%2520PTEN-null%2520driven%2520endometrial%2520epithelial%2520tumor%2520development%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26spage%3D14885%26epage%3D14897%26doi%3D10.18632%2Foncotarget.7450" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rachidi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, B. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drake, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogretmen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowart, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannun, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiosis, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span> <span> </span><span class="NLM_article-title">Endoplasmic reticulum heat shock protein gp96 maintains liver homeostasis and promotes hepatocellular carcinogenesis</span>. <i>J. Hepatol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">879</span>– <span class="NLM_lpage">888</span>, <span class="refDoi"> DOI: 10.1016/j.jhep.2014.11.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.1016%2Fj.jhep.2014.11.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=25463537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitFCru7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2015&pages=879-888&author=S.+Rachidiauthor=S.+Sunauthor=B.+X.+Wuauthor=E.+Jonesauthor=R.+R.+Drakeauthor=B.+Ogretmenauthor=L.+A.+Cowartauthor=C.+J.+Clarkeauthor=Y.+A.+Hannunauthor=G.+Chiosisauthor=B.+Liuauthor=Z.+Li&title=Endoplasmic+reticulum+heat+shock+protein+gp96+maintains+liver+homeostasis+and+promotes+hepatocellular+carcinogenesis&doi=10.1016%2Fj.jhep.2014.11.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Endoplasmic reticulum heat shock protein gp96 maintains liver homeostasis and promotes hepatocellular carcinogenesis</span></div><div class="casAuthors">Rachidi, Saleh; Sun, Shaoli; Wu, Bill X.; Jones, Elizabeth; Drake, Richard R.; Ogretmen, Besim; Cowart, L. Ashley; Clarke, Christopher J.; Hannun, Yusuf A.; Chiosis, Gabriela; Liu, Bei; Li, Zihai</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hepatology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">879-888</span>CODEN:
                <span class="NLM_cas:coden">JOHEEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-8278</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Background & Aims: gp96, or grp94, is an endoplasmic reticulum (ER)-localized heat shock protein 90 paralog that acts as a protein chaperone and plays an important role for example in ER homeostasis, ER stress, Wnt and integrin signaling, and calcium homeostasis, which are vital processes in oncogenesis.  However, the cancer-intrinsic function of gp96 remains controversial.  Methods: We studied the roles of gp96 in liver biol. in mice via an Albumin promoter-driven Cre recombinase-mediated disruption of gp96 gene, hsp90b1.  The impact of gp96 status on hepatic carcinogenesis in response to diethyl-nitrosoamine (DENA) was probed.  The roles of gp96 on human hepatocellular carcinoma cells (HCC) were also examd. pharmacol. with a targeted gp96 inhibitor.  Results: We demonstrated that gp96 maintains liver development and hepatocyte function in vivo, and its loss genetically promotes adaptive accumulation of long chain ceramides, accompanied by steatotic regeneration of residual gp96+ hepatocytes.  The need for compensatory expansion of gp96+ cells in the gp96- background predisposes mice to develop carcinogen-induced hepatic hyperplasia and cancer from gp96+ but not gp96- hepatocytes.  We also found that genetic and pharmacol. inhibition of gp96 in human HCCs perturbed multiple growth signals, and attenuated proliferation and expansion.  Conclusions: gp96 is a pro-oncogenic chaperone and an attractive therapeutic target for HCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrexEwdBOAeDrVg90H21EOLACvtfcHk0liD79eQNBeyuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitFCru7w%253D&md5=33319c103ee2f44e92089321851ab22d</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.jhep.2014.11.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jhep.2014.11.010%26sid%3Dliteratum%253Aachs%26aulast%3DRachidi%26aufirst%3DS.%26aulast%3DSun%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DB.%2BX.%26aulast%3DJones%26aufirst%3DE.%26aulast%3DDrake%26aufirst%3DR.%2BR.%26aulast%3DOgretmen%26aufirst%3DB.%26aulast%3DCowart%26aufirst%3DL.%2BA.%26aulast%3DClarke%26aufirst%3DC.%2BJ.%26aulast%3DHannun%26aufirst%3DY.%2BA.%26aulast%3DChiosis%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DZ.%26atitle%3DEndoplasmic%2520reticulum%2520heat%2520shock%2520protein%2520gp96%2520maintains%2520liver%2520homeostasis%2520and%2520promotes%2520hepatocellular%2520carcinogenesis%26jtitle%3DJ.%2520Hepatol.%26date%3D2015%26volume%3D62%26spage%3D879%26epage%3D888%26doi%3D10.1016%2Fj.jhep.2014.11.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hua, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White-Gilbertson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kellner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rachidi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Usmani, S. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiosis, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Depinho, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span> <span> </span><span class="NLM_article-title">Molecular chaperone gp96 is a novel therapeutic target of multiple myeloma</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">6242</span>– <span class="NLM_lpage">6251</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-13-2083</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.1158%2F1078-0432.CCR-13-2083" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=24077352" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslyku7jP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=6242-6251&author=Y.+Huaauthor=S.+White-Gilbertsonauthor=J.+Kellnerauthor=S.+Rachidiauthor=S.+Z.+Usmaniauthor=G.+Chiosisauthor=R.+Depinhoauthor=Z.+Liauthor=B.+Liu&title=Molecular+chaperone+gp96+is+a+novel+therapeutic+target+of+multiple+myeloma&doi=10.1158%2F1078-0432.CCR-13-2083"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Chaperone gp96 Is a Novel Therapeutic Target of Multiple Myeloma</span></div><div class="casAuthors">Hua, Yunpeng; White-Gilbertson, Shai; Kellner, Joshua; Rachidi, Saleh; Usmani, Saad Z.; Chiosis, Gabriela; DePinho, Ronald; Li, Zihai; Liu, Bei</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6242-6251</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: gp96 (grp94) is a key downstream chaperone in the endoplasmic reticulum (ER) to mediate unfolded protein response (UPR) and the pathogenesis of multiple myeloma is closely linked to dysregulated UPR.  In this study, we aimed to det. the roles of gp96 in the initiation and progression of multiple myeloma in vivo and in vitro.  Exptl. Design: We generated a mouse model with overexpression of XBP1s and conditional deletion of gp96 in B-cell compartment simultaneously to identify the roles of gp96 in the development of multiple myeloma in vivo.  Using a short hairpin RNA (shRNA) system, we silenced gp96 in multiple human multiple myeloma cells and examd. the effect of gp96 knockdown on multiple myeloma cells by cell proliferation, cell-cycle anal., apoptosis assay, immunohistochem., and human myeloma xenograft model.  The anticancer activity of gp96 selective inhibitor, WS13, was evaluated by apoptosis assay and MTT assay.  Results: Genetic deletion of gp96 in XBP1s-Tg mice attenuates multiple myeloma.  Silencing of gp96 causes severe compromise in human multiple myeloma cell growth through inhibiting Wnt-LRP-survivin pathway.  We also confirmed that knockdown of gp96 decreased human multiple myeloma growth in a murine xenograft model.  The targeted gp96 inhibitor induced apoptosis and blocked multiple myeloma cell growth, but did not induce apoptosis in pre-B leukemic cells.  We have demonstrated that myeloma growth is dependent on gp96 both genetically and pharmacol.  Conclusions: gp96 is essential for multiple myeloma cell proliferation and survival, suggesting that gp96 is a novel therapeutic target for multiple myeloma.  Clin Cancer Res; 19(22); 6242-51. ©2013 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqd-ajwmlaUPrVg90H21EOLACvtfcHk0lizq6gsAukAmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslyku7jP&md5=adb618074ee3e9d6ee4795b95c1d906c</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-13-2083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-13-2083%26sid%3Dliteratum%253Aachs%26aulast%3DHua%26aufirst%3DY.%26aulast%3DWhite-Gilbertson%26aufirst%3DS.%26aulast%3DKellner%26aufirst%3DJ.%26aulast%3DRachidi%26aufirst%3DS.%26aulast%3DUsmani%26aufirst%3DS.%2BZ.%26aulast%3DChiosis%26aufirst%3DG.%26aulast%3DDepinho%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DB.%26atitle%3DMolecular%2520chaperone%2520gp96%2520is%2520a%2520novel%2520therapeutic%2520target%2520of%2520multiple%2520myeloma%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2013%26volume%3D19%26spage%3D6242%26epage%3D6251%26doi%3D10.1158%2F1078-0432.CCR-13-2083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dejeans, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glorieux, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guenin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sid, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rousseau, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bisig, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delvenne, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buc Calderon, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verrax, J.</span></span> <span> </span><span class="NLM_article-title">Overexpression of GRP94 in breast cancer cells resistant to oxidative stress promotes high levels of cancer cell proliferation and migration: Implications for tumor recurrence</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">993</span>– <span class="NLM_lpage">1002</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2011.12.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.1016%2Fj.freeradbiomed.2011.12.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=22245095" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtFSitbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=993-1002&author=N.+Dejeansauthor=C.+Glorieuxauthor=S.+Gueninauthor=R.+Beckauthor=B.+Sidauthor=R.+Rousseauauthor=B.+Bisigauthor=P.+Delvenneauthor=P.+Buc+Calderonauthor=J.+Verrax&title=Overexpression+of+GRP94+in+breast+cancer+cells+resistant+to+oxidative+stress+promotes+high+levels+of+cancer+cell+proliferation+and+migration%3A+Implications+for+tumor+recurrence&doi=10.1016%2Fj.freeradbiomed.2011.12.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of GRP94 in breast cancer cells resistant to oxidative stress promotes high levels of cancer cell proliferation and migration: Implications for tumor recurrence</span></div><div class="casAuthors">Dejeans, Nicolas; Glorieux, Christophe; Guenin, Samuel; Beck, Raphael; Sid, Brice; Rousseau, Rejane; Bisig, Bettina; Delvenne, Philippe; Buc Calderon, Pedro; Verrax, Julien</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">993-1002</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Targeting the altered redox status of cancer cells is emerging as an interesting approach to potentiate chemotherapy.  However, to maximize the effectiveness of this strategy and define the correct chemotherapeutic assocns., it is important to understand the biol. consequences of chronically exposing cancer cells to reactive oxygen species (ROS).  Using an H2O2-generating system, we selected a ROS-resistant MCF-7 breast cancer cell line, namely Resox cells.  By exploring different survival pathways that are usually induced during oxidative stress, we identified a constitutive overexpression of the endoplasmic reticulum chaperone, GRP94, in these cells, whereas levels of its cytoplasmic homolog HSP90, or GRP78, were not modified.  This overexpression was not mediated by constitutive unfolded protein response (UPR) activation.  The increase in GRP94 is tightly linked to an increase in cell proliferation and migration capacities, as shown by GRP94-silencing expts.  Interestingly, we also obsd. that GRP94 silencing inhibits migration and proliferation of the highly aggressive MDA-MB-231 cells.  By immunohistochem., we showed that GRP94 expression was higher in recurrent human breast cancers than in their paired primary neoplasias.  Similar to the situation in the Resox cells, this increase was not assocd. with an increase in UPR activation in recurrent tumors.  In conclusion, this study suggests that GRP94 overexpression may be a hallmark of aggressiveness and recurrence in breast cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvjqFOXM39gbVg90H21EOLACvtfcHk0lizq6gsAukAmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtFSitbs%253D&md5=7125eef26433c15ec7b357151ecc5d20</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2011.12.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2011.12.019%26sid%3Dliteratum%253Aachs%26aulast%3DDejeans%26aufirst%3DN.%26aulast%3DGlorieux%26aufirst%3DC.%26aulast%3DGuenin%26aufirst%3DS.%26aulast%3DBeck%26aufirst%3DR.%26aulast%3DSid%26aufirst%3DB.%26aulast%3DRousseau%26aufirst%3DR.%26aulast%3DBisig%26aufirst%3DB.%26aulast%3DDelvenne%26aufirst%3DP.%26aulast%3DBuc%2BCalderon%26aufirst%3DP.%26aulast%3DVerrax%26aufirst%3DJ.%26atitle%3DOverexpression%2520of%2520GRP94%2520in%2520breast%2520cancer%2520cells%2520resistant%2520to%2520oxidative%2520stress%2520promotes%2520high%2520levels%2520of%2520cancer%2520cell%2520proliferation%2520and%2520migration%253A%2520Implications%2520for%2520tumor%2520recurrence%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2012%26volume%3D52%26spage%3D993%26epage%3D1002%26doi%3D10.1016%2Fj.freeradbiomed.2011.12.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chiu, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, L. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, A. J.</span></span> <span> </span><span class="NLM_article-title">Molecular chaperones as a common set of proteins that regulate the invasion phenotype of head and neck cancer</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">4629</span>– <span class="NLM_lpage">4641</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-10-2107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.1158%2F1078-0432.CCR-10-2107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=21642380" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovFehtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=4629-4641&author=C.+C.+Chiuauthor=C.+Y.+Linauthor=L.+Y.+Leeauthor=Y.+J.+Chenauthor=Y.+C.+Luauthor=H.+M.+Wangauthor=C.+T.+Liaoauthor=J.+T.+Changauthor=A.+J.+Cheng&title=Molecular+chaperones+as+a+common+set+of+proteins+that+regulate+the+invasion+phenotype+of+head+and+neck+cancer&doi=10.1158%2F1078-0432.CCR-10-2107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Chaperones as a Common Set of Proteins That Regulate the Invasion Phenotype of Head and Neck Cancer</span></div><div class="casAuthors">Chiu, Ching-Chi; Lin, Chien-Yu; Lee, Li-Yu; Chen, Yin-Ju; Lu, Ya-Ching; Wang, Hung-Ming; Liao, Chun-Ta; Chang, Joseph Tung-Chieh; Cheng, Ann-Joy</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4629-4641</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: The goal of this study was to establish a common set of mols. that regulate cell invasion in head and neck cancer (HNC).  Exptl. Design: Five invasive sublines derived from HNC cell lines were established using the Matrigel selection method.  Proteomic technol., MetaCore algorithm, and reverse transcriptase-PCR methods were used to search for mols. that contribute to the invasion phenotype.  Cellular functional analyses and clin. assocn. studies were applied to examine the significance of the mols.  RESULTS: Fifty-two proteins were identified in more than two of the four independent proteomic expts., including 10 (19%) mol. chaperones.  Seven chaperones were confirmed to be differentially expressed in five sublines, Hsp90α, Hsp90β, Hsp90-B1/Gp96, Hsp70-A5/Grp78, and HYOU1, that upregulate, whereas Hsp60 and glucosidase-α neutral AB (GANAB) downregulate.  Four mols. were further investigated.  In all cell lines, knockdown of Hsp60 or GANAB and silencing of Gp96 or Grp78 considerably enhanced or reduced cell migration and invasion, resp.  Clin. assocn. studies consistently revealed that low levels of Hsp60 or GANAB and high levels of Gp96 or Grp78 are significantly assocd. with advanced cancer (P < 0.001 to P = 0.047, resp., for the four mols.) and poor survival (P < 0.001 to P = 0.025, resp., for the four mols.).  CONCLUSION: Our study defined mol. chaperones as a common set of proteins that regulate the invasion phenotype of HNC.  Loss of the tumor suppression function of Hsp60 or GANAB and acquisition of the oncogenic function of Gp96 or Grp78 contribute to aggressive cancers.  These mols. may serve as prognostic markers and targets for cancer drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKUAtEObTjBbVg90H21EOLACvtfcHk0lizq6gsAukAmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovFehtrg%253D&md5=399536844963a661fedfd375164da245</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-10-2107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-10-2107%26sid%3Dliteratum%253Aachs%26aulast%3DChiu%26aufirst%3DC.%2BC.%26aulast%3DLin%26aufirst%3DC.%2BY.%26aulast%3DLee%26aufirst%3DL.%2BY.%26aulast%3DChen%26aufirst%3DY.%2BJ.%26aulast%3DLu%26aufirst%3DY.%2BC.%26aulast%3DWang%26aufirst%3DH.%2BM.%26aulast%3DLiao%26aufirst%3DC.%2BT.%26aulast%3DChang%26aufirst%3DJ.%2BT.%26aulast%3DCheng%26aufirst%3DA.%2BJ.%26atitle%3DMolecular%2520chaperones%2520as%2520a%2520common%2520set%2520of%2520proteins%2520that%2520regulate%2520the%2520invasion%2520phenotype%2520of%2520head%2520and%2520neck%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2011%26volume%3D17%26spage%3D4629%26epage%3D4641%26doi%3D10.1158%2F1078-0432.CCR-10-2107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masuda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, Y. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takano, Y.</span></span> <span> </span><span class="NLM_article-title">Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas</span>. <i>Hum. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">1042</span>– <span class="NLM_lpage">1049</span>, <span class="refDoi"> DOI: 10.1016/j.humpath.2007.11.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.1016%2Fj.humpath.2007.11.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=18482745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnsF2qu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2008&pages=1042-1049&author=H.+C.+Zhengauthor=H.+Takahashiauthor=X.+H.+Liauthor=T.+Haraauthor=S.+Masudaauthor=Y.+F.+Guanauthor=Y.+Takano&title=Overexpression+of+GRP78+and+GRP94+are+markers+for+aggressive+behavior+and+poor+prognosis+in+gastric+carcinomas&doi=10.1016%2Fj.humpath.2007.11.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas</span></div><div class="casAuthors">Zheng, Hua-chuan; Takahashi, Hiroyuki; Li, Xiao-han; Hara, Takuo; Masuda, Shinji; Guan, Yi-fu; Takano, Yasuo</div><div class="citationInfo"><span class="NLM_cas:title">Human Pathology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1042-1049</span>CODEN:
                <span class="NLM_cas:coden">HPCQA4</span>;
        ISSN:<span class="NLM_cas:issn">0046-8177</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Summary: Glucose-related proteins (GRPs) are ubiquitously expressed in endoplasmic reticulum and able to assist in protein folding and assembly; consequently, they are considered as mol. chaperones.  GRP78 and GRP94 expression was induced by glucose starvation and up-regulated in the malignancies.  To clarify the roles of both mols. in tumorigenesis and progression of gastric carcinomas, immunohistochem. was used on tissue microarray contg. gastric carcinomas, adenomas, and nonneoplastic mucosa using the antibodies against GRP78 and GRP94, with a comparison of their expression with clinicopathol. parameters of carcinomas.  Gastric carcinoma cell lines (MKN28, AGS, MKN45, KATO-III, and HGC-27) were studied for both proteins by immunohistochem. and Western blot.  There was more expression of both proteins in gastric carcinoma and adenoma than in nonneoplastic mucosas (P < .05).  All gastric carcinoma cell lines showed their expression at different levels.  They were pos. correlated with tumor size, depth of invasion, lymphatic and venous invasion, lymph node metastasis, and Union Internationale Contre le Cancer staging (P < .05), with pos. relationship between both proteins (P < .05).  Univariate anal. indicated the postsurgical cumulative survival rate of patients with pos. GRP78 or GRP94 expression to be lower than that in those without GRP78 or GRP94 expression (P < .05), but the close link disappeared if stratified according to depth of invasion (P > .05).  Multivariate anal. showed that age, depth of invasion, lymphatic invasion, lymph node metastasis, Union Internationale Contre le Cancer staging, and Lauren classification (P < .05), but not GRP78 and GRP94 expression, were independent prognostic factors for carcinomas (P > .05).  Up-regulated expression of GRP78 and GRP94 was possibly involved in pathogenesis, growth, invasion, and metastasis of gastric carcinomas.  They were considered objective and effective markers for the aggressive behavior and poor prognosis in gastric carcinomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokt8ggPAG35rVg90H21EOLACvtfcHk0liIpGApNzsqxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnsF2qu74%253D&md5=7b96bfff001cb6c04ade258a1f7c64a3</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.humpath.2007.11.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.humpath.2007.11.009%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DH.%2BC.%26aulast%3DTakahashi%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DX.%2BH.%26aulast%3DHara%26aufirst%3DT.%26aulast%3DMasuda%26aufirst%3DS.%26aulast%3DGuan%26aufirst%3DY.%2BF.%26aulast%3DTakano%26aufirst%3DY.%26atitle%3DOverexpression%2520of%2520GRP78%2520and%2520GRP94%2520are%2520markers%2520for%2520aggressive%2520behavior%2520and%2520poor%2520prognosis%2520in%2520gastric%2520carcinomas%26jtitle%3DHum.%2520Pathol.%26date%3D2008%26volume%3D39%26spage%3D1042%26epage%3D1049%26doi%3D10.1016%2Fj.humpath.2007.11.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stothert, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suntharalingam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huard, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fontaine, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crowley, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lieberman, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickey, C. A.</span></span> <span> </span><span class="NLM_article-title">Exploiting the interaction between Grp94 and aggregated myocilin to treat glaucoma</span>. <i>Hum. Mol. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">6470</span>– <span class="NLM_lpage">6480</span>, <span class="refDoi"> DOI: 10.1093/hmg/ddu367</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.1093%2Fhmg%2Fddu367" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=25027323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitl2ntb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2014&pages=6470-6480&author=A.+R.+Stothertauthor=A.+Suntharalingamauthor=D.+J.+Huardauthor=S.+N.+Fontaineauthor=V.+M.+Crowleyauthor=S.+Mishraauthor=B.+S.+Blaggauthor=R.+L.+Liebermanauthor=C.+A.+Dickey&title=Exploiting+the+interaction+between+Grp94+and+aggregated+myocilin+to+treat+glaucoma&doi=10.1093%2Fhmg%2Fddu367"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Exploiting the interaction between Grp94 and aggregated myocilin to treat glaucoma</span></div><div class="casAuthors">Stothert, Andrew R.; Suntharalingam, Amirthaa; Huard, Dustin J. E.; Fontaine, Sarah N.; Crowley, Vincent M.; Mishra, Sanket; Blagg, Brian S. J.; Lieberman, Raquel L.; Dickey, Chad A.</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6470-6480</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Gain-of-function mutations in the olfactomedin domain of the MYOC gene facilitate the toxic accumulation of amyloid-contg. myocilin aggregates, hastening the onset of the prevalent ocular disorder primary open-angle glaucoma.  Aggregation of wild-type myocilin has been reported in other glaucoma subtypes, suggesting broader relevance of misfolded myocilin across the disease spectrum, but the absence of myocilin does not cause disease.  Thus, strategies aimed at eliminating myocilin could be therapeutically relevant for glaucoma.  Here, a novel and selective Grp94 inhibitor reduced the levels of several mutant myocilin proteins as well as wild-type myocilin when forced to misfold in cells.  This inhibitor rescued mutant myocilin toxicity in primary human trabecular meshwork cells.  Mechanistically, in vitro kinetics studies demonstrate that Grp94 recognizes on-pathway aggregates of the myocilin olfactomedin domain (myoc-OLF), accelerates rates of aggregation and co-ppts. with myoc-OLF.  These results indicate that aberrant myocilin quaternary structure drives Grp94 recognition, rather than peptide motifs exposed by unfolded protein.  Inhibition of Grp94 ameliorates the effects of Grp94-accelerated myoc-OLF aggregation, and Grp94 remains in soln.  In cells, when wild-type myocilin is driven to misfold and aggregate, it becomes a client of Grp94 and sensitive to Grp94 inhibition.  Taken together, the interaction of Grp94 with myocilin aggregates can be manipulated by cellular environment and genetics; this process can be exploited with Grp94 inhibitors to promote the clearance of toxic forms of myocilin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeQYeK777kKLVg90H21EOLACvtfcHk0liIpGApNzsqxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitl2ntb8%253D&md5=cbabbce383403838a4cbc3ffe24bdce8</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddu367&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddu367%26sid%3Dliteratum%253Aachs%26aulast%3DStothert%26aufirst%3DA.%2BR.%26aulast%3DSuntharalingam%26aufirst%3DA.%26aulast%3DHuard%26aufirst%3DD.%2BJ.%26aulast%3DFontaine%26aufirst%3DS.%2BN.%26aulast%3DCrowley%26aufirst%3DV.%2BM.%26aulast%3DMishra%26aufirst%3DS.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%26aulast%3DLieberman%26aufirst%3DR.%2BL.%26aulast%3DDickey%26aufirst%3DC.%2BA.%26atitle%3DExploiting%2520the%2520interaction%2520between%2520Grp94%2520and%2520aggregated%2520myocilin%2520to%2520treat%2520glaucoma%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2014%26volume%3D23%26spage%3D6470%26epage%3D6480%26doi%3D10.1093%2Fhmg%2Fddu367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rosser, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicchitta, C. V.</span></span> <span> </span><span class="NLM_article-title">Ligand interactions in the adenosine nucleotide-binding domain of the Hsp90 chaperone, GRP94. I. Evidence for allosteric regulation of ligand binding</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>275</i></span>,  <span class="NLM_fpage">22798</span>– <span class="NLM_lpage">22805</span>, <span class="refDoi"> DOI: 10.1074/jbc.M001477200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.1074%2Fjbc.M001477200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=22798-22805&author=M.+F.+Rosserauthor=C.+V.+Nicchitta&title=Ligand+interactions+in+the+adenosine+nucleotide-binding+domain+of+the+Hsp90+chaperone%2C+GRP94.+I.+Evidence+for+allosteric+regulation+of+ligand+binding&doi=10.1074%2Fjbc.M001477200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M001477200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M001477200%26sid%3Dliteratum%253Aachs%26aulast%3DRosser%26aufirst%3DM.%2BF.%26aulast%3DNicchitta%26aufirst%3DC.%2BV.%26atitle%3DLigand%2520interactions%2520in%2520the%2520adenosine%2520nucleotide-binding%2520domain%2520of%2520the%2520Hsp90%2520chaperone%252C%2520GRP94.%2520I.%2520Evidence%2520for%2520allosteric%2520regulation%2520of%2520ligand%2520binding%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D22798%26epage%3D22805%26doi%3D10.1074%2Fjbc.M001477200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Soldano, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jivan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicchitta, C. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gewirth, D. T.</span></span> <span> </span><span class="NLM_article-title">Structure of the N-terminal domain of GRP94. Basis for ligand specificity and regulation</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>278</i></span>,  <span class="NLM_fpage">48330</span>– <span class="NLM_lpage">48338</span>, <span class="refDoi"> DOI: 10.1074/jbc.M308661200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.1074%2Fjbc.M308661200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=12970348" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpt1Gjt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=48330-48338&author=K.+L.+Soldanoauthor=A.+Jivanauthor=C.+V.+Nicchittaauthor=D.+T.+Gewirth&title=Structure+of+the+N-terminal+domain+of+GRP94.+Basis+for+ligand+specificity+and+regulation&doi=10.1074%2Fjbc.M308661200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the N-terminal Domain of GRP94: Basis for Ligand Specificity and Regulation</span></div><div class="casAuthors">Soldano, Karen L.; Jivan, Arif; Nicchitta, Christopher V.; Gewirth, Daniel T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">48330-48338</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">GRP94, the endoplasmic reticulum (ER) paralog of the chaperone Hsp90, plays an essential role in the structural maturation or secretion of a subset of proteins destined for transport to the cell surface, such as the Toll-like receptors 2 and 4, and IgG, resp.  GRP94 differs from cytoplasmic Hsp90 by exhibiting very weak ATP binding and hydrolysis activity.  GRP94 also binds selectively to a series of substituted adenosine analogs.  The high resoln. crystal structures at 1.75-2.1 Å of the N-terminal and adjacent charged domains of GRP94 in complex with N-ethylcarboxamidoadenosine (NECA), radicicol, and 2-chlorodideoxyadenosine reveals a structural mechanism for ligand discrimination among hsp90 family members.  The structures also identify a putative subdomain that may act as a ligand-responsive switch.  The residues of the charged region fold into a disordered loop whose termini are ordered and continue the twisted beta sheet that forms the structural core of the N-domain.  This continuation of the beta sheet past the charged domain suggests a structural basis for the assocn. of the N-terminal and middle domains of the full-length chaperone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1SkIPU21-TLVg90H21EOLACvtfcHk0liIpGApNzsqxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpt1Gjt78%253D&md5=0d83c7ac820dbdab6faf940dd1052ad0</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M308661200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M308661200%26sid%3Dliteratum%253Aachs%26aulast%3DSoldano%26aufirst%3DK.%2BL.%26aulast%3DJivan%26aufirst%3DA.%26aulast%3DNicchitta%26aufirst%3DC.%2BV.%26aulast%3DGewirth%26aufirst%3DD.%2BT.%26atitle%3DStructure%2520of%2520the%2520N-terminal%2520domain%2520of%2520GRP94.%2520Basis%2520for%2520ligand%2520specificity%2520and%2520regulation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D48330%26epage%3D48338%26doi%3D10.1074%2Fjbc.M308661200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patel, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seidler, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Que, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taldone, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finotti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephani, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gewirth, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiosis, G.</span></span> <span> </span><span class="NLM_article-title">Paralog-selective Hsp90 inhibitors define tumor-specific regulation of HER2</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">677</span>– <span class="NLM_lpage">684</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1335</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.1038%2Fnchembio.1335" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=23995768" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlGltb7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=677-684&author=P.+D.+Patelauthor=P.+Yanauthor=P.+M.+Seidlerauthor=H.+J.+Patelauthor=W.+Sunauthor=C.+Yangauthor=N.+S.+Queauthor=T.+Taldoneauthor=P.+Finottiauthor=R.+A.+Stephaniauthor=D.+T.+Gewirthauthor=G.+Chiosis&title=Paralog-selective+Hsp90+inhibitors+define+tumor-specific+regulation+of+HER2&doi=10.1038%2Fnchembio.1335"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Paralog-selective Hsp90 inhibitors define tumor-specific regulation of HER2</span></div><div class="casAuthors">Patel, Pallav D.; Yan, Pengrong; Seidler, Paul M.; Patel, Hardik J.; Sun, Weilin; Yang, Chenghua; Que, Nanette S.; Taldone, Tony; Finotti, Paola; Stephani, Ralph A.; Gewirth, Daniel T.; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">677-684</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Although the Hsp90 chaperone family, comprised in humans of four paralogs, Hsp90α, Hsp90β, Grp94 and Trap-1, has important roles in malignancy, the contribution of each paralog to the cancer phenotype is poorly understood.  This is in large part because reagents to study paralog-specific functions in cancer cells have been unavailable.  Here the authors combine compd. library screening with structural and computational analyses to identify purine-based chem. tools that are specific for Hsp90 paralogs.  The authors show that Grp94 selectivity is due to the insertion of these compds. into a new allosteric pocket.  The authors use these tools to demonstrate that cancer cells use individual Hsp90 paralogs to regulate a client protein in a tumor-specific manner and in response to proteome alterations.  Finally, the authors provide new mechanistic evidence explaining why selective Grp94 inhibition is particularly efficacious in certain breast cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAIwIoA9btZLVg90H21EOLACvtfcHk0li8rRDHO-1iFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlGltb7J&md5=8bdfb2c60b4171bbdd6046e455e413bb</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1335&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1335%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DP.%2BD.%26aulast%3DYan%26aufirst%3DP.%26aulast%3DSeidler%26aufirst%3DP.%2BM.%26aulast%3DPatel%26aufirst%3DH.%2BJ.%26aulast%3DSun%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DQue%26aufirst%3DN.%2BS.%26aulast%3DTaldone%26aufirst%3DT.%26aulast%3DFinotti%26aufirst%3DP.%26aulast%3DStephani%26aufirst%3DR.%2BA.%26aulast%3DGewirth%26aufirst%3DD.%2BT.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DParalog-selective%2520Hsp90%2520inhibitors%2520define%2520tumor-specific%2520regulation%2520of%2520HER2%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2013%26volume%3D9%26spage%3D677%26epage%3D684%26doi%3D10.1038%2Fnchembio.1335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patel, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ochiana, S. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tramentozzi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brooks, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolaender, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shrestha, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finotti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leifer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gewirth, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taldone, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiosis, G.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship in a purine-scaffold compound series with selectivity for the endoplasmic reticulum Hsp90 paralog Grp94</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">3922</span>– <span class="NLM_lpage">3943</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00197</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00197" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BC2MXntVWnsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3922-3943&author=H.+J.+Patelauthor=P.+D.+Patelauthor=S.+O.+Ochianaauthor=P.+Yanauthor=W.+Sunauthor=M.+R.+Patelauthor=S.+K.+Shahauthor=E.+Tramentozziauthor=J.+Brooksauthor=A.+Bolaenderauthor=L.+Shresthaauthor=R.+Stephaniauthor=P.+Finottiauthor=C.+Leiferauthor=Z.+Liauthor=D.+T.+Gewirthauthor=T.+Taldoneauthor=G.+Chiosis&title=Structure-activity+relationship+in+a+purine-scaffold+compound+series+with+selectivity+for+the+endoplasmic+reticulum+Hsp90+paralog+Grp94&doi=10.1021%2Facs.jmedchem.5b00197"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationship in a Purine-Scaffold Compound Series with Selectivity for the Endoplasmic Reticulum Hsp90 Paralog Grp94</span></div><div class="casAuthors">Patel, Hardik J.; Patel, Pallav D.; Ochiana, Stefan O.; Yan, Pengrong; Sun, Weilin; Patel, Maulik R.; Shah, Smit K.; Tramentozzi, Elisa; Brooks, James; Bolaender, Alexander; Shrestha, Liza; Stephani, Ralph; Finotti, Paola; Leifer, Cynthia; Li, Zihai; Gewirth, Daniel T.; Taldone, Tony; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3922-3943</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Grp94 is involved in the regulation of a restricted no. of proteins and represents a potential target in a host of diseases, including cancer, septic shock, autoimmune diseases, chronic inflammatory conditions, diabetes, coronary thrombosis, and stroke.  The authors have recently identified a novel allosteric pocket located in the Grp94 N-terminal binding site that can be used to design ligands with a 2-log selectivity over the other Hsp90 paralogs.  Here the authors perform extensive SAR investigations in this ligand series and rationalize the affinity and paralog selectivity of choice derivs. by mol. modeling.  The authors then use this to design I, a deriv. with good potency for Grp94 (IC50 = 0.22 μM) and selectivity over other paralogs (>100- and 33-fold for Hsp90α/β and Trap-1, resp.).  The paralog selectivity and target-mediated activity of I was confirmed in cells through several functional readouts.  Compd. I was also inert when tested against a large panel of kinases.  The authors show that I has biol. activity in several cellular models of inflammation and cancer and also present here for the first time the in vivo profile of a Grp94 inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-3SSMDJ2Ti7Vg90H21EOLACvtfcHk0li8rRDHO-1iFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXntVWnsbg%253D&md5=4c341cedaf3aa4d08afa43cbca301717</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00197%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DH.%2BJ.%26aulast%3DPatel%26aufirst%3DP.%2BD.%26aulast%3DOchiana%26aufirst%3DS.%2BO.%26aulast%3DYan%26aufirst%3DP.%26aulast%3DSun%26aufirst%3DW.%26aulast%3DPatel%26aufirst%3DM.%2BR.%26aulast%3DShah%26aufirst%3DS.%2BK.%26aulast%3DTramentozzi%26aufirst%3DE.%26aulast%3DBrooks%26aufirst%3DJ.%26aulast%3DBolaender%26aufirst%3DA.%26aulast%3DShrestha%26aufirst%3DL.%26aulast%3DStephani%26aufirst%3DR.%26aulast%3DFinotti%26aufirst%3DP.%26aulast%3DLeifer%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DGewirth%26aufirst%3DD.%2BT.%26aulast%3DTaldone%26aufirst%3DT.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DStructure-activity%2520relationship%2520in%2520a%2520purine-scaffold%2520compound%2520series%2520with%2520selectivity%2520for%2520the%2520endoplasmic%2520reticulum%2520Hsp90%2520paralog%2520Grp94%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D3922%26epage%3D3943%26doi%3D10.1021%2Facs.jmedchem.5b00197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Immormino, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metzger, L. E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reardon, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dollins, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gewirth, D. T.</span></span> <span> </span><span class="NLM_article-title">Different poses for ligand and chaperone in inhibitor-bound Hsp90 and GRP94: Implications for paralog-specific drug design</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>388</i></span>,  <span class="NLM_fpage">1033</span>– <span class="NLM_lpage">1042</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2009.03.071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.1016%2Fj.jmb.2009.03.071" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=388&publication_year=2009&pages=1033-1042&author=R.+M.+Immorminoauthor=L.+E.+T.+Metzgerauthor=P.+N.+Reardonauthor=D.+E.+Dollinsauthor=B.+S.+Blaggauthor=D.+T.+Gewirth&title=Different+poses+for+ligand+and+chaperone+in+inhibitor-bound+Hsp90+and+GRP94%3A+Implications+for+paralog-specific+drug+design&doi=10.1016%2Fj.jmb.2009.03.071"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2009.03.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2009.03.071%26sid%3Dliteratum%253Aachs%26aulast%3DImmormino%26aufirst%3DR.%2BM.%26aulast%3DMetzger%26aufirst%3DL.%2BE.%2BT.%26aulast%3DReardon%26aufirst%3DP.%2BN.%26aulast%3DDollins%26aufirst%3DD.%2BE.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%26aulast%3DGewirth%26aufirst%3DD.%2BT.%26atitle%3DDifferent%2520poses%2520for%2520ligand%2520and%2520chaperone%2520in%2520inhibitor-bound%2520Hsp90%2520and%2520GRP94%253A%2520Implications%2520for%2520paralog-specific%2520drug%2520design%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2009%26volume%3D388%26spage%3D1033%26epage%3D1042%26doi%3D10.1016%2Fj.jmb.2009.03.071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duerfeldt, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maynard, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eletto, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostrovsky, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shinogle, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argon, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicchitta, C. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, B. S.</span></span> <span> </span><span class="NLM_article-title">Development of a Grp94 inhibitor</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">9796</span>– <span class="NLM_lpage">9804</span>, <span class="refDoi"> DOI: 10.1021/ja303477g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja303477g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BC38XnslGqsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2012&pages=9796-9804&author=A.+S.+Duerfeldtauthor=L.+B.+Petersonauthor=J.+C.+Maynardauthor=C.+L.+Ngauthor=D.+Elettoauthor=O.+Ostrovskyauthor=H.+E.+Shinogleauthor=D.+S.+Mooreauthor=Y.+Argonauthor=C.+V.+Nicchittaauthor=B.+S.+Blagg&title=Development+of+a+Grp94+inhibitor&doi=10.1021%2Fja303477g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a Grp94 inhibitor</span></div><div class="casAuthors">Duerfeldt, Adam S.; Peterson, Laura B.; Maynard, Jason C.; Ng, Chun Leung; Eletto, Davide; Ostrovsky, Olga; Shinogle, Heather E.; Moore, David S.; Argon, Yair; Nicchitta, Christopher V.; Blagg, Brian S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9796-9804</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) represents a promising therapeutic target for the treatment of cancer and other diseases.  Unfortunately, results from clin. trials have been disappointing as off-target effects and toxicities have been obsd.  These detriments may be a consequence of pan-Hsp90 inhibition, as all clin. evaluated Hsp90 inhibitors simultaneously disrupt all four human Hsp90 isoforms.  Using a structure-based approach, we designed an inhibitor of Grp94, the ER-resident Hsp90.  The effect manifested by compd. (I) on several Grp94 and Hsp90α/β (cytosolic isoforms) clients were investigated.  Compd. I prevented intracellular trafficking of the Toll receptor, inhibited the secretion of IGF-II, affected the conformation of Grp94, and suppressed Drosophila larval growth, all Grp94-dependent processes.  In contrast, compd. I had no effect on cell viability or cytosolic Hsp90α/β client proteins at similar concns.  The design, synthesis, and evaluation of I are described herein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoayCAvZU_mzrVg90H21EOLACvtfcHk0lj1a_f35Rx3ZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnslGqsLw%253D&md5=00c0b3f15f2cfd04658225c8a6fb708d</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fja303477g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja303477g%26sid%3Dliteratum%253Aachs%26aulast%3DDuerfeldt%26aufirst%3DA.%2BS.%26aulast%3DPeterson%26aufirst%3DL.%2BB.%26aulast%3DMaynard%26aufirst%3DJ.%2BC.%26aulast%3DNg%26aufirst%3DC.%2BL.%26aulast%3DEletto%26aufirst%3DD.%26aulast%3DOstrovsky%26aufirst%3DO.%26aulast%3DShinogle%26aufirst%3DH.%2BE.%26aulast%3DMoore%26aufirst%3DD.%2BS.%26aulast%3DArgon%26aufirst%3DY.%26aulast%3DNicchitta%26aufirst%3DC.%2BV.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%26atitle%3DDevelopment%2520of%2520a%2520Grp94%2520inhibitor%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2012%26volume%3D134%26spage%3D9796%26epage%3D9804%26doi%3D10.1021%2Fja303477g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crowley, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khandelwal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stothert, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huard, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muth, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duerfeldt, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kizziah, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lieberman, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickey, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, B. S.</span></span> <span> </span><span class="NLM_article-title">Development of glucose regulated protein 94-selective inhibitors based on the BnIm and Radamide scaffold</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">3471</span>– <span class="NLM_lpage">3488</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00085</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00085" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BC28XksFGrs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=3471-3488&author=V.+M.+Crowleyauthor=A.+Khandelwalauthor=S.+Mishraauthor=A.+R.+Stothertauthor=D.+J.+Huardauthor=J.+Zhaoauthor=A.+Muthauthor=A.+S.+Duerfeldtauthor=J.+L.+Kizziahauthor=R.+L.+Liebermanauthor=C.+A.+Dickeyauthor=B.+S.+Blagg&title=Development+of+glucose+regulated+protein+94-selective+inhibitors+based+on+the+BnIm+and+Radamide+scaffold&doi=10.1021%2Facs.jmedchem.6b00085"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Glucose Regulated Protein 94-Selective Inhibitors Based on the BnIm and Radamide Scaffold</span></div><div class="casAuthors">Crowley, Vincent M.; Khandelwal, Anuj; Mishra, Sanket; Stothert, Andrew R.; Huard, Dustin J. E.; Zhao, Jinbo; Muth, Aaron; Duerfeldt, Adam S.; Kizziah, James L.; Lieberman, Raquel L.; Dickey, Chad A.; Blagg, Brian S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3471-3488</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">(Arylmethyl)imidazolylethyl chlorodihydroxybenzoates I (R = Ph, 4-FC6H4, 4-ClC6H4, 4-BrC6H4, 4-IC6H4, 4-MeC6H4, 4-EtC6H4, 4-i-PrC6H4, 4-NCC6H4, 4-HC≡CC6H4, 4-F3CC6H4, 4-PhC6H4, 4-MeOC6H4, 3,4-Cl2C6H3, 1-naphthyl, 2-naphthyl, 5-quinolinyl, 3-FC6H4, 3-ClC6H4, 3-BrC6H4, 3-IC6H4, 3-MeOC6H4, 3-MeC6H4, 3-PhC6H4, 2-FC6H4, 2-ClC6H4, 2-BrC6H4, 2-MeC6H4, 2-H2NC6H4, 2-MeOC6H4, 2-EtC6H4, 2-EtOC6H4, 2-i-PrOC6H4, 2-n-PrOC6H4, 2-F3CC6H4, 2-MeO-4-MeC6H3, 3-furanyl, 2-furanyl, 5-Me-2-furanyl, 5-Cl-2-furanyl, 3,5-dimethyl-2-furanyl, 2-thienyl, 3-thienyl, 5-Me-2-thienyl, 5-Cl-2-thienyl, 4-Cl-2-thienyl, 3-Cl-2-thienyl, 5-isoxazolyl, 2-thiazolyl, 3-vinyl-2-thienyl, 3-vinyl-2-furanyl, 3-Et-2-thienyl, 2-pyridinyl, 3-pyridinyl, 4-pyridinyl, 5-pyrimidinyl) were prepd. as selective inhibitors of glucose regulated protein 94 (Grp94), the endoplasmic reticulum-resident isoform of the heat shock protein 90 (Hsp90), for potential use in the treatment of glaucoma and cancer; the effect of the aryl substituents on Grp94 binding and selectivity was detd.  I were prepd. by the cyclocondensation of a bissilylated chloro(oxopropyl)dihydroxybenzoate with glyoxal and arylmethylamines RCH2NH2 (R = Ph, 4-FC6H4, 4-ClC6H4, 4-BrC6H4, 4-IC6H4, 4-MeC6H4, 4-EtC6H4, 4-i-PrC6H4, 4-NCC6H4, 4-HC≡CC6H4, 4-F3CC6H4, 4-PhC6H4, 4-MeOC6H4, 3,4-Cl2C6H3, 1-naphthyl, 2-naphthyl, 5-quinolinyl, 3-FC6H4, 3-ClC6H4, 3-BrC6H4, 3-IC6H4, 3-MeOC6H4, 3-MeC6H4, 3-PhC6H4, 2-FC6H4, 2-ClC6H4, 2-BrC6H4, 2-MeC6H4, 2-H2NC6H4, 2-MeOC6H4, 2-EtC6H4, 2-EtOC6H4, 2-i-PrOC6H4, 2-n-PrOC6H4, 2-F3CC6H4, 2-MeO-4-MeC6H3, 3-furanyl, 2-furanyl, 5-Me-2-furanyl, 5-Cl-2-furanyl, 3,5-dimethyl-2-furanyl, 2-thienyl, 3-thienyl, 5-Me-2-thienyl, 5-Cl-2-thienyl, 4-Cl-2-thienyl, 3-Cl-2-thienyl, 5-isoxazolyl, 2-thiazolyl, 3-vinyl-2-thienyl, 3-vinyl-2-furanyl, 3-Et-2-thienyl, 2-pyridinyl, 3-pyridinyl, 4-pyridinyl, 5-pyrimidinyl) followed by desilylation.  I (R = 2-MeO-4-MeC6H3CH2, 5-chloro-2-furanylmethyl) were tested as inhibitors of cell migration in a cancer metastasis model and for their enhancement of the degrdn. of mutants of the protein myocilin in a glaucoma model.  The structures of the lead compd. radamide bound to Hsp82 and Grp94 and of I (R = 5-chloro-2-furanyl) bound to the N-terminal domain of Hsp94 lacking its acidic linker were detd. by X-ray crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3v_0NEYj1Z7Vg90H21EOLACvtfcHk0lj1a_f35Rx3ZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XksFGrs7k%253D&md5=c73bbf30c243e281aae197689162c9e1</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00085%26sid%3Dliteratum%253Aachs%26aulast%3DCrowley%26aufirst%3DV.%2BM.%26aulast%3DKhandelwal%26aufirst%3DA.%26aulast%3DMishra%26aufirst%3DS.%26aulast%3DStothert%26aufirst%3DA.%2BR.%26aulast%3DHuard%26aufirst%3DD.%2BJ.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DMuth%26aufirst%3DA.%26aulast%3DDuerfeldt%26aufirst%3DA.%2BS.%26aulast%3DKizziah%26aufirst%3DJ.%2BL.%26aulast%3DLieberman%26aufirst%3DR.%2BL.%26aulast%3DDickey%26aufirst%3DC.%2BA.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%26atitle%3DDevelopment%2520of%2520glucose%2520regulated%2520protein%252094-selective%2520inhibitors%2520based%2520on%2520the%2520BnIm%2520and%2520Radamide%2520scaffold%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D3471%26epage%3D3488%26doi%3D10.1021%2Facs.jmedchem.6b00085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huard, D. J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crowley, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cordova, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomlin, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickey, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koren, J.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blair, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, B. S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lieberman, R. L.</span></span> <span> </span><span class="NLM_article-title">Trifunctional high-throughput screen identifies promising scaffold to inhibit Grp94 and treat myocilin-associated glaucoma</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">933</span>– <span class="NLM_lpage">941</span>, <span class="refDoi"> DOI: 10.1021/acschembio.7b01083</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.7b01083" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFOnurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&pages=933-941&author=D.+J.+E.+Huardauthor=V.+M.+Crowleyauthor=Y.+Duauthor=R.+A.+Cordovaauthor=Z.+Sunauthor=M.+O.+Tomlinauthor=C.+A.+Dickeyauthor=J.+Korenauthor=L.+Blairauthor=H.+Fuauthor=B.+S.+J.+Blaggauthor=R.+L.+Lieberman&title=Trifunctional+high-throughput+screen+identifies+promising+scaffold+to+inhibit+Grp94+and+treat+myocilin-associated+glaucoma&doi=10.1021%2Facschembio.7b01083"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Trifunctional High-Throughput Screen Identifies Promising Scaffold To Inhibit Grp94 and Treat Myocilin-Associated Glaucoma</span></div><div class="casAuthors">Huard, Dustin J. E.; Crowley, Vincent M.; Du, Yuhong; Cordova, Ricardo A.; Sun, Zheying; Tomlin, Moya O.; Dickey, Chad A.; Koren, John; Blair, Laura; Fu, Haian; Blagg, Brian S. J.; Lieberman, Raquel L.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">933-941</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Gain-of-function mutations within the olfactomedin (OLF) domain of myocilin result in its toxic intracellular accumulation and hasten the onset of open-angle glaucoma.  The absence of myocilin does not cause disease; therefore, strategies aimed at eliminating myocilin could lead to a successful glaucoma treatment.  The endoplasmic reticulum Hsp90 paralog Grp94 accelerates OLF aggregation.  Knockdown or pharmacol. inhibition of Grp94 in cells facilitates clearance of mutant myocilin via a non-proteasomal pathway.  Here, the authors expanded the support for targeting Grp94 over cytosolic paralogs Hsp90α and Hsp90β.  The authors then developed a high-throughput screening assay to identify new chem. matter capable of disrupting the Grp94/OLF interaction.  When applied to a blind, focused library of 17 Hsp90 inhibitors, the authors' miniaturized single-read in vitro thioflavin T -based kinetics aggregation assay exclusively identified compds. that target the chaperone N-terminal nucleotide binding site.  In follow up studies, one compd. decreased the extent of co-aggregation of Grp94 with OLF in a dose-dependent manner in vitro, and enabled clearance of the aggregation-prone full-length myocilin variant I477N in cells without inducing the heat shock response or causing cytotoxicity.  Comparison of the co-crystal structure of compd. 2 (I) and another non-selective hit in complex with the N-terminal domain of Grp94 reveals a docking mode tailored to Grp94 and explains its selectivity.  A new lead compd. has been identified, supporting a targeted chem. biol. assay approach to develop a protein degrdn.-based therapy for myocilin-assocd. glaucoma by selectively inhibiting Grp94.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrxuX4fPaDAbVg90H21EOLACvtfcHk0lj1a_f35Rx3ZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFOnurk%253D&md5=166a3573601578f4662206eeee3cca85</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Facschembio.7b01083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.7b01083%26sid%3Dliteratum%253Aachs%26aulast%3DHuard%26aufirst%3DD.%2BJ.%2BE.%26aulast%3DCrowley%26aufirst%3DV.%2BM.%26aulast%3DDu%26aufirst%3DY.%26aulast%3DCordova%26aufirst%3DR.%2BA.%26aulast%3DSun%26aufirst%3DZ.%26aulast%3DTomlin%26aufirst%3DM.%2BO.%26aulast%3DDickey%26aufirst%3DC.%2BA.%26aulast%3DKoren%26aufirst%3DJ.%26aulast%3DBlair%26aufirst%3DL.%26aulast%3DFu%26aufirst%3DH.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%2BJ.%26aulast%3DLieberman%26aufirst%3DR.%2BL.%26atitle%3DTrifunctional%2520high-throughput%2520screen%2520identifies%2520promising%2520scaffold%2520to%2520inhibit%2520Grp94%2520and%2520treat%2520myocilin-associated%2520glaucoma%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2018%26volume%3D13%26spage%3D933%26epage%3D941%26doi%3D10.1021%2Facschembio.7b01083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crowley, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huard, D. J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lieberman, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, B. S. J.</span></span> <span> </span><span class="NLM_article-title">Second generation Grp94-selective inhibitors provide opportunities for the inhibition of metastatic cancer</span>. <i>Chem. - Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">15775</span>– <span class="NLM_lpage">15782</span>, <span class="refDoi"> DOI: 10.1002/chem.201703398</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.1002%2Fchem.201703398" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=28857290" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFOltrjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=15775-15782&author=V.+M.+Crowleyauthor=D.+J.+E.+Huardauthor=R.+L.+Liebermanauthor=B.+S.+J.+Blagg&title=Second+generation+Grp94-selective+inhibitors+provide+opportunities+for+the+inhibition+of+metastatic+cancer&doi=10.1002%2Fchem.201703398"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Second Generation Grp94-Selective Inhibitors Provide Opportunities for the Inhibition of Metastatic Cancer</span></div><div class="casAuthors">Crowley, Vincent M.; Huard, Dustin J. E.; Lieberman, Raquel L.; Blagg, Brian S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">62</span>),
    <span class="NLM_cas:pages">15775-15782</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Glucose regulated protein 94 (Grp94) is the endoplasmic reticulum (ER) resident isoform of the 90-kDa heat shock protein (Hsp90) family and its inhibition represents a promising therapeutic target for the treatment of many diseases.  Modification of the first generation cis-amide bioisostere imidazole to alter the angle between the resorcinol ring and the benzyl side chain via cis-amide replacements produced compds. with improved Grp94 affinity and selectivity.  Structure-activity relationship studies led to the discovery of compd. 30 (Me 3-chloro-2-(2-(4-fluorobenzyl)phenethyl)-4,6-dihydroxybenzoate), which exhibits 540 nM affinity and 73-fold selectivity towards Grp94.  Grp94 is responsible for the maturation and trafficking of proteins assocd. with cell signaling and motility, including select integrins.  The Grp94-selective inhibitor 30 was shown to exhibit potent anti-migratory effects against multiple aggressive and metastatic cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQGZJljYE02LVg90H21EOLACvtfcHk0ljb7WA10Xg3IA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFOltrjN&md5=784809d71abe5da007438172fbdb7f0d</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1002%2Fchem.201703398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201703398%26sid%3Dliteratum%253Aachs%26aulast%3DCrowley%26aufirst%3DV.%2BM.%26aulast%3DHuard%26aufirst%3DD.%2BJ.%2BE.%26aulast%3DLieberman%26aufirst%3DR.%2BL.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%2BJ.%26atitle%3DSecond%2520generation%2520Grp94-selective%2520inhibitors%2520provide%2520opportunities%2520for%2520the%2520inhibition%2520of%2520metastatic%2520cancer%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2017%26volume%3D23%26spage%3D15775%26epage%3D15782%26doi%3D10.1002%2Fchem.201703398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Que, N. L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crowley, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duerfeldt, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kent, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, B. S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gewirth, D. T.</span></span> <span> </span><span class="NLM_article-title">Structure based design of a Grp94-selective inhibitor: Exploiting a key residue in Grp94 to optimize paralog-selective binding</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">2793</span>– <span class="NLM_lpage">2805</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01608</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01608" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BC1cXktlGhsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=2793-2805&author=N.+L.+S.+Queauthor=V.+M.+Crowleyauthor=A.+S.+Duerfeldtauthor=J.+Zhaoauthor=C.+N.+Kentauthor=B.+S.+J.+Blaggauthor=D.+T.+Gewirth&title=Structure+based+design+of+a+Grp94-selective+inhibitor%3A+Exploiting+a+key+residue+in+Grp94+to+optimize+paralog-selective+binding&doi=10.1021%2Facs.jmedchem.7b01608"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Structure Based Design of a Grp94-Selective Inhibitor: Exploiting a Key Residue in Grp94 To Optimize Paralog-Selective Binding</span></div><div class="casAuthors">Que, Nanette L. S.; Crowley, Vincent M.; Duerfeldt, Adam S.; Zhao, Jinbo; Kent, Caitlin N.; Blagg, Brian S. J.; Gewirth, Daniel T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2793-2805</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Grp94 and Hsp90, the ER and cytoplasmic hsp90 paralogs, share a conserved ATP-binding pocket that has been targeted for therapeutics.  Paralog-selective inhibitors may lead to drugs with fewer side effects.  Here, the authors analyzed 1 (BnIm), a benzyl imidazole resorcinylic inhibitor, for its mode of binding.  The structures of 1 bound to Hsp90 and Grp94 reveal large conformational changes in Grp94 but not Hsp90 that expose site 2, a binding pocket adjacent to the central ATP cavity that is ordinarily blocked.  The Grp94:1 structure reveals a flipped pose of the resorcinylic scaffold that inserts into the exposed site 2.  The authors exploited this flipped binding pose to develop a Grp94-selective deriv. of 1.  The authors' structural anal. shows that the ability of the ligand to insert its benzyl imidazole substituent into site 1, a different side pocket off the ATP binding cavity, is the key to exposing site 2 in Grp94.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhACqcGHClIrVg90H21EOLACvtfcHk0ljb7WA10Xg3IA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXktlGhsLw%253D&md5=a44f6bf0bd3df65cf20ca570a1ef37b8</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01608&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01608%26sid%3Dliteratum%253Aachs%26aulast%3DQue%26aufirst%3DN.%2BL.%2BS.%26aulast%3DCrowley%26aufirst%3DV.%2BM.%26aulast%3DDuerfeldt%26aufirst%3DA.%2BS.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DKent%26aufirst%3DC.%2BN.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%2BJ.%26aulast%3DGewirth%26aufirst%3DD.%2BT.%26atitle%3DStructure%2520based%2520design%2520of%2520a%2520Grp94-selective%2520inhibitor%253A%2520Exploiting%2520a%2520key%2520residue%2520in%2520Grp94%2520to%2520optimize%2520paralog-selective%2520binding%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D2793%26epage%3D2805%26doi%3D10.1021%2Facs.jmedchem.7b01608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khandelwal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crowley, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, B. S. J.</span></span> <span> </span><span class="NLM_article-title">Resorcinol-based Grp94-selective inhibitors</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1013</span>– <span class="NLM_lpage">1018</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.7b00193</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.7b00193" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVejs73K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=1013-1018&author=A.+Khandelwalauthor=V.+M.+Crowleyauthor=B.+S.+J.+Blagg&title=Resorcinol-based+Grp94-selective+inhibitors&doi=10.1021%2Facsmedchemlett.7b00193"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Resorcinol-Based Grp94-Selective Inhibitors</span></div><div class="casAuthors">Khandelwal, Anuj; Crowley, Vincent M.; Blagg, Brian S. J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1013-1018</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Glucose regulated protein 94 (Grp94) is the endoplasmic reticulum resident of the 90 kDa heat shock protein (Hsp90) family and represents a promising therapeutic target for the treatment of several diseases.  Grp94 is the most unique member of the 90 kDa heat shock protein family due to a five amino acid insertion into its primary sequence, which creates hydrophobic subpockets exclusive to Grp94 that can be utilized for selective inhibition.  The first resorcinol-based Grp94-selective inhibitor I to take advantage of the hydrophobic S2 subpocket has been developed and shown to manifest low nanomolar affinity and ∼10-fold selectivity for Grp94.  Furthermore, these Grp94-selective inhibitors manifest low micromolar GI50 values against multiple myeloma cells, supporting Grp94 as an emerging target for the treatment of this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGok_wSMzlEsHLVg90H21EOLACvtfcHk0ljb7WA10Xg3IA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVejs73K&md5=a398cf6e5adaacc4892aed8b2340b901</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.7b00193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.7b00193%26sid%3Dliteratum%253Aachs%26aulast%3DKhandelwal%26aufirst%3DA.%26aulast%3DCrowley%26aufirst%3DV.%2BM.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%2BJ.%26atitle%3DResorcinol-based%2520Grp94-selective%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D8%26spage%3D1013%26epage%3D1018%26doi%3D10.1021%2Facsmedchemlett.7b00193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stothert, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickey, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, B. S.</span></span> <span> </span><span class="NLM_article-title">Transformation of the non-selective aminocyclohexanol-based Hsp90 inhibitor into a Grp94-seletive scaffold</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">244</span>– <span class="NLM_lpage">253</span>, <span class="refDoi"> DOI: 10.1021/acschembio.6b00747</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.6b00747" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVGqurjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=244-253&author=S.+J.+Mishraauthor=S.+Ghoshauthor=A.+R.+Stothertauthor=C.+A.+Dickeyauthor=B.+S.+Blagg&title=Transformation+of+the+non-selective+aminocyclohexanol-based+Hsp90+inhibitor+into+a+Grp94-seletive+scaffold&doi=10.1021%2Facschembio.6b00747"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Transformation of the Non-Selective Aminocyclohexanol-Based Hsp90 Inhibitor into a Grp94-Seletive Scaffold</span></div><div class="casAuthors">Mishra, Sanket J.; Ghosh, Suman; Stothert, Andrew R.; Dickey, Chad A.; Blagg, Brian S. J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">244-253</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Glucose regulated protein 94 kDa, Grp94, is the endoplasmic reticulum (ER) localized isoform of heat shock protein 90 (Hsp90) that is responsible for the trafficking and maturation of toll-like receptors, Igs, and integrins.  As a result, Grp94 has emerged as a therapeutic target to disrupt cellular communication, adhesion, and tumor proliferation, potentially with fewer side effects compared to pan-inhibitors of all Hsp90 isoforms.  Although, the N-terminal ATP binding site is highly conserved among all four Hsp90 isoforms, recent cocrystal structures of Grp94 have revealed subtle differences between Grp94 and other Hsp90 isoforms that has been exploited for the development of Grp94-selective inhibitors.  In the current study, a structure-based approach has been applied to a Grp94 nonselective compd., SNX 2112, which led to the development of 8j (ACO1), a Grp94-selective inhibitor that manifests ∼440 nM affinity and >200-fold selectivity against cytosolic Hsp90 isoforms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEVr4w6ywqwLVg90H21EOLACvtfcHk0lgXtl34dEGfeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVGqurjF&md5=5e9924483ab0c13f9a819a2d4bda55ee</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Facschembio.6b00747&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.6b00747%26sid%3Dliteratum%253Aachs%26aulast%3DMishra%26aufirst%3DS.%2BJ.%26aulast%3DGhosh%26aufirst%3DS.%26aulast%3DStothert%26aufirst%3DA.%2BR.%26aulast%3DDickey%26aufirst%3DC.%2BA.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%26atitle%3DTransformation%2520of%2520the%2520non-selective%2520aminocyclohexanol-based%2520Hsp90%2520inhibitor%2520into%2520a%2520Grp94-seletive%2520scaffold%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2017%26volume%3D12%26spage%3D244%26epage%3D253%26doi%3D10.1021%2Facschembio.6b00747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cosinroger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hausmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogler, G.</span></span> <span> </span><span class="NLM_article-title">The role of the chaperone Grp94/Gp96 in the intestinal barrier and innate immune functions</span>. <i>Curr. Immunol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">64</span>– <span class="NLM_lpage">70</span>, <span class="refDoi"> DOI: 10.2174/1573395513666170316105529</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.2174%2F1573395513666170316105529" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2017&pages=64-70&author=J.+Cosinrogerauthor=M.+Hausmannauthor=G.+Rogler&title=The+role+of+the+chaperone+Grp94%2FGp96+in+the+intestinal+barrier+and+innate+immune+functions&doi=10.2174%2F1573395513666170316105529"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.2174%2F1573395513666170316105529&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1573395513666170316105529%26sid%3Dliteratum%253Aachs%26aulast%3DCosinroger%26aufirst%3DJ.%26aulast%3DHausmann%26aufirst%3DM.%26aulast%3DRogler%26aufirst%3DG.%26atitle%3DThe%2520role%2520of%2520the%2520chaperone%2520Grp94%252FGp96%2520in%2520the%2520intestinal%2520barrier%2520and%2520innate%2520immune%2520functions%26jtitle%3DCurr.%2520Immunol.%2520Rev.%26date%3D2017%26volume%3D13%26spage%3D64%26epage%3D70%26doi%3D10.2174%2F1573395513666170316105529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span> <span> </span><span class="NLM_article-title">Endoplasmic reticulum stress in hepatic steatosis and inflammatory bowel diseases</span>. <i>Front. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">242</span>, <span class="refDoi"> DOI: 10.3389/fgene.2014.00242</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.3389%2Ffgene.2014.00242" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=25120559" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A280%3ADC%252BC2M%252Fhs1agug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=242&author=B.+Guoauthor=Z.+Li&title=Endoplasmic+reticulum+stress+in+hepatic+steatosis+and+inflammatory+bowel+diseases&doi=10.3389%2Ffgene.2014.00242"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Endoplasmic reticulum stress in hepatic steatosis and inflammatory bowel diseases</span></div><div class="casAuthors">Guo Beichu; Li Zihai</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in genetics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">242</span>
        ISSN:<span class="NLM_cas:issn">1664-8021</span>.
    </div><div class="casAbstract">As an adaptive response to the overloading with misfolded proteins in the endoplasmic reticulum (ER), ER stress plays critical roles in maintaining protein homeostasis in the secretory pathway to avoid damage to the host.  Such a conserved mechanism is accomplished through three well-orchestrated pathways known collectively as unfolded protein response (UPR).  Persistent and pathological ER stress has been implicated in a variety of diseases in metabolic, inflammatory, and malignant conditions.  Furthermore, ER stress is directly linked with inflammation through UPR pathways, which modulate transcriptional programs to induce the expression of inflammatory genes.  Importantly, the inflammation induced by ER stress is directly responsible for the pathogenesis of metabolic and inflammatory diseases.  In this review, we will discuss the potential signaling pathways connecting ER stress with inflammation.  We will also depict the interplay between ER stress and inflammation in the pathogenesis of hepatic steatosis, inflammatory bowel diseases and colitis-associated colon cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSmNUMurqDlwe_Q9URG6Dx8fW6udTcc2eaHMPKFLKdSubntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M%252Fhs1agug%253D%253D&md5=1c05f05871761f9fd931b24efa4953a9</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.3389%2Ffgene.2014.00242&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffgene.2014.00242%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DZ.%26atitle%3DEndoplasmic%2520reticulum%2520stress%2520in%2520hepatic%2520steatosis%2520and%2520inflammatory%2520bowel%2520diseases%26jtitle%3DFront.%2520Genet.%26date%3D2014%26volume%3D5%26spage%3D242%26doi%3D10.3389%2Ffgene.2014.00242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xavier, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Podolsky, D. K.</span></span> <span> </span><span class="NLM_article-title">Unravelling the pathogenesis of inflammatory bowel disease</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>448</i></span>,  <span class="NLM_fpage">427</span>– <span class="NLM_lpage">434</span>, <span class="refDoi"> DOI: 10.1038/nature06005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.1038%2Fnature06005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=17653185" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotFajurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=448&publication_year=2007&pages=427-434&author=R.+J.+Xavierauthor=D.+K.+Podolsky&title=Unravelling+the+pathogenesis+of+inflammatory+bowel+disease&doi=10.1038%2Fnature06005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Unraveling the pathogenesis of inflammatory bowel disease</span></div><div class="casAuthors">Xavier, R. J.; Podolsky, D. K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">448</span>
        (<span class="NLM_cas:issue">7152</span>),
    <span class="NLM_cas:pages">427-434</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Recently, substantial advances in the understanding of the mol. pathogenesis of inflammatory bowel disease (IBD) have been made owing to three related lines of investigation.  First, IBD has been found to be the most tractable of complex disorders for discovering susceptibility genes, and these have shown the importance of epithelial barrier function, and innate and adaptive immunity in disease pathogenesis.  Second, efforts directed towards the identification of environmental factors implicate commensal bacteria (or their products), rather than conventional pathogens, as drivers of dysregulated immunity and IBD.  Third, murine models, which exhibit many of the features of ulcerative colitis and seem to be bacteria-driven, have helped unravel the pathogenesis/mucosal immunopathol. of IBD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-TNsEuEfK-rVg90H21EOLACvtfcHk0lgXtl34dEGfeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotFajurs%253D&md5=36ac0f7c55f5cef41249390397ec9562</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1038%2Fnature06005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature06005%26sid%3Dliteratum%253Aachs%26aulast%3DXavier%26aufirst%3DR.%2BJ.%26aulast%3DPodolsky%26aufirst%3DD.%2BK.%26atitle%3DUnravelling%2520the%2520pathogenesis%2520of%2520inflammatory%2520bowel%2520disease%26jtitle%3DNature%26date%3D2007%26volume%3D448%26spage%3D427%26epage%3D434%26doi%3D10.1038%2Fnature06005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staron, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, B. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morales, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crosson, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomlinson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span> <span> </span><span class="NLM_article-title">Essential roles of grp94 in gut homeostasis via chaperoning canonical Wnt pathway</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">6877</span>– <span class="NLM_lpage">6882</span>, <span class="refDoi"> DOI: 10.1073/pnas.1302933110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.1073%2Fpnas.1302933110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=23572575" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BC3sXot1Ghtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=6877-6882&author=B.+Liuauthor=M.+Staronauthor=F.+Hongauthor=B.+X.+Wuauthor=S.+Sunauthor=C.+Moralesauthor=C.+E.+Crossonauthor=S.+Tomlinsonauthor=I.+Kimauthor=D.+Wuauthor=Z.+Li&title=Essential+roles+of+grp94+in+gut+homeostasis+via+chaperoning+canonical+Wnt+pathway&doi=10.1073%2Fpnas.1302933110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Essential roles of grp94 in gut homeostasis via chaperoning canonical Wnt pathway</span></div><div class="casAuthors">Liu, Bei; Staron, Matthew; Hong, Feng; Wu, Bill X.; Sun, Shaoli; Morales, Crystal; Crosson, Craig E.; Tomlinson, Stephen; Kim, Ingyu; Wu, Dianqing; Li, Zihai</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6877-6882</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Increasing evidence points to a role for the protein quality control in the endoplasmic reticulum (ER) in maintaining intestinal homeostasis.  However, the specific role for general ER chaperones in this process remains unknown.  Herein, we report that a major ER heat shock protein grp94 interacts with MesD, a crit. chaperone for the Wnt coreceptor low-d. lipoprotein receptor-related protein 6 (LRP6).  Without grp94, LRP6 fails to export from the ER to the cell surface, resulting in a profound loss of canonical Wnt signaling.  The significance of this finding is demonstrated in vivo in that grp94 loss causes a rapid and profound compromise in intestinal homeostasis with gut-intrinsic defect in the proliferation of intestinal crypts, compromise of nuclear β-catenin translocation, loss of crypt-villus structure, and impaired barrier function.  Taken together, our work has uncovered the role of grp94 in chaperoning LRP6-MesD in coordinating intestinal homeostasis, placing canonical Wnt-signaling pathway under the direct regulation of the general protein quality control machinery in the ER.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7emg80iB5gLVg90H21EOLACvtfcHk0liaHl1HXJHj5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXot1Ghtrs%253D&md5=221593fe9162fee07b700367633663e1</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1302933110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1302933110%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DStaron%26aufirst%3DM.%26aulast%3DHong%26aufirst%3DF.%26aulast%3DWu%26aufirst%3DB.%2BX.%26aulast%3DSun%26aufirst%3DS.%26aulast%3DMorales%26aufirst%3DC.%26aulast%3DCrosson%26aufirst%3DC.%2BE.%26aulast%3DTomlinson%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DI.%26aulast%3DWu%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DZ.%26atitle%3DEssential%2520roles%2520of%2520grp94%2520in%2520gut%2520homeostasis%2520via%2520chaperoning%2520canonical%2520Wnt%2520pathway%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D6877%26epage%3D6882%26doi%3D10.1073%2Fpnas.1302933110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hua, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwanowycz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westwater, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reizis, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span> <span> </span><span class="NLM_article-title">Gut homeostasis and regulatory T cell induction depend on molecular chaperone gp96 in CD11c+ cells</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">2171</span>, <span class="refDoi"> DOI: 10.1038/s41598-017-02415-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.1038%2Fs41598-017-02415-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=28526855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A280%3ADC%252BC1crpsFehtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=2171&author=Y.+Huaauthor=Y.+Yangauthor=S.+Sunauthor=S.+Iwanowyczauthor=C.+Westwaterauthor=B.+Reizisauthor=Z.+Liauthor=B.+Liu&title=Gut+homeostasis+and+regulatory+T+cell+induction+depend+on+molecular+chaperone+gp96+in+CD11c%2B+cells&doi=10.1038%2Fs41598-017-02415-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Gut homeostasis and regulatory T cell induction depend on molecular chaperone gp96 in CD11c(+) cells</span></div><div class="casAuthors">Hua Yunpeng; Yang Yi; Iwanowycz Stephen; Li Zihai; Liu Bei; Hua Yunpeng; Sun Shaoli; Westwater Caroline; Reizis Boris</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2171</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The intestinal immunity and tolerance are orchestrated by both the innate and the adaptive immune system.  Intestinal professional antigen presenting cells (pAPCs) recognize and respond to the gut microbiota through multiple pattern-recognition receptors, including TLRs and NLRs.  How gut pAPCs maintain mucosal homeostasis remains incompletely understood.  Heat shock protein gp96, also known as grp94, is an essential immune chaperone for TLRs.  However, the role of gp96 in regulating CD11c(+) APCs in the gut immunity and tolerance is unknown.  By a genetic strategy, we report here that selective deletion of gp96 from CD11c(+) cells in mice results in alteration of dendritic cell and T cell subsets in the gut as well as loss of antigen-specific regulatory T cell induction in the mesenteric lymph nodes.  Strikingly, these conditional gp96-null mice developed spontaneous colitis, had increased levels of systemic and fecal IgA, and were highly susceptible to chemical-induced colitis.  Our findings for the first time demonstrate that gp96 is essential for CD11c(+) cells to induce regulatory T cells and maintain gut homeostasis, illustrating the importance of protein immune chaperone in safeguarding against immune pathology.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT6YKB3A0KYQdbHMBt0mMIXfW6udTcc2eYv4ZsNss47ubntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1crpsFehtQ%253D%253D&md5=5af60a8e5e10da36da1c0fcbfcdd02ff</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1038%2Fs41598-017-02415-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-017-02415-7%26sid%3Dliteratum%253Aachs%26aulast%3DHua%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DS.%26aulast%3DIwanowycz%26aufirst%3DS.%26aulast%3DWestwater%26aufirst%3DC.%26aulast%3DReizis%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DB.%26atitle%3DGut%2520homeostasis%2520and%2520regulatory%2520T%2520cell%2520induction%2520depend%2520on%2520molecular%2520chaperone%2520gp96%2520in%2520CD11c%252B%2520cells%26jtitle%3DSci.%2520Rep.%26date%3D2017%26volume%3D7%26spage%3D2171%26doi%3D10.1038%2Fs41598-017-02415-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morales, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rachidi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouyang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallace, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garret-Mayer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span> <span> </span><span class="NLM_article-title">Immune chaperone gp96 drives the contributions of macrophages to inflammatory colon tumorigenesis</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">446</span>– <span class="NLM_lpage">459</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-13-1677</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.1158%2F0008-5472.CAN-13-1677" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2014&pages=446-459&author=C.+Moralesauthor=S.+Rachidiauthor=F.+Hongauthor=S.+Sunauthor=X.+Ouyangauthor=C.+Wallaceauthor=Y.+Zhangauthor=E.+Garret-Mayerauthor=J.+Wuauthor=B.+Liuauthor=Z.+Li&title=Immune+chaperone+gp96+drives+the+contributions+of+macrophages+to+inflammatory+colon+tumorigenesis&doi=10.1158%2F0008-5472.CAN-13-1677"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-13-1677&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-13-1677%26sid%3Dliteratum%253Aachs%26aulast%3DMorales%26aufirst%3DC.%26aulast%3DRachidi%26aufirst%3DS.%26aulast%3DHong%26aufirst%3DF.%26aulast%3DSun%26aufirst%3DS.%26aulast%3DOuyang%26aufirst%3DX.%26aulast%3DWallace%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DGarret-Mayer%26aufirst%3DE.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DZ.%26atitle%3DImmune%2520chaperone%2520gp96%2520drives%2520the%2520contributions%2520of%2520macrophages%2520to%2520inflammatory%2520colon%2520tumorigenesis%26jtitle%3DCancer%2520Res.%26date%3D2014%26volume%3D74%26spage%3D446%26epage%3D459%26doi%3D10.1158%2F0008-5472.CAN-13-1677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schreiter, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hausmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spoettl, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strauch, U. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bataille, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoelmerich, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herfarth, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falk, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogler, G.</span></span> <span> </span><span class="NLM_article-title">Glycoprotein (gp) 96 expression: induced during differentiation of intestinal macrophages but impaired in Crohn’s disease</span>. <i>Gut</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">935</span>– <span class="NLM_lpage">943</span>, <span class="refDoi"> DOI: 10.1136/gut.2004.053116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.1136%2Fgut.2004.053116" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2005&pages=935-943&author=K.+Schreiterauthor=M.+Hausmannauthor=T.+Spoettlauthor=U.+G.+Strauchauthor=F.+Batailleauthor=J.+Schoelmerichauthor=H.+Herfarthauthor=W.+Falkauthor=G.+Rogler&title=Glycoprotein+%28gp%29+96+expression%3A+induced+during+differentiation+of+intestinal+macrophages+but+impaired+in+Crohn%E2%80%99s+disease&doi=10.1136%2Fgut.2004.053116"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1136%2Fgut.2004.053116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fgut.2004.053116%26sid%3Dliteratum%253Aachs%26aulast%3DSchreiter%26aufirst%3DK.%26aulast%3DHausmann%26aufirst%3DM.%26aulast%3DSpoettl%26aufirst%3DT.%26aulast%3DStrauch%26aufirst%3DU.%2BG.%26aulast%3DBataille%26aufirst%3DF.%26aulast%3DSchoelmerich%26aufirst%3DJ.%26aulast%3DHerfarth%26aufirst%3DH.%26aulast%3DFalk%26aufirst%3DW.%26aulast%3DRogler%26aufirst%3DG.%26atitle%3DGlycoprotein%2520%2528gp%2529%252096%2520expression%253A%2520induced%2520during%2520differentiation%2520of%2520intestinal%2520macrophages%2520but%2520impaired%2520in%2520Crohn%25E2%2580%2599s%2520disease%26jtitle%3DGut%26date%3D2005%26volume%3D54%26spage%3D935%26epage%3D943%26doi%3D10.1136%2Fgut.2004.053116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hausmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiessling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mestermann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webb, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spottl, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andus, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scholmerich, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herfarth, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falk, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogler, G.</span></span> <span> </span><span class="NLM_article-title">Toll-like receptors 2 and 4 are up-regulated during intestinal inflammation</span>. <i>Gastroenterology</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>122</i></span>,  <span class="NLM_fpage">1987</span>– <span class="NLM_lpage">2000</span>, <span class="refDoi"> DOI: 10.1053/gast.2002.33662</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.1053%2Fgast.2002.33662" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2002&pages=1987-2000&author=M.+Hausmannauthor=S.+Kiesslingauthor=S.+Mestermannauthor=G.+Webbauthor=T.+Spottlauthor=T.+Andusauthor=J.+Scholmerichauthor=H.+Herfarthauthor=K.+Rayauthor=W.+Falkauthor=G.+Rogler&title=Toll-like+receptors+2+and+4+are+up-regulated+during+intestinal+inflammation&doi=10.1053%2Fgast.2002.33662"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1053%2Fgast.2002.33662&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fgast.2002.33662%26sid%3Dliteratum%253Aachs%26aulast%3DHausmann%26aufirst%3DM.%26aulast%3DKiessling%26aufirst%3DS.%26aulast%3DMestermann%26aufirst%3DS.%26aulast%3DWebb%26aufirst%3DG.%26aulast%3DSpottl%26aufirst%3DT.%26aulast%3DAndus%26aufirst%3DT.%26aulast%3DScholmerich%26aufirst%3DJ.%26aulast%3DHerfarth%26aufirst%3DH.%26aulast%3DRay%26aufirst%3DK.%26aulast%3DFalk%26aufirst%3DW.%26aulast%3DRogler%26aufirst%3DG.%26atitle%3DToll-like%2520receptors%25202%2520and%25204%2520are%2520up-regulated%2520during%2520intestinal%2520inflammation%26jtitle%3DGastroenterology%26date%3D2002%26volume%3D122%26spage%3D1987%26epage%3D2000%26doi%3D10.1053%2Fgast.2002.33662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span> <span> </span><span class="NLM_article-title">Expression of Toll-like receptors in the mucosa of patients with ulcerative colitis</span>. <i>Exp. Ther. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1455</span>– <span class="NLM_lpage">1459</span>, <span class="refDoi"> DOI: 10.3892/etm.2015.2258</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.3892%2Fetm.2015.2258" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=25780451" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnvValsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2015&pages=1455-1459&author=Y.+Fanauthor=B.+Liu&title=Expression+of+Toll-like+receptors+in+the+mucosa+of+patients+with+ulcerative+colitis&doi=10.3892%2Fetm.2015.2258"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of Toll-like receptors in the mucosa of patients with ulcerative colitis</span></div><div class="casAuthors">Fan, Yujing; Liu, Bingrong</div><div class="citationInfo"><span class="NLM_cas:title">Experimental and Therapeutic Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1455-1459</span>CODEN:
                <span class="NLM_cas:coden">ETMXA2</span>;
        ISSN:<span class="NLM_cas:issn">1792-0981</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">Patients with ulcerative colitis (UC) have a high risk of developing colorectal cancer.  The aim of the present study was to evaluate the expression pattern of Toll-like receptors (TLRs) in the colonic mucosa of patients with UC.  Colonic mucosal biopsy specimens were collected during colonoscopy from 30 patients with UC and 30 patients with normal findings as controls.  The protein and mRNA expression levels of TLRs 1-4 and TLR9 were measured by immunohistochem. and reverse transcription-quant. polymerase chain reaction anal., resp.  The results showed that the mRNA and protein expression of TLR2, TLR4 and TLR9, but not TLR1 and TLR3, was significantly increased in the colonic mucosa of patients with UC compared with that in the normal controls.  TLR (TLR2, TLR4 and TLR9) immunoreactivity was found in the cytoplasm of epithelial cells in the mucosa, and occasionally in the endothelium of small vessels of the stromal tissues.  In conclusion, TLR2, TLR4 and TLR9 expression may be important in the biol. pathogenesis of UC.  TLR alterations in the innate response system may contribute to the pathogenesis of UC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFQxXqpNl3bbVg90H21EOLACvtfcHk0ljI4CzNm5zzOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnvValsL8%253D&md5=df8e09126d636769f10f1f7ea6f7c4f0</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.3892%2Fetm.2015.2258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fetm.2015.2258%26sid%3Dliteratum%253Aachs%26aulast%3DFan%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DB.%26atitle%3DExpression%2520of%2520Toll-like%2520receptors%2520in%2520the%2520mucosa%2520of%2520patients%2520with%2520ulcerative%2520colitis%26jtitle%3DExp.%2520Ther.%2520Med.%26date%3D2015%26volume%3D9%26spage%3D1455%26epage%3D1459%26doi%3D10.3892%2Fetm.2015.2258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veal, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fadden, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rice, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eaves, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strachan, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barabasz, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foley, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barta, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silinski, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Partridge, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DuBois, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freed, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steed, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ommen, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodward, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCall, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markworth, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinkley, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenks, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otto, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pronk, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verleysen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, S. E.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel 2-aminobenzamide inhibitors of heat shock protein 90 as potent, selective and orally active antitumor agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">4288</span>– <span class="NLM_lpage">4305</span>, <span class="refDoi"> DOI: 10.1021/jm900230j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900230j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BD1MXns1Onsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4288-4305&author=K.+H.+Huangauthor=J.+M.+Vealauthor=R.+P.+Faddenauthor=J.+W.+Riceauthor=J.+Eavesauthor=J.+P.+Strachanauthor=A.+F.+Barabaszauthor=B.+E.+Foleyauthor=T.+E.+Bartaauthor=W.+Maauthor=M.+A.+Silinskiauthor=M.+Huauthor=J.+M.+Partridgeauthor=A.+Scottauthor=L.+G.+DuBoisauthor=T.+Freedauthor=P.+M.+Steedauthor=A.+J.+Ommenauthor=E.+D.+Smithauthor=P.+F.+Hughesauthor=A.+R.+Woodwardauthor=G.+J.+Hansonauthor=W.+S.+McCallauthor=C.+J.+Markworthauthor=L.+Hinkleyauthor=M.+Jenksauthor=L.+Gengauthor=M.+Lewisauthor=J.+Ottoauthor=B.+Pronkauthor=K.+Verleysenauthor=S.+E.+Hall&title=Discovery+of+novel+2-aminobenzamide+inhibitors+of+heat+shock+protein+90+as+potent%2C+selective+and+orally+active+antitumor+agents&doi=10.1021%2Fjm900230j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Novel 2-Aminobenzamide Inhibitors of Heat Shock Protein 90 as Potent, Selective and Orally Active Antitumor Agents</span></div><div class="casAuthors">Huang, Kenneth H.; Veal, James M.; Fadden, R. Patrick; Rice, John W.; Eaves, Jeron; Strachan, Jon-Paul; Barabasz, Amy F.; Foley, Briana E.; Barta, Thomas E.; Ma, Wei; Silinski, Melanie A.; Hu, Mei; Partridge, Jeffrey M.; Scott, Anisa; DuBois, Laura G.; Freed, Tiffany; Steed, Paul M.; Ommen, Andy J.; Smith, Emilie D.; Hughes, Philip F.; Woodward, Angela R.; Hanson, Gunnar J.; McCall, W. Stephen; Markworth, Christopher J.; Hinkley, Lindsay; Jenks, Matthew; Geng, Lifeng; Lewis, Meredith; Otto, James; Pronk, Bert; Verleysen, Katleen; Hall, Steven E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4288-4305</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel class of heat shock protein 90 (Hsp90) inhibitors was developed from an unbiased screen to identify protein targets for a diverse compd. library.  These indol-4-one and indazol-4-one derived 2-aminobenzamides showed strong binding affinity to Hsp90, and optimized analogs exhibited nanomolar antiproliferative activity across multiple cancer cell lines.  Heat shock protein 70 (Hsp70) induction and specific client protein degrdn. in cells on treatment with the inhibitors supported Hsp90 inhibition as the mechanism of action.  Computational chem. and X-ray crystallog. anal. of selected member compds. clearly defined the protein-inhibitor interaction and assisted the design of analogs. 4-[6,6-Dimethyl-4-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl]-2-[(trans-4-hydroxycyclohexyl)amino]benzamide (SNX-2112) (I) was identified as highly selective and potent (IC50 Her2 = 11 nM, HT-29 = 3 nM); its prodrug amino-acetic acid 4-[2-carbamoyl-5-(6,6-dimethyl-4-oxo-3-trifluoromethyl-4,5,6,7-tetrahydro-indazol-1-yl)-phenylamino]-cyclohexyl ester methanesulfonate (SNX-5422) (II)was orally bioavailable and efficacious in a broad range of xenograft tumor models (e.g. 67% growth delay in a HT-29 model) and is now in multiple phase I clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFjrhELWrFkbVg90H21EOLACvtfcHk0ljI4CzNm5zzOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXns1Onsrk%253D&md5=99e5039e1761e9099d634acd79a15a6a</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm900230j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900230j%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DK.%2BH.%26aulast%3DVeal%26aufirst%3DJ.%2BM.%26aulast%3DFadden%26aufirst%3DR.%2BP.%26aulast%3DRice%26aufirst%3DJ.%2BW.%26aulast%3DEaves%26aufirst%3DJ.%26aulast%3DStrachan%26aufirst%3DJ.%2BP.%26aulast%3DBarabasz%26aufirst%3DA.%2BF.%26aulast%3DFoley%26aufirst%3DB.%2BE.%26aulast%3DBarta%26aufirst%3DT.%2BE.%26aulast%3DMa%26aufirst%3DW.%26aulast%3DSilinski%26aufirst%3DM.%2BA.%26aulast%3DHu%26aufirst%3DM.%26aulast%3DPartridge%26aufirst%3DJ.%2BM.%26aulast%3DScott%26aufirst%3DA.%26aulast%3DDuBois%26aufirst%3DL.%2BG.%26aulast%3DFreed%26aufirst%3DT.%26aulast%3DSteed%26aufirst%3DP.%2BM.%26aulast%3DOmmen%26aufirst%3DA.%2BJ.%26aulast%3DSmith%26aufirst%3DE.%2BD.%26aulast%3DHughes%26aufirst%3DP.%2BF.%26aulast%3DWoodward%26aufirst%3DA.%2BR.%26aulast%3DHanson%26aufirst%3DG.%2BJ.%26aulast%3DMcCall%26aufirst%3DW.%2BS.%26aulast%3DMarkworth%26aufirst%3DC.%2BJ.%26aulast%3DHinkley%26aufirst%3DL.%26aulast%3DJenks%26aufirst%3DM.%26aulast%3DGeng%26aufirst%3DL.%26aulast%3DLewis%26aufirst%3DM.%26aulast%3DOtto%26aufirst%3DJ.%26aulast%3DPronk%26aufirst%3DB.%26aulast%3DVerleysen%26aufirst%3DK.%26aulast%3DHall%26aufirst%3DS.%2BE.%26atitle%3DDiscovery%2520of%2520novel%25202-aminobenzamide%2520inhibitors%2520of%2520heat%2520shock%2520protein%252090%2520as%2520potent%252C%2520selective%2520and%2520orally%2520active%2520antitumor%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4288%26epage%3D4305%26doi%3D10.1021%2Fjm900230j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Larrosa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tome-Carneiro, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yanez-Gascon, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alcantara, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selma, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beltran, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Conesa, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urban, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucas, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomas-Barberan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morales, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espin, J. C.</span></span> <span> </span><span class="NLM_article-title">Preventive oral treatment with resveratrol pro-prodrugs drastically reduce colon inflammation in rodents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">7365</span>– <span class="NLM_lpage">7376</span>, <span class="refDoi"> DOI: 10.1021/jm1007006</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1007006" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=7365-7376&author=M.+Larrosaauthor=J.+Tome-Carneiroauthor=M.+J.+Yanez-Gasconauthor=D.+Alcantaraauthor=M.+V.+Selmaauthor=D.+Beltranauthor=M.+T.+Garcia-Conesaauthor=C.+Urbanauthor=R.+Lucasauthor=F.+Tomas-Barberanauthor=J.+C.+Moralesauthor=J.+C.+Espin&title=Preventive+oral+treatment+with+resveratrol+pro-prodrugs+drastically+reduce+colon+inflammation+in+rodents&doi=10.1021%2Fjm1007006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjm1007006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1007006%26sid%3Dliteratum%253Aachs%26aulast%3DLarrosa%26aufirst%3DM.%26aulast%3DTome-Carneiro%26aufirst%3DJ.%26aulast%3DYanez-Gascon%26aufirst%3DM.%2BJ.%26aulast%3DAlcantara%26aufirst%3DD.%26aulast%3DSelma%26aufirst%3DM.%2BV.%26aulast%3DBeltran%26aufirst%3DD.%26aulast%3DGarcia-Conesa%26aufirst%3DM.%2BT.%26aulast%3DUrban%26aufirst%3DC.%26aulast%3DLucas%26aufirst%3DR.%26aulast%3DTomas-Barberan%26aufirst%3DF.%26aulast%3DMorales%26aufirst%3DJ.%2BC.%26aulast%3DEspin%26aufirst%3DJ.%2BC.%26atitle%3DPreventive%2520oral%2520treatment%2520with%2520resveratrol%2520pro-prodrugs%2520drastically%2520reduce%2520colon%2520inflammation%2520in%2520rodents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D7365%26epage%3D7376%26doi%3D10.1021%2Fjm1007006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span> <span> </span><span class="NLM_article-title">Cathelicidin-BF, a novel antimicrobial peptide from bungarus fasciatus, attenuates disease in a dextran sulfate sodium model of colitis</span>. <i>Mol. Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1648</span>– <span class="NLM_lpage">1661</span>, <span class="refDoi"> DOI: 10.1021/acs.molpharmaceut.5b00069</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.molpharmaceut.5b00069" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BC2MXltFSms74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=1648-1661&author=H.+Zhangauthor=X.+Xiaauthor=F.+Hanauthor=Q.+Jiangauthor=Y.+Rongauthor=D.+Songauthor=Y.+Wang&title=Cathelicidin-BF%2C+a+novel+antimicrobial+peptide+from+bungarus+fasciatus%2C+attenuates+disease+in+a+dextran+sulfate+sodium+model+of+colitis&doi=10.1021%2Facs.molpharmaceut.5b00069"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Cathelicidin-BF, a novel antimicrobial peptide from Bungarus fasciatus, attenuates disease in a dextran sulfate sodium model of colitis</span></div><div class="casAuthors">Zhang, Haiwen; Xia, Xi; Han, Feifei; Jiang, Qin; Rong, Yili; Song, Deguang; Wang, Yizhen</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1648-1661</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Antimicrobial peptides are mols. of innate immunity.  Cathelicidin-BF is the first cathelicidin peptide found in reptiles.  However, the immunoregulatory and epithelial barrier protective properties of C-BF have not been reported.  Inflammatory bowel diseases, including ulcerative colitis and Crohn's disease, can lead to colon cancer, the third most common malignant tumor.  The objective is to develop the new found cathelicidin-BF as a therapeutic to patients of ulcerative colitis.  The morphol. of the colon epithelium was obsd. by H&E staining; apoptosis index and infiltration of inflammatory cells in colonic epithelium were measured by TUNEL and immunohistochem.; the expression level of endogenous mCRAMP was analyzed by immunofluorescence; and phosphorylation of the transcription factors c-jun and NF-κB in colon were analyzed by Western blot.  Our results showed that the morphol. of the colon epithelium in the C-BF+DSS group was improved compared with the DSS group.  Apoptosis and infiltration of inflammatory cells in colonic epithelium were also significantly attenuated in the C-BF+DSS group compared with the DSS group, and the expression level of endogenous mCRAMP in the DSS group was significantly higher than other groups.  DSS-induced phosphorylation level of c-jun and NF-κB while C-BF effectively inhibited phosphorylation of NF-κB (p65).  The barrier protective effect of C-BF was still excellent.  In conclusion, C-BF effectively attenuated inflammation and improved disrupted barrier function.  Notably, this is the first report to demonstrate that C-BF attenuates DSS-induced UC both through the regulation of intestinal immune and retention of barrier function, and the exact pathway was through NF-κB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruWkK6y3u4sbVg90H21EOLACvtfcHk0lgDpi7TZ6KBRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXltFSms74%253D&md5=2a6bf9718f3072d3b629287027634844</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Facs.molpharmaceut.5b00069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.molpharmaceut.5b00069%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DXia%26aufirst%3DX.%26aulast%3DHan%26aufirst%3DF.%26aulast%3DJiang%26aufirst%3DQ.%26aulast%3DRong%26aufirst%3DY.%26aulast%3DSong%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DY.%26atitle%3DCathelicidin-BF%252C%2520a%2520novel%2520antimicrobial%2520peptide%2520from%2520bungarus%2520fasciatus%252C%2520attenuates%2520disease%2520in%2520a%2520dextran%2520sulfate%2520sodium%2520model%2520of%2520colitis%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2015%26volume%3D12%26spage%3D1648%26epage%3D1661%26doi%3D10.1021%2Facs.molpharmaceut.5b00069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, B. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gan, H. T.</span></span> <span> </span><span class="NLM_article-title">PI3K/Akt signaling pathway is involved in the pathogenesis of ulcerative colitis</span>. <i>Inflammation Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">727</span>– <span class="NLM_lpage">734</span>, <span class="refDoi"> DOI: 10.1007/s00011-011-0325-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.1007%2Fs00011-011-0325-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=21442372" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotFClsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2011&pages=727-734&author=X.+L.+Huangauthor=J.+Xuauthor=X.+H.+Zhangauthor=B.+Y.+Qiuauthor=L.+Pengauthor=M.+Zhangauthor=H.+T.+Gan&title=PI3K%2FAkt+signaling+pathway+is+involved+in+the+pathogenesis+of+ulcerative+colitis&doi=10.1007%2Fs00011-011-0325-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">PI3K/Akt signaling pathway is involved in the pathogenesis of ulcerative colitis</span></div><div class="casAuthors">Huang, Xiao Li; Xu, Jin; Zhang, Xiao Hui; Qiu, Bo Yun; Peng, Lan; Zhang, Meng; Gan, Hua Tian</div><div class="citationInfo"><span class="NLM_cas:title">Inflammation Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">727-734</span>CODEN:
                <span class="NLM_cas:coden">INREFB</span>;
        ISSN:<span class="NLM_cas:issn">1023-3830</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Basel</span>)
        </div><div class="casAbstract">The purpose of this study was to investigate the role of the PI3K/Akt signaling pathway in the pathogenesis of ulcerative colitis (UC).  Mucosal biopsy specimens from 54 active UC cases and adjacent normal tissues from 18 colon cancer cases were investigated.  Twenty-eight Balb/c mice were randomly divided into 4 groups.  Dextran sulfate sodium (DSS) soln. (5%) was used to develop the mouse colitis model.  After treatment with wortmannin (a PI3K inhibitor), disease activity index (DAI) and histol. score was detd. for each group of mice.  Expression of phosphorylated Akt (p-Akt) in UC patients and mouse intestinal mucosa was detd. by immunohistochem. staining.  The authors also detd. the effect of wortmannin on tumor necrosis factor-α (TNF-α) expression in intestinal biopsy tissues of UC patients and mice with DSS-induced colitis.  Wortmannin significantly reduced the level of p-Akt and TNF-α in the colitis tissues of UC patients and DSS-treated mice.  Wortmannin significantly alleviated the inflammation of colitis as assessed by DAI and histol. score in DSS-treated mice.  The PI3K/Akt signal transduction pathway is involved in the regulation and release of pro-inflammatory cytokines such as TNF-α and plays an important role in the development and progression of UC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6MaR3fUqW_bVg90H21EOLACvtfcHk0lgDpi7TZ6KBRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotFClsLs%253D&md5=82007486848ee52dd95b9f076852a74c</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1007%2Fs00011-011-0325-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00011-011-0325-6%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DX.%2BL.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DX.%2BH.%26aulast%3DQiu%26aufirst%3DB.%2BY.%26aulast%3DPeng%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DGan%26aufirst%3DH.%2BT.%26atitle%3DPI3K%252FAkt%2520signaling%2520pathway%2520is%2520involved%2520in%2520the%2520pathogenesis%2520of%2520ulcerative%2520colitis%26jtitle%3DInflammation%2520Res.%26date%3D2011%26volume%3D60%26spage%3D727%26epage%3D734%26doi%3D10.1007%2Fs00011-011-0325-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Setia, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nehru, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanyal, S. N.</span></span> <span> </span><span class="NLM_article-title">Upregulation of MAPK/Erk and PI3K/Akt pathways in ulcerative colitis-associated colon cancer</span>. <i>Biomed. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">1023</span>– <span class="NLM_lpage">1029</span>, <span class="refDoi"> DOI: 10.1016/j.biopha.2014.09.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=10.1016%2Fj.biopha.2014.09.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=25443414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1WitbjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2014&pages=1023-1029&author=S.+Setiaauthor=B.+Nehruauthor=S.+N.+Sanyal&title=Upregulation+of+MAPK%2FErk+and+PI3K%2FAkt+pathways+in+ulcerative+colitis-associated+colon+cancer&doi=10.1016%2Fj.biopha.2014.09.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Upregulation of MAPK/Erk and PI3K/Akt pathways in ulcerative colitis-associated colon cancer</span></div><div class="casAuthors">Setia, Shruti; Nehru, Bimla; Sanyal, Sankar Nath</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine & Pharmacotherapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1023-1029</span>CODEN:
                <span class="NLM_cas:coden">BIPHEX</span>;
        ISSN:<span class="NLM_cas:issn">0753-3322</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">An extracellular signal like a cytokine or chemokine, secreted in the inflammatory microenvironment can activate the mitogen activated protein kinase (MAPK) pathway by binding to a cytokine receptor tyrosine kinase, which further activates tyrosine kinases such as Janus Kinase-3 (Jak-3).  This signal is transferred from Jak-3 to the DNA in the nucleus of the cell by a chain of kinases, ultimately activating extracellular receptor kinase (Erk/MAPK).  The latter phosphorylates c-myc, an oncogene, which alters the levels and activities of many transcription factors leading to cell survival, proliferation and invasion.  The oncogenic PI3K pathway plays a similar role by activating c-myc, leading to cell survival and proliferation.  The present study explores the role of ulcerative colitis in colon cancer by investigating the activities of tyrosine kinase activated MAPK pathway and various components of the PI3K pathway including PI3K, PTEN, PDK1, GSK3β, Akt, mTOR, Wnt and β-catenin.  This was done by western blot and fluorescent immunohistochem. anal. of the above-mentioned proteins.  Also, the morphol. and histol. investigation of the colonic samples from various animal groups revealed significant alterations as compared to the control in both inflammatory as well as carcinogenic conditions.  These effects were reduced to a large extent by the co-administration of celecoxib, a second-generation non-steroidal anti-inflammatory drug (NSAID).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoULXkCB2i94rVg90H21EOLACvtfcHk0liAdmIgW2doaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1WitbjO&md5=04b413fe62457c940100c2ddcc7504ab</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.biopha.2014.09.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopha.2014.09.006%26sid%3Dliteratum%253Aachs%26aulast%3DSetia%26aufirst%3DS.%26aulast%3DNehru%26aufirst%3DB.%26aulast%3DSanyal%26aufirst%3DS.%2BN.%26atitle%3DUpregulation%2520of%2520MAPK%252FErk%2520and%2520PI3K%252FAkt%2520pathways%2520in%2520ulcerative%2520colitis-associated%2520colon%2520cancer%26jtitle%3DBiomed.%2520Pharmacother.%26date%3D2014%26volume%3D68%26spage%3D1023%26epage%3D1029%26doi%3D10.1016%2Fj.biopha.2014.09.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z. Y.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and initial evaluation of affinity-based small-molecule probes for fluorescent visualization and specific detection of keap1</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">7305</span>– <span class="NLM_lpage">7310</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00775</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00775" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=7305-7310&author=M.+C.+Luauthor=H.+S.+Zhouauthor=Q.+D.+Youauthor=Z.+Y.+Jiang&title=Design%2C+synthesis%2C+and+initial+evaluation+of+affinity-based+small-molecule+probes+for+fluorescent+visualization+and+specific+detection+of+keap1&doi=10.1021%2Facs.jmedchem.6b00775"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00775&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00775%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DM.%2BC.%26aulast%3DZhou%26aufirst%3DH.%2BS.%26aulast%3DYou%26aufirst%3DQ.%2BD.%26aulast%3DJiang%26aufirst%3DZ.%2BY.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520initial%2520evaluation%2520of%2520affinity-based%2520small-molecule%2520probes%2520for%2520fluorescent%2520visualization%2520and%2520specific%2520detection%2520of%2520keap1%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D7305%26epage%3D7310%26doi%3D10.1021%2Facs.jmedchem.6b00775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3O0I" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3O0I','PDB','3O0I'); return false;">PDB: 3O0I</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3O2F" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3O2F','PDB','3O2F'); return false;">PDB: 3O2F</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1YT2" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1YT2','PDB','1YT2'); return false;">PDB: 1YT2</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4NH9" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4NH9','PDB','4NH9'); return false;">PDB: 4NH9</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i108"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00800">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_52734"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b00800">10.1021/acs.jmedchem.8b00800</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Detailed scoring criteria for DAI (Table S1); representative images to show the general status of the UC mice at day 7 (Figure S1); <sup>1</sup>H, <sup>13</sup>C NMR, and HRMS (ESI) spectra of compounds <b>42</b>–<b>86</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00800/suppl_file/jm8b00800_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Coordinates information for structure representation (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00800/suppl_file/jm8b00800_si_002.pdb">PDB</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00800/suppl_file/jm8b00800_si_003.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00800/suppl_file/jm8b00800_si_001.pdf">jm8b00800_si_001.pdf (6.65 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00800/suppl_file/jm8b00800_si_002.pdb">jm8b00800_si_002.pdb (142.88 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00800/suppl_file/jm8b00800_si_003.csv">jm8b00800_si_003.csv (3.27 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b00800&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-21%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b00800%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b00800" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                12MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679970dfff753d12","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
